SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

 

SCHEDULE 13E-3

 

RULE 13E-3 TRANSACTION STATEMENT

UNDER SECTION 13(E) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

 

 

RealD Inc.

(Name of the Issuer)

 

 

 

 

 

RealD Inc.

 

Rhombus Cinema Holdings, LLC
RT Rhombus Holdings, Inc.
Rhombus Merger Sub, Inc.
Rizvi Opportunistic Equity Fund III, L.P.
Rizvi Traverse GP III, LLC

 

Mr. Michael V. Lewis
The MVL Trust, dated as of August 3, 2010

 

 

 

(Names of Person(s) Filing Statement)

 

Common Stock, par value $0.0001 per share
(Title of Class of Securities)

 

75604L105
(CUSIP Number of Class of Securities)

 

 

 

 

 

 

 

 

RealD Inc.
100 North Crescent Drive, Suite 200
Beverly Hills, California 90210
Facsimile:  (310) 388-1539
Attn:  Vivian W. Yang

 

Rizvi Traverse Management, LLC
260 East Brown Street, Suite 380
Birmingham, Michigan 48009
Facsimile:  (917) 591-7400
Attn:  Audrey DiMarzo

 

Michael V. Lewis, c/o RealD Inc.
100 North Crescent Drive, Suite 200
Beverly Hills, California 90210
Facsimile:  (310) 388-1539
 Attn:  Michael V. Lewis

 

(Name, Address, and Telephone Numbers of Person Authorized to Receive Notices
and Communications on Behalf of the Persons Filing Statement)

 

With copies to

 

Wachtell, Lipton, Rosen & Katz
52 West 52nd Street
New York, New York 10019
Facsimile:  (212) 403-2314
Attn:  David Shapiro, Esq.

 

Latham & Watkins LLP
355 South Grand Avenue
Los Angeles, California, 90071
Facsimile:  (213) 891-8763
Attn:  Jason Silvera, Esq.

 

Freshfields Bruckhaus Deringer US LLP
601 Lexington Avenue, 31st Floor
New York, New York 10022
Facsimile:  (212) 277-4037
Attn:  Matthew F. Herman, Esq.

 

 

 

 

 

 

This statement is filed in connection with (check the appropriate box):

a.       x              The filing of solicitation materials or an information statement subject to Regulation 14A, Regulation 14C or Rule 13e-3(c) under the Securities Exchange Act of 1934.

b.      o                The filing of a registration statement under the Securities Act of 1933.

c.       o                A tender offer.

d.      o                None of the above.

 

Check the following box if the soliciting materials or information statement referred to in checking box (a) are preliminary copies:  x

 

Check the following box if the filing is a final amendment reporting the results of the transaction:  o

 

Calculation of Filing Fee

 

Transaction valuation*

$531,764,930

Amount of filing fee

$53,549

 

*               Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11:

 

In accordance with Exchange Act Rule 0-11(c), the filing fee of $53,549 was determined by multiplying 0.0001007 by the aggregate merger consideration of $531,764,930. The aggregate merger consideration was calculated by multiplying the 45,818,252 outstanding shares of common stock, the 1,374,682 shares of common stock subject to restricted stock units and the 601,044 shares of performance-based stock to be acquired pursuant to the merger by the per share merger consideration of $11.00, and adding the foregoing sum to (i) $27,200 (the amount of stock-based compensation that may be issued prior to the closing of the merger) and (ii) the product obtained by multiplying 1,792,782, representing the number of outstanding employee stock options, by $3.35, representing the per share merger consideration of $11.00 less the $7.65 weighted average exercise price of the outstanding employee stock options.

 

x    Check the box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule, and the date of its filing.

 

Amount Previously Paid:

$53,549

Filing Party:

RealD Inc.

Form or Registration No.:

Schedule 14A

Date Filed:

November 25, 2015

 

 



 

Introduction

 

This Rule 13E-3 Transaction Statement, together with the exhibits hereto (this “Transaction Statement”), is being filed with the Securities and Exchange Commission (the “SEC”) pursuant to Section 13(e) of the Securities Exchange Act of 1934, as amended (together with the rules and regulations promulgated thereunder, the “Exchange Act”), jointly by (i) RealD Inc., a Delaware corporation (the “Company”), (ii) Rhombus Cinema Holdings, LLC, a Delaware limited liability company (“Purchaser”), (iii) RT Rhombus Holdings, Inc., a Delaware corporation and a direct wholly owned subsidiary of Purchaser (“RT Rhombus”), (iv) Rhombus Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of RT Rhombus (“Merger Sub”), (v) Rizvi Opportunistic Equity Fund III, L.P., a Delaware limited partnership, (vi) Rizvi Traverse GP III, LLC, a Delaware limited liability company, (vii) Michael V. Lewis, an individual and the chairman and chief executive officer of the Company, and (viii) the MVL Trust, dated as of August 3, 2010 (each a “Filing Person” and collectively, the “Filing Persons”).

 

This Transaction Statement relates to the Agreement and Plan of Merger, dated as of November 8, 2015 (as it may be amended from time to time, the “Merger Agreement”), by and among the Company, Purchaser and Merger Sub.  Pursuant to the Merger Agreement, if the conditions to the closing of the merger are either satisfied or waived, Merger Sub will be merged with and into the Company, the separate corporate existence of Merger Sub will cease and the Company will continue its corporate existence under Delaware law as the surviving corporation in the merger, as an indirect wholly owned subsidiary of Purchaser.  Upon completion of the merger, each share of the Company’s common stock, par value $.0001 per share (“Common Stock”), other than shares owned by the Company, Purchaser, Merger Sub, Michael V. Lewis, the MVL Trust, dated August 3, 2010, and holders who have properly demanded and not withdrawn a demand for appraisal rights, will be converted into the right to receive $11.00 per share in cash, without interest and less any required withholding taxes.  Following the completion of the merger, the Common Stock will no longer be publicly traded, and holders of the Common Stock that has been converted will cease to have any ownership interest in the Company.

 

Concurrently with the filing of this Transaction Statement, the Company is filing with the SEC a preliminary proxy statement (the “Proxy Statement”) under Regulation 14A of the Exchange Act, pursuant to which the Company’s board of directors is soliciting proxies from stockholders of the Company in connection with the merger.  The Proxy Statement is attached hereto as Exhibit (a)(1).  A copy of the Merger Agreement is attached to the Proxy Statement as Annex A and is incorporated herein by reference.  As of the date hereof, the Proxy Statement is in preliminary form, and is subject to completion or amendment.

 

Pursuant to General Instruction F to Schedule 13E-3, the information in the Proxy Statement, including all annexes, exhibits and appendices thereto, is expressly incorporated by reference herein in its entirety, and responses to each item herein are qualified in their entirety by the information contained in the Proxy Statement.  The cross-references below are being supplied pursuant to General Instruction G to Schedule 13E-3 and show the location in the Proxy Statement of the information required to be included in response to the items of Schedule 13E-3.

 

All information contained in, or incorporated by reference into, this Transaction Statement concerning each Filing Person was supplied by such Filing Person.

 

2



 

Item 1.                         Summary Term Sheet

 

Regulation M-A Item 1001

 

The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Summary Term Sheet”

 

“Questions and Answers About the Special Meeting and the Merger”

 

Item 2.                         Subject Company Information

 

Regulation M-A Item 1002

 

(a)                               Name and address.  The Company’s name, and the address and telephone number of its principal executive offices are as follows:

 

RealD Inc.
100 North Crescent Drive, Suite 200
Beverly Hills, California 90210
(310) 385-4000

 

(b)                              Securities.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Questions and Answers About the Special Meeting and the Merger”

 

“The Special Meeting—Record Date and Quorum”

 

“The Special Meeting—Required Vote for the Merger”

 

“Important Information Regarding RealD—Security Ownership of Certain Beneficial Owners and Management”

 

(c)                               Trading market and price.  The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:

 

“Important Information Regarding RealD—Market Price of the Company’s Common Stock”

 

(d)                             Dividends.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“The Merger Agreement—Conduct of Business Pending the Merger”

 

“Important Information Regarding RealD—Market Price of the Company’s Common Stock”

 

3



 

(e)                               Prior public offerings.  The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:

 

“Important Information Regarding RealD—Prior Public Offerings”

 

(f)                                Prior stock purchases.  The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:

 

“Important Information Regarding RealD—Transactions in Common Stock”

 

Item 3.                         Identity and Background of Filing Person

 

Regulation M-A Item 1003

 

(a)- (c) The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“The Parties to the Merger”

 

“Important Information Regarding RealD”

 

“Important Information Regarding Purchaser, RT Rhombus, Merger Sub and the Rizvi Filing Persons”

 

“Important Information Regarding the Rollover Investors”

 

Item 4.                         Terms of the Transaction

 

Regulation M-A Item 1004

 

(a)                               Material terms.

 

(1) Not applicable.

 

(2)(i) The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Summary Term Sheet”

 

“Questions and Answers About the Special Meeting and the Merger”

 

(2)(ii) The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Summary Term Sheet”

 

“Questions and Answers About the Special Meeting and the Merger”

 

“Special Factors—Purposes and Reasons of the Company for the Merger”

 

4



 

“Special Factors—Certain Effects of the Merger”

 

“Special Factors—Interests of the Company’s Directors and Executive Officers in the Merger”

 

“The Merger Agreement—Effect of the Merger on Common Stock”

 

“The Merger Agreement—Treatment of Company Equity Awards”

 

“The Merger Agreement—Payment with respect to Common Stock and Equity Awards in the Merger”

 

(2)(iii) The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Special Factors—Background of the Merger”

 

“Special Factors—Reasons for the Merger; Recommendation of the Board of Directors; Fairness of the Merger”

 

“Special Factors—Purposes and Reasons of the Company for the Merger”

 

“Special Factors—Purposes and Reasons of the Rizvi Filing Persons, Purchaser, RT Rhombus, Merger Sub and Rollover Investors for the Merger”

 

(2)(iv) The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Questions and Answers About the Special Meeting and the Merger”

 

“The Special Meeting—Required Vote for the Merger”

 

“The Merger Agreement—Conditions to the Merger”

 

(2)(v) The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Questions and Answers About the Special Meeting and the Merger”

 

“Special Factors—Certain Effects of the Merger”

 

“Special Factors—Interests of the Company’s Directors and Executive Officers in the Merger”

 

“The Merger Agreement—Effect of the Merger on Common Stock”

 

“Agreements Involving Common Stock”

 

5



 

(2)(vi) The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:

 

“Special Factors—Anticipated Accounting Treatment of the Merger”

 

(2)(vii) The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Questions and Answers About the Special Meeting and the Merger”

 

“Special Factors—Certain Effects of the Merger”

 

“Special Factors—Material U.S. Federal Income Tax Consequences of the Merger”

 

(c)                               Different terms.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Special Factors—Certain Effects of the Merger”

 

“Special Factors—Interests of the Company’s Directors and Executive Officers in the Merger”

 

“The Merger Agreement—Effect of the Merger on Common Stock”

 

“Agreements Involving Common Stock”

 

(d)                             Appraisal rights.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“The Merger Agreement—Effect of the Merger on Common Stock”

 

“Rights of Appraisal”

 

Annex C—Section 262 of the Delaware General Corporation Law

 

(e)                               Provisions for unaffiliated security holders.  The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:

 

“Provisions for Unaffiliated Stockholders”

 

(f)                                Eligibility for listing or trading.  Not applicable.

 

Item 5.                         Past Contacts, Transactions, Negotiations and Agreements

 

Regulation M-A Item 1005

 

(a)(1) - (2) Transactions.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

6



 

“Special Factors—Background of the Merger”

 

“Special Factors—Certain Effects of the Merger”

 

“Special Factors—Interests of the Company’s Directors and Executive Officers in the Merger”

 

“The Merger Agreement—Effect of the Merger on Common Stock”

 

“Agreements Involving Common Stock”

 

“Important Information Regarding RealD—Transactions in Common Stock”

 

(b) - (c) Significant corporate events; Negotiations or contacts.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Special Factors—Background of the Merger”

 

“Special Factors—Reasons for the Merger; Recommendation of the Board of Directors; Fairness of the Merger”

 

“Special Factors—Position of the Rizvi Filing Persons, Purchaser, RT Rhombus and Merger Sub as to Fairness of the Merger”

 

“Special Factors—Position of the Rollover Investors as to Fairness of the Merger”

 

“Special Factors—Purposes and Reasons of the Company for the Merger”

 

“Special Factors—Purposes and Reasons of the Rizvi Filing Persons, Purchaser, RT Rhombus, Merger Sub and Rollover Investors for the Merger”

 

“Special Factors—Interests of the Company’s Directors and Executive Officers in the Merger”

 

“The Merger Agreement”

 

“Agreements Involving Common Stock”

 

“Important Information Regarding RealD—Transactions in Common Stock”

 

(e)                               Agreements involving the subject company’s securities.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Questions and Answers About the Special Meeting and the Merger”

 

“Special Factors—Certain Effects of the Merger”

 

“Special Factors—Financing”

 

“Special Factors—Limited Guaranty”

 

7



 

“Special Factors—Interests of the Company’s Directors and Executive Officers in the Merger”

 

“The Special Meeting—Required Vote for the Merger”

 

“The Merger Agreement”

 

“Agreements Involving Common Stock—Voting Agreement”

 

“Agreements Involving Common Stock—Rollover Commitment Letter”

 

Item 6.                         Purposes of the Transaction, and Plans or Proposals.

 

Regulation M-A Item 1006

 

(b)                              Use of securities acquired.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Special Factors—Certain Effects of the Merger”

 

“The Merger Agreement—Effect of the Merger on Common Stock”

 

“The Merger Agreement—Treatment of Company Equity Awards”

 

(c)(1) - (8) Plans.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Questions and Answers About the Special Meeting and the Merger”

 

“Special Factors—Background of the Merger”

 

“Special Factors—Reasons for the Merger; Recommendation of the Board of Directors; Fairness of the Merger”

 

“Special Factors—Position of the Rizvi Filing Persons, Purchaser, RT Rhombus and Merger Sub as to Fairness of the Merger”

 

“Special Factors—Position of the Rollover Investors as to Fairness of the Merger”

 

“Special Factors—Purposes and Reasons of the Company for the Merger”

 

“Special Factors—Purposes and Reasons of the Rizvi Filing Persons, Purchaser, RT Rhombus, Merger Sub and Rollover Investors for the Merger”

 

“Special Factors—Plans for the Company after the Merger”

 

“Special Factors—Certain Effects of the Merger”

 

“Special Factors—Financing”

 

8



 

“Special Factors—Interests of the Company’s Directors and Executive Officers in the Merger”

 

“The Merger Agreement—Structure of the Merger”

 

“The Merger Agreement—Effect of the Merger on Common Stock”

 

“The Merger Agreement—Treatment of Company Equity Awards”

 

Item 7.                         Purposes, Alternatives, Reasons and Effects

 

Regulation M-A Item 1013

 

(a)                               Purposes.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Special Factors—Background of the Merger”

 

“Special Factors—Reasons for the Merger; Recommendation of the Board of Directors; Fairness of the Merger”

 

“Special Factors—Purposes and Reasons of the Company for the Merger”

 

“Special Factors—Purposes and Reasons of the Rizvi Filing Persons, Purchaser, RT Rhombus, Merger Sub and Rollover Investors for the Merger”

 

(b)                              Alternatives.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Special Factors—Background of the Merger”

 

“Special Factors—Reasons for the Merger; Recommendation of the Board of Directors; Fairness of the Merger”

 

“Special Factors—Purposes and Reasons of the Company for the Merger”

 

“Special Factors—Purposes and Reasons of the Rizvi Filing Persons, Purchaser, RT Rhombus, Merger Sub and Rollover Investors for the Merger”

 

“Special Factors—Plans for the Company after the Merger”

 

(c)                               Reasons.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Special Factors—Background of the Merger”

 

“Special Factors—Reasons for the Merger; Recommendation of the Board of Directors; Fairness of the Merger”

 

9



 

“Special Factors—Opinion of Moelis & Company LLC”

 

“Special Factors—Position of the Rizvi Filing Persons, Purchaser, RT Rhombus and Merger Sub as to Fairness of the Merger”

 

“Special Factors—Position of the Rollover Investors as to Fairness of the Merger”

 

“Special Factors—Purposes and Reasons of the Company for the Merger”

 

“Special Factors—Purposes and Reasons of the Rizvi Filing Persons, Purchaser, RT Rhombus, Merger Sub and Rollover Investors for the Merger”

 

“Special Factors—Plans for the Company after the Merger”

 

“Special Factors—Certain Effects of the Merger”

 

Annex B—Opinion of Moelis & Company LLC

 

(d)                             Effects.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Questions and Answers About the Special Meeting and the Merger”

 

“Special Factors—Background of the Merger”

 

“Special Factors—Reasons for the Merger; Recommendation of the Board of Directors; Fairness of the Merger”

 

“Special Factors—Purposes and Reasons of the Company for the Merger”

 

“Special Factors—Purposes and Reasons of the Rizvi Filing Persons, Purchaser, RT Rhombus, Merger Sub and Rollover Investors for the Merger”

 

“Special Factors—Plans for the Company After the Merger”

 

“Special Factors—Certain Effects of the Merger”

 

“Special Factors—Interests of the Company’s Directors and Executive Officers in the Merger”

 

“Special Factors—Material U.S. Federal Income Tax Consequences of the Merger”

 

“Special Factors—Fees and Expenses”

 

“The Merger Agreement—Structure of the Merger”

 

“The Merger Agreement—Effect of the Merger on Common Stock”

 

“The Merger Agreement—Treatment of Company Equity Awards”

 

10



 

Item 8.                         Fairness of the Transaction

 

Regulation M-A Item 1014

 

(a) - (b) Fairness; Factors considered in determining fairness.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Special Factors—Background of the Merger”

 

“Special Factors—Reasons for the Merger; Recommendation of the Board of Directors; Fairness of the Merger”

 

“Special Factors—Opinion of Moelis & Company LLC”

 

“Special Factors—Position of the Rizvi Filing Persons, Purchaser, RT Rhombus and Merger Sub as to Fairness of the Merger”

 

“Special Factors—Position of the Rollover Investors as to Fairness of the Merger”

 

“Special Factors—Purposes and Reasons of the Company for the Merger”

 

“Special Factors—Purposes and Reasons of the Rizvi Filing Persons, Purchaser, RT Rhombus, Merger Sub and Rollover Investors for the Merger”

 

“Special Factors—Interests of The Company’s Directors and Executive Officers in the Merger”

 

 

Annex B—Opinion of Moelis & Company LLC

 

(c)                               Approval of security holders.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Questions and Answers About the Special Meeting and the Merger”

 

“The Special Meeting—Record Date and Quorum”

 

“The Special Meeting—Required Vote for the Merger”

 

“The Merger Agreement—Conditions to the Merger”

 

(d)                             Unaffiliated representative.  An unaffiliated representative was not retained to act solely on behalf of unaffiliated security holders for purposes of negotiating the terms of the transaction or preparing a report concerning the fairness of the transaction.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Special Factors—Background of the Merger”

 

11



 

“Special Factors—Reasons for the Merger; Recommendation of the Board of Directors; Fairness of the Merger”

 

“Special Factors—Opinion of Moelis & Company LLC”

 

“Special Factors—Position of the Rizvi Filing Persons, Purchaser, RT Rhombus and Merger Sub as to Fairness of the Merger”

 

“Special Factors—Position of the Rollover Investors as to Fairness of the Merger”

 

Annex B—Opinion of Moelis & Company LLC

 

(e)                               Approval of directors.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Questions and Answers About the Special Meeting and the Merger”

 

“Special Factors—Background of the Merger”

 

“Special Factors—Reasons for the Merger; Recommendation of the Board of Directors; Fairness of the Merger”

 

“Special Factors—Position of the Rizvi Filing Persons, Purchaser, RT Rhombus and Merger Sub as to Fairness of the Merger”

 

“Special Factors—Position of the Rollover Investors as to Fairness of the Merger”

 

“Special Factors—Interests of the Company’s Directors and Executive Officers in the Merger”

 

“The Special Meeting—Recommendation of the Board of Directors”

 

(f)                                Other offers.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Special Factors—Background of the Merger”

 

“Special Factors—Reasons for the Merger; Recommendation of the Board of Directors; Fairness of the Merger”

 

Item 9.                         Reports, Opinions, Appraisals and Certain Negotiations

 

Regulation M-A Item 1015

 

(a) - (c) Report, opinion or appraisal; Preparer and summary of the report, opinion or appraisal; Availability of documents.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Special Factors—Background of the Merger”

 

12



 

“Special Factors—Reasons for the Merger; Recommendation of the Board of Directors; Fairness of the Merger”

 

“Special Factors—Opinion of Moelis & Company LLC”

 

“Where You Can Find Additional Information”

 

Annex B—Opinion of Moelis & Company LLC

 

Materials Prepared for Discussion, dated November 6, 2015, presented by Moelis & Company LLC to the Board of Directors of RealD is incorporated herein by reference.

 

Materials Prepared for Discussion, dated October 15, 2015, presented by Moelis & Company LLC to the Board of Directors of RealD is incorporated herein by reference.

 

The reports, opinions or appraisals referenced in this Item 9 will be made available for inspection and copying at the principal executive offices of the Company during its regular business hours.

 

Item 10.                 Source and Amounts of Funds or Other Consideration

 

Regulation M-A Item 1007

 

(a) - (b), (d) Source of funds; Conditions; Borrowed funds.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Special Factors—Financing”

 

“Special Factors—Interests of the Company’s Directors and Executive Officers in the Merger”

 

“Agreements Involving Common Stock—Rollover Commitment Letter”

 

(c)                               Expenses.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Special Factors—Fees and Expenses”

 

“The Merger Agreement—Termination Fees; Reimbursement of Expenses”

 

Item 11.                 Interest in Securities of the Subject Company

 

Regulation M-A Item 1008

 

(a)                               Securities ownership.  The information set forth in the Proxy Statement under the following caption is incorporated herein by reference:

 

“Important Information Regarding RealD—Security Ownership of Certain Beneficial Owners and Management”

 

13



 

As of November 24, 2015, the directors and executive officers of each of the Purchaser, RT Rhombus, Merger Sub and the Rizvi Filing Persons do not beneficially own any shares of Common Stock.

 

(b)                              Securities transactions.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Agreements Involving Common Stock”

 

“Important Information Regarding RealD—Transactions in Common Stock”

 

Item 12.                 The Solicitation or Recommendation

 

Regulation M-A Item 1012

 

(d)                             Intent to tender or vote in a going-private transaction.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Questions and Answers About the Special Meeting and the Merger”

 

“Special Factors—Reasons for the Merger; Recommendation of the Board of Directors; Fairness of the Merger”

 

“Special Factors—Position of the Rizvi Filing Persons, Purchaser, RT Rhombus and Merger Sub as to Fairness of the Merger”

 

“Special Factors—Position of the Rollover Investors as to Fairness of the Merger”

 

“Special Factors—Purposes and Reasons of the Company for the Merger”

 

“Special Factors—Purposes and Reasons of the Rizvi Filing Persons, Purchaser, RT Rhombus, Merger Sub and Rollover Investors for the Merger”

 

“Special Factors—Interests of the Company’s Directors and Executive Officers in the Merger”

 

“The Special Meeting—Required Vote for the Merger”

 

“Agreements Involving Common Stock”

 

(e)                               Recommendation of others.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Questions and Answers About the Special Meeting and the Merger”

 

“Special Factors—Reasons for the Merger; Recommendation of the Board of Directors; Fairness of the Merger”

 

14



 

“Special Factors—Position of the Rizvi Filing Persons, Purchaser, RT Rhombus and Merger Sub as to Fairness of the Merger”

 

“Special Factors—Position of the Rollover Investors as to Fairness of the Merger”

 

“Special Factors—Purposes and Reasons of the Company for the Merger”

 

“Special Factors—Purposes and Reasons of the Rizvi Filing Persons, Purchaser, RT Rhombus, Merger Sub and Rollover Investors for the Merger”

 

“Special Factors—Interests of the Company’s Directors and Executive Officers in the Merger”

 

Item 13.                 Financial Information

 

Regulation M-A Item 1010

 

(a)                               Financial statements.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Important Information Regarding RealD—Selected Historical Financial Information”

 

“Important Information Regarding RealD—Ratio of Earnings to Fixed Charges”

 

“Important Information Regarding RealD—Book Value Per Share”

 

“Where You Can Find Additional Information”

 

(b)                              Pro forma information.  Not applicable.

 

Item 14.                 Persons/Assets, Retained, Employed, Compensated or Used

 

Regulation M-A Item 1009

 

(a) - (b) Solicitations or recommendations; Employees and corporate assets.  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Questions and Answers About the Special Meeting and the Merger”

 

“Special Factors—Background of the Merger”

 

“Special Factors—Reasons for the Merger; Recommendation of the Board of Directors; Fairness of the Merger”

 

“Special Factors—Interests of the Company’s Directors and Executive Officers in the Merger”

 

“Special Factors—Fees and Expenses”

 

15



 

“The Special Meeting—Solicitation of Proxies”

 

“The Special Meeting—Additional Assistance”

 

Item 15.                 Additional Information

 

Regulation M-A Item 1011

 

(b)                              Golden Parachute Compensation:  The information set forth in the Proxy Statement under the following captions is incorporated herein by reference:

 

“Questions and Answers About the Special Meeting and the Merger”

 

“Special Factors—Interests of the Company’s Directors and Executive Officers in the Merger”

 

“Special Factors— Quantification of Potential Payments to the Company’s Named Executive Officers in Connection with the Merger”

 

(c)                               Other material information.  The information set forth in the Proxy Statement, including all annexes thereto, is incorporated herein by reference.

 

Item 16.                 Exhibits

 

Regulation M-A Item 1016

 

(a)(1) Preliminary Proxy Statement of RealD Inc. (incorporated herein by reference to the Schedule 14A filed concurrently with the Securities and Exchange Commission).

 

(a)(2) Form of Proxy Card (incorporated herein by reference to the Proxy Statement).

 

(a)(3) Letter to RealD Stockholders (incorporated herein by reference to the Proxy Statement).

 

(a)(4) Notice of Special Meeting of Stockholders (incorporated herein by reference to the Proxy Statement).

 

(a)(5) Press Release dated November 9, 2015 (filed as Exhibit 99.1 to the Company’s Current Report on Form 8-K, filed November 9, 2015 and incorporated herein by reference).

 

(a)(6) Draft RLD Transaction Employee Letter, delivered on November 9, 2015 (incorporated by reference to the Schedule 14A filed with the SEC on November 9, 2015).

 

(a)(7) Draft RLD Employee FAQ, delivered on November 9, 2015 (incorporated by reference to the Schedule 14A filed with the SEC on November 9, 2015).

 

(b)(1) Debt Commitment Letter, dated as of November 8, 2015, by and between RT Rhombus Holdings, Inc. and Jefferies Finance LLC

 

16



 

(c)(1) Opinion of Moelis & Company LLC, dated November 8, 2015 (incorporated herein by reference to Annex B of the Schedule 14A filed concurrently with the Securities and Exchange Commission).

 

(c)(2) Materials Prepared for Discussion, dated November 6, 2015, presented by Moelis & Company LLC  to the Board of Directors of RealD Inc.

 

(c)(3) Materials Prepared for Discussion, dated October 15, 2015, presented by Moelis & Company LLC to the Board of Directors of RealD Inc.

 

(d)(1) Agreement and Plan of Merger, by and among ReadD Inc., Rhombus Cinema Holdings, LLC and Rhombus Merger Sub, Inc., dated as of November 8, 2015 (incorporated herein by reference to Annex A of the Schedule 14A filed concurrently with the Securities and Exchange Commission).

 

(d)(2) Limited Guaranty, by Rizvi Opportunistic Equity Fund III, L.P., in favor of RealD Inc, dated as of November 8, 2015.

 

(d)(3) Amended and Restated Voting Agreement, by and among Michael V. Lewis, the MVL Trust dated August 3, 2010 and Rhombus Cinema Holdings, LLC, dated as of November 25, 2015.

 

(d)(4) Amended and Restated Rollover Investment Commitment Letter, by and among Michael V. Lewis, the MVL Trust dated August 3, 2010, and Rhombus Cinema Holdings, LLC, dated as of November 25, 2015.

 

(d)(5) Form of Employment Agreement, by and between Michael V. Lewis and RealD Inc.

 

(d)(6) Equity Financing Commitment Letter, by and between Rhombus Cinema Holdings, LLC and Rizvi Opportunistic Equity Fund III, L.P., dated as of November 8, 2015

 

(d)(7) Amended and Restated Equity Commitment Letter, by and among Fortress Credit Advisors LLC, Rhombus Cinema Holdings, LLC, and Rizvi Traverse Management, LLC, dated as of November 25, 2015

 

(f)(1) Section 262 of the Delaware General Corporation Law (incorporated herein by reference to Annex C of the Schedule 14A filed concurrently with the Securities and Exchange Commission).

 

(g) None.

 

17



 

SIGNATURE

 

After due inquiry and to the best of each of the undersigneds knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

 

Dated as of November 25, 2015

 

 

REALD INC.

 

 

 

 

 

By:

/s/ Vivian W. Yang

 

 

Name:  Vivian W. Yang

 

Title:  General Counsel

 

 

 

RIZVI TRAVERSE GP III, LLC

 

 

 

 

 

By:

/s/ Ben Kohn

 

 

Name:  Ben Kohn

 

Title:  Managing Director

 

 

 

RIZVI OPPORTUNISTIC EQUITY FUND III, L.P.

 

 

 

 

 

By:

Rizvi Traverse GP III, LLC, its general partner

 

 

 

 

 

By:

/s/ Ben Kohn

 

 

Name:  Ben Kohn

 

Title:  Managing Director

 

 

 

RHOMBUS CINEMA HOLDINGS, LLC

 

 

 

 

 

By:

/s/ Ben Kohn

 

 

Name:  Ben Kohn

 

Title:  Authorized Signatory

 

 

 

RHOMBUS MERGER SUB, INC.

 

 

 

 

 

By:

/s/ Ben Kohn

 

 

Name:  Ben Kohn

 

Title:  President

 

 

 

RT RHOMBUS HOLDINGS, INC.

 

 

 

 

 

By:

/s/ Ben Kohn

 

 

Name:  Ben Kohn

 

Title:  President

 

18



 

 

MICHAEL V. LEWIS

 

 

 

 

 

By:

/s/ Michael V. Lewis

 

 

Name:  Michael V. Lewis

 

 

 

THE MVL TRUST DATED AUGUST 3, 2010

 

 

 

 

 

By:

/s/ Michael V. Lewis

 

 

Name:  Michael V. Lewis

 

Title:  Trustee

 

19




Exhibit (b)(1)

 

EXECUTION VERSION

 

JEFFERIES FINANCE LLC

520 Madison Avenue

New York, New York 10022

 

CONFIDENTIAL

 

November 8, 2015

 

RT Rhombus Holdings, Inc.

c/o Rizvi Traverse

9465 Wilshire Blvd., Suite 840

Beverly Hills, CA 90212

Attn:              Ben Kohn

 

 

Project Rhombus

$15.0 Million Senior Secured Revolving Facility

$300.0 Million Senior Secured Bridge Facility

Commitment Letter

Ladies and Gentlemen:

 

You have advised us that RT Rhombus Holdings, Inc., a Delaware corporation (“Holdings” or “you”), intends to directly or indirectly acquire (the “Acquisition”), all of the capital stock of the entity previously identified by you to us as “Rhombus” (the “Acquired Business”) pursuant to the Acquisition Agreement (as defined in Exhibit A hereto). You have further advised Jefferies Finance LLC (“Jefferies Finance”, the “Initial Lender”, the “Commitment Party,” “we” or “us”) that, in connection with the foregoing, you intend to consummate the other Transactions described in the Transaction Description attached hereto as Exhibit A. Capitalized terms used but not defined herein are used with the meanings assigned to them on the Exhibits attached hereto (such Exhibits, together with this letter, collectively, the “Commitment Letter”).

 

1.                                    Commitments

 

In connection with the Transactions, Jefferies Finance is pleased to inform you of its commitment to provide 100% of the Revolving Commitments and 100% of the Bridge Commitments, upon the terms expressly set forth in this Commitment Letter (including, without limitation, each of the Exhibits attached hereto, including the Summary of Terms and Conditions attached hereto as Exhibit B (the “Revolving Facility Term Sheet”) and Exhibit C (the “Bridge Facility Term Sheet”, and collectively with the Revolving Facility Term Sheet, the “Term Sheet”), and the closing and funding of the Facilities is subject solely to the specified closing conditions set forth in Section 6 below and Exhibit D hereto. Our commitments are subject to your acceptance of the engagement letter, dated the date hereof (together with any exhibits, schedules or annexes thereto, the “Engagement Letter”) between you and Jefferies LLC (“Jefferies”).

 

2.                                    Titles and Roles

 

It is agreed that:

 



 

(i)                                  Jefferies Finance will act as lead arranger and bookrunner for each of the Facilities (in such capacity, the “Lead Arranger”),

 

(ii)                              Jefferies Finance will act as sole administrative agent and collateral agent for the Revolving Facility (the “Revolving Facility Administrative Agent”), and

 

(iii)                          Jefferies Finance will act as sole administrative agent and collateral agent for the Bridge Facility (the “Bridge Facility Administrative Agent” and, together with the Revolving Facility Administrative Agent, the “Administrative Agents”).

 

It is further agreed that Jefferies Finance will have “left” placement on any marketing materials or other documentation used in connection with any of the Facilities and will have the rights and responsibilities customarily associated with such name placement. In addition, you hereby retain, and will cause your affiliates to retain, Jefferies to act in the capacities and in connection with the matters set forth in the Engagement Letter. The parties hereto agree that no other agents or arrangers will be appointed, no other titles will be awarded and no compensation (other than that compensation expressly contemplated by this Commitment Letter, the Fee Letter and the Engagement Letter) will be paid in connection with the Facilities unless you and we shall so agree.

 

3.                                    Syndication

 

The Lead Arranger intends to syndicate the Facilities to a group of banks, financial institutions and other lenders, reasonably acceptable to you (together with the Initial Lender, the “Lenders”); provided that, the Lead Arranger will not syndicate to (a) those persons that are direct competitors of Holdings and its subsidiaries or the Company and its subsidiaries to the extent identified by you or Rizvi Traverse and associated funds and affiliates (other than a portfolio company) (the “Sponsor”) to us by name in writing from time to time, (b) those banks, financial institutions and other persons separately identified by name by you or the Sponsor to us in writing prior to the date hereof or (c) in the case of clauses (a) or (b), any of their affiliates, other than Bona Fide Debt Funds (as defined below), that are reasonably identifiable as affiliates solely on the basis of their name (provided that the Lead Arranger and the Administrative Agents shall have no obligation to carry out due diligence in order to identify such affiliates) (it being understood that the Facilities Documentation (as defined in Exhibit D) shall (i) provide that assignments and participations to any Disqualified Institution and natural persons shall be restricted as set forth in Exhibit B and Exhibit C and (ii) contain a representation by any buyer under an assignment and assumption agreement that it qualifies as an Eligible Assignee) (such persons or entities in clause (a), (b) or (c), collectively, the “Disqualified Institutions”); provided, that the foregoing shall not apply retroactively to disqualify any parties that have previously acquired an assignment or participation interest in the Loans to the extent such party was not a Disqualified Institution at the time of the applicable assignment or participation, as the case may be. For purposes of the foregoing, a “Bona Fide Debt Fund” means any debt fund affiliate of such entities mentioned in clauses (a) and (b) of the immediately preceding sentence that is primarily engaged in, or advises funds or other investment vehicles that are engaged in, making, purchasing, holding or otherwise investing in commercial loans, notes, bonds and similar extensions of credit or securities in the ordinary course of its business and whose managers are not involved with the investment of such competitor or affiliate. Notwithstanding any other

 

2



 

provision of this Commitment Letter to the contrary and notwithstanding any assignment by the Initial Lender, (a) the Initial Lender shall not be relieved or novated from its obligations hereunder (including its obligation to fund the Facilities on the Closing Date) in connection with any syndication, assignment or participation of the Facilities, including its commitments in respect thereof, until the initial funding of the Facilities on the Closing Date, (b) no assignment or novation shall become effective with respect to all or any portion of the Initial Lender’s commitments in respect of the Facilities until the initial funding of the Facilities on the Closing Date and (c) the Initial Lender shall retain exclusive control over all rights and obligations with respect to its commitments in respect of the Facilities, including all rights with respect to consents, modifications, supplements and amendments, until the Closing Date has occurred.

 

The Lead Arranger intends to commence syndication efforts with respect to the Facilities promptly following your execution and delivery of this Commitment Letter and, until the earlier to occur of (a) a Successful Syndication (as defined in the Fee Letter) and (b) the date that is 60 days after the Closing Date (such period, the “Syndication Period”), you agree to assist (and to use commercially reasonable efforts to cause the Sponsor and the Company to assist) the Lead Arranger in completing a syndication reasonably satisfactory to the Lead Arranger and you. Such assistance shall include (i) using your commercially reasonable efforts to ensure that the syndication efforts benefit from your existing banking relationships and the existing lending and investment banking relationships of the Sponsor and those of the Company, (ii) direct contact between your and the Sponsor’s senior management, representatives and advisors and the proposed Lenders (and using your commercially reasonable efforts to obtain such contact between the senior management, representatives and advisors of the Company and the proposed Lenders), (iii) your and the Sponsor’s assistance (and using your commercially reasonable efforts to cause the senior management, representatives and advisors of the Company to assist) in the preparation of customary and reasonably available marketing materials to be used in connection with the syndication of the Facilities, including the Projections (as hereinafter defined), (iv) the hosting, with the Lead Arranger, of one meeting of prospective Lenders at a time and location (and additional meetings as the Lead Arranger may reasonably request, including one-on-one meetings, which may be held by conference call) to be mutually agreed (and using your commercially reasonable efforts to cause the senior management, representatives and advisors of the Company to be available for such meetings), (v) your ensuring (and, with respect to the Company and its subsidiaries, using commercially reasonable efforts to ensure) that, until the end of the Syndication Period, there shall be no other issues of debt securities or commercial bank or other credit facilities of Holdings, Borrower and their respective subsidiaries and the Company and its subsidiaries being offered, placed or arranged (other than (A) the Facilities and the Notes, (B) indebtedness permitted to remain outstanding after the Closing Date under the Acquisition Agreement, including capital leases, purchase money debt and intercompany debt, (C) foreign working capital lines, (D) letters of credit remaining outstanding, (E) deferred payments and compensation under the Acquisition Agreement and (F) other debt to be mutually agreed (“Permitted Surviving Debt”)), which could reasonably be expected to have an adverse impact on the primary syndication of the Facilities, (vi) using commercially reasonable efforts to obtain prior to the commencement of the Marketing Period (as defined in Exhibit D hereto) (provided that, it is understood and agreed that nothing in this clause (vi) shall be a condition to the commencement of the Marketing Period) (x) public corporate/family ratings for the Borrower and (y) public ratings for the Facilities and the Notes, in each case, from each of Moody’s Investors Service, Inc. (“Moody’s”) and Standard & Poor’s Financial Services LLC (“S&P”) and

 

3



 

(vii) using commercially reasonable efforts to promptly provide to us (including to use commercially reasonable efforts to cause the Company to provide to us) all reasonably available material information with respect to you, the Company and your and its subsidiaries and the Transactions as the Lead Arranger may reasonably request in connection with the syndication of the Facilities or the offering of the Notes. Notwithstanding anything to the contrary contained in this Commitment Letter or the Fee Letter, none of the foregoing, including without limitation the obtaining of the ratings referred to above nor the commencement or the completion of the syndication of the Facilities shall constitute a condition precedent to the initial extensions of credit under the applicable Facilities on the Closing Date.

 

Subject to the second paragraph of Section 3, the Lead Arranger, in its capacity as such, will manage, in consultation with you (and subject to your rights set forth in the second and third preceding paragraphs), all aspects of the syndication, including decisions as to the selection of institutions (other than Disqualified Institutions) to be approached and when they will be approached, when the Lenders’ commitments will be accepted, which Lenders (other than Disqualified Institutions) will participate, the allocation of the commitments among the Lenders and the amount and distribution of fees among the Lenders.

 

You acknowledge that (a) the Lead Arranger on your behalf will make available Information (as defined below), Projections and other customary offering and marketing materials and presentations, to the proposed syndicate of Lenders by posting the information package and presentation on IntraLinks, SyndTrak Online or another similar electronic system or by electronic mail and (b) certain prospective Lenders may be “public side” Lenders (i.e., Lenders that have personnel that do not wish to receive material non-public information (within the meaning of the United States Federal securities laws, “MNPI”) with respect to you, the Company, your and its subsidiaries, the respective securities of any of the foregoing or the Acquisition and who may be engaged in investment and other market-related activities with respect to such entities’ securities). At the request of the Lead Arranger, you agree to assist, and to use commercially reasonable efforts to cause the Company and its subsidiaries to assist, in the preparation of the Confidential Information Memorandum to be used in connection with the syndication of the Facilities consisting exclusively of information and documentation with respect to the Company, the Company’s securities and the Acquisition that is not material with respect to you, the Company, your or its respective affiliates, the Acquisition or any of your or their respective securities for purposes of United States Federal and state securities laws or is publicly available (or would be publicly available if the Company were a public reporting company) (all such information and documentation being “Public Lender Information” and with any information and documentation that is not Public Lender Information being referred to herein as “Private Lender Information”). It is understood that in connection with your assistance described above, customary authorization letters executed by Holdings will be included in any information package and presentation whereby you authorize the distribution of such information to prospective Lenders, containing a customary “10b-5” representation and a representation by you to the Lead Arranger that the Public Lender Information does not include MNPI about you, the Company, your or its subsidiaries or the respective securities of any of the foregoing, and will contain customary language exculpating us, our affiliates, you, the Sponsor, the Company and your and their affiliates with respect to any liability related to the use of the contents of such Public Lender Information or any marketing material by the recipients thereof in violation of applicable securities laws. You acknowledge and agree that the following documents may be

 

4



 

distributed to potential Lenders wishing to receive only the Public Lender Information unless you notify us otherwise within a reasonable time prior to their intended distribution (and the Lead Arranger shall provide such documents to you for review within a reasonable period of time prior to distribution): (a) drafts and final definitive documentation with respect to the Facilities (excluding any fee letters); (b) administrative materials prepared by the Lead Arranger for prospective Lenders (such as a Lender meeting invitation, allocations and funding and closing memoranda (but excluding any projections)); and (c) notification of changes in the terms of the Facilities (other than any terms in the Fee Letter or any other fee letter). You also agree to identify that portion of any other Information (as defined below) as relating to you or the Company or your or its subsidiaries (the “Borrower Materials”) to be distributed to “public side” Lenders and that you will clearly and conspicuously mark such materials “PUBLIC” which, at a minimum, shall mean that the word “PUBLIC” shall appear prominently on the first page thereof. By marking Borrower Materials “PUBLIC”, you shall be deemed to have authorized the Lead Arranger and the proposed Lenders to treat such Borrower Materials as not containing any MNPI with respect to you, the Company, your or its subsidiaries or the respective securities of any of the foregoing (it being understood that you shall not be under any obligation to mark the Information “PUBLIC”). You agree that, unless expressly identified as Public Lender Information, each document to be disseminated by the Lead Arranger (or any Administrative Agent) to any Lender in connection with the Facilities will be deemed to contain Private Lender Information.

 

4.                                    Information

 

You hereby represent and warrant that, and with respect to the Company and its subsidiaries, to your knowledge that, (a) all written information, other than the Projections (as defined below), other projections, budgets, estimates, forward looking statements and information of a general economic or industry-specific nature, concerning you or the Company or your or its subsidiaries (the “Information”), that has been or will be made available to us by you or your representatives in connection with the transactions contemplated hereby, when taken as a whole, does not or will not, when furnished, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements contained therein taken as a whole, not materially misleading in light of the circumstances under which such statements are made, and (b) the Projections that have been or will be made available to us by or on behalf of you in connection with the transactions contemplated hereby have been or will be prepared in good faith based upon assumptions believed by you to be reasonable at the time prepared and at the time being furnished (it being recognized by the Commitment Party that (i) such Projections are not to be viewed as facts or a guarantee of performance and are subject to significant uncertainties and contingencies many of which are beyond your control and (ii) no assurance can be given that any particular projections will be realized, and that actual results during the period or periods covered by any such Projections may differ from the projected results, and such differences may be material). You agree that if, at any time prior to the end of the Syndication Period, you become aware that any of the representations and warranties in the preceding sentence are incorrect, when taken as a whole, in any material respect if the Information or Projections were being furnished and such representations and warranties in the first sentence of this paragraph were being made at such time, then you will use commercially reasonable efforts to promptly supplement the Information and the Projections so that (with respect to Information and Projections relating to the Company or its subsidiaries, to your knowledge) such

 

5



 

representations and warranties, as supplemented, are correct, when taken as a whole, in all material respects, under those circumstances. The accuracy of the foregoing representations and warranties, whether or not supplemented, shall not be a condition to the obligations of the Commitment Party hereunder. You understand that in arranging and syndicating the Facilities we may use and rely on the Information and the Projections without independent verification thereof, and we do not assume responsibility for the accuracy or completeness of the Information or the Projections.

 

5.                                    Fees.

 

As consideration for the commitments and agreements of the Commitment Party hereunder and under the Engagement Letter, you agree to pay or cause to be paid on the date when due and payable the nonrefundable compensation described in the separate fee and closing payments letter dated the date hereof and delivered herewith (the “Fee Letter”) by and among you and Jefferies Finance, on the terms and subject to the conditions expressly set forth therein.

 

6.                                    Conditions

 

Notwithstanding anything in this Commitment Letter, the Fee Letter, the Engagement Letter, the Facilities Documentation or any other letter agreement or other undertaking concerning the financing of the transactions contemplated hereby to the contrary, (A) the commitments of the Initial Lender hereunder and the Lead Arranger’s agreement to perform the services described herein are subject only to the conditions expressly set forth in the Revolving Facility Term Sheet under the heading “CERTAIN CONDITIONS - Initial Conditions”, in the Bridge Facility Term Sheet under the heading “CERTAIN CONDITIONS - Initial Conditions” and in Exhibit D hereto (collectively, the “Exclusive Funding Conditions”), (B) the only conditions (express or implied) to the availability of the Facilities on the Closing Date are the Exclusive Funding Conditions and (C) to the extent the Specified Acquisition Agreement Representations with respect to the Company and its subsidiaries are qualified or subject to “material adverse effect,” the definition thereof shall be “Material Adverse Effect” as defined in the Acquisition Agreement for purposes of the representation and warranties made or to be made on or as of the Closing Date.

 

Notwithstanding anything in this Commitment Letter, the Fee Letter, the Engagement Letter, the Facilities Documentation or any other letter agreement or other undertaking concerning the financing of the transactions contemplated hereby to the contrary, (a) the only representations and warranties, the accuracy of which shall be a condition to availability of the Facilities on the Closing Date, shall be (i) such of the representations and warranties made by or with respect to the Company and its subsidiaries in the Acquisition Agreement as are material to the interests of the Lenders, but only to the extent that you or your applicable affiliates have the right (determined without regard to any notice requirement) to terminate your (or their) obligations under the Acquisition Agreement or decline to consummate the Acquisition as a result of a breach of such representations and warranties in the Acquisition Agreement (the “Specified Acquisition Agreement Representations”) and (ii) the Specified Representations (as defined below) (the representations and warranties described in clauses (i) and (ii) being the “Closing Date Representations”), and (b) the terms of the Facilities Documentation shall be in a form such that they do not impair the availability of the Facilities on the Closing Date if the

 

6



 

Exclusive Funding Conditions are satisfied (or waived), it being understood that, to the extent any lien search or security interest in the Collateral cannot be provided on the Closing Date (other than (w) the execution and delivery of security agreements reasonably acceptable to the Administrative Agents, (x) the pledge and perfection of Collateral with respect to which a lien may be perfected by the filing of financing statements under the Uniform Commercial Code (“UCC”), (y) the delivery of stock certificates and stock powers for such equity interests that are “certificated securities” (as defined in Article 8 of the Uniform Commercial Code) of Company and domestic subsidiaries of the Company that are part of the Collateral and (z) the delivery of completed intellectual property security agreements for intellectual property of the Borrower and each Guarantor that is registered or for which an application has been filed with the United States Patent and Trademark Office or the United States Copyright Office (other than “intent to use” trademark applications)) after your use of commercially reasonable efforts to do so without undue burden or expense, then the provision and/or perfection, as applicable, of any such lien search or security interest in such Collateral shall not constitute a condition precedent to the availability of the Facilities, but shall instead be provided within ninety days after the Closing Date, subject to such extensions as are reasonably agreed by the Revolving Facility Administrative Agent, pursuant to arrangements to be mutually agreed by the parties hereto acting reasonably. “Specified Representations” means the representations in the Facilities Documentation relating to corporate or other organizational existence, organizational power and authority of the Borrower and the Guarantors (as they relate to due authorization, execution, delivery and performance of the Facilities Documentation); due authorization, execution, delivery and enforceability, in each case relating to the entering into and performance of such Facilities Documentation; solvency as of the Closing Date (after giving effect to the Transactions) of Holdings and its restricted subsidiaries on a consolidated basis (in form and scope consistent with the Solvency Certificate attached as Annex I to Exhibit D hereto); no conflicts of the Facilities Documentation with charter documents of the Borrower or any Guarantor; Federal Reserve margin regulations; the Investment Company Act; PATRIOT Act; OFAC; FCPA; anti-laundering laws; and the creation, perfection and first priority status (with respect to the Revolving Facility) or second priority status (with respect to the Bridge Facility) of the security interests in the Collateral (subject to customary permitted liens to be agreed) and subject in all respects to the foregoing provisions of this paragraph. This paragraph, and the provisions herein, shall be referred to as the “Certain Funds Provision”.

 

7.                                    Indemnification and Expenses

 

You agree (a) to indemnify and hold harmless the Commitment Party, its affiliates and controlling persons and the respective directors, officers, employees, partners, advisors, agents and other representatives of each of the foregoing and their respective successors (each, an “indemnified person”) from and against any and all actual losses (excluding lost profits), claims, damages, liabilities and expenses, joint or several, to which any such indemnified person may become subject arising out of or in connection with this Commitment Letter or the Fee Letter, the Transactions, the Facilities, the contemplated use of proceeds thereof or any related transaction or any claim, litigation, investigation or proceeding (a “Proceeding”) relating to any of the foregoing, regardless of whether any indemnified person is a party thereto, whether or not such Proceedings are brought by you, the Company, your or its equity holders, affiliates, creditors or any other person, and to reimburse each indemnified person within thirty days of written demand (together with reasonable backup documentation) for any reasonable and

 

7



 

documented out-of-pocket expenses incurred in connection with investigating or defending any of the foregoing (but limited, in the case of legal fees and expenses, to one outside counsel to such indemnified persons taken as a whole and, in the case of an actual or potential conflict of interest, one additional counsel to the affected indemnified persons taken as a whole and, to the extent reasonably necessary, one local counsel in each relevant material jurisdiction (and in the case of a conflict of interest, one additional counsel to the affected persons taken as a whole) but no other third-party advisors without your prior written consent); provided, that the foregoing indemnity will not, as to any indemnified person, apply to (x) losses, claims, damages, liabilities or related expenses to the extent they arise from (i) the willful misconduct, bad faith or gross negligence of such indemnified person (or its Related Persons) as determined in a final, non-appealable judgment of a court of competent jurisdiction, (ii) the material breach of the Commitment Letter or the Fee Letter by such indemnified person (or its Related Persons), as determined in a final, non-appealable judgment of a court of competent jurisdiction, or (iii) any disputes solely among indemnified persons (other than any claims against the Commitment Party in its capacity as an Administrative Agent, the Lead Arranger or any similar role under the Facilities, but not any other person or entity party to any such claim or dispute) and not arising out of any act or omission of Holdings, the Borrower or the Company, or any of your or their respective subsidiaries, and (b) if the Closing Date occurs, to reimburse the Commitment Party and its affiliates for all reasonable and documented out-of-pocket expenses (including, but not limited to, reasonable and documented out-of-pocket due diligence expenses, syndication expenses, travel expenses, and reasonable and documented out-of-pocket fees, charges and disbursements of one outside counsel to the Commitment Party and to the extent reasonably necessary, one local counsel in each relevant material jurisdiction to the Commitment Party, incurred in connection with each of the Facilities and any related documentation (including this Commitment Letter, the Fee Letter and the Facilities Documentation) or the administration, amendment, modification or waiver of any of the foregoing) within 30 days of written demand (including documentation reasonably supporting in detail such request) or, to the extent of such expenses and fees outstanding as of the Closing Date, on the Closing Date to the extent written demand including documentation reasonably supporting such request is provided at least two business days prior to the Closing Date. No person or entity a party hereto nor any indemnified person shall be liable for any damages arising from the use by others of Information or other materials obtained through electronic, telecommunications or other information transmission systems, including, without limitation, SyndTrak, Intralinks, the internet, email or similar electronic transmission systems, in each case, except to the extent any such damages are found in a final non-appealable judgment of a court of competent jurisdiction to have resulted from the gross negligence, bad faith or willful misconduct of, or material breach of this Commitment Letter or the Fee Letter by, such person or entity (or the Related Persons of such person or entity) as determined in a final, non-appealable judgment of a court of competent jurisdiction. None of the indemnified persons or you, the Sponsor, the Company or any of your or their respective affiliates or the respective directors, officers, employees, advisors, and agents of the foregoing shall be liable for any indirect, special, punitive or consequential damages in connection with this Commitment Letter, the Fee Letter, the Facilities or the transactions contemplated hereby; provided that nothing contained in this sentence shall limit your indemnification and reimbursement obligations to the extent expressly set forth herein. For purposes hereof, a “Related Person” of any indemnified person means (1) its affiliates and controlling persons, (2) the respective directors, officers, employees or partners of such indemnified person or any of its

 

8



 

controlling person or controlled affiliates and (3) the respective advisors, agents and other representatives of such indemnified person or any of its controlling person or controlled affiliates, in the case of this clause (3) acting at the instructions of such indemnified person

 

You shall not be liable for any settlement of any Proceeding (or expenses related thereto) effected without your consent (which consent shall not be unreasonably withheld or delayed), but if settled with your written consent, or if there is a final judgment for the plaintiff against an indemnified person in any such Proceeding, you agree to indemnify and hold harmless each indemnified person to the extent and in the manner set forth above. You shall not, without the prior written consent of an indemnified person (which consent shall not be unreasonably withheld, conditioned or delayed), effect any settlement of any pending or threatened Proceeding against an indemnified person in respect of which indemnity could have been sought hereunder by such indemnified person unless (a) such settlement includes an unconditional release of such indemnified person in form and substance reasonably satisfactory to such indemnified person from all liability or claims that are the subject matter of such Proceeding and (b) such settlement does not include any statement as to any admission of fault, culpability or a failure to act by or on behalf of such indemnified person.

 

8.                                    Sharing of Information, Absence of Fiduciary Relationship, Affiliate Activities

 

You acknowledge that the Commitment Party (and its affiliates, including Jefferies) are full service securities firms and each such person may from time to time (a) effect transactions, for its own or its affiliates’ account or the account of customers, and hold positions in loans, securities or options on loans or securities of you, the Company or your or their affiliates and of other companies that may be the subject of the transactions contemplated by this Commitment Letter or with which you, the Sponsor, the Company or its subsidiaries may have commercial or other relationships or (b) provide debt financing, equity capital, investment banking, financial advisory services, securities trading, hedging, financing and brokerage activities and financial planning and benefits counseling to other companies in respect of which you may have conflicting interests. In addition, consistent with the Commitment Party’s policy to hold in confidence the affairs of its customers, the Commitment Party will not furnish information obtained from you, the Sponsor, the Company or your or their respective affiliates and representatives to any of their other clients (or to clients of their affiliates) or in connection with the performance by the Commitment Party and its affiliates of services for their other clients (or for clients of their affiliates), except to the extent permitted below. You also acknowledge that the Commitment Party and its affiliates have no obligation to use in connection with the transactions contemplated hereby, or to furnish to you, confidential information obtained from other companies or other persons.

 

You further acknowledge and agree that (a) no fiduciary, advisory or agency relationship between you and us is intended to be or has been created in respect of any of the transactions contemplated by this Commitment Letter, irrespective of whether we or our affiliates have advised or are advising you on other matters, (b) we, on the one hand, and you, on the other hand, have an arms-length business relationship that does not directly or indirectly give rise to, nor do you rely on, any fiduciary duty on our part, (c) in connection therewith and with the process leading to the Transactions, the Commitment Party and its affiliates (as the case may be) are acting solely as a principal and not as agents or fiduciaries of you or any other person, (d) you

 

9



 

are capable of evaluating and understanding, and you understand and accept, the terms, risks and conditions of the transactions contemplated by this Commitment Letter, (e) you have consulted legal, accounting, regulatory and tax advisors to the extent you deemed appropriate and you are not relying on the Commitment Party for such advice, (f) you have been advised that we and our affiliates are engaged in a broad range of transactions that may involve interests that differ from your and your affiliates’ interests and that we and our affiliates have no obligation to disclose such interests and transactions to you and your affiliates by virtue of any fiduciary, advisory or agency relationship and (g) neither the Commitment Party nor its affiliates has any obligation to you or your affiliates with respect to the transactions contemplated hereby except those obligations expressly set forth herein or in any other express writing executed and delivered by the Commitment Party and the Borrower.

 

You further acknowledge and agree that you are responsible for making your own independent judgment with respect to the transactions contemplated by this Commitment Letter and the process leading thereto. You waive, to the fullest extent permitted by law, any claims you may have against the Commitment Party for breach of fiduciary duty or alleged breach of fiduciary duty and agree that the Commitment Party shall not have any liability (whether direct or indirect) to you in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on behalf of or in right of you, including your stockholders, employees or creditors.

 

9.                                    Confidentiality

 

This Commitment Letter and the Fee Letter, in each case, are delivered to you on the understanding that neither this Commitment Letter nor the Fee Letter nor any of their respective terms shall be disclosed, to any other person except (a) the Sponsor and your and its respective officers, directors (or comparable persons), employees, affiliates, attorneys, accountants, agents and advisors on a confidential and “need-to-know” basis, (b) the Company and its shareholders, employees, attorneys, accountants, agents and advisors on a confidential and “need-to-know” basis (provided that any disclosure of the Fee Letter or its terms or substance to the Company under this clause (b) shall be, prior to the consummation of the Acquisition, redacted in respect of (x) the amounts, percentages and basis points of compensation set forth therein and (y) any other provisions therein relating to the pricing and other economic terms of the Facilities), (c) in any legal, judicial or administrative proceeding or as otherwise required by applicable law, rule or regulation (including the Commitment Letter (but not the Fee Letter or any of the contents thereof), other than the aggregate fee amount) in connection with any Securities and Exchange Commission filings relating to the Acquisition) or as requested by a governmental authority (in which case you agree, to the extent permitted by law, rule or regulation, to inform us promptly thereof), (d) in connection with the exercise of any remedy or enforcement of any right under this Commitment Letter and the Fee Letter, (e) the Term Sheets and Exhibit D hereto (but not the Fee Letter or the contents thereof other than the existence thereof and the aggregate amount of fees paid or payable thereunder as part of projections, pro forma information and a generic disclosure of aggregate sources and uses) may be disclosed to potential Lenders and to any rating agency in connection with the Acquisition and (f) the aggregate fee amounts paid or payable under the Fee Letter may be disclosed in financial statements. The foregoing restrictions shall cease to apply after the Facilities Documentation shall have been executed and delivered by the parties hereto to the extent superseded thereby (other than with respect to any economics referenced in paragraph 1 of the Fee Letter).

 

10


 


 

The Commitment Party shall treat confidentially all information delivered to the Commitment Party by you, the Company, the Sponsor or your or its respective affiliates and representatives in connection with the Acquisition and the other Transactions and only use such information for the purposes of providing the services contemplated by this Commitment Letter; provided, however, that nothing herein shall prevent the Commitment Party from disclosing any such information (a) to rating agencies in connection with obtaining the ratings described above, (b) to any Lenders or participants or prospective Lenders or participants (other than Disqualified Institutions), (c) in any legal, judicial, or administrative proceeding or other compulsory process or otherwise as required by applicable law, rule or regulations or as requested by a governmental authority (in which case the Commitment Party shall promptly notify you, in advance, to the extent permitted by law, rule or regulation, except with respect to any audit or examination conducted by bank accountants or any governmental bank regulatory authority exercising examination or regulatory authority, in which case, promptly notify you, in advance, to the extent lawfully permitted to do so), (d) upon the request or demand of any governmental or regulatory authority having jurisdiction over the Commitment Party or any of its affiliates or upon the good faith determination by counsel that such information should be disclosed in light of ongoing oversight or review of the Commitment Party by any such governmental or regulatory authority having jurisdiction over the Commitment Party or its affiliates (in which case the Commitment Party shall, except with respect to any audit or examination conducted by bank accountants or any governmental bank regulatory authority exercising examination or regulatory authority, promptly notify you, in advance, to the extent lawfully permitted to do so), (e) to the officers, directors, employees, legal counsel, independent auditors, professionals and other experts or agents of the Commitment Party (collectively, “Representatives”) on a “need-to-know” basis and who are informed of the confidential nature of such information and agree to keep information of this type confidential, (f) to any of its affiliates related funds, and managed accounts and Representatives of its affiliates related funds, and managed accounts on a “need-to-know” basis (provided, that the Commitment Party shall be responsible for the compliance of its Representatives, affiliates and Representatives of its affiliates with this paragraph) solely in connection with the Facilities and the related Transactions and matters reasonably related thereto, (g) to the extent any such information becomes publicly available other than by reason of disclosure by the Commitment Party, its affiliates or Representatives in breach of this Commitment Letter or other obligation of confidentiality owed to you, the Sponsor, the Company or their respective affiliates, (h) for purposes of establishing a “due diligence” defense, (i) to the extent that such information is received by the Commitment Party or its Representatives from a third party that is not known by the Commitment Party to be subject to applicable confidentiality obligations to you or your affiliates, the Sponsor or the Company or its affiliates and (j) to enforce their respective rights or remedies hereunder or under the Fee Letter or the Facilities Documentation; provided, that the disclosure of any such information to any Lenders or prospective Lenders or participants referred to above shall be made subject to the acknowledgment and acceptance by such Lender or prospective Lender or participant that such information is being disseminated on a confidential basis (on substantially the terms set forth in this paragraph or as is otherwise reasonably acceptable to you and the Commitment Party, including, without limitation, as agreed in any confidential information memorandum or other marketing materials) in accordance with the standard syndication processes of the Commitment Party or customary market standards for dissemination of such type of information, in the event of any electronic access through Intralinks, another website or similar electronic system or

 

11



 

platform, which shall in any event require “click through” or other affirmative action on the part of the recipient to access such information and acknowledge its confidentiality obligations in respect thereof, in each case on terms reasonably acceptable to you. The Commitment Party’s obligations under this paragraph shall automatically terminate and be superseded by the confidentiality provisions in the Facilities Documentation upon the execution and delivery thereof and shall in any event terminate two (2) years after the date hereof.

 

10.       Miscellaneous

 

This Commitment Letter shall not be assignable by any party hereto (except (i) by you to one or more of your affiliates that is a newly formed domestic “shell” company controlled, directly or indirectly, by the Sponsor to effect the consummation of the Acquisition and (ii) by the Commitment Party to one or more of its affiliates) without the prior written consent of the Commitment Party or you, as applicable (and any purported assignment without such consent shall be null and void), is intended to be solely for the benefit of the parties hereto and the indemnified persons and is not intended to and does not confer any benefits upon, or create any rights in favor of, any person other than the parties hereto and the indemnified persons to the extent expressly set forth herein, except to the extent that you and we otherwise agree in writing and is not intended to create a fiduciary relationship among the parties hereto. This Commitment Letter may not be amended or waived except by an instrument in writing signed by you and the Commitment Party. This Commitment Letter may be executed in any number of counterparts, each of which shall be an original, and all of which, when taken together, shall constitute one agreement. Delivery of an executed signature page of this Commitment Letter by facsimile or other electronic transmission (e.g., “pdf” or “tif”) shall be effective as delivery of a manually executed counterpart hereof. This Commitment Letter and the Fee Letter are the only agreements that have been entered into among us and you with respect to the Facilities and set forth the entire understanding of the parties with respect thereto. Subject to the limitations set forth in this Commitment Letter, the Commitment Party may perform the duties and activities described hereunder through any of its affiliates (other than any Disqualified Institutions) and the provisions of the third paragraph immediately preceding this paragraph shall apply with equal force and effect to any of such affiliates so performing any such duties or activities. This Commitment Letter shall be governed by, and construed and interpreted in accordance with, the laws of the State of New York without regard to principles of conflicts of law; provided, however, that the laws of the State of Delaware shall govern in determining (a) the interpretation of a “Material Adverse Effect” and whether a “Material Adverse Effect” has occurred, (b) the accuracy of any Specified Acquisition Agreement Representation and whether as a result of any inaccuracy thereof you (or your affiliates) have the right (without regard to any notice requirement) to terminate your (or their) obligations (or to refuse to consummate the Acquisition) under the Acquisition Agreement and (c) whether the Acquisition has been consummated in accordance with the terms of the Acquisition Agreement (in each case, without regard to principles of conflicts of law thereof, to the extent that the same are not mandatorily applicable by statute and would require or permit the application of the law of another jurisdiction). Each of the parties hereto agrees that (i) this Commitment Letter is a binding and enforceable agreement with respect to the subject matter herein, including an agreement to negotiate in good faith the Facilities Documentation by the parties hereto in a manner consistent with this Commitment Letter, notwithstanding that the funding of the Facilities is subject to the specified closing conditions set forth in Section 6 above and Exhibit D hereto and (ii) the Fee Letter is a

 

12



 

binding and enforceable agreement with respect to the subject matter contained therein. Section headings used herein are for convenience of reference only and are not to affect the construction of, or to be taken into consideration in interpreting, this Commitment Letter.

 

Each of the parties hereto (and, to the extent the benefits herein are accepted by such persons and entities, each other indemnified person) irrevocably and unconditionally (a) submits, for itself and its property, to the exclusive jurisdiction of any federal court sitting in the Borough of Manhattan in the City of New York or, if that court does not have subject matter jurisdiction, in any state court located in the City and County of New York, and any appellate court from any thereof, over any suit, action or proceeding arising out of or relating to the Transactions or the other transactions contemplated hereby, this Commitment Letter or the Fee Letter or the performance of services hereunder or thereunder or for recognition or enforcement of any judgment and agrees that all claims in respect of any such action or proceeding shall be heard and determined in such New York state or, to the extent permitted by law, in such federal court; provided, however, that the Commitment Party shall be entitled to assert jurisdiction over you and your property in any court in which jurisdiction may be held over you or your property under applicable law, and (b) agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. You and we agree that service of any process, summons, notice or document by registered mail addressed to any of the parties hereto at the applicable addresses above shall be effective service of process for any suit, action or proceeding brought in any such court. You and we hereby irrevocably and unconditionally waive, to the fullest extent you and we may legally and effectively do so, any objection to the laying of venue of any such suit, action or proceeding brought in any court in accordance with clause (a) of the first sentence of this paragraph and any claim that any such suit, action or proceeding has been brought in any inconvenient forum. YOU AND WE (AND, TO THE EXTENT THE BENEFITS HEREIN ARE ACCEPTED BY SUCH PERSONS AND ENTITIES, EACH OTHER INDEMNIFIED PERSON) HEREBY IRREVOCABLY WAIVE (TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW) TRIAL BY JURY IN ANY SUIT, ACTION, PROCEEDING, CLAIM OR COUNTERCLAIM BROUGHT BY OR ON BEHALF OF ANY PARTY RELATED TO OR ARISING OUT OF THE TRANSACTIONS, THIS COMMITMENT LETTER OR THE FEE LETTER OR THE PERFORMANCE OF SERVICES HEREUNDER OR THEREUNDER.

 

The Commitment Party hereby notifies you that, pursuant to the requirements of the USA PATRIOT Act, Title III of Pub. L. 107-56 (signed into law on October 26, 2001) (the “PATRIOT Act”), it is required to obtain, verify and record information that identifies the Borrower and each Guarantor, which information includes names, addresses, tax identification numbers and other information that will allow the Commitment Party and each Lender to identify the Borrower and each Guarantor in accordance with the PATRIOT Act. This notice is given in accordance with the requirements of the PATRIOT Act and is effective for the Commitment Party, each Lender and each prospective Lender.

 

The syndication, assistance, indemnification, jurisdiction, waiver of jury trial, service of process, venue, governing law, sharing of information, no agency or fiduciary duty, and confidentiality provisions contained herein and in the Fee Letter shall remain in full force and effect regardless of whether definitive financing documentation shall be executed and delivered

 

13



 

and notwithstanding the termination of this Commitment Letter or the commitments hereunder; provided, that your obligations under this Commitment Letter (other than (a) the confidentiality obligations, which shall terminate in accordance with their respective terms, (b) your understandings and agreements regarding no agency or fiduciary duty and (c) the syndication assistance provisions (including the obligation to update Information and Projections), which shall terminate at the end of the Syndication Period) shall automatically terminate and be superseded by the provisions of the Facilities Documentation upon the initial funding thereunder and the payment of all amounts owed pursuant to this Commitment Letter and the Fee Letter on the Closing Date, and you shall automatically be released from all liability in connection therewith at such time. You may terminate the Commitment Party’s commitments hereunder in whole (but not in part) at any time subject to the provisions of the preceding sentence.

 

If the foregoing correctly sets forth our agreement, please indicate your acceptance of the terms of this Commitment Letter and the Fee Letter by returning to us executed counterparts by Holdings of both of this Commitment Letter and the Fee Letter not later than 11:59 p.m., New York City time, on November 9, 2015. This Commitment Letter and the Fee Letter will automatically expire at such time if we have not received such executed counterparts in accordance with the preceding sentence. In the event that the initial borrowing under the Facilities does not occur on or before the Expiration Date (as defined below), then this Commitment Letter and the commitments hereunder shall automatically terminate unless we shall, in our sole discretion, agree in writing to an extension. “Expiration Date” means the earliest of (i) 11:59 p.m., New York City time, on the date that is 150 days after the execution date of the Acquisition Agreement, (ii) the Closing Date, (iii) the closing of the Acquisition without the use of the Facilities and (iv) the valid termination of the Acquisition Agreement prior to the closing of the Acquisition; provided that the termination of any commitment pursuant to this sentence does not prejudice your rights and remedies in respect of any breach of this Commitment Letter. In addition, our commitment hereunder to provide the Bridge Facility shall terminate and/or be reduced as, and to the extent, set forth in clause (e) of Exhibit A hereto.

 

[THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK]

 

14



 

We are pleased to have been given the opportunity to assist you in connection with this important financing.

 

 

Very truly yours,

 

 

 

JEFFERIES FINANCE LLC

 

 

 

 

 

By

/s/ Brian Buoye

 

 

  Name:

Brian Buoye

 

 

  Title:

Managing Director

 

[Project Rhombus – Commitment Letter Signature Page]

 



 

Accepted and agreed to as of
the date first above written:

 

 

 

RT RHOMBUS HOLDINGS, INC., a
Delaware corporation

 

 

 

 

 

 

 

By:

/s/ Ben Kohn

 

Name:

Ben Kohn

 

Title:

President

 

 

[Project Rhombus – Commitment Letter Signature Page]

 



 

EXHIBIT A

 

PROJECT RHOMBUS

 

$15.0 Million Revolving Facility

$300.0 Million Bridge Facility

Transaction Summary

 

Capitalized terms used but not defined in this Exhibit A shall have the meanings set forth in the letter to which this Exhibit A is attached or in Exhibits B, C or D thereto.

 

The Sponsor and certain other investors designated by Sponsor (together with the Sponsor, collectively, the “Investors”) intend, directly or indirectly, to acquire RealD Inc., a Delaware corporation (the “Company”) and its subsidiaries, all as set forth in the below-defined Acquisition Agreement. In connection therewith:

 

(a)        RT Cinema Holdings, LLC, a Delaware limited liability company (“Ultimate Holdings”), which owns 100% of the equity of Holdings and is controlled directly or indirectly by the Sponsor, and Rhombus Merger Sub, Inc., a Delaware corporation (“Merger Sub”), a direct subsidiary of Holdings, will enter into that certain Agreement and Plan of Merger, dated as of November 8, 2015, with certain other parties thereto (together with the exhibits and disclosure schedules thereto, the “Acquisition Agreement”), whereby Merger Sub will merge with and into the Company (the “Merger”) with the Company continuing as the surviving corporation of the Merger pursuant to the terms of the Acquisition Agreement. Immediately after giving effect to the Merger, the Company will become and assume the obligations of Merger Sub as the Borrower.

 

(b)        The Investors, directly or indirectly, will contribute an amount in cash to Ultimate Holdings (which will subsequently contribute such amount to Holdings as common capital and which Holdings will contribute to Merger Sub as common capital) as common equity and/or Qualified Preferred Equity (to be defined on terms reasonably acceptable to the Lead Arranger (and the Lead Arranger confirms that the terms set forth in the Preferred Commitment Letter (as defined in the Acquisition Agreement) are acceptable)), which, when combined with the value of the equity investment of certain existing equity holders of the Company rolled over or otherwise invested in connection with the Transactions on or prior to such time (such contribution of common equity, Qualified Preferred Equity and rolled over equity, the “Equity Contribution”), will constitute immediately after giving effect to the Acquisition, in the aggregate not less than 47.5% of sum of (1) the aggregate amount of the Facilities and/or the Notes funded on the Closing Date and any other indebtedness for borrowed money plus (2) the amount of the Equity Contribution; provided that immediately upon the consummation of the Acquisition, the Sponsor will hold, directly or indirectly, the power to vote, or direct the voting of, Equity Interests constituting no less than 50.1% of the aggregate amount of the issued and outstanding voting equity of Holdings.

 

(c)        All existing third party debt for borrowed money of the Company and its subsidiaries, if any, will be refinanced, commitments related thereto will be terminated

 

A-1



 

and security interests or guaranties provided in connection therewith will be terminated or released (the “Refinancing”), other than, in each case, Permitted Surviving Debt.

 

(d)       The Borrower will obtain a senior secured revolving credit facility (the “Revolving Facility”) as described in Exhibit B to the Commitment Letter.

 

(e)        The Borrower will (i) issue and sell senior secured notes in a Rule 144A or other private placement yielding $300.0 million in gross cash proceeds consisting of dollar denominated senior secured notes (the “Notes”) and/or (ii) to the extent that less than $300.0 million in gross cash proceeds of Notes are received by the Borrower on or prior to the Closing Date, borrow up to the difference in senior secured increasing rate loans under a senior secured bridge credit facility as described in Exhibit C to the Commitment Letter (the “Bridge Facility” and, together with the Revolving Facility, the “Facilities”) consisting of senior secured increasing rate loans in the original principal amount of $300.0 million (the “Bridge Loans”), minus the gross cash proceeds received by the Borrower on or prior to the Closing Date from the Notes issued on or prior to the Closing Date.

 

(f)        The proceeds of the Equity Contribution, the Bridge Facility and/or the Notes and/or cash on hand at the Company and its subsidiaries on the Closing Date will be applied to fund the Acquisition and the Refinancing and to pay the fees, premiums, expenses and other transaction costs incurred in connection with the Transactions (as defined below), including those amounts set forth in the Fee Letter (the “Transaction Costs”).

 

The transactions described above are collectively referred to herein as the “Transactions”. For purposes of the Commitment Letter and the Fee Letter, the “Closing Date” shall mean the date of the satisfaction or waiver of the Exclusive Funding Conditions, the funding of the Facilities and the consummation of the Acquisition.

 

A-2



 

EXHIBIT B

 

PROJECT RHOMBUS

 

Revolving Facility

Summary of Terms and Conditions

 

Set forth below is a summary of the principal terms and conditions for the Revolving Facility. Capitalized terms used but not defined in this Exhibit B shall have the meanings set forth in the letter to which this Exhibit B is attached or in Exhibits A, C or D attached thereto.

 

1.         PARTIES

 

Borrower:

Initially, Merger Sub, and, following the Acquisition, the Company as the survivor of the Merger contemplated thereby (collectively, the “Borrower”).

 

 

Guarantors:

Holdings and each of the Borrower’s direct and indirect wholly-owned U.S. subsidiaries (collectively, the “Guarantors” and together with Holdings and the Borrower, each a “Loan Party” and collectively, the “Loan Parties”), except (i) any U.S. subsidiary of a foreign subsidiary, any U.S. subsidiary that has no material assets other than the capital stock of, or debt obligations or other investments in, foreign subsidiaries, or any U.S. subsidiary treated as disregarded as an entity separate from its owner under Treasury Regulations Section 301.7701-3 that owns an interest in the stock or debt obligations of a foreign corporation (each, a “Pass-Through Foreign Holdco”), (ii) unrestricted subsidiaries, (iii) captive insurance companies, (iv) not-for-profit subsidiaries, (v) special purpose entities, (vi) immaterial subsidiaries (defined in a manner to be mutually agreed, the “Immaterial Subsidiaries”), (vii) to the extent a guarantee is prohibited or restricted by contracts with an unaffiliated third party as in existence on the Closing Date or at the time such subsidiary becomes a subsidiary and not entered into in contemplation thereof or by applicable law (including any requirement to obtain governmental authority or third party consent), rule or regulation or could result in material adverse tax consequences as reasonably determined in good faith by Borrower in consultation with the Revolving Facility Administrative Agent and (viii) to the extent the Revolving Facility Administrative Agent and Borrower mutually determine the cost and/or burden (including any adverse tax consequences) of obtaining the guaranty outweigh the benefit to the Revolving Lenders shall be required to provide an unconditional guaranty (collectively, the “Guarantees”) of all amounts owing under the Revolving Facility and all obligations of the Borrower and the Guarantors under any

 

B-1



 

 

swap and cash management obligation to any Revolving Lender or Lead Arranger or the Revolving Facility Administrative Agent or any affiliate of the foregoing, or any person that is any of the foregoing at the time such swap or cash management obligation was entered into unless expressly designated to the Revolving Facility Administrative Agent as not an Obligation by the Borrower pursuant to arrangements to be agreed (the “Secured Banking Arrangements”).

 

 

 

Notwithstanding anything to the contrary contained herein, the requirements of the preceding paragraph shall be, as of the Closing Date, subject to the limitations set forth in the Commitment Letter.

 

 

 

All the above-described guarantees shall be created on terms, and pursuant to documentation mutually and reasonably satisfactory to the Revolving Facility Administrative Agent and the Borrower.

 

 

 

Notwithstanding anything to the contrary, the Revolving Facility Documentation shall include customary exclusions for Guarantors that are not “eligible contract participants” (as defined in the Commodity Exchange Act (7 U.S.C. section 1 et seq., as amended from time to time), and any successor statute) from guaranteeing obligations of any Loan Party that relate to the hedging arrangements or any other swap or other hedge obligations or arrangements.

 

 

 

Any guarantees to be issued in respect of the Bridge Facility or the Notes (as applicable) shall rank pari passu in right of payment with the Obligations under the Guarantees.

 

 

Revolving Facility Administrative Agent:

Jefferies Finance.

 

 

Lead Arranger:

Jefferies Finance (in such capacity, the “Lead Arranger”)

 

 

Lenders:

A syndicate of banks, financial institutions and other entities, including the Initial Lender, arranged by the Commitment Party (excluding any Disqualified Institutions) (collectively, the “Revolving Lenders”); provided, that nothing herein shall affect the consent rights of the Borrower set forth below under the heading “Assignments and Participations.”

 

2.         TYPES AND AMOUNTS OF REVOLVING CREDIT FACILITY

 

Type and Amount:

A senior secured revolving credit facility (the “Revolving Facility”; the commitments thereunder, the “Revolving

 

B-2



 

 

Commitments”) in an aggregate principal amount of $15.0 million (the loans thereunder, together with (unless the context otherwise requires) the Swingline Loans referred to below, the “Revolving Loans”). The Revolving Loans will be available in US Dollars.

 

 

Availability and Maturity:

The final maturity date of the Revolving Facility shall be four and one-half (4 1/2) years from the Closing Date (the “Revolving Loan Maturity Date”).

 

 

 

Revolving Loans may be borrowed, repaid and reborrowed on and after the Closing Date (without premium or penalty) and prior to the Revolving Loan Maturity Date in accordance with the terms of the Revolving Facility Documentation referred to below; provided, that no Revolving Loans shall be borrowed on the Closing Date.

 

 

Use of Proceeds:

The proceeds of the Revolving Loans will be used after the Closing Date, to finance the working capital needs of the Borrower and its restricted subsidiaries and for general corporate purposes of the Borrower and its restricted subsidiaries (including for capital expenditures, acquisitions, investments, restricted payments and any other transaction not prohibited by the Revolving Facility Documentation).

 

 

Letters of Credit:

An amount to be agreed of the Revolving Facility shall be available for the issuance of stand-by and documentary letters of credit (the “Letters of Credit”) by Jefferies Finance or any Revolving Lender reasonably satisfactory to the Revolving Facility Administrative Agent and the Borrower (in such capacity, the “Issuing Lender”); provided that no Issuing Lender shall be required to issue documentary Letters of Credit without its consent and the aggregate amount of all Letters of Credit issued by a Revolving Lender shall not exceed such Revolving Lender’s ratable share of the Revolving Commitments. No Letter of Credit shall have an expiration date after the earlier of (a) one year (180 days in the case of documentary letters of credit) after the date of issuance unless consented to by the Issuing Lender and (b) five business days prior to the Revolving Loan Maturity Date (unless 103% cash collateralized or backstopped with another letter of credit for the period thereafter); provided, that any Letter of Credit with a one-year tenor may provide for the renewal thereof for additional one-year periods (which shall in no event extend beyond the date referred to in clause (b) above, unless 103% cash collateralized or backstopped with another letter of credit for the period thereafter). Letters of Credit shall be issued in US Dollars.

 

B-3



 

 

Drawings under any Letter of Credit shall be reimbursed by the Borrower (whether with its own funds or with the proceeds of Revolving Loans) within one business day after notice of such drawing. To the extent that the Borrower does not so reimburse the Issuing Lender, the Revolving Lenders shall be irrevocably and unconditionally obligated to fund participations in the reimbursement obligations on a pro rata basis.

 

 

 

Letters of Credit may be issued on the Closing Date to replace or provide credit support for any existing letters of credit (including by “grandfathering” such existing letters of credit into the Revolving Facility).

 

 

 

If any Revolving Lender becomes a “defaulting lender” (to be mutually defined), then the Letter of Credit exposure of such defaulting Revolving Lender will automatically be reallocated among the non-defaulting Revolving Lenders pro rata in accordance with their commitments under the Revolving Facility up to an amount such that the revolving credit exposure of such non-defaulting Revolving Lender does not exceed its commitment. In the event that such reallocation does not fully cover the Letter of Credit exposure of such defaulting lender, the applicable Issuing Lender may require the Borrower to 103% cash collateralize such “uncovered” exposure in respect of each outstanding Letter of Credit and will have no obligation to issue new Letters of Credit, or to extend, renew or amend existing Letters of Credit to the extent Letter of Credit exposure would exceed the commitments of the non-defaulting Revolving Lenders, unless such “uncovered” exposure is 103% cash collateralized.

 

 

Swingline Loans:

An amount to be agreed of the Revolving Facility shall be available for swingline loans (the “Swingline Loans”) from the Revolving Facility Administrative Agent (in such capacity, the “Swingline Lender”) on same-day notice in integral multiples to be agreed. Any Swingline Loans will reduce availability under the Revolving Facility on a dollar-for-dollar basis. Each Revolving Lender shall be irrevocably and unconditionally required to purchase a participation in each Swingline Loan on a pro rata basis; provided that in no event shall the swingline exposure of any Revolving Lender exceed its Revolving Commitments. Swingline Loans shall be settled on a weekly basis.

 

 

 

If any Revolving Lender becomes a defaulting lender, then the Swingline Loan exposure of such defaulting lender will

 

B-4



 

 

automatically be reallocated among the non-defaulting lenders pro rata in accordance with their Revolving Commitments up to an amount such that the revolving credit exposure of such non-defaulting lender does not exceed its commitments. In the event that such reallocation does not fully cover the Swingline Loan exposure of such defaulting lender, the Swingline Lender may require the Borrower to repay such “uncovered” exposure and will have no obligation to make new Swingline Loans to the extent Swingline Loan exposure would exceed the commitments of the non-defaulting lenders.

 

3.         CERTAIN PAYMENT PROVISIONS

 

Fees and Interest Rates:

As set forth in Annex I to Exhibit B attached hereto.

 

 

Closing Fees:

As set forth in the Fee Letter.

 

 

Optional Prepayments and Commitment Reductions:

Optional prepayments of borrowings under the Revolving Facility and optional reductions of the unutilized portion of the commitments thereunder will be permitted at any time, in minimum principal amounts to be agreed, without premium or penalty (subject to reimbursement of the Revolving Lenders’ redeployment costs in the case of a prepayment of Eurodollar Loans other than on the last day of the relevant interest period).

 

 

Mandatory Prepayments:

Subject to the Intercreditor Agreement, the following amounts will be applied to prepay Revolving Loans, with no corresponding permanent reduction of the Revolving Commitments:

 

 

 

(a)      100% of the net proceeds of any incurrence of indebtedness after the Closing Date (other than indebtedness permitted under the Revolving Facility Documentation) by Holdings or any of its subsidiaries; and

 

 

 

(b)      100% of the net proceeds of any non-ordinary course sale or other disposition of assets by the Borrower or any of its subsidiaries (including (i) as a result of casualty or condemnation and (ii) any issuance or sale of equity by Holdings or any of its subsidiaries) (with certain exceptions and reinvestment rights to be mutually agreed upon).

 

 

 

All such mandatory prepayments shall be applied without premium or penalty (except for breakage costs, if any) to the outstandings under the Revolving Facility (without a concomitant and equal reduction of the commitments thereunder).

 

 

 

The Revolving Loans will be prepaid or the Letters of Credit will

 

B-5



 

 

be cash collateralized so that the outstandings under the Revolving Facility do not at any time exceed the Revolving Commitments.

 

 

4.         COLLATERAL

 

 

Collateral:

Subject to the Certain Funds Provision and the provisions of the immediately following paragraph, (i) the obligations of the Borrower and the Guarantors in respect of the Revolving Facility and (ii) the Secured Banking Arrangements shall be secured by (a) perfected pledge of all the capital stock of the Borrower and a perfected pledge of all the capital stock in first-tier, wholly-owned restricted subsidiaries directly held by the Borrower or any Guarantor (which pledge, (i)(A) in the case of equity interests of all existing first-tier foreign subsidiaries shall be limited to 100% of the non-voting equity interests (if any) and 65% of the voting equity interests of such foreign subsidiary and such pledges shall be documented under New York law, (B) in the case of equity interests of any Pass-Through Foreign Holdco shall be limited to 100% of the non-voting equity interests (if any) and 65% of the voting equity interests of such Pass-Through Foreign Holdco, (ii) shall not include any equity interests in a joint venture, (iii) shall not include equity interests in entities where any Loan Party holds 50% or less of the outstanding equity interests of such entity and (iv) shall not include the equity interests of the Immaterial Subsidiaries or any unrestricted subsidiaries; and (b) perfected security interests in substantially all other property of the Borrower and the Guarantors (the “Collateral”), in each case subject to permitted liens and to certain customary exceptions.

 

 

 

Notwithstanding anything to the contrary, (A) no action shall be taken to grant (other than in the case of clauses (v) and (x) below) or perfect any security interest in any of the following: (a)(i) any fee-owned real property located outside the U.S.; (ii) any fee-owned real property located in the U.S. having a fair market value equal to or less than an amount to be mutually agreed; (iii) any leasehold interest (with no requirement to obtain leasehold mortgages, landlord waivers, estoppels or collateral access letters); (iv) motor vehicles, airplanes, vessels and other assets subject to certificates of title; (v) letter of credit rights (other than to the extent consisting of a supporting obligation that can be perfected by the filing of a Uniform Commercial Code financing statement), chattel paper, intercompany notes and commercial tort claims less than amounts to be mutually determined; (vi) any governmental licenses or state or local franchises, charters and authorizations to the extent security interest is prohibited or restricted thereby (except to the extent

 

B-6



 

 

such prohibition or restriction is ineffective under the Uniform Commercial Code); (vii) pledges and security interests prohibited or restricted by applicable law (including any requirement to obtain the consent of any governmental authority or third party) or impossible or impracticable to obtain under applicable law; (viii) any lease, license or agreement or any property subject to a permitted agreement binding on the asset at the time of the acquisition thereof to the extent that a grant of a security interest therein would violate or invalidate, such lease, license or agreement or create a right of termination in favor of any other party thereto or otherwise require consent thereunder (after giving effect to the applicable anti-assignment provisions of the Uniform Commercial Code or other applicable law) other than proceeds and receivables thereof; (ix) any assets to the extent a security interest in such assets could reasonably be expected to result in material adverse tax consequences as reasonably determined by the Borrower in consultation with the Revolving Facility Administrative Agent; (x) cash and cash equivalents (other than cash and cash equivalents representing proceeds of other “Collateral”), deposit and securities accounts (including securities entitlements and related assets) and any other assets requiring perfection through control agreements or perfection by “control” (other than certificates evidencing equity in the Borrower and certain of its subsidiaries required to be pledged pursuant to the preceding paragraph (or, if applicable, uncertificated security control agreements), instruments and tangible chattel paper) (control agreements or perfection by “control” shall not be required in any event) (in each case except to the extent that a lien on such assets can be perfected by the filing of a Uniform Commercial Code financing statement); (xi) any intent-to-use application trademark application prior to the filing of a “Statement of Use” or “Amendment to Allege Use” with respect thereto; (xii) interests in joint ventures and non-wholly owned subsidiaries which cannot be pledged without the consent of third parties after giving effect to the applicable anti-assignment provisions of the Uniform Commercial Code or other applicable law; (xiii) any property subject to a purchase money arrangement or capital leases or any cash collateral securing letters of credit outstanding on the Closing Date; (xiv) equity interests and assets of unrestricted subsidiaries and certain (to be agreed) Immaterial Subsidiaries; and (xv) assets where the cost of obtaining a security interest therein (including any adverse tax consequences) exceeds the practical benefit to the Revolving Lenders afforded thereby, as mutually and reasonably determined by the Revolving Facility Administrative Agent and the Borrower; (B) any non-U.S. assets or assets that require action under the law of any non-U.S.

 

B-7



 

 

jurisdiction to create or perfect a security interest in such assets, including any intellectual property registered in any non-U.S. jurisdiction (and no security agreements or pledge agreements governed under the laws of any non-U.S. jurisdiction); and (C) certain other assets and property to be mutually and reasonably agreed.

 

 

 

All the above-described pledges, security interests and mortgages shall be created on terms to be mutually agreed and subject to exceptions permitted under the Revolving Facility Documentation. Notwithstanding the foregoing, the requirements of the preceding paragraphs of this “Collateral” section shall be, as of the Closing Date, subject to the Certain Funds Provision. No foreign law governed documents or foreign law opinions shall be required in connection with the Revolving Facility Documentation.

 

 

Intercreditor Agreement:

The liens securing the Revolving Facility and any Secured Banking Arrangements will be senior in priority to the liens securing the Bridge Facility or the Notes (as applicable). The indebtedness under the Revolving Facility and the Guarantees will rank pari passu in right of payment with the indebtedness under the Bridge Facility and the Notes and the guarantees, respectively, thereof. The priority of the security interests and related creditor rights between the Revolving Facility (and any Secured Banking Arrangements) and the Bridge Facility or the Notes will be set forth in an intercreditor agreement (the “Intercreditor Agreement”) containing customary provisions for second-lien bridge facilities similar to the Bridge Facility or second-lien notes of a type similar to the Notes, and otherwise reasonably satisfactory to the Revolving Facility Administrative Agent.

 

5.                                    CERTAIN CONDITIONS

 

 

Initial Conditions:

Subject to the Certain Funds Provision, the availability of the Revolving Facility on the Closing Date will be subject only to the Exclusive Funding Conditions.

 

 

On-Going Conditions after the Closing Date:

After the Closing Date, the making of each Revolving Loan or the issuance of a Letter of Credit shall be conditioned upon (a) delivery of a notice of borrowing or credit extension, (b) the accuracy in all material respects (or in all respects if qualified by materiality or material adverse effect) of all representations and warranties in the Revolving Facility Documentation and (c) there being no default or event of default in existence at the time of, or immediately after giving effect to the making of, such extension

 

B-8



 

 

of credit.

 

 

6.                                    DOCUMENTATION

 

 

Representations and Warranties:

Limited to the following (applicable to the Borrower and its restricted subsidiaries and, in certain instances to be agreed, Holdings, to be made as provided in “CERTAIN CONDITIONS — On-Going Conditions” described above), subject, in each case, in all respects to the Certain Funds Provision), in each case with customary materiality qualifiers, thresholds, exceptions, limitations and qualifications to be mutually agreed: organizational existence and qualification; entity power and authorization; compliance with laws; no contravention with organizational documents and applicable law; governmental authorizations; due authorization, execution, delivery and enforceability of the Revolving Facility Documentation; accuracy of financial statements and other written information; projections; disclosure; no Material Adverse Effect (after the Closing Date); litigation; labor matters; ownership of property; taxes; margin regulations; Investment Company Act; intellectual property; ERISA compliance; environmental matters; passive holding companies; insurance; OFAC, FCPA, PATRIOT Act and other anti-terrorism and anti-money laundering laws; subsidiaries; solvency of Holdings and its restricted subsidiaries (on a consolidated basis) as of the Closing Date; use of proceeds; and creation and perfection of security interests in Collateral (subject to the Certain Funds Provision above, permitted liens and other exceptions to perfection to be mutually agreed).

 

 

 

Material Adverse Effect” means, after the Closing Date, any event, change or condition that, individually or in the aggregate, has had, or would reasonably be expected to have (a) a material adverse effect on the business or financial condition or results of operations of Holdings and its restricted subsidiaries, taken as a whole, (b) a material and adverse effect on the material rights and remedies of the Revolving Facility Administrative Agent (other than due to the action or inaction of the Revolving Facility Administrative Agent, the Revolving Lenders or any other secured party under the Revolving Facility Documentation) or (c) a material and adverse effect on the ability of the Borrower and Guarantors, taken as a whole, to perform their payment obligations under the Revolving Facility Documentation.

 

 

Affirmative Covenants (Including Reporting Requirements):

Subject to the Certain Funds Provision, and limited to the following (applicable to), the Borrower and its restricted subsidiaries and, in certain instances to be agreed, Holdings), in each case with customary materiality qualifiers, thresholds, exceptions, limitations

 

B-9



 

 

and qualifications to be mutually agreed: (x) quarterly (for each of the first three quarters of each fiscal year commencing with the first fiscal quarter ending after the Closing Date) unaudited financials within 45 days after such fiscal quarter end (60 days for each of the first two fiscal quarters ending after the Closing Date that are not year ends), and (y) annual audited financial statements (accompanied by an audit opinion from a nationally recognized accounting firm or other accounting firm reasonably acceptable to the Revolving Facility Administrative Agent without any qualification or exception as to “going concern” or the scope of the audit, except any “going concern” qualification or exception as a result of current maturity of the Revolving Facility) within 90 days after the fiscal year end (135 days for the fiscal year ending March 31, 2016; provided that the Borrower shall be required to deliver quarterly unaudited financials for the fourth quarter of such fiscal year within 75 days after such fiscal quarter end), in each case, for Borrower and its restricted subsidiaries on a consolidated basis (accompanied, in the case of clauses (x) and (y), by customary management discussion and analysis); compliance certificates with such financial statements (which shall not include a bring down of any representations or warranties); annual budgets (on a quarterly basis for the then current year) within 90 days after the beginning of fiscal year; notices upon defaults and events of default under the Revolving Facility and other customary material events; other information about the operations, business affairs and financial condition of the Holdings and its restricted subsidiaries upon reasonable written request of the Revolving Facility Administrative Agent (other than information subject to attorney/client privilege or confidentiality obligations not created in contemplation of the Revolving Facility); payment of taxes; preservation of existence; maintenance of properties material to the business (other than ordinary wear and tear, casualty and condemnation); maintenance of adequate insurance; compliance with laws; ERISA compliance; environmental matters; PATRIOT Act, OFAC, FCPA, embargoed persons and other anti-terrorism and anti-money laundering laws; books and records; inspection rights; changes in fiscal year; covenant to guarantee obligations and give security; limitations on material changes to line of business; use of proceeds; additional security and guarantees; further assurances (including information regarding collateral); designation of unrestricted subsidiaries; maintenance of intellectual property rights; and quarterly lender conference calls.

 

 

Financial Covenant:

A maximum Total Net Leverage Ratio (the “Financial Covenant”), which covenant will be tested on a quarterly basis at the end of each full fiscal quarter after the Closing Date, commencing with the

 

B-10



 

 

second full fiscal quarter ending after the Closing Date, where the aggregate principal amount of all Revolving Loans and Swingline Loans and the face amount of all issued and outstanding Letters of Credit outstanding under the Revolving Facility exceeds 35% of the Revolving Commitments, and shall be based on a 30% cushion to Consolidated EBITDA (to be defined in the Revolving Facility Documentation) for each rolling four-quarter period of Borrower and its restricted subsidiaries set forth in the projection model delivered by the Sponsor to the Lead Arranger on October 11, 2015 (the “Projections”).

 

 

 

Any cash common equity or Qualified Preferred Equity (collectively, “Permitted Equity”) contribution made to Holdings (and then immediately contributed, directly or indirectly, as cash common equity to the Borrower) during any applicable fiscal quarter and on or prior to the day that is fifteen (15) business days after the day on which financial statements are required to be delivered for such fiscal quarter (such period, the “Cure Period”) will, at the request of the Borrower, be included in the calculation of Consolidated EBITDA solely for the purposes of determining compliance with the Financial Covenant at the end of such fiscal quarter and applicable subsequent periods which include such fiscal quarter (any such equity contribution so included in the calculation of Consolidated EBITDA, a “Specified Equity Contribution”); provided that (a) no more than two Specified Equity Contribution may be made in any consecutive four fiscal quarter period, and no more than five (5) Specified Equity Contributions may be made during the term of the Revolving Facility, (b) the amount of any Specified Equity Contribution shall be no greater than the amount required to cause the Borrower to be in compliance with the Financial Covenant, and (c) all Specified Equity Contributions shall be disregarded for all purposes under the Revolving Facility Documentation, including for purposes of determining any increase to any baskets with respect to covenants contained in the Revolving Facility Documentation and for any other calculation of Consolidated EBITDA other than for purposes of determining compliance with the Financial Covenant and if used to prepay the Revolving Loans, for reducing pro forma Consolidated Indebtedness as described in the subsequent paragraph. So long as the Borrower provides notice of its intent to effectuate a Specified Equity Contribution during the first 5 business days of the Cure Period, until the expiration of the Cure Period, (i) no actions or remedies in respect of the default under the Financial Covenant may be taken by the Revolving Facility Administrative Agent or any Revolving Lender during the period prior to the receipt of a Specified Equity Contribution unless the applicable 15 business day

 

B-11



 

 

period has expired without the making of the Specified Equity Contribution, (ii) the Borrower shall not be permitted to borrow Revolving Loans or Swingline Loans and new Letters of Credit shall not be issued unless and until the Specified Equity Contribution is made or all existing events of default are waived or cured and (iii) if the Specified Equity Contribution is not made on or before the expiration of the Cure Period, the Revolving Facility Administrative Agent and any Revolving Lender may take any actions or remedies permitted under the Revolving Facility Documentation; provided that if the Borrower does not provide notice of its intent to effectuate a Specified Equity Contribution during the first 5 business days of the Cure Period, the restrictions in the foregoing clause (i) shall not apply.

 

 

 

To the extent any Specified Equity Contribution is used to prepay the Revolving Loans (so long as such prepayment is accompanied by permanent reductions of the Revolving Commitments), there shall be a pro forma reduction in Consolidated Indebtedness (as defined in the Revolving Facility Documentation) for determining compliance with the Financial Covenant in future quarters.

 

 

Negative Covenants:

Limited to the following (to be applicable to Holdings, the Borrower and its restricted subsidiaries): indebtedness (including mandatorily redeemable equity interests, guarantees and other contingent obligations with respect to indebtedness); liens; sale and leaseback transactions; investments (including acquisitions, loans, etc.), loans and advances (with carve outs for, among others to be agreed, (a) loans or advances to employees in an amount not to exceed an amount to be agreed and (b) investments, loans and advances to joint ventures (including non-wholly owned subsidiaries) in an amount to be agreed); asset sales; mergers, acquisitions, consolidations, liquidations and dissolutions; dividends and other payments in respect of equity interests and other restricted payments; transactions with affiliates; prepayments, redemptions and repurchases of subordinated, junior lien or unsecured indebtedness; modifications of organizational documents or debt instruments; limitations on certain restrictions on subsidiaries; limitations on issuance of capital stock and creation of subsidiaries; limitations on business activities; limitations on accounting changes; changes in fiscal year and fiscal quarter; and no further negative pledges. Special purpose “holding company” covenants shall apply at all times to Holdings.

 

 

 

The negative covenants will be subject to exceptions, qualifications and “baskets” to be mutually agreed upon. The negative covenants will also permit the creation of joint ventures and investments in,

 

B-12



 

 

and loans and advances to, joint ventures in respect of certain lines of business or geographical expansions, in each case subject to limitations to be agreed.

 

 

Unrestricted Subsidiaries:

The Revolving Facility Documentation will contain provisions pursuant to which, subject to customary limitations on investments, loans, advances to, and other investments in, unrestricted subsidiaries, the Borrower will be permitted to designate any existing or subsequently acquired or organized subsidiary as an “unrestricted subsidiary” and subsequently re-designate any such unrestricted subsidiary as a “restricted subsidiary”; provided that (a) no event of default shall have occurred and be continuing or immediately would result from any such designation, and (b) such designation of a restricted subsidiary as an unrestricted subsidiary shall be deemed to constitute an investment (or reduction in an outstanding investment in the case of a designation of an unrestricted subsidiary as a restricted subsidiary); provided, further, that any dividends, interest, returns, profits, distributions, income and similar amounts received in cash or cash equivalents in respect of such investment shall be added back to any investment basket used. Unrestricted subsidiaries will not be subject to the mandatory prepayment, representation and warranty, affirmative or negative covenant or event of default provisions of the Revolving Facility Documentation and the cash held by, results of operations, indebtedness and interest expense of unrestricted subsidiaries will not be taken into account for purposes of determining the Financial Covenant contained in the Revolving Facility Documentation.

 

 

Events of Default:

Limited to the following (applicable to Borrower, its restricted subsidiaries and, in certain instances, Holdings), and subject to grace periods to be agreed, notice requirements, thresholds, and materiality qualifications to be mutually agreed: defaults for nonpayment of principal, interest, fees or other amounts (with five (5) business day grace period for interest, fees and other amounts); failure to perform negative covenants (and the affirmative covenant to maintain the Borrower’s existence in its state of organization and deliver notices of default under the Revolving Facility Documentation) or, to the extent applicable, the Financial Covenant (provided, that the Borrower’s failure to perform or observe the Financial Covenant is subject to the equity cure rights mentioned in this Revolving Facility Term Sheet); incorrectness in any material respect of representations and warranties when made or deemed made; cross-defaults and cross-acceleration to other indebtedness subject to threshold amount to be mutually agreed (after all applicable grace and notice periods have expired); bankruptcy and insolvency proceedings (subject to a 60-day cure period in the case

 

B-13



 

 

of involuntary bankruptcy or insolvency proceedings), other than any Immaterial Subsidiary; monetary final and non-appealable judgment defaults subject to thresholds and threshold amounts to be mutually agreed (in excess of insurance and third party indemnities and taking into account any insurance deductibles); customary ERISA events that would result in a Material Adverse Effect; actual or asserted invalidity of the Revolving Facility Documentation or any material guarantee, material security or intercreditor documents or material portion of the Collateral (other than to the extent a result of the action or inaction of the Revolving Facility Administrative Agent, the Revolving Lenders, the other secured parties under the Revolving Facility Documentation or their affiliates, officers, employees, agents, attorneys or representatives); and change of control (to include a pre- and post-IPO provision and to include as permitted holders the direct and indirect equity holders of Holdings on the Closing Date and their affiliates (other than any portfolio companies controlled by such affiliates)).

 

 

Voting:

Amendments and waivers of the Revolving Facility Documentation will require the approval of Revolving Lenders (other than defaulting lenders) holding more than 50% of the aggregate principal amount of the Loans and Revolving Commitments (the “Required Lenders”), except that (i) the consent of each Revolving Lender directly and adversely affected thereby (but not the Required Lenders and in the case of (i)(a), only the Revolving Lenders increasing their commitments shall be deemed directly and adversely affected thereby) shall be required with respect to, (a) increases in the commitment of such Revolving Lender, (b) reductions of principal, interest or fees owed to such Revolving Lender (other than any waivers or extensions of mandatory prepayments or a waiver, extension or reduction in any default interest), (c) extensions of the final maturity or the scheduled due date of any interest or fee payment due to such Revolving Lender (other than waivers of default interest, defaults or events of default, waivers or extensions of any mandatory prepayments or default interest) and (d) “waterfall”, pro rata sharing and pro rata payment provisions (with any Revolving Lender declining payment or reducing a payment made to them being “directly and adversely affected”); (ii) the consent of all Revolving Lenders shall be required with respect to (a) releases of all or substantially all of the value of the Guarantors or all or substantially all of the Collateral, in each case, except as otherwise permitted and (b) reductions in voting thresholds; and (iii) the consent of the Revolving Facility Administrative Agent, the Issuing Lender and the Swingline Lender shall be required with respect to amendments and waivers directly affecting its rights or duties. It is understood that additional

 

B-14



 

 

extensions of credit permitted under the Revolving Facility Documentation shall not require the consent of all Revolving Lenders.

 

 

 

The Revolving Facility Documentation shall contain customary provisions relating to (a) “defaulting” lenders, Issuing Lender and agents (including for insolvency), including provisions relating to providing cash collateral to support Swingline Loans or Letters of Credit (after reallocation to other non-”defaulting” lenders), the suspension of voting rights and rights to receive fees of and interest, non-payment/escrow of amounts owed to, and assignment and (if no event of default exists) termination of commitments or Loans of, such Revolving Lenders and (b) the right of the Borrower to replace (and/or terminate commitments of) or pay off Loans and obligations in full owed to a Revolving Lender (as the Borrower shall elect) in connection with amendments and waivers requiring the consent of all Revolving Lenders or of all Revolving Lenders directly and adversely affected thereby (so long as the Required Lenders or at least a majority (in dollar amount) of the Revolving Lenders directly and adversely affected thereby consent, as applicable), increased costs, taxes, etc. and “defaulting” or insolvent Revolving Lenders.

 

 

Assignments and Participations:

Assignments and transfers shall require the prior written consent of the Borrower (not to be unreasonably withheld, conditioned or delayed (it being understood that the Borrower prohibiting assignments to a Disqualified Institutions is reasonable) and shall be deemed to be given if the Borrower has not responded within ten business days of a formal written request by the Revolving Facility Administrative Agent for such written consent) unless the new lender is an existing Revolving Lender, an affiliate of a Revolving Lender, a related fund of a Revolving Lender, or a managed account of the Revolving Lender or during a payment or bankruptcy event of default or in connection with the primary syndication of the Revolving Facility to which the Borrower has previously consented in writing. For the avoidance of doubt, assignments and transfers and participations shall not be permitted to Disqualified Institutions.

 

 

 

Notwithstanding anything to the contrary, no Revolving Lender shall enter into any agreement with any participant that will permit such participant to influence or control the voting rights of such Lender except with regard to (a) reductions of principal, interest or fees owing to such participant (other than waivers, reductions or extensions of any mandatory prepayment or default interest), (b) extensions of final scheduled maturity or times for payment of

 

B-15



 

 

interest or fees owing to such participant (other than waivers of default interest, defaults or events of default, waivers or extensions of any mandatory prepayments or default interest) and (c) releases of Collateral or guarantees requiring the approval of all Revolving Lenders.

 

 

 

All assignments will also require the consent of the Revolving Facility Administrative Agent, the Issuing Lender and the Swingline Lender, not to be unreasonably withheld or delayed. Each assignment will be in an amount of an integral multiple of $1,000,000 or, if less, all of such Revolving Lender’s remaining Revolving Loans and Revolving Commitments of the applicable class.

 

 

Yield Protection:

The Revolving Facility Documentation shall contain provisions (a) protecting the Revolving Lenders against increased costs or loss of yield resulting from changes in reserve, capital adequacy and other requirements of law (including increased costs attributable to the Dodd-Frank Wall Street Reform and Consumer Protection Act and Basel III on terms to be mutually agreed), (b) indemnifying the Revolving Lenders for “breakage costs” incurred in connection with, among other things, any prepayment of a Eurodollar Loan (as defined in Annex I to Exhibit B hereto) on a day other than the last day of an interest period with respect thereto (other than lost profits) and (c) providing the Revolving Lenders with a customary tax gross up.

 

 

Expenses and Indemnification:

If, but only if, the Closing Date occurs, the Borrower shall pay promptly following written demand (including documentation reasonably supporting such request) (a) all reasonable and documented out-of-pocket expenses of the Revolving Facility Administrative Agent, the Issuing Lender and the Lead Arranger associated with the syndication of the Revolving Facility and the preparation, execution, delivery and administration of the Revolving Facility Documentation and any amendment or waiver with respect thereto (but limited, in the case of legal fees and expenses, to the reasonable and documented fees, disbursements and other charges of one outside counsel to the Revolving Facility Administrative Agent, the Issuing Lender, the Lead Arranger and the Revolving Lenders, taken as a whole and to the extent reasonably necessary one local counsel in each relevant jurisdiction) and (b) all reasonable and documented out-of-pocket expenses of the Revolving Facility Administrative Agent, the Issuing Lender and the Lead Arranger and the Revolving Lenders (but limited, in the case of legal fees and expenses, to the fees, disbursements and other charges of one outside counsel to the

 

B-16



 

 

Revolving Facility Administrative Agent and the Revolving Lenders, taken as a whole (and in the case of a conflict of interest, one additional counsel to the affected persons taken as a whole and to the extent reasonably necessary one local counsel in each relevant jurisdiction)) in connection with the enforcement of the Revolving Facility Documentation or protection of rights thereunder.

 

 

 

If, but only if, the Closing Date occurs, the Revolving Facility Administrative Agent, the Issuing Lender and the Lead Arranger and the Revolving Lenders (and their respective affiliates and their respective officers, directors, employees, advisors and agents) will be indemnified and held harmless against, any actual and direct losses (other than lost profits), claims, damages, liabilities or reasonable documented out-of-pocket expenses (but limited, in the case of legal fees and expenses, to the reasonable and documented fees, disbursements and other charges of one outside counsel to the indemnified persons taken as a whole (and, in the case of a conflict of interest, one additional counsel to the affected indemnified persons, taken as a whole and to the extent reasonably necessary one local counsel in each relevant jurisdiction)) incurred in respect of the financing contemplated hereby or the use or the proposed use of proceeds thereof, except, in the case of any indemnified person, to the extent they arise from (i) the gross negligence, bad faith or willful misconduct of such indemnified person (or any of its Related Persons), in each case, as determined by a final, non-appealable judgment of a court of competent jurisdiction, (ii) the material breach of such indemnified person or material breach of the Revolving Facility Documentation by such indemnified person (or any of its Related Persons) as determined in a final, non-appealable judgment of a court of competent jurisdiction, (iii) any disputes solely among indemnified persons (other than any claims against an indemnified person in its capacity or in fulfilling its role as the Revolving Facility Administrative Agent, a Lead Arranger or any similar role under the Revolving Facility) and not arising out of any act or omission of the Borrower or any of its affiliates, or (iv) entering into a settlement agreement related thereto without the written consent of the Borrower (which consent shall not to be unreasonably withheld or delayed) (for the avoidance of doubt, if settled with Borrower’s written consent, or if there is a final judgment for the plaintiff against an indemnified person in any proceeding, the Borrower shall indemnify and hold harmless each indemnified person to the extent and in the manner set forth above).

 

 

Governing Law and

New York.

 

B-17



 

Forum:

 

 

 

Counsel to the Revolving Facility Administrative Agent and the Lead Arranger:

Paul Hastings LLP.

 

B-18



 

Annex I to Exhibit B

 

INTEREST AND CERTAIN FEES

 

Interest Rate Options:

The Borrower may elect that the Loans comprising each borrowing bear interest at a rate per annum equal to (a) the ABR plus the Applicable Margin or (b) the Eurodollar Rate, plus the Applicable Margin; provided, that all Swingline Loans shall bear interest at a rate per annum equal to the ABR plus the Applicable Margin.

 

 

 

As used herein:

 

 

 

ABR” means the highest of (i) the “U.S. Prime Lending Rate” as published in The Wall Street Journal (the “Prime Rate”), (ii) the Federal funds effective rate from time to time, plus 0.50% per annum and (iii) the Eurodollar Rate for an interest period of one month, plus 1.00% per annum.

 

 

 

ABR Loans” means Loans bearing interest based upon the ABR.

 

 

 

Applicable Margin” means, with respect to Revolving Loans (including Swingline Loans), (i) 4.50% in the case of ABR Loans and (ii) 5.50% in the case of Eurodollar Loans

 

 

 

Eurodollar Rate” means the higher of (i) 1.00% and (ii) the rate (adjusted for statutory reserve requirements for eurocurrency liabilities) for eurocurrency deposits for a period equal to one, two, three, six, or, to the extent agreed to by all relevant affected Revolving Lenders, twelve months (as selected by the Borrower) appearing on LIBOR01 Page published by Reuters the “Published LIBOR Rate”.

 

 

 

Eurodollar Loans” means Loans bearing interest based upon the Eurodollar Rate.

 

 

Interest Payment Dates:

In the case of ABR Loans, quarterly in arrears.

 

 

 

In the case of Eurodollar Loans, on the last day of each relevant interest period and, in the case of any interest period longer than three months, on each successive date three months after the first day of such interest period.

 

 

Commitment Fees:

The Borrower shall pay to the Revolving Lenders (other than defaulting lenders) a commitment fee calculated at a rate per annum equal to 0.50% on the average daily unused portion of the Revolving Facility, payable quarterly in arrears. Swingline Loans shall, for purposes of the commitment fee calculations only, not

 

B-I-1



 

 

be deemed to be a utilization of the Revolving Facility.

 

 

Letter of Credit Fees:

The Borrower shall pay a fee on all outstanding Letters of Credit at a per annum rate equal to the Applicable Margin then in effect with respect to Eurodollar Loans under the Revolving Facility on the face amount of each such Letter of Credit. Such fee shall be shared ratably among the Revolving Lenders (other than defaulting lenders) participating in the Revolving Facility and shall be payable quarterly in arrears.

 

 

 

A fronting fee in an amount to be agreed (but in any event not to exceed 0.125% per annum) on the face amount of each Letter of Credit shall be payable quarterly in arrears to the Issuing Lender for its own account. The Borrower shall also pay to the Issuing Lender for its own account such Issuing Lender’s customary and reasonable issuance and administration fees.

 

 

Default Rate:

During the continuance of a bankruptcy event of default or an event of default in the payment of any amount under the Revolving Facility, overdue amounts owed to Revolving Lenders (other than defaulting lenders) shall bear interest at 2.00% per annum above the rate otherwise applicable thereto (or, in the event there is no applicable rate, 2.00% per annum in excess of the rate otherwise applicable to Revolving Loans maintained as ABR Loans from time to time).

 

 

Rate and Fee Basis:

All per annum rates shall be calculated on the basis of a year of 360 days (or 365/366 days, in the case of ABR Loans, the interest rate payable on which is then based on the Prime Rate) for actual days elapsed.

 

B-I-2



 

EXHIBIT C

 

PROJECT RHOMBUS

 

Bridge Facility

Summary of Terms and Conditions

 

Set forth below is a summary of the principal terms and conditions for the Bridge Facility. Capitalized terms used but not defined in this Exhibit C shall have the meanings set forth in the letter to which this Exhibit C is attached or in Exhibits A, B or D attached thereto.

 

1.                                    PARTIES

 

 

 

Borrower:

The Borrower (as defined in Exhibit B to the Commitment Letter) under the Revolving Facility (the “Borrower”).

 

 

Guarantors:

Each of the Guarantors (as defined in Exhibit B to the Commitment Letter) under the Revolving Facility (collectively, the “Guarantors” and together with Holdings and the Borrower, each a “Loan Party” and collectively, the “Loan Parties”).

 

 

Bridge Facility Administrative Agent:

Jefferies Finance.

 

 

Lead Arranger:

Jefferies Finance (in such capacity, the “Lead Arranger”).

 

 

Lenders:

A syndicate of banks, financial institutions and other entities, including the Initial Lender, arranged by the Commitment Party (excluding any Disqualified Institutions) (collectively, the “Bridge Lenders”); provided, that nothing herein shall affect the consent rights of the Borrower set forth below under the heading “Assignments and Participations.”

 

 

2.                                    TYPES AND AMOUNTS OF BRIDGE FACILITY

 

 

Type and Amount:

Senior secured increasing rate bridge loans (the “Bridge Facility”; the commitments thereunder, the “Bridge Commitments”) in an aggregate principal amount equal to $300.0 million (the “Bridge Loans”). At the option of the Lead Arranger, the Bridge Loans may be replaced with, or originally made in the form of, notes on identical economic terms. The Bridge Loans will be available in US Dollars.

 

 

Maturity:

One year from the funding date of the Bridge Loans (the “Bridge Loan Maturity Date”).

 

 

Use of Proceeds:

The proceeds of the Bridge Loans will be used to finance a portion of the Transactions (including related fees and expenses,

 

C-1



 

 

upfront fees and original issue discount and other Transaction Costs).

 

 

Rollover:

If the Bridge Loans are not repaid in full on or prior to the Bridge Loan Maturity Date, and provided that no Conversion Default (as defined below) has occurred and is continuing, the Bridge Loans shall automatically be converted on the Bridge Loan Maturity Date into senior secured term loans due on the fourth anniversary of the Bridge Loan Maturity Date (the “Term Loans”) in an aggregate principal amount equal to the aggregate principal amount of Bridge Loans so converted. The Term Loans will have the terms set forth in Annex I to Exhibit C to the Commitment Letter.

 

 

 

Under circumstances to be agreed between the Lead Arranger and the Borrower, Term Loans may be exchanged by the holders thereof for exchange notes (“Exchange Notes”), which will have the terms set forth in Annex II to Exhibit C to the Commitment Letter; provided that the Borrower may defer each issuance of Exchange Notes (other than an exchange of all remaining Term Loans into Exchange Notes) until such time as the Borrower shall have received requests to issue at least $50.0 million in aggregate principal amount of Exchange Notes. The Exchange Notes will be issued under an indenture that will have the terms set forth in Annex II to Exhibit C to the Commitment Letter. In connection with each such exchange, if requested by any Bridge Lender that is a Bridge Lender as of the Closing Date (each, an “Initial Bridge Lender”), the Borrower shall (i) deliver to such Bridge Lender that is receiving Exchange Notes, and to such other Bridge Lenders as each such Initial Bridge Lender requests, an offering memorandum of the type customarily utilized in a Rule 144A offering of high yield securities covering the resale of such Exchange Notes by such Bridge Lenders, in such form and substance as reasonably acceptable to the Borrower and such Initial Bridge Lender, and keep such offering memorandum updated in a manner as would be required pursuant to a customary Rule 144A securities purchase agreement, (ii) execute an exchange agreement containing provisions customary in Rule 144A securities purchase agreements (including indemnification provisions) if requested by such Initial Bridge Lender, (iii) deliver or cause to be delivered such opinions and accountants’ comfort letters addressed to the Initial Bridge Lenders and such certificates as the Initial Bridge Lenders may request in form and substance satisfactory to the Initial Bridge Lenders and (iv) take such other actions, and cause its advisors, auditors and counsel to take such actions, as reasonably requested by the Initial Bridge Lenders in connection with issuances or resales of Exchange Notes, including

 

C-2



 

 

providing such information regarding the business and operations of the Borrower and its subsidiaries as is reasonably requested by any prospective holder of Exchange Notes and customarily provided in due diligence investigations in connection with purchases or resales of securities.

 

 

 

Conversion Default” shall mean (i) any event of default under the Bridge Documentation, (ii) any payment default under the Revolving Facility, or (iii) a breach under the Fee Letter.

 

 

 

The Term Loans will be governed by the provisions of the Bridge Documentation and will have the same terms as the Bridge Loans except as expressly set forth in Annex I to Exhibit C to the Commitment Letter.

 

 

3.                                    CERTAIN PAYMENT PROVISIONS

 

 

Interest Rate:

The Bridge Loans will bear interest at a rate per annum equal to the higher of (i) three-month LIBOR, adjusted quarterly, and (ii) 1.00%, in either case, plus a spread of 11.00% (the “Rate”). The Rate will increase by (i) 75 basis points commencing with the date that is 90 days following the Closing Date, plus (ii) an additional 75 basis points upon each subsequent 90-day period. Interest on the Bridge Loans (excluding default interest, if any) shall not exceed the Total Cap (as defined in the Fee Letter), in each case, without giving effect to any default interest. Interest will be payable quarterly in arrears, on the Bridge Loan Maturity Date and on the date of any prepayment of the Bridge Loans. For amounts outstanding after the Bridge Loan Maturity Date, interest will be payable on demand at the default rate.

 

 

Default Rate:

During the continuance of a bankruptcy event of default or an event of default in the payment of any amount under the Bridge Facility, overdue amounts owed to Bridge Lenders shall bear interest at 2.00% per annum above the rate otherwise applicable thereto.

 

 

Closing Fees:

As set forth in the Fee Letter.

 

 

Optional Repayment:

The Bridge Loans may be repaid, in whole or in part, on a pro rata basis, at the option of the Borrower at any time, at a price equal to 100% of the principal amount thereof, plus all accrued and unpaid interest and fees to the date of repayment.

 

 

Mandatory Prepayments:

Subject to the Intercreditor Agreement, the Borrower will repay the Bridge Loans with the net proceeds from (i) any direct or indirect public offering or private placement of Notes or any other issuance or sale of (x) debt securities or equity securities of the

 

C-3



 

 

Borrower or a parent holding company of the Borrower or (y) debt securities of any of their subsidiaries, (ii) the incurrence of any other indebtedness for borrowed money (other than Revolving Loans under the Revolving Facility as in effect on the Closing Date and certain other limited exceptions to be mutually agreed upon) by the Borrower or any of their subsidiaries, (iii) sales of assets or any issuance or sales of equity of the Borrower, any parent holding company thereof or any subsidiary of the Borrower in excess of any amounts reinvested, and (iv) receipt of insurance or condemnation proceeds by the Borrower, a parent holding company of the Borrower or any of their subsidiaries in excess of any amounts reinvested, in each case, at 100% of the principal amount of the Bridge Loans repaid, plus accrued fees and all accrued and unpaid interest and fees to the date of the repayment.

 

 

Change of Control:

Each holder of the Bridge Loans will be entitled to require the Borrower, and the Borrower shall offer, to repay the Bridge Loans held by such holder, at a price of 100% of the principal amount thereof, plus all accrued fees and all accrued and unpaid interest to the date of repayment, upon the occurrence of a “change of control” (to be defined in the Bridge Documentation in a manner similar to the definition of such term contained in indentures governing similar high yield debt securities, as determined by the Lead Arranger, but excluding the Transactions; provided that, such definition shall include as permitted holders the direct and indirect equity holders of Holdings on the Closing Date and their affiliates (other than any portfolio companies controlled by such affiliates)).

 

 

4.                                    COLLATERAL

 

 

 

Collateral:

As provided in Exhibit B to the Commitment Letter.

 

 

Intercreditor Agreement:

As provided in Exhibit B to the Commitment Letter.

 

 

5.                                    CERTAIN CONDITIONS

 

Initial Conditions:

The incurrence of the Bridge Loans under the Bridge Facility on the Closing Date will be subject only to the applicable conditions precedent set forth in Section 6 of the Commitment Letter and Exhibit D to the Commitment Letter.

 

 

6.                                    DOCUMENTATION

 

 

Representations and Warranties:

Consistent with Exhibit B to the Commitment Letter, with such changes and additions as are appropriate in connection with the Bridge Loans.

 

C-4



 

Covenants:

Consistent with Exhibit B to the Commitment Letter, with such changes and additions as are appropriate in connection with the Bridge Loans (it being understood that there shall be no financial maintenance covenant under the Bridge Documentation). In particular, the restricted payments (including prepayments of debt) and debt incurrence covenants will be more restrictive in connection with the Bridge Loans than the equivalent provisions for the Revolving Facility.

 

 

Events of Default:

Consistent with Exhibit B to the Commitment Letter, with such changes and additions as are customary in connection with the Bridge Loans; provided that the cross-default to the Revolving Facility shall only be to (i) payment, bankruptcy and other specified events of default to be mutually agreed upon and (ii) a cross acceleration to the Revolving Facility. The engagement of an investment bank other than an investment bank satisfactory to the Lead Arranger in its sole discretion in order to provide Permanent Instruments (as defined in the Fee Letter) shall be deemed an event of default.

 

 

Voting:

Amendments and waivers of the Bridge Documentation will require the approval of Bridge Lenders holding more than 50% of the aggregate principal amount of the Bridge Loans, Term Loans or Exchange Notes, as the case may be (the “Required Lenders”), except that (i) the consent of each Bridge Lender directly and adversely affected thereby (but not the Required Lenders and in the case of (i)(a), only the Bridge Lenders increasing their commitments shall be deemed directly and adversely affected thereby) shall be required with respect to, (a) increases in the amount or extensions of the expiration date of the commitment of such Bridge Lender, (b) reductions of principal, interest or fees (including any prepayment fee) owed to such Bridge Lender (other than any waivers or extensions of mandatory prepayments or a waiver, extension or reduction in any default interest), (c) reductions in the amount or extensions of the final maturity of any Bridge Loan, Term Loan or Exchange Note, as the case may be, or the reduction of the non-call period for any Exchange Note, as applicable, (d) “waterfall”, pro rata sharing and pro rata payment provisions (with any Bridge Lender declining payment or reducing a payment made to them being “directly and adversely affected”) and (e) modifications to the assignment provisions of the Bridge Documentation that further restrict assignments thereunder; and (ii) the consent of all Bridge Lenders shall be required with respect to (a) releases of all or substantially all of the value of the Guarantors or all or substantially all of the Collateral, in each case, except as otherwise permitted, (b) reductions in voting thresholds, (c) alterations of (or additions to) the restrictions on the ability of

 

C-5



 

 

Bridge Lenders to exchange Term Loans for Exchange Notes, (d) modification of the rights to exchange Term Loans into Exchange Notes or (e) except as expressly permitted, assignments by any Loan Party of its rights or obligations under the Bridge Facility.

 

 

Transferability:

Each holder of Bridge Loans will be free to (x) sell or transfer all or any part of its Bridge Loans to any third party with the consent of the Bridge Facility Administrative Agent (not to be unreasonably withheld) in compliance with applicable law (provided that such holder shall give prompt written notice to the Bridge Facility Administrative Agent and the Borrower of any such sale or transfer), (y) sell participations in all or a portion of the Bridge Loans (subject to customary voting restrictions), and (z) pledge any or all of the Bridge Loans in accordance with applicable law.

 

 

Yield Protection:

As provided in Exhibit B to the Commitment Letter.

 

 

Expenses and Indemnification:

If, but only if, the Closing Date occurs, the Borrower shall pay promptly following written demand (including documentation reasonably supporting such request) (a) all reasonable and documented out-of-pocket expenses of the Bridge Facility Administrative Agent and the Lead Arranger associated with the syndication of the Bridge Facility and the preparation, execution, delivery and administration of the Bridge Documentation and any amendment or waiver with respect thereto (but limited, in the case of legal fees and expenses, to the reasonable and documented fees, disbursements and other charges of one outside counsel to the Bridge Facility Administrative Agent, the Lead Arranger and the Bridge Lenders, taken as a whole and to the extent reasonably necessary one local counsel in each relevant jurisdiction) and (b) all reasonable and documented out-of-pocket expenses of the Bridge Facility Administrative Agent and the Lead Arranger and the Bridge Lenders (but limited, in the case of legal fees and expenses, to the fees, disbursements and other charges of one outside counsel to the Bridge Facility Administrative Agent and the Bridge Lenders, taken as a whole (and in the case of a conflict of interest, one additional counsel to the affected persons taken as a whole and to the extent reasonably necessary one local counsel in each relevant jurisdiction)) in connection with the enforcement of the Bridge Documentation or protection of rights thereunder.

 

 

 

If, but only if, the Closing Date occurs, the Bridge Facility Administrative Agent, the Lead Arranger and the Bridge Lenders (and their respective affiliates and their respective officers, directors, employees, advisors and agents) will be indemnified and held harmless against, any actual and direct losses (other than lost profits), claims, damages, liabilities or reasonable and documented

 

C-6



 

 

out-of-pocket expenses (but limited, in the case of legal fees and expenses, to the reasonable and documented fees, disbursements and other charges of one outside counsel to the indemnified persons taken as a whole (and, in the case of a conflict of interest, one additional counsel to the affected indemnified persons, taken as a whole and to the extent reasonably necessary one local counsel in each relevant jurisdiction)) incurred in respect of the financing contemplated hereby or the use or the proposed use of proceeds thereof, except, in the case of any indemnified person, to the extent they arise from (i) the gross negligence, bad faith or willful misconduct of such indemnified person (or any of its Related Persons), in each case, as determined by a final, non-appealable judgment of a court of competent jurisdiction, (ii) the material breach of such indemnified person or material breach of the Bridge Documentation by such indemnified person (or any of its Related Persons) as determined in a final, non-appealable judgment of a court of competent jurisdiction, (iii) any disputes solely among indemnified persons (other than any claims against an indemnified person in its capacity or in fulfilling its role as the Bridge Facility Administrative Agent, a Lead Arranger or any similar role under the Bridge Facility) and not arising out of any act or omission of the Borrower or any of its affiliates, or (iv) entering into a settlement agreement related thereto without the written consent of the Borrower (which consent shall not to be unreasonably withheld or delayed) (for the avoidance of doubt, if settled with Borrower’s written consent, or if there is a final judgment for the plaintiff against an indemnified person in any proceeding, the Borrower shall indemnify and hold harmless each indemnified person to the extent and in the manner set forth above).

 

 

Governing Law and Forum:

New York.

 

 

Counsel to the Bridge Facility Administrative Agent and the Lead Arranger:

Paul Hastings LLP.

 

C-7



 

ANNEX I to EXHIBIT C

 

Term Loans

 

On the Bridge Loan Maturity Date, so long as no Conversion Default has occurred and is continuing, the outstanding Bridge Loans will be converted automatically into Term Loans. The Term Loans will be governed by the provisions of the Bridge Documentation and, except as expressly set forth below, will have the same terms as the Bridge Loans.

 

Maturity:

The Term Loans will mature on the fourth anniversary of the Bridge Loan Maturity Date.

 

 

Interest Rate:

The Bridge Loans will bear interest at a rate per annum equal to the Total Cap (as defined in the Fee Letter).

 

 

 

Notwithstanding the foregoing, during the continuance of a bankruptcy event of default or an event of default in the payment of any amount under the Bridge Documentation, overdue amounts owed to Bridge Lenders shall bear interest at 2.00% per annum above the rate otherwise applicable thereto and shall be payable on demand.

 

 

Change of Control:

Each holder of the Term Loans will be entitled to require the Borrower, and the Borrower shall offer, to repay the Term Loans held by such holder, at a price of 101% of the principal amount thereof, plus all accrued fees and all accrued and unpaid interest to the date of repayment, upon the occurrence of a “change of control” (to be defined in the Bridge Documentation in a manner similar to the definition of such term contained in indentures governing similar high yield debt securities, but excluding the Transactions); provided that, such definition shall include as permitted holders the direct and indirect equity holders of Holdings on the Closing Date and their affiliates (other than any portfolio companies controlled by such affiliates)).

 

C-I-1



 

ANNEX II to EXHIBIT C

 

Exchange Notes

 

At any time on or after the Bridge Loan Maturity Date, upon five or more business days’ prior notice, the Term Loans may, at the option of any Bridge Lender, be exchanged for a principal amount of Exchange Notes equal to 100% of the aggregate principal amount of the Term Loans so exchanged (plus any accrued interest thereon not required to be paid in cash). The Borrower will issue Exchange Notes under an indenture (the “Indenture”) that complies with the Trust Indenture Act of 1939, as amended. The Borrower will appoint a trustee acceptable to the Bridge Lenders.

 

Maturity:

The Exchange Notes will mature on the fourth anniversary of the Bridge Loan Maturity Date.

 

 

Interest Rate:

Each Exchange Note will bear interest at a rate per annum equal to the Total Cap (as defined in the Fee Letter).

 

 

 

Interest will be payable in arrears semi-annually.

 

 

 

Notwithstanding the foregoing, during the continuance of a bankruptcy event of default or an event of default in the payment of any amount under the Bridge Documentation, overdue amounts owed to Bridge Lenders shall bear interest at 2.00% per annum above the rate otherwise applicable thereto and shall be payable on demand.

 

 

Transferability:

If the Term Loans are converted to Exchange Notes, the Borrower, upon request by any holder of such Exchange Notes or the Bridge Facility Administrative Agent, shall be required to ensure that such Exchange Notes are DTC-eligible.

 

 

Optional Redemption:

Exchange Notes will be non-callable until the first anniversary of the Bridge Loan Maturity Date (subject to a 35% “equity clawback” and a customary make-whole provision acceptable to the Lead Arranger). Thereafter, each Exchange Note will be callable at par plus accrued interest plus a premium equal to three-quarters of the coupon on such Exchange Note, which premium shall decline to zero on the date that is the third anniversary of the Bridge Loan Maturity Date.

 

 

Excess Cash Flow Offer:

For each fiscal year commencing with the fiscal year ending March 31, 2017, on the tenth (10th) business day following the delivery of its audited financials (or the date such audited financial statements were required to be delivered), the Borrower will be required to make an offer to purchase (an “Excess Cash Flow Offer”), to all holders of Exchange Notes to purchase at a purchase price equal to 100% of the principal amount thereof

 

C-II-1



 

 

(plus accrued and unpaid interest), a principal amount of Notes equal to the greater of (x) $10.0 million and (y) 75% of the Borrower’s and its restricted subsidiaries’ excess cash flow (to be defined) for such fiscal year. Such offer shall be made in a manner similar to offers to purchase contained in indentures governing similar high yield debt securities.

 

 

Defeasance Provisions:

Customary defeasance provisions for offerings and transactions of this type.

 

 

Modification:

Customary modification provisions for offerings and transaction of this type.

 

 

Change of Control:

The Borrower will be required to repurchase the Exchange Notes following the occurrence of a “change of control” (to be defined in the Bridge Documentation in a manner similar to such term contained in indentures governing similar high yield debt securities, but excluding the Transactions; provided that, such definition shall include as permitted holders the direct and indirect equity holders of Holdings on the Closing Date and their affiliates (other than any portfolio companies controlled by such affiliates)) at 101% of the outstanding principal amount thereof.

 

 

Covenants:

The Indenture will include covenants similar to those contained in indentures governing similar high yield debt securities (but more restrictive in certain respects).

 

 

Events of Default:

The Indenture will provide for events of default similar to those contained in indentures governing similar high yield debt securities.

 

C-II-2



 

EXHIBIT D

 

PROJECT RHOMBUS

 

Conditions

 

The availability of the Facilities shall be subject to the satisfaction or waiver by the Commitment Party of only the following conditions (subject to the Certain Funds Provision). Capitalized terms used but not defined in this Exhibit D have the meanings set forth in the letter to which this Exhibit D is attached or in Exhibits A, B or C thereto.

 

1.                                    The definitive documentation for the Revolving Facility (the “Revolving Facility Documentation”) and the definitive documentation for the Bridge Facility (the “Bridge Documentation”, and together with the Revolving Facility Documentation, the “Facilities Documentation”) shall have been executed and delivered by each of the Borrower and the Guarantors (which, for the avoidance of doubt, shall not include control agreements, landlord waivers, insurance deliverables or any mortgages and shall be subject to the Certain Funds Provision), and the Commitment Party shall have received:

 

(a)                               customary notices of borrowing;

 

(b)                              customary closing certificates and domestic legal opinions, domestic organizational charter documents of Loan Parties certified by appropriate public officials, good standing certificates in the jurisdiction of organization of Loan Parties, lien search results and resolutions of Loan Parties; and

 

(c)                               a certificate (substantially in the form of Annex I to this Exhibit D) from the chief financial officer (or other officer with reasonably equivalent duties) of the Borrower or Holdings certifying that the Borrower or Holdings and its subsidiaries, on a consolidated basis immediately after giving effect to the Transactions, are solvent.

 

2.                                    The Equity Contribution shall have been received in the manner described in Exhibit A to the Commitment Letter.

 

3.                                    On the Closing Date, after giving effect to the Transactions, none of Holdings, the Borrower or any of its restricted subsidiaries shall have any third party indebtedness for borrowed money other than the Facilities, the Notes and Permitted Surviving Debt.

 

4.                                    The Acquisition shall be consummated in all material respects in accordance with the Acquisition Agreement substantially concurrently with the initial funding of the Facilities (or the issuance of the Notes in lieu of the Bridge Facility) without any material amendment, waiver, modification or consent not consented to by the Administrative Agents and the Lead Arranger (each such consent not to be unreasonably withheld, delayed or conditioned) other than waivers, modifications, consents, or amendments, which would not be (in the aggregate) materially adverse to the interests of the Lenders or the Lead Arranger; provided further (i) increases in purchase price if funded with common equity or Qualified Preferred Equity shall not be deemed to be materially adverse to the interests of the Lenders or the Lead Arranger and shall not require the consent of the Administrative Agents or the Lead Arranger, (ii) decreases in purchase price

 

D-1



 

of not more than 15% shall not be deemed to be materially adverse to the interests of the Lenders or the Lead Arranger and shall not require the consent of the Administrative Agents or the Lead Arranger if applied pro rata among the Bridge Facility and/or the Notes and the Equity Contribution; provided that in no event shall the aggregate amount of the Bridge Facility and/or the Notes be less than $250.0 million and (iii) any amendment, waiver, consent or other modifications to the definition of “Material Adverse Effect” set forth in the Acquisition Agreement shall be deemed materially adverse to the interests of the Lenders and the Lead Arranger.

 

5.                                    Since the date of the Acquisition Agreement, there shall not have occurred any change or event that constitutes a Material Adverse Effect (as defined in the Acquisition Agreement).

 

6.                                    The Lead Arranger shall have received (i) audited consolidated balance sheets and related statements of income and cash flows of the Company for the last three fiscal years ended at least 90 days prior to the Closing Date (it being understood and agreed that such audited consolidated financial statements have been delivered for the fiscal years ending March 31, 2015, March 31, 2014 and March 31, 2013), (ii) unaudited consolidated balance sheets and related statements of income and cash flows of the Company for each fiscal quarter of the Company (other than the fourth fiscal quarter) ended after the close of its most recent fiscal year and at least 45 days prior to the Closing Date and (iii) a pro forma consolidated balance sheet and related statements of income and cash flows of the Borrower as of and for the twelve-month period ending on the last day of the most recently completed four-fiscal quarter period ended at least 45 days (or 90 days in case such period is the end of the Borrower’s fiscal year) prior to the Closing Date, prepared after giving effect to the Transactions as if the Transactions had occurred at the beginning of such period.

 

7.                                    (a)                               Jefferies shall have received, as soon as practicable and in no event later than 15 consecutive business days prior to the Closing Date, a customary printed preliminary offering memorandum (the “Preliminary Offering Memorandum”) relating to the issuance of the Notes that contains all financial statements, pro forma financial statements, business and other financial data required by Regulation S-X and Regulation S-K under the Securities Act and of the type and form customarily included in offering memoranda relating to high yield debt offerings pursuant to Rule 144A promulgated under the Securities Act and permitting the Lead Arranger to receive the customary comfort letters contemplated by paragraph 8 of this Exhibit D (subject to completion by such auditors of customary procedures relating thereto, including the receipt of customary representation letters), subject to customary exceptions for Rule 144A offering memoranda including that such offering memorandum shall not be required to include financial statements or information required by Rules 3-10 or 3-16 of Regulation S-X, Compensation Discussion and Analysis otherwise required by Regulation S-K Item 402(b) or other information customarily excluded from a Rule 144A offering memorandum (collectively, the “Required Information”). The Lead Arranger shall have been afforded a period of not less than 15 consecutive business days after delivery of such complete printed Preliminary Offering Memorandum to seek to place the Notes (such period, the “Required Marketing Period”); provided, that (1) the date of November 27, 2015 shall not be included in the calculation of the Marketing Period (but for the avoidance of doubt, the exclusion of such dates shall not restart the Marketing Period) and (2) if the Marketing Period shall not have concluded on or prior to December 18, 2015, it shall not commence until January 4, 2016.

 

D-2



 

(b)                              Notwithstanding the foregoing, the Required Marketing Period shall be deemed not to have commenced, if, prior to the completion of such 15 consecutive business day period, (A) any of the independent accountants that have audited the financial statements contained in the Preliminary Offering Memorandum shall have withdrawn its audit opinion with respect to any year-end audited financial statements set forth in the Preliminary Offering Memorandum, (B) the financial statements included in the Preliminary Offering Memorandum would be required to be updated under Rule 3-12 of Regulation S-X in order to be sufficiently current on any day beginning on the first day of such 15 consecutive business day period and ending on the pricing date of the Notes to permit a registration statement using such financial statements to be declared effective by the SEC on the pricing date of the Notes, in which case the Required Marketing Period shall not be deemed to commence until the receipt of updated financial information that would be required under Rule 3-12 of Regulation S-X to permit a registration statement using such financial statements to be declared effective by the SEC, or (C) Holdings or the Company shall have publicly announced any intention to restate any material financial information included in the Preliminary Offering Memorandum, in which case the Required Marketing Period shall be deemed not to commence unless and until such restatement has been completed.

 

8.                                    Each of the independent accountants that have audited the financial statements included in the Preliminary Offering Memorandum shall make available and have delivered to the Lead Arranger, no later than the delivery to the Lead Arranger of the Preliminary Offering Memorandum in accordance with preceding paragraph 7(a), a draft of a customary comfort letter with respect to the Acquired Business, including as to customary negative assurances, covering the financial statements and other financial data included or incorporated by reference in the Preliminary Offering Memorandum, which such auditors have confirmed they are prepared to issue at the pricing date of the Notes.

 

9.                                    The Administrative Agents shall have received, at least five business days prior to the Closing Date, all documentation and other information with respect to Borrower that is requested by each Administrative Agent at least ten business days prior to the Closing Date and is required by regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including, without limitation, the PATRIOT Act.

 

10.                            Payment of all fees and expenses due and payable to the Commitment Party and the Lenders required to be paid on the Closing Date from the proceeds of the initial funding under the Facilities for which invoices have been received by the Borrower at least two business days in advance.

 

11.                            The Specified Acquisition Agreement Representations and Specified Representations shall be true and correct in all material respects.

 

12.                            Subject to the Certain Funds Provision, (a) with respect to the Revolving Facility, all actions necessary to establish that the Revolving Facility Administrative Agent will have a perfected first priority security interest (subject to liens permitted under the Revolving Facility Documentation) in the Collateral under the Revolving Facility and (b) with respect to the Bridge Facility, all actions necessary to establish that the Bridge Facility Administrative Agent will have a perfected second priority security interest (subject to liens permitted under the Bridge Documentation) in the Collateral under the Bridge Facility; provided that, in the case of clauses

 

D-3



 

(a) and (b), only to the extent such Collateral (including the creation or perfection of any security interest) is required to be provided on the Closing Date.

 

D-4



 

Annex I to Exhibit D

 

FORM OF SOLVENCY CERTIFICATE

 

[·], _____

 

This Solvency Certificate is being executed and delivered pursuant to Section [·] of that certain [·]1 (the “Credit Agreement”); the terms defined therein being used herein as therein defined.

 

I, [·], the [chief financial officer/equivalent officer] of Holdings, solely in such capacity and not in an individual capacity, hereby certify that I am the [chief financial officer/equivalent officer] of Holdings and that I am generally familiar with the businesses and assets of Holdings and its Restricted Subsidiaries (taken as a whole), I have made such other investigations and inquiries as I have deemed appropriate and I am duly authorized to execute this Solvency Certificate on behalf of Holdings pursuant to the Credit Agreement.

 

I further certify, solely in my capacity as [chief financial officer/equivalent officer] of Holdings/, and not in my individual capacity, as of the date hereof and after giving effect to the Transactions and the incurrence of the indebtedness and obligations being incurred in connection with the Credit Agreement and the Transactions on the date hereof, that, (i) the sum of the debt (including contingent liabilities) of Holdings and its Restricted Subsidiaries, taken as a whole, does not exceed the present fair saleable value (on a going concern basis) of the assets of Holdings and its Restricted Subsidiaries, taken as a whole; (ii) the capital of Holdings and its Restricted Subsidiaries, taken as a whole, is not unreasonably small in relation to the business of Holdings or its Restricted Subsidiaries, taken as a whole, contemplated as of the date hereof; and (iii) Holdings and its Restricted Subsidiaries, taken as a whole, do not intend to incur, or believe that they will incur, debts including current obligations beyond their ability to pay such debt as they mature in the ordinary course of business. For the purposes hereof, the amount of any contingent liability at any time shall be computed as the amount that, in light of all of the facts and circumstances existing at such time, represents the amount that can reasonably be expected to become an actual or matured liability (irrespective of whether such contingent liabilities meet the criteria for accrual under Statement of Financial Accounting Standard No. 5).

 

[Remainder of page intentionally left blank]

 

 

 

 


1 Description of Credit Agreement to be inserted.

 

D-I-1



 

IN WITNESS WHEREOF, I have executed this Solvency Certificate on the date first written above.

 

 

 

 

 

 

By:

 

 

 

Name:

[·]

 

 

Title:

[·]

 

D-I-2




Exhibit (c)(2)

 

STRICTLY CONFIDENTIAL Project Rhombus Presentation to the Board of Directors November 6, 2015

GRAPHIC

 


STRICTLY CONFIDENTIAL Table of Contents I. II. III. Executive Summary Historical Performance Valuation Perspectives 3 12 17 Appendices A. B. Additional Valuation Detail Rhombus Overview 31 35 [ 1 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL Disclaimer This presentation has been prepared by Moelis & Company LLC (“Moelis”) for exclusive use of the Board of Directors of RealD Inc. (the “Company”) in considering the transaction described herein based on information provided by the Company and upon information from third party sources. Moelis has not assumed any responsibility for independently verifying the accuracy of such information, and disclaims any liability with respect to the information herein. In this presentation, Moelis, at the Company’s direction, has used certain projections, forecasts or other forward-looking statements with respect to the Company and/or other parties involved in the transaction which were provided to Moelis by the Company and/or such other parties and which Moelis has assumed, at the Company’s direction, were prepared based on the best available estimates and judgments of the management of the Company and/or such other parties as to the future performance of the Company and/or such other parties. This presentation is provided as of the date hereof and Moelis assumes no obligation to update it or correct any information herein. This presentation is solely for informational purposes. This presentation is not intended to provide the sole basis for any decision on any transaction and is not a recommendation with respect to any transaction. The recipient should make its own independent business decision based on all other information, advice and the recipient’s own judgment. This presentation is not an offer to sell or a solicitation of an offer to buy any business, security, option, commodity, future, loan or currency. It is not a commitment to underwrite any security, to loan any funds or to make any investment. Moelis does not offer tax, accounting, actuarial or legal advice. Absent Moelis’ prior written consent, this material, whether in whole or in part, may not be copied, photocopied, or duplicated in any form by any means, or redistributed. Moelis and its related investment banking entities provide mergers and acquisitions, recapitalization, restructuring, corporate finance and other financial advisory services to clients and affiliates of Moelis provide investment management services to clients. Personnel of Moelis or such affiliates may make statements or provide advice that is contrary to information included in this material. The proprietary interests of Moelis or its affiliates may conflict with your interests. In addition, Moelis and its affiliates and their personnel may from time to time have positions in or effect transactions in securities referred to in this material (or derivatives of such securities), or serve as a director of companies referred to in this presentation. Moelis and its affiliates may have advised, may seek to advise and may in the future advise or invest in companies referred to in this presentation. [ 2 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL I. Executive Summary

GRAPHIC

 


STRICTLY CONFIDENTIAL Situation Overview  On May 2, 2014, Starboard Value LP (“Starboard”) filed a Schedule 13D indicating that it owned 6.3% of Rhombus' outstanding common stock  On October 1, 2014, after market close, Starboard publicly offered to acquire the remaining shares in Rhombus (the “Company”) it did not own for $12.00 per share in cash, which represented a 29% premium to Rhombus' closing price  At such time, Starboard had increased its stake to 9.9% of the Company’s outstanding common stock  During its Q2 FY 2015 earnings call on November 3, 2014, the Company responded to Starboard’s offer, stating the Board had carefully reviewed the unsolicited indication of interest and unanimously determined not to pursue it  Management and the Board of Directors at the same time stated that the value of the business would “benefit from the strength of its cinema platform and upcoming film slate, the value inherent in (Rhombus') IP portfolio and the changes being made to reduce operating expenses and capital expenditures”  The Company also announced it was actively evaluating alternatives for restructuring its R&D efforts  In particular, the Company explored third-party funding options for InteliLight, however, those discussions did not ultimately result in third party funding for the InteliLight business  On December 4, 2014, the Company announced it would reduce pro forma FY 2016 operating expenses by $11.5mm and capital expenditures by $4.5mm  On February 9, 2015, Rhombus announced its Board of Directors had initiated a process to explore a full range of strategic alternatives and that the Company had engaged Moelis as its financial advisor to assist in the evaluation of such alternatives  During the strategic alternatives review process, multiple Board meetings were held where Moelis provided updates on available alternatives, and the Board of Directors discussed next steps, including a potential sale of the Company  Moelis contacted 71 potential buyers, consisting of 11 strategic and 60 financial potential buyers, regarding their level of interest in purchasing the Company  Of the 71 potential buyers contacted, 36 ultimately signed a nondisclosure agreement and received confidential information in March 2015 regarding Rhombus (4 strategic and 32 financial, including Starboard) [ 4 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL Situation Overview (cont’d)  On April 17, 2015, five potential buyers submitted initial indications of interest (“IOI”) for the Company (1 strategic and 4 financial, including Starboard)  The values submitted in the IOI’s received ranged from $12.00 to 15.00 per share  A sixth IOI, with a value range of $12.50 to $14.50 per share, was received from another strategic buyer on July 2, 2015    The Company conducted six management presentations during the months of May, June and September Following management presentations, the Company, Moelis and potential buyers began conducting due diligence Consistent with the Company’s normal budgeting process, during the months of June through September, the Company’s financial projections were revised, in part or in total, four times due to:  Lower than expected financial results for certain 3D films  Certain films no longer being slated to be shown in 3D (e.g., The Hunger Games: Mockingjay Part 2 in the US)  An inability for the Company to reduce its operating expenses to the levels announced on December 4, 2014 due to Management’s decision to continue to invest in select R&D initiatives  As a result, the Adjusted EBITDA projections provided to potential buyers in March 2015 were revised downward:  Adjusted EBITDA Projections (March 2015): FY 2016 - $86.6mm, FY 2017E - $90.0mm, FY 2018E - $96.2mm  Adjusted EBITDA Projections (September 2015): FY 2016 - $73.1mm, FY 2017E - $83.3mm, FY 2018E - $90.9mm  On June 11, 2015, the Company reported FY 2015 Q4 Adjusted EBITDA of $2.4mm versus consensus estimates of $1.2mm and EPS of ($0.36) versus consensus estimates of ($0.34)  On August 5, 2015, the Company reported FY 2016 Q1 Adjusted EBITDA of $24.6mm versus consensus estimates of $26.5mm and EPS of $0.14 versus consensus estimates of $0.16  Following the FY 2016 Q1 earnings announcement, the Company’s stock price fell from $12.60 on August 4, 2015 to its 52-week low of $8.91 on August 24, 2015 [ 5 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL Situation Overview (cont’d)  Between the months of May and September all potential buyers other than Rizvi Traverse Management LLC (“Rizvi”) officially dropped out of the process or ceased performing due diligence on the Company  Reasons buyers provided for dropping out of the process included:  Perceived risk around the 3D industry  Concerns over customer renewal risk and rates  Concerns over dependence on film slate  Concerns regarding organic growth within the core business  Company’s inability to achieve operating expense reduction plan  A few potential buyers from earlier in the process re-emerged, but did not engage in meaningful due diligence  The Company asked Rizvi for its final bid on October 13, 2015; at which time Rizvi offered $10.35 per share, which represented a 12% premium to the Company’s unaffected share price on October 1, 2014  Rizvi’s proposal was subject to reaching agreement with Michael Lewis regarding rollover and voting of his existing shares of stock of the Company and his continued employment by Rhombus following the consummation of the transaction  Additionally, Rizvi submitted an issues list regarding the merger agreement and draft debt and equity commitment papers  On October 15, 2015, the Board of Directors held a meeting where Rizvi’s bid was reviewed along with other strategic alternatives  During the meeting, the Board authorized Moelis to engage in price negotiations with Rizvi  Prior to the meeting, a potential buyer that had previously disengaged to pursue another transaction expressed an interest in continuing due diligence; the Board concluded that engaging with the potential buyer could put the Rizvi offer at risk given the limited due diligence performed to date by said potential buyer; the Board determined not to move forward with the potential buyer [ 6 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL Situation Overview (cont’d)  At the direction of the Board, between October 16 and October 18, Moelis, on behalf of the Company, engaged in multiple price negotiations with Rizvi  Rhombus proposed a counter offer of $12.00 per share  Rizvi then raised its bid to $10.60 per share  Rhombus proposed a counter offer of $11.60 per share  Rizvi then raised its bid to $11.00 per share and stated that this represented their best and final offer  On October 19, 2015, the Board of Directors held a meeting where the $11.00 per share offer from Rizvi, which represented a 19% premium to the Company’s unaffected share price on October 1, 2014, was reviewed  The Board authorized the Company to move forward with completing outstanding diligence and negotiating transaction-related agreements for a potential transaction at $11.00 per share, subject to final approval of the transaction by the Board of Directors  Following the October 19, 2015 meeting of the Board of Directors, Michael Lewis, Rhombus' CEO and Chairman, began negotiating a separate agreement with Rizvi to roll his equity as part of the transaction Rizvi conditioned its October 13, 2015 offer on reaching agreement with Michael Lewis on these matters  Michael Lewis’ preference was to not roll his entire equity stake in the transaction, but he ultimately agreed to rollover all of his currently outstanding shares at Rizvi’s request  Certain options of Michael Lewis, however, will be cashed out in the transaction in the same manner as the other holders of such options  The Board is aware of these discussions  [ 7 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL Strategic Alternatives Process Summary 71 potential buyers were contacted during the process, with 36 parties receiving an Overview Presentation, 6 parties submitting an initial bid, and 1 party submitting a final bid Public announcement regarding the strategic alternatives process was made on February 9, 2015 [ 8 ] Strategic Financial 71Contacted 11 60 36Signed NDA and Received OP 4 32 61st Round Bids Received 2 4 6 1 Received Management Presentation 2 4 Final Bid Received 0 1

GRAPHIC

 


STRICTLY CONFIDENTIAL Summary of Parties that Received Overview Presentations Listed below are the parties that received an Overview Presentation☨ Party A Party N Party Y Rizvi Traverse * Party O Party Z Starboard Value * Party P Party AA Party D* Party Q Party BB Party E* Party R Party CC Party H* Party S Party DD Party I Party T Party EE Party J Party U Party FF Party K Party V Party GG Party L Party W Party HH Party M Party X Party F * Party II Party JJ Party G * * Denotes party that submitted first round bid and final round bid * Denotes party which submitted first round bid and/or participated in management presentation ☨Names of parties (other than Rizvi Traverse and Starboard Value) have been replaced with generic references. [ 9 ] STRATEGIC PARTIES (4) FINANCIAL PARTIES (32)

GRAPHIC

 


STRICTLY CONFIDENTIAL Rizvi Offer Summary RIZVI OFFER IMPLIED VALUATION IMPLIED TRANSACTION MULTIPLES ($ in millions, except per share amounts) TEV / Adj. Adj. EBITDA EBITDA Management Estimates LTM 06/30/15A Adj. EBITDA CY15E Adj. EBITDA (Latest Forecast) CY16E Adj. EBITDA (Latest Forecast) ³ $52.7 56.4 88.8 Fully Diluted Shares Outstanding ¹ 53.658 Plus: Debt (as of 11/02/15) Plus: Minority Interest (as of 09/30/15) Less: Cash (as of 11/02/15) $38.0 (0.5) (76.8) TEV / Adj. Adj. EBITDA EBITDA Consensus Estimates ⁴ LTM 06/30/15A Adj. EBITDA CY15E Adj. EBITDA CY16E Adj. EBITDA $52.7 49.2 79.4 Premium / (Discount) Per Share Price Premium (Unaffected) ² Price 1-Day Prior (10/01/14) 10-Day Prior VWAP 30-Day Prior VWAP $9.27 9.63 9.83  Although not a factor in the financial analysis, Moelis notes that the transaction premia on either an unaffected or current basis is generally below observed M&A market averages Premium / (Discount) Per Share Price Premium (Current) Price Current (11/04/15) 10-Day Prior VWAP 30-Day Prior VWAP $10.25 10.22 10.16 Source: 1. 2. 3. 4. Management, Company Information, Capital IQ Calculated based on securities outstanding as of 10/28/15 Unaffected dates as of 11/01/14; date of Starboard offer As directed by Rhombus management, nine months ending 12/31/16 estimated based on FY2017 projections and average quarterly EBITDA contributions over the past four years Consensus estimates as of 11/04/15 [ 10 ] 7.32% 7.63% 8.27% 18.66% 14.26% 11.93% 10.5x 11.2x 6.9x Total Enterprise Value$551.0 10.5x 9.8x 6.2x Implied Equity Value$590.2 Offer Price$11.00

GRAPHIC

 


STRICTLY CONFIDENTIAL Rizvi Offer Summary (cont’d)   Implied Market Cap: $590 million LTM 06/30/15 Adjusted EBITDA Multiple: 10.5x  Preferred Equity: $140 million (provided by Fortress, with 10% paid-in-kind coupon)  Conditions for payment of termination fee: would be a breach of fiduciary duties to the stockholders of Rhombus  Conditions for payment of termination fee: after the end of the marketing period  Largely standard for public company transaction Source: Draft merger agreement dated 11/05/15 [ 11 ] 1. LTM Adjusted EBITDA (as of 6/30/15) and CY15 Adjusted EBITDA of $52.7 and $56.4 million (based on management estimates), respectively; adjusted for share-based compensation, impairment of assets and intangibles, as well as certain expenses related to the cost reduction plan and non-recurring expenses MERGER CONSIDERATION ¹  Per Share Price (% Premium): $11.00 (18.66% premium to unaffected stock price on 10/01/14 and a 5.47% premium to stock price on 10/19/15)  Implied TEV: $551 million  CY15 Adjusted EBITDA Multiple: 9.8x FINANCING  Funded Debt: $300 million  PF Leverage: 5.2x LTM 06/30/15E PF Adj. Financeable EBITDA ($57.6 million) EQUITY ROLLOVER  Concurrent with the execution of the merger agreement, Michael Lewis will enter into a rollover commitment letter with the purchaser (Michael Lewis currently owns 10.6% of fully diluted shares outstanding) VOTING AGREEMENT  Concurrent with the execution of the merger agreement, Michael Lewis agrees to vote their shares in favor of the transaction contemplated by the agreement COMPANY TERMINATION FEE  $24 million paid by Company to the Purchaser within three business days of the termination  If the Purchaser terminates because Board of Directors effects an Adverse Recommendation Change prior to the stockholders meeting or the Company has a material breach of the non-solicitation provision or covenant to call and hold a stockholders meeting  If the Company terminates because Board of Directors has received a superior proposal and failure to accept such proposal  If either Purchaser or the Company terminates because stockholder approval is not given and the Board of Directors affects an Adverse Recommendation Change  If Purchaser or the Company terminates because the End Date is reached or stockholder approval is not given, or Purchaser terminates because the Company breaches its reps, warranties or fails to perform its covenants, a person who has made or announced a takeover proposal and the Company enters into a definitive agreement or consummates such proposal within 12 months of the termination PURCHASER TERMINATION FEE  $29 million paid by Purchaser to the Company within three business days of the termination  If the marketing period has ended and all other conditions to closing are met and Purchaser fails to close within 2 business days  If Purchaser breaches any of its reps & warrants or fails to perform its covenants EXPENSE REIMBURSEMENT  Reasonable out-of-pocket fees and expenses, up to a cap, if agreement is terminated due to a failure to obtain stockholder approval REPRESENTATIONS AND WARRANTIES  No survival of reps and warranties

GRAPHIC

 


STRICTLY CONFIDENTIAL II. Historical Performance

GRAPHIC

 


STRICTLY CONFIDENTIAL Rhombus Stock Price Performance RHOMBUS TWO-YEAR STOCK PRICE PERFORMANCE 05/02/14 Starboard Files 13D 10/01/14 Pre-Starboard Offer 02/09/15 Pre-Strategic Alternatives 06/11/15 Q4 FY2015 Earnings 08/05/15 Q1 FY2016 Earnings $15.00 3.500 $12.00 2.800 Rizvi Offer Current Price $11.00 $10.25 $9.00 2.100 52 Week High (02/19/15) 13.42 $6.00 1.400 $3.00 0.700 $ ---- Nov-13 Capital IQ Market data as of 11/04/15 Mar-14 Jul-14 Nov-14 Mar-15 Jul-15 Nov-15 Source: Note: 1. 2. Stake acquired April 22, 2014; Starboard subsequently filed Reported FY 2015 Q4 Adjusted EBITDA of $2.4mm versus consensus estimates of $1.2mm and EPS of ($0.36) versus consensus estimates of ($0.34) and that Rhombus continues to review its strategic alternatives Reported FY 2016 Q1 Adjusted EBITDA of $24.6mm versus consensus estimates of $26.5mm and EPS of $0.14 versus consensus estimates of $0.16 and that Rhombus continues to review its strategic alternatives [ 13 ] 3. Price per Share ($) Trading Volume Indicating 6.3% Stake ¹($9.27 )AnnouncementAnnouncement ²Announcement ³ ($11.03) Share Price Performance Close Price (11/04/15)$10.25 52 Week Low (08/24/15)8.91 Historical Share PricesLowVWAPHigh 10 Days$9.94$10.22$10.49 30 Days9.6910.1610.54 6 Months8.9111.0013.04 1 Year8.9111.4413.42 18 Months8.91 2 Years6.94 11.2613.42 10.6013.42

GRAPHIC

 


STRICTLY CONFIDENTIAL Rhombus Box Office Over Time RHOMBUS BOX OFFICE PERFORMANCE OVER TIME (FY 2012 – Q1 FY 2016) ($ in millions) $532 $278 Q1 12 Q2 12 Q3 12 Q4 12 Q1 13Q2 13 Q3 13Q4 13 Q1 14 Q2 14 Q3 14 Q4 14 Q1 15 Q2 15 Q3 15 Q4 15 Q1 16 Europe Russia Latin America Australasia Domestic Overall 3D Take Rates Europe Russia Latin America Australasia Domestic [ 14 ] Source: Rentrak Note: % of 3D Box Office for Rentrak reporting countries only; does not include China 69% 61% 67% 68% 71% 55% 53% 59% 52% 38% 55% 46% 47% 46% 44% 39% 44% 73% 74% 76% 82% 79% 74% 81% 78% 72% 69% 82% 80% 75% 66% 59% 58% 64% 50% 47% 58% 55% 53% 49% 52% 56% 49% 45% 54% 48% 47% 48% 40% 40% 51% 73% 62% 59% 68% 60% 59% 56% 54% 40% 31% 40% 28% 25% 23% 27% 19% 25% NA NA 52% 66% 47% 38% 45% 52% 37% 26% 44% 34% 35% 33% 32% 36% 38% $1,174 $933 $838 $787 $841 $724 $589 $708 $751 $617 $326 $582 $496 $642$614

GRAPHIC

 


STRICTLY CONFIDENTIAL Financial Performance Since IPO RHOMBUS REVENUE BY QUARTER SINCE IPO ($ in millions) $59 $58 $38 $28 Q1 11 Q2 11 Q3 11 Q4 11 Q1 12 Q2 12 Q3 12 Q4 12 Q1 13 Q2 13 Q3 13 Q4 13 Q1 14 Q2 14 Q3 14 Q4 14 Q1 15 Q2 15 Q3 15 Q4 15 Q1 16 Q2 16E RHOMBUS ADJUSTED EBITDA BY QUARTER SINCE IPO ($ in millions) Q1 11 Q2 11 Q3 11 Q4 11 Q1 12 Q2 12 Q3 12 Q4 12 Q1 13 Q2 13 Q3 13 Q4 13 Q1 14 Q2 14 Q3 14 Q4 14 Q1 15 Q2 15 Q3 15 Q4 15 Q1 16 Q2 16E [ 15 ] Source: Company filings, Management estimates $17$17$18 $44 $23 $21 $23 $25 $26 $16$18 $9 $14$13$14 $18 $16 $14 $14 $8 $11 $2 FY15 Adj. EBITDA: $52 FY14 Adj. EBITDA: $65 FY13 Adj. EBITDA: $63 FY12 Adj. EBITDA: $105 FY11 Adj. EBITDA: $62 $65$65 $88 $68 $59$55 $55 $54 $60 $49$50 $55 $47$45 $44 $41 $47 $33 FY15 Revenue: $163 FY14 Revenue: $199 FY13 Revenue: $216 FY12 Revenue: $247 FY11 Revenue: $246

GRAPHIC

 


STRICTLY CONFIDENTIAL Wall Street Commentary SELECT ANALYST COMMENTARY  “Fundamental improvement in profitability will result from the improved film slate over the next several quarters combined with cost cuts and somewhat better product gross margins”  “The strategic evaluation should provide an added support to the stock” $15.00 $67.2mm 10/08/15 Buy  “We believe our preview this week is more timely given the increasing potential for positive actions around the strategic review between now and that earnings release date.”  “With almost 9 months since the Board began its strategic review process...we believe the pressure may be on for this process to come to a conclusion”  “We continue to believe the risk/reward remains attractive at these levels given…the variety of potential outcomes to the process” 10/27/15 Buy $16.00 $69.4mm  “We view the continued strategic review as a negative at this stage, the realistic pool of bidders is relatively limited and will not include exhibitors or studios and as a result we are perplexed as to the duration the review has taken other than to think a sale is unlikely” N/A $68.3mm 10/13/15 Hold  “Investors have been frustrated with the slow strategic evaluation process which has resulted in numerous extensions to the bidding deadline”  “We think additional bidders and updated financials are the reason for the most recent delay”  “The delay is not a bad thing for…shareholders in our view, as it brings in fresh bidders, enables [Rhombus] to update financials (better film performance and better clarity on consumer initiatives), provides more time to resolve patent lawsuits, but also keeps Starboard Value at bay” $15.00 $67.6mm 10/12/15 Buy  “Filed an 8K declaring that the deadline for proxy submissions has been extended yet again to the period between October 15th and 30th…we take the extension as a signal that the company's process is still ongoing”  “Our belief is that management is using the extra time to finalize some sort of licensing agreement around its consumer technology”  “Baring that the strategic process concludes with the sale of the company, we anticipate management unveils some cost cuts, but we believe that it will take the influence of a major shareholder, like Starboard, to pressure the company to cut deep enough to maximize the opportunity” 10/13/15 $14.00 $76.6mm Buy [ 16 ] Source: Wall Street Research MEAN$15.00$70.0mm MANAGEMENT$73.1mm TARGET PRICE FY16E ADJ. EBITDA

GRAPHIC

 


STRICTLY CONFIDENTIAL III. Valuation Perspectives

GRAPHIC

 


STRICTLY CONFIDENTIAL Rhombus Management Financial Projections OVERVIEW  The Company has provided periodic updates to projected FY16 to potential buyers throughout the process The current projections were provided to buyers at the end of September 2015 In addition to the updated FY16 financials, the Company provided revised estimates for FY17 and FY18 Revenues License Product & Other  $137.8 77.8 $132.5 66.7 $109.3 54.1 $122.8 69.1 $130.7 70.2 $138.9 70.4  Total Revenues $215.6 $199.2 $163.5 $192.0 $200.8 $209.3 Revenue model was updated and based on projected film slate for all years of the projection period (previously FY17 and FY18 were projected using growth rates) Film slate includes unidentified titles (three in 2017 and four in 2018) Assumes Company would remain in Boulder and Beverly Hills facilities Forecast includes minimum projected InteliLight revenues from contract with leading computer technology company and associated expenses required to support the business; does not include growth case projections for the InteliLight business  % Growth (12.6%) (7.6%) (18.0%) 17.4% 4.6% 4.2%  Total COGS $125.4 $104.0 $82.7 $88.3 $78.8 $77.0   Gross Margin 41.8% 47.8% 49.4% 54.0% 60.8% 63.2% Operating Expenses Sales & Marketing Research & Development General & Administrative $19.5 25.3 47.8 $19.7 27.1 50.6 $19.5 21.7 49.4 $20.0 14.4 52.2 $20.8 21.6 45.6 $21.1 22.1 46.0  Growth case not included because InteliLight upside is highly speculative given InteliLight is in development and business model remains unproven Certain expenses during projection period may facilitate growth in future years  Total Operating Expenses $92.6 $97.4 $90.6 $86.6 $88.0 $89.2 Includes revenues from indigenous content for China   Does not include forecasted investment case for LUXE, Rhombus' PLF venture Assumes 15% discount on exhibitor renewals No CapEx investment to support exhibitor renewals For the purposes of analyzing calendar year results, as directed by Rhombus Management, quarterly FY2017 and FY2018 projections were estimated by applying average quarterly EBITDA contributions over the past four years to full year FY2017 and FY2018 estimates [ 18 ]    EBITDA Margin 26.9% 32.7% 31.8% 38.1% 41.5% 43.4% Source: 1. Company Management estimates Calculated as operating income plus depreciation & amortization, stock-based compensation, restructuring & impairment and in FY13A-FY15A only, gains/losses on foreign exchange Adjusted EBITDA ¹$57.9$65.1$52.0$73.1$83.3$90.9 Operating Income($2.4)($2.2)($9.8)$17.1$34.0$43.1 Gross Profit$90.2$95.3$80.8$103.7$122.1$132.3 ($ in millions) Fiscal Year Ended March 31, 2013A2014A2015A2016E2017E2018E

GRAPHIC

 


STRICTLY CONFIDENTIAL Fiscal Year 2016 EBITDA Bridge The initial budget shared with buyers contemplated $86.6 million of FY16 Adjusted EBITDA; latest forecast shared with buyers projects $73.1 million of FY16 Adjusted EBITDA ¹ FY16 EBITDA FORECAST ($ in millions) $86.6 $6.8 Budgeted Adj. EBITDA Reduction in License Gross Profit Increase in Glass Gross Increase in Consumer Increase in Operating Expenses ² Reduction in EBITDA Adjustments ³ Latest Estimate Adj. EBITDA Profit / Other Gross Profit EBITDA MARGIN 45% 38% Source: 1. 2. 3. Company Management estimates Adjusted EBITDA projections before public company cost savings Increase in operating expenses comprised of increase of S&M and G&A expense of $4.4 and $4.3 million, respectively, and a reduction of R&D expense of $0.2 million Reduction in EBITDA adjustments comprised of increase in D&A expense of $0.9 million and reduction in restructuring and impairment expenses of $2.0 million [ 19 ] ) $1.8$8.5 $1.2Latest forecast shared with buyers (as of Sep-15 $1.1$73.1 Projections provided in Overview Presentation for buyers (as of Mar-15)

GRAPHIC

 


STRICTLY CONFIDENTIAL Valuation Summary Per Share Price Premiums (Unaffected) ¹ Statistic $9.27 9.63 9.83 1-Day Prior to Starboard offer (10/01/14) 10-Day VWAP Prior to Starboard offer 30-Day VWAP Prior to Starboard offer 10.6% 6.5% 4.3% 18.7% 14.3% 11.9% Per Share Price Premiums (Current) Statistic $10.25 10.22 10.16 Current (11/04/15) 10-Day Prior VWAP 30-Day Prior VWAP --0.3% 0.9% 7.3% 7.6% 8.3% FD Shares Outstanding 53.579 53.658 Plus: Net Debt ² ($39.2) ($39.2) Valuation Multiples (Management) Statistic Valuation Multiples (Consensus) ⁴ Statistic Source: 1. 2. 3. 4. Company Management estimates, Capital IQ, Wall Street Research, Company Filings Unaffected dates based from 10/01/14, date of Starboard offer Includes debt and cash balances as of 11/0215 and minority interest as of 09/30/15 As directed by Rhombus management, nine months ending 12/31/16 estimated based on FY2017 projections and average quarterly EBITDA contributions over the past four years Consensus estimates as of 11/04/15 [ 20 ] TEV / LTM (6/30/15) EBITDA$52.79.7x10.5x TEV / CY2015E EBITDA49.210.4x11.2x TEV / CY2016E EBITDA79.46.4x6.9x TEV / LTM (6/30/15) EBITDA$52.79.7x10.5x TEV / CY2015E EBITDA56.49.0x9.8x TEV / CY2016E EBITDA ³88.85.7x6.2x Implied Enterprise Value$509.9$551.0 Market Capitalization$549.2$590.2 ($ in millions, except per share figures) CurrentRizvi 11/04/15Offer $10.25$11.00

GRAPHIC

 


STRICTLY CONFIDENTIAL Valuation Overview ($ in millions, except per share figures) Current Price: $10.25 ($56.4) $14.79 attributable to Company tax Source: Notes: 1. Company Management, Capital IQ Current price as of 11/04/15 As directed by Rhombus management, nine months ending 12/31/16 estimated based on FY2017 projections and average quarterly EBITDA contributions over the past four years [ 21 ] METHODOLOGY VALUATION RANGES COMMENTARY SELECTED PUBLICLY TRADED COMPANIES Rhombus Rizvi Offer: $11.00 $9.68 8.5x – 11.0x $12.31CY2015E Adj. EBITDA 7.5x – 10.0x $13.16$17.31CY2016E Adj. EBITDA ¹ ($88.8) SELECTED PRECEDENT TRANSACTIONS $8.60 8.0x – 11.5x $12.04LTM 06/30/15A Adj. EBITDA ($52.7) DISCOUNTED CASH FLOW 10.8% - 13.8% Discount Rate $9.25 2.0% - 4.0% Perpetuity Growth Rate Includes $0.35 - $0.44 per share value attributes (Implied Terminal EBITDA Multiple of 4.8x – 8.5x) Price per Share$8.00$10.00$12.00$14.00$16.00$18.00 Implied TEV$388$496$606$718$831$947

GRAPHIC

 


STRICTLY CONFIDENTIAL Selected Publicly Traded Companies Analysis Overview  Although none of the selected companies are directly comparable to Rhombus given the unique nature of Rhombus' business, Moelis focused on selected companies operating in the following categories:  Media / Technology Licensing  Theater Exhibitors  Other IP Licensing Moelis believes EBITDA multiples are more relevant than sales multiples in this case  Accounting for the margin profile of Rhombus' business  Area of focus for research analysts in valuing the comparable businesses Because of the inherent differences amongst the businesses, operations and prospects of Rhombus and those of the selected publicly-traded companies, Moelis made judgments to select appropriate reference ranges shown on page 21 for the selected companies trading analysis Relevant Rhombus attributes include:  Vast majority of revenues derived from technology licensing  Exposure to the cyclicality of the film slate  COGS comprised of cinema system depreciation and glasses; operating expenses largely scalable As a result, Moelis deemed media and licensing businesses as most relevant, given industry dynamics  Theater businesses require higher capital expenditures and have a different cost structure  IP licensing businesses lack exposure to film slate and also have a different cost structure For the purposes of analyzing calendar year results, as directed by Rhombus Management, quarterly FY2017 and FY2018 projections were estimated by applying average quarterly EBITDA contributions over the past four years to full year FY2017 and FY2018 estimates While IMAX may operate in the same industry as Rhombus, there are a number of differences between the business models of the two companies:  IMAX provides an end-to-end cinematic solution combining proprietary software, theater architecture and equipment, resulting in high customer switching costs  IMAX typically receives a larger percentage of the exhibitor’s box-office receipts than Rhombus  IMAX in some cases receives concession revenues       [ 22 ]  IMAX is more diversified, generating revenues from both 2D and 3D films

GRAPHIC

 


STRICTLY CONFIDENTIAL Selected Publicly Traded Companies VALUATION BENCHMARKING Media / Technology Licensing Dolby Laboratories ¹ $35.27 76% $3,729 $3,108 3.2x 3.0x 2.9x 11.0x 10.0x 9.5x IMAX 38.71 88% 2,774 2,767 7.5x 7.2x 6.5x 19.1x 16.9x 14.6x TiVo 9.26 70% 964 653 1.7x 1.5x 1.3x 5.4x 4.5x 3.7x Rovi 9.74 37% 809 1,697 3.3x 3.0x 2.6x 9.0x 7.9x 6.1x DTS ² 30.88 81% 554 627 3.5x 3.1x 2.8x 11.0x 9.2x 7.9x Theater Exhibitors Cinemark $35.56 78% $4,143 $5,617 2.0x 1.9x 1.8x 8.4x 8.1x 7.5x Regal Entertainment 19.45 79% 3,059 5,309 1.7x 1.7x 1.6x 8.7x 8.4x 8.0x AMC Entertainment ³ 25.84 72% 2,601 4,285 1.4x 1.4x 1.3x 7.9x 7.7x 7.3x Other IP Licensing Iconix Brand Group $16.22 40% $783 $2,304 5.5x 5.3x 5.3x 10.6x 10.4x 9.9x Sequential Brands Group ⁴ 12.90 69% 537 941 9.8x 8.8x 8.1x 15.4x 14.2x 12.3x Source: 1. 2. Company Management estimates, Capital IQ, Wall Street Research, Company Filings Financials calendarized for year end 12/31 2015E revenue and EBITDA pro forma for an estimated $34mm and $4mm in revenue and EBITDA, respectively, assuming the iBiquity acquisition closed at the beginning of the year; total debt and cash pro forma for $135mm of additional debt and $37mm use of cash to fund the acquisition 2015E EBITDA pro forma for an estimated $8.5mm in EBITDA assuming the Starplex acquisition closed at the beginning of the year 2015E revenue pro forma for an estimated $6mm and $7mm and of incremental revenue assuming the Jessica Simpson Collection (estimated assuming EBITDA margins equal to existing SBQG business) and Joes Jeans acquisitions, respectively closed at the beginning of the year; 2015E EBITDA pro forma for an estimated $4mm and $5mm of incremental EBITDA assuming the Jessica Simpson Collection and Joes Jeans acquisitions, respectively, closed at the beginning of the year; total debt pro forma for $60mm of additional debt to fund the Joes Jeans acquisition As directed by Rhombus management, quarterly FY2017 and FY2018 projections estimated using average quarterly EBITDA contributions over the past four years 3. 4. [ 23 ] 5. Rhombus at Offer - Consensus ¹$11.0081%$590$5513.3x3.0x2.9x11.2x6.9x6.4x Rhombus at Offer - Mgmt Projections ¹ ⁵$11.0081%5905513.2x2.7x2.7x9.8x6.2x6.1x Other IP Licensing Average54%7.6x7.1x6.7x13.0x12.3x11.1x Other IP Licensing Median54%7.6x7.1x6.7x13.0x12.3x11.1x Theater Exhibitors Average76%1.7x1.7x1.6x8.3x8.1x7.6x Theater Exhibitors Median78%1.7x1.7x1.6x8.4x8.1x7.5x Media / Technology Licensing Average70%3.8x3.6x3.2x11.1x9.7x8.4x Media / Technology Licensing Median76%3.3x3.0x2.8x11.0x9.2x7.9x As of 11/04/15Share% of 52MarketEnterprise EV / Revenue EV / EBITDA ($ in millions, except per share amounts)PriceWeek HighValueValueCY'15ECY'16ECY'17ECY'15ECY'16ECY'17E

GRAPHIC

 


STRICTLY CONFIDENTIAL Selected Publicly Traded Companies (cont’d) OPERATING METRICS BENCHMARKING Media / Technology Licensing Dolby Laboratories ¹ $973 $1,029 $1,088 5.8% 5.7% $284 $311 $326 29.2% 30.2% 30.0% 0.8% IMAX 369 385 425 4.3% 10.4% 145 164 189 39.3% 42.6% 44.6% 5.3% TiVo 395 428 491 8.3% 14.6% 122 146 178 30.8% 34.1% 36.3% 5.4% Rovi 510 567 651 11.2% 14.8% 189 216 279 37.0% 38.1% 43.0% 5.9% DTS ² 177 203 221 14.9% 8.7% 54 68 80 30.7% 33.5% 36.0% 5.3% Theater Exhibitors Cinemark $2,854 $2,957 $3,120 3.6% 5.5% $666 $695 $747 23.3% 23.5% 24.0% 0.6% Regal Entertainment 3,136 3,191 3,286 1.8% 3.0% 611 628 664 19.5% 19.7% 20.2% 0.7% AMC Entertainment ³ 2,963 3,083 3,217 4.0% 4.4% 537 555 584 18.1% 18.0% 18.2% 0.0% Other IP Licensing Iconix Brand Group $422 $431 $431 2.3% (0.1%) $218 $222 $232 51.6% 51.4% 53.8% 2.2% Sequential Brands Group ⁴ 97 111 134 14.6% 21.3% 62 73 90 64.4% 65.7% 66.9% 2.4% Source: 1. 2. Company Management estimates, Capital IQ, Wall Street Research, Company Filings Financials calendarized for year end 12/31 2015E revenue and EBITDA pro forma for an estimated $34mm and $4mm in revenue and EBITDA, respectively, assuming the iBiquity acquisition closed at the beginning of the year; total debt and cash pro forma for $135mm of additional debt and $37mm use of cash to fund the acquisition 2015E EBITDA pro forma for an estimated $8.5mm in EBITDA assuming the Starplex acquisition closed at the beginning of the year 2015E revenue pro forma for an estimated $6mm and $7mm and of incremental revenue assuming the Jessica Simpson Collection (estimated assuming EBITDA margins equal to existing SBQG business) and Joes Jeans acquisitions, respectively closed at the beginning of the year; 2015E EBITDA pro forma for an estimated $4mm and $5mm of incremental EBITDA assuming the Jessica Simpson Collection and Joes Jeans acquisitions, respectively, closed at the beginning of the year; total debt pro forma for $60mm of additional debt to fund the Joes Jeans acquisition As directed by Rhombus management, quarterly FY2017 and FY2018 projections estimated using average quarterly EBITDA contributions over the past four years 3. 4. [ 24 ] 5. Rhombus at Offer - Consensus ¹$168$183$191 9.1%4.3%$49$79$8629.3%43.4%45.2%15.9% Rhombus at Offer - Mgmt Projections ¹ ⁵ 17420720819.2%0.2% 56 89 9132.4%42.8%43.8%11.3% Other IP Licensing Average8.5%10.6%58.0%58.5%60.3%2.3% Other IP Licensing Median8.5%10.6%58.0%58.5%60.3%2.3% Theater Exhibitors Average3.1%4.3%20.3%20.4%20.8%0.5% Theater Exhibitors Median3.6%4.4%19.5%19.7%20.2%0.6% Media / Technology Licensing Average8.9%10.8%33.4%35.7%37.9%4.5% Media / Technology Licensing Median8.3%10.4%30.8%34.1%36.3%5.3% As of 11/04/15 ($ in millions, except per share amounts) RevenueGrowthEBITDAEBITDA Margin CY'15ECY'16ECY'17E '15E-'16E '16E-'17E CY'15ECY'16ECY'17ECY'15ECY'16ECY'17E'15-'17 ∆

GRAPHIC

 


STRICTLY CONFIDENTIAL Selected Precedent Transactions Analysis Overview  Moelis evaluated precedent transactions in selected relevant segments  Media / Technology Licensing  Theater Exhibitors  Other IP Licensing  The number of truly comparable transactions is very limited; and because of the inherent differences amongst the transactions, operations and prospects of Rhombus and those of the selected target companies, Moelis made judgments to select appropriate reference ranges shown on page 21 for the selected precedent transactions analysis  This analysis includes transactions dating back to 2010  Selected precedent transactions were analyzed on LTM EBITDA multiples  Moelis analyzed the selected precedent transactions, taking into consideration market conditions at the time the transaction was announced  Moelis deemed transactions involving media and licensing businesses as most relevant, given industry dynamics  Theater businesses require higher capital expenditures and have a different cost structure  IP licensing businesses lack exposure to film slate and also have a different cost structure [ 25 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL Selected Precedent Transactions Analysis ($ in millions) Media / Technology Licensing Nov-14 ChyronHego Corporation Vector Capital 115 58 5 8% 2.0x NM 332 177 37 21% 1.9x 9.0x Jun-12 Miranda Technologies Belden 110 34 3 7% 3.3x NM Apr-12 SRS Labs DTS 198 75 (0) NM 2.6x NM Jun-10 DivX Sonic Solutions Theater Exhibitors $172 $90 $16 18% 1.9x 10.8x Jul-15 Starplex ³ AMC Entertainment 238 NA NA NA NA NA Feb-13 Hollywood Theaters ³ Regal Entertainment 259 243 41 17% 1.1x 6.3x Jul-12 CinemaxX Vue Beteiligungs 730 NA 84 NA NA 8.7x Nov-10 Vue Entertainment Doughty Hanson & Co. Other IP Licensing Jun-15 Martha Stewart Sequential Brands $316 $126 $9 7% 2.5x NM Jul-12 Classic Media DreamWorks Animation 155 82 NA NA 1.9x NA Mar-11 RC2 Corporation Tomy Corporation 627 448 63 14% 1.4x 10.0x Apr-10 Peanuts Worldwide Iconix 175 76 17 22% 2.3x 10.4x Source: Note: 1. 2. 3. Company Management estimates, Capital IQ, Wall Street Research, Company Filings, Press Releases Excludes transactions less than $100 million EBITDA not disclosed; EBIT used as proxy (midpoint of range given for 2015 operating income) 19.9% investment from Twenty-First Century Fox Based on research estimates [ 26 ] Oct-15RhombusRizvi Traverse$551$161$5332.6%3.4x10.5x Other IP Licensing Average$337$164$3125.0%3.3x12.3x Other IP Licensing Median2971261918.1%2.3x10.4x Jul-10PlayboyRizvi Traverse; Hugh Hefner297225209%1.3x14.7x Oct-11HIT EntertainmentMattel6801807240%3.8x9.5x Mar-13Brand MatterSequential Brands10811658%9.8x16.9x Theater Exhibitors Average$818$815$11416.9%1.3x8.0x Theater Exhibitors Median2592436317.8%1.1x8.2x May-12AMC EntertainmentDalian Wanda2,6312,60033213%1.0x7.9x Nov-12Rave CinemasCinemark2402294218%1.0x5.8x Jun-13Vue EntertainmentAIMCo; OMERS1,45591517219%1.6x8.5x Media / Technology Licensing Average$271$117$1314.3%2.4x9.5x Media / Technology Licensing Median2099078.9%2.3x9.0x Dec-10Sonic SolutionsRovi Corporation66910676%NMNM May-12Bona Film ²Twenty-First Century Fox351151NANA2.3xNA Feb-14Grass Valley USABelden220290279%0.8x8.1x Sep-15iBiquity DigitalDTS$172$45$15 ¹33%3.8x11.5x ¹ DateImplied AnnouncedTargetAcquirorTEV LTMEBITDATEV / LTM RevenueEBITDAMarginRevenueEBITDA

GRAPHIC

 


STRICTLY CONFIDENTIAL Discounted Cash Flow Analysis Overview  Moelis relied on projected FY2016, FY2017 and FY2018 financials provided by Rhombus Management in September 2015  Management’s forecast reflects its perspective regarding the future prospects of the Company on a standalone basis as a public company  Forecast includes projected InteliLight revenues from contract with leading computer technology company and associated expenses required to support the business; does not include growth case projections for the InteliLight business (from May 2015)  Growth case not included because InteliLight upside is highly speculative given InteliLight is in development and business model remains unproven Utilizing Rhombus Management’s projections, Moelis performed a 2.25 year discount cashed flow analysis  Terminal value represents approximately 80% of the total enterprise value at mid-point of valuation range Projected financials discounted to December 31, 2015 at Rhombus' weighted average cost of capital (“WACC”)  Discount rate reference range of 10.8% – 13.8%  Beta reference range of 1.0 to 1.4       Rhombus 2-year and 5-year asset beta of 0.780 and 1.594, respectively Moelis derived its reference range based on a narrowed beta range for Rhombus Moelis also observed the 2-and 5-year asset beta of its comparable companies Moelis observed that although IMAX’s relevance to the selected publicly traded companies analysis is limited (see page 22), IMAX is relevant to the discounted cash flow analysis because IMAX’s market exposure is similar to Rhombus’ and is consistent with Rhombus’ 2-and 5-year asset beta levels  Moelis utilized projected balance sheet information provided by management for quarter ending 12/31/15 Moelis utilized the perpetuity growth method to calculate the terminal value  Based on the topline trend in the business during recent historical periods through the end of the projected period, which shows a slowdown in topline growth, Moelis used a perpetuity growth rate range of 2.0% to 4.0% to calculate terminal value, which begins at domestic GDP growth and goes higher due to the Company’s exposure to higher growth markets and potential upside from the Company’s growth initiatives including InteliLight and PLF As part of the analysis, Moelis has taken into account Rhombus' NOLs  Gross federal NOL balance of $133.7 million per Rhombus FY 2015 10-K filing  Following discussions with management, analysis assumes first year of NOL utilization is FY2020; NOLs assumed to be subsequently used evenly over the next ten years  Assumes additional $8.5 million of NOLs generated per year in FY2016 – FY2019  The NOL valuation contemplates a standalone valuation (i.e., not assuming a change of control and potential implications of a Section 382 Limitation)  Applied against Company’s marginal tax rate of 40%   [ 27 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL Discounted Cash Flow Analysis UNLEVERED FREE CASH FLOWS EBITDA Less: Depreciation & Amortization Less: Share-Based Compensation Less: Impairment $19.2 (9.7) (2.9) (0.7) $83.3 (33.4) (13.4) (2.4) $90.9 (32.0) (13.4) (2.4) $90.9 (15.0) (13.4) --EBIT $5.8 $34.0 $43.1 $62.5 Less: Taxes at 40.0% Plus: Depreciation & Amortization Plus: Share-Based Compensation Plus: Impairment Less: Increases in Working Capital Less: Capital Expenditures ($2.3) 9.7 2.9 0.7 (2.4) (3.5) ($13.6) 33.4 13.4 2.4 (0.2) (15.0) ($17.2) 32.0 13.4 2.4 (0.2) (15.0) ($25.0) 15.0 13.4 --(0.2) (15.0) Unlevered Free Cash Flow $10.9 $54.4 $58.5 $50.7 PRICE PER SHARE ² IMPLIED EXIT MULTIPLE Discount Rate 10.8% 11.8% 12.8% 13.8% Perpetuity Growth Rate Discount Rate 10.8% 11.8% 12.8% 13.8% Perpetuity Growth Rate 2.0% 2.5% 3.0% 3.5% 4.0% 2.0% 2.5% 3.0% 3.5% 4.0% Source: 1. 2. Company Management Assumes terminal year D&A equal to terminal year capital expenditures Includes present value of expected future tax savings from the $133.7mm federal net operating loss carryforward balance as of 03/31/15, assuming an additional $8.5mm of annual NOLS generated from FY2016-FY2019; represents $0.35 to $0.44 per share (for discount rates of 10.8%-13.8%, respectively) [ 28 ] 6.5x6.9x7.4x7.9x8.5x 5.8x6.1x6.5x7.0x7.4x 5.3x5.5x5.9x6.2x6.6x 4.8x5.1x5.3x5.6x5.9x $12.01$12.58$13.22$13.95$14.79 10.9011.3611.8612.4213.06 10.0010.3710.7711.2211.72 9.259.559.8810.2410.64 3 Mo Ending,Fiscal Year Ending March 31,Terminal ($ in millions)03/31/16E2017E2018EFCF ¹

GRAPHIC

 


STRICTLY CONFIDENTIAL Changes and Modifications Since October 2014 Selected Publicly Traded Companies Analysis  Presentations prior to today utilized market databases to calculate market values and enterprise values; market values and enterprise values contained herein are sourced from publicly available company filings In the October 2014 presentation, DTS and Dolby Laboratories were misclassified in the IP Licensing segment and were reclassified into the Media / Technology Licensing segment in the October 2015 presentation Included CY 2017 Revenue, EBITDA and corresponding valuation multiples in the materials herein   Selected Precedent Transaction Analysis  Presentations prior to today utilized market and news databases to calculate implied TEV to LTM revenue and EBITDA multiples; implied TEV to LTM revenue and EBITDA multiples contained herein sourced from publicly available company filings, Wall Street Research and publicly available market and news databases Additions, Removals and Reclassifications  Removed LiveTV/Thales Avionics transaction given lack of comparable business characteristics of LiveTV to Rhombus  Added iBiquity Digital/DTS, ChyronHego/Vector Capital, Starplex/AMC and Martha Stewart/Sequential Brands given their announcement subsequent to the initial October 2014 presentation  Reclassified Bona Film/Twenty-First Century Fox from Theater Exhibitors segment to Media/Technology Licensing segment to better reflect underlying business characteristics TEV/LTM EBITDA Multiples Reclassified as Not Available (“NA”) or Not Meaningful (“NM”)  Reclassified Bona Film/Twenty-First Century Fox transaction to NA due to inability to verify market and news database financial results  Transaction comparability is limited given minority investment and limited licensing revenue exposure  Reclassified DivX/Sonic Solutions transaction to NM; initial analysis utilized market and news database derived multiple; current presentation utilizes publicly available company filings, which yields a negative EBITDA rendering the multiple NM  Reclassified Hollywood Theatres/Regal Entertainment transaction to NA; initial analysis utilized market and news database derived multiple; current presentation utilizes publicly available company filings, which do not disclose target financials, rendering the multiple NA  Reclassified Classic Media/DreamWorks Animation transaction to NM due to inability to verify market and news database financial results   Financial  CY 2016 Management Adj. EBITDA estimates have increased from $80.3mm (per October 2015 materials) to $88.8mm in current materials due to calendarization calculation error [ 29 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL Appendix

GRAPHIC

 


STRICTLY CONFIDENTIAL A. Additional Valuation Detail

GRAPHIC

 


STRICTLY CONFIDENTIAL Weighted Average Cost of Capital Analysis PEER GROUP BETA ANALYSIS Media / Technology Licensing IMAX 0.984 1.425 22 2,774 0.8% 26.0% 0.978 1.417 5.8% Rovi 1.533 1.192 1,036 809 56.2% 55.2% 0.974 0.757 7.4% Theater Exhibitors Regal Entertainment 0.786 1.011 2,349 3,059 43.4% 39.7% 0.537 0.691 5.5% Other IP Licensing Sequential Brands Group ⁴ 1.074 2.924 355 537 39.8% 48.8% 0.802 2.185 5.8% Source: Notes: 1. 2. 3. 4. Bloomberg, Company filings, U.S. Department of the Treasury, 2015 Duff & Phelps Market data as of 11/04/15 2-year weekly and 5-year monthly adjusted beta per Bloomberg Average of the past 8 quarters per Capital IQ Pro forma for iBiquity acquisition; reflects $135mm of additional debt and $37mm use of cash to fund the acquisition; debt/total cap prior to acquisition was 4.5% Pro forma for Joes Jeans acquisition; reflects $60mm of additional debt used to fund the acquisition per company press release [ 32 ] Rhombus0.8191.674$38$5506.5%27.8%0.7801.5944.0% Other IP Licensing Average1.0352.24053.1%38.4%0.6071.4145.6% Other IP Licensing Median1.0352.24053.1%38.4%0.6071.4145.6% Iconix Brand Group0.9961.556$1,543$78366.3%28.1%0.4120.6445.5% Theater Exhibitors Average0.850 1.05539.4%37.2%0.6010.7435.6% Theater Exhibitors Median0.8111.01141.8%39.7%0.6270.6915.6% AMC Entertainment ³0.9531.2611,8642,60141.8%31.5%0.6390.8465.9% Cinemark0.8110.894$2,039$4,14333.0%40.4%0.6270.6915.6% Media / Tech. Licensing Average1.0911.23521.8%33.9%0.9021.0495.4% Media / Tech. Licensing Median0.9841.24322.4%27.9%0.9380.9855.1% DTS ³1.0441.34516055422.4%27.9%0.8641.1133.8% TiVo0.9541.24340396429.5%37.2%0.7560.9854.4% Dolby Laboratories0.9380.972$--$3,729--23.4%0.9380.972NA As of 11/04/15Levered Beta 1TotalMVDebt/EffectiveAsset BetaInt. Expense / ($ in millions)2-Year5-YearDebtEquityTotal CapTax Rate ²2-Year5-YearTotal Debt

GRAPHIC

 


STRICTLY CONFIDENTIAL Weighted Average Cost of Capital Analysis (cont’d) ILLUSTRATIVE COST OF CAPITAL CALCULATION WACC SENSITIVITY Long-Term Risk Free Rate ¹ Market Risk Premium ² Size Premium ³ Tax Rate ⁴ Cost of Debt ⁵ Debt / Total Cap Unlevered Beta 2.66% 6.21% 1.000 1.100 1.200 1.300 1.400 2.42% 36.7% 5.1% --5.0% 10.0%  Beta reference range of 1.0 to 1.4  Rhombus 2-year and 5-year asset beta of 0.780 and 1.594, respectively  Moelis derived its reference range based on a narrowed beta range for Rhombus  Moelis also observed the 2-and 5-year asset beta of its comparable companies  Moelis observed that although IMAX’s relevance to the selected publicly traded companies analysis is limited (see page 22), IMAX is relevant to the discounted cash flow analysis because IMAX’s market exposure is similar to Rhombus’ and is consistent with Rhombus’ 2-and 5-year asset beta levels  5-year beta more relevant data set for following reasons:  Rhombus contract renewal cycle takes place over five-plus year time period  Premium priced film tickets are highly sensitive to broader economic cycles, therefore it is useful to incorporate longer time periods  Rhombus’ exposure to film slate makes the Company highly dependent on intermittent films that perform exceptionally well in 3D (e.g., Avatar and Gravity), therefore it is useful to incorporate longer time periods Source: Notes: 1. 2. 3. 4. 5. Bloomberg, Company filings, U.S. Department of the Treasury, 2015 Duff & Phelps Valuation Handbook Market data as of 11/04/15 U.S. Department of the Treasury, 20-Year Treasury Supply-side long-horizon expected equity risk premium per 2015 Duff & Phelps Valuation Handbook Average of CRSP deciles 8 and 9 per 2015 Duff & Phelps Valuation Handbook Rhombus federal statutory rate plus state tax rate, net of federal benefits per latest 10-K Median of Media / Technology Licensing peer group [ 33 ] 11.3%11.9%12.5%13.2%13.8% 11.1%11.7%12.3%12.9%13.5% 10.9%11.5%12.1%12.7%13.3%

GRAPHIC

 


STRICTLY CONFIDENTIAL NOL Analysis The following analysis assumes additional $8.5 million of NOLs generated per year in FY2016 – FY2019 Beginning Balance $167.7 $154.3 $141.0 $127.6 $114.2 $100.9 $87.5 $74.1 $60.7 $47.4 $34.0 NOL Usage (13.4) (13.4) (13.4) (13.4) (13.4) (13.4) (13.4) (13.4) (13.4) (13.4) (13.4) Ending Balance $133.7 $154.3 $141.0 $127.6 $114.2 $100.9 $87.5 $74.1 $60.7 $47.4 $34.0 $20.6 Tax Savings $5.3 $5.3 $5.3 $5.3 $5.3 $5.3 $5.3 $5.3 $5.3 $5.3 $5.3 PV OF NOL TAX SAVINGS VALUE PER SHARE Discount Rate 10.80% 11.80% 12.80% 13.80% Discount Rate 10.80% 11.80% 12.80% 13.80% [ 34 ] Source: Management, public filings $0.44 0.40 0.38 0.35 $23.4 21.7 20.1 18.7 Fiscal Year Ending March 31, ($ in millions, except per share values)03/31/15A2020E2021E2022E2023E2024E2025E2026E2027E2028E2029E2030E

GRAPHIC

 


STRICTLY CONFIDENTIAL B. Rhombus Overview

GRAPHIC

 


STRICTLY CONFIDENTIAL Overview of Rhombus Rhombus is a licensor of 3D and other visual technologies worldwide BUSINESS OVERVIEW RHOMBUS FY15A GLOBAL BOX OFFICE ($ in millions)  Formed in 2003, Rhombus licenses 3D projection technology to exhibitors worldwide under long-term exclusive agreements $38 $125 $284  Domestic Europe Latin America Australia / Asia Russia Market leader with a network including more than 26,500 screens in 72 countries with 1,200 exhibitors $939   18 of the world’s top 25 exhibitors use Rhombus 3D For FYE 03/31/15, Rhombus had total revenues of $163.5 million and EBITDA of $52.0 million $622  Headquartered in Beverly Hills, California TOP EXHIBITORS RHOMBUS FY16E REVENUE BY PRODUCT ($ in millions) ($ in millions) $3.8 Wanda China $12.1 11/15/17 $64.0 Cinemark Int'l LatAm 7.6 12/31/18 License Revenue Glasses Revenue Other Revenue ³ AMC Domestic 7.6 12/31/18 Regal Domestic 7.0 12/31/18 $124.2 Odeon/UCI EMEA 4.8 01/31/17 Source: Notes: 1. 2. 3. Management TTM as of 09/30/15 Represents earliest contract expiration date (exhibitors subject to a number of contract expiration dates) Includes theater revenues and consumer product revenue [ 36 ] CineworldEMEA3.512/31/18 EuropalacesEMEA6.306/30/16 CineplexDomestic7.212/31/15 CinepolisLatAm7.612/31/19 Cinemark USADomestic7.912/31/18 ExhibitorRegionTTM Rev. ¹Renewal Date ²

GRAPHIC

 


STRICTLY CONFIDENTIAL Overview of Rhombus (cont’d) GROWTH INITIATIVES MANAGEMENT & BOARD Co-Founder, Chairman of the Board of Directors, and CEO  A PLF theater is a premier theater-going experience with defined standards and technologically superior equipment +1,500 existing PLF screens globally LUXE PLF brand is an opportunity for Rhombus to offer a holistic PLF brand to exhibitors amongst fragmented PLF landscape 10 LUXE installations in Russia, with an additional 22 new auditoriums under contract in Russia, China and Eastern Europe Generates revenue on 2D and 3D tickets sold Michael Lewis   Leo Bannon EVP of Global Operations   Anthony Marcoly President of Worldwide Cinema    Intelligent backlight technology for LCD displays Uses technology to control a given display’s light fields The technology enables a number of device display modes: sunlight, wide angle, privacy, (glasses free) 3D and power savings Addressable display market of over 2.4 billion units Over 25 active patent families Rhombus signed exclusive contract with a leading computer technology company  Exclusivity for notebook devices with permanently attached keyboards, or sold with a detachable keyboard as an integral part of the product, with an LCD panel size 10” or above Frank Biondi Lead Director    P. Gordon Hodge Director Sherry Lansing Director [ 37 ] Source: Management David HabigerDirector Richard Grand-JeanDirector InteliLight Board of Directors Michael LewisCo-Founder, Chairman of the Board of Directors, and CEO Vivian YangEVP, General Counsel Drew SkarupaCFO Premium Large Format (PLF) Management

GRAPHIC

 


STRICTLY CONFIDENTIAL Overview of Rhombus (cont’d) RHOMBUS SHAREHOLDER SUMMARY (AS OF MOST RECENT FILINGS) Bares Capital Management, Inc. Starboard Value LP 7,102,434 4,950,000 13.9% 9.7% T. Rowe Price Associates, Inc. The Vanguard Group, Inc. 3,785,614 2,912,090 7.4% 5.7% BlackRock Fund Advisors Nokomis Capital LLC 2,212,379 1,585,876 4.3% 3.1% Rivulet Capital LLC Fidelity Management & Research Co. 1,504,938 1,181,924 3.0% 2.3% Gabelli Funds LLC SSgA Funds Management, Inc. 1,129,176 665,029 2.2% 1.3% Remaining Institutional Holders 10,690,380 21.0% Michael Lewis (CEO) 5,338,319 10.5% All Other Insiders 841,184 1.7% Retail & Other 12,360,883 13.8% [ 38 ] Source: Management, public filings, FactSet Total Shareholders (as of 07/29/15)50,921,907100.0% Total Insiders6,179,50312.1% Total Institutional Shareholders37,719,84074.1% Shares% Shares OwnedOustanding

GRAPHIC

 


STRICTLY CONFIDENTIAL Contact Information Moelis & Company LLC is a U.S.-registered broker dealer and a member of FINRA & SIPC. Moelis & Company LLC 1999 Avenue of the Stars, Suite 1900 Los Angeles, CA 90067 Tel: 310-443-2300 399 Park Avenue, 5th Floor New York, NY 10022 Tel: 212-883-3800

GRAPHIC

 



Exhibit (c)(3)

 

STRICTLY CONFIDENTIAL Project Rhombus Discussion Materials October 15, 2015

GRAPHIC

 


STRICTLY CONFIDENTIAL Disclaimer This presentation has been prepared by Moelis & Company LLC (“Moelis”) for exclusive use by the Board of Directors of RealD Inc. (“Rhombus” or the “Company”) in considering the transaction described herein based on information provided by the Company and publicly available information. Moelis has not assumed any responsibility for independently verifying the information herein, and Moelis makes no representation or warranty as to the accuracy, completeness or reasonableness of the information herein. In this presentation, Moelis, at the Company’s direction, has used certain projections, forecasts or other forward-looking statements with respect to the Company and/or other parties involved in the transaction which were provided to Moelis by the Company and/or such other parties and which Moelis has assumed, at the Company’s direction, were prepared based on the best available estimates and judgments of the management of the Company and/or such other parties as to the future performance of the Company and/or such other parties. This presentation speaks only as of its date and Moelis assumes no obligation to update it or to advise any person that its conclusions or advice has changed. This presentation is solely for informational purposes. This presentation is not intended to provide the sole basis for any decision on any transaction and is not a recommendation with respect to any transaction. The recipient should make his or her own independent business decision based on all other information, advice and the recipient’s own judgment. This presentation is not an offer to sell or a solicitation of an indication of interest to purchase any security, option, commodity, future, loan or currency. It is not a commitment to underwrite any security, to loan any funds or to make any investment. Moelis does not offer tax, accounting or legal advice. Moelis provides mergers and acquisitions, restructuring and other advisory services to clients and its affiliates manage private investment partnerships. Its personnel may make statements or provide advice that is contrary to information contained in this material. Our proprietary interests may conflict with your interests. Moelis may from time to time have positions in or effect transactions in securities described in this presentation. Moelis may have advised, may currently advise, may seek to advise and may in the future advise or invest in companies mentioned in this presentation. This presentation is confidential and may not be disclosed to any other person or relied upon without the prior written consent of Moelis. [ 1 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL Table of Contents I. II. III. IV. Process Update Situation Overview Preliminary Valuation Perspectives Review of Strategic Alternatives 4 12 17 22 Appendices A. B. C. D. Additional Valuation Detail Shareholder Basis Analysis Historical Box Office Trends Rizvi Bid Package 27 32 34 36 [ 2 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL Agenda  Review strategic alternatives process and final round bid received  Review current situation at Rhombus  Discuss preliminary valuation perspectives  Review strategic alternatives available to the Company and discuss next steps [ 3 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL I. Process Update

GRAPHIC

 


STRICTLY CONFIDENTIAL Strategic Alternatives Process Summary Over 70 potential buyers were contacted during the process, with 36 parties receiving an Overview Presentation, 6 parties submitting an initial bid, and 1 party submitting a final bid Public announcement regarding the strategic alternatives process was made on February 9, 2015 [ 5 ] Strategic Financial 71Contacted 11 60 36Signed NDA and Received OP 4 32 61st Round Bid Received 2 4 6 1 Received Management Presentation 2 4 Final Bid Received 0 1

GRAPHIC

 


STRICTLY CONFIDENTIAL Summary of Parties that Received Overview Presentations Listed below are the parties that received an Overview Presentation☨ Party A Party N Party Y Rizvi Traverse * Party O Party Z Starboard Value * Party P Party AA Party D* Party Q Party BB Party E* Party R Party CC Party H* Party S Party DD Party I Party T Party EE Party J Party U Party FF Party K Party V Party GG Party L Party W Party HH Party M Party X Party F * Party II Party JJ Party G * * Denotes party that submitted first round bid and final round bid * Denotes party which submitted first round bid and/or participated in management presentation ☨Names of parties (other than Rizvi Traverse and Starboard Value) have been replaced with generic references. [ 6 ] STRATEGIC PARTIES (4) FINANCIAL PARTIES (32)

GRAPHIC

 


STRICTLY CONFIDENTIAL Rizvi Traverse Final Bid Summary party transactions) 1. LTM Adjusted EBITDA (as of 6/30/15) and CY15 Adjusted EBITDA of $52.7 and $56.4 million, respectively; adjusted for share-based compensation, impairment of assets and intangibles, as well as certain expenses related to the cost reduction plan and non-recurring expenses Borrower will issue and sell senior secured notes in a Rule 144A or other private placement yielding $275 million in gross cash proceeds consisting of dollar denominated senior secured notes and / or borrow under a senior secured bridge credit facility in the original principal amount of $275 million on or prior to the closing date [ 7 ] 2. VALUATION ¹  Per Share Price (% Premium): $10.35 (3.9% premium to 10-Day VWAP)  Implied Market Cap: $556 million  Implied TEV: $517 million  LTM 06/30/15 Adjusted EBITDA Multiple: 9.8x  CY15 Adjusted EBITDA Multiple: 9.2x FINANCING  Funded Debt: $280 million ($275 million Bridge Facility and/or Senior Secured Notes, $5 million Revolver Draw) ²  PF Leverage: 4.9x LTM 06/30/15E PF Adj. Financeable EBITDA ($57.6 million)  Revolver: LIBOR plus [550]bps  Bridge Facility: Three-month LIBOR plus a [TBD] spread  Cash on Balance Sheet: $57 million  Equity: $283 million PROPOSED CHANGES TO CONTRACT TERMS  Rollover: Michael Lewis to roll his shares of common stock  Company equity awards: Treatment is subject to completion of Purchaser’s review of equity plans and award agreements  Reps & Warranties: Expand reps and warranties to include additional customary provisions, add 3-year look back where customary, addition of other customary reps and warranties (e.g., customer/exhibitor relationships and related  Modifications to certain covenants including No Solicitation, Adverse Recommendation Change, Fiduciary Standard, standard for Superior Proposal, Intervening Events, Matching Right / Last Look  Company Termination Fee: 4% of equity value  Purchaser Termination Fee: 5% of equity value  Expense Reimbursement: Up to 1% of equity value if agreement is terminated due to a failure to obtain shareholder approval TIMING  Announcement: Prepared to move towards signing definitive documentation by November 6, 2015  Closing: No later than 30 days following delivery of the Rhombus’s Q3 2016 financial statements (assuming delivery by January 15, 2016)

GRAPHIC

 


STRICTLY CONFIDENTIAL Overview of the Offer Rizvi Traverse offered $10.35 per share of Rhombus common stock RIZVI OFFER IMPLIED VALUATION IMPLIED TRANSACTION MULTIPLES ($ in millions, except per share amounts) TEV / Adj. Adj. EBITDA EBITDA Management Estimates LTM 06/30/15A Adj. EBITDA CY15E Adj. EBITDA (Latest Forecast) CY16E Adj. EBITDA ³ $52.7 56.4 80.3 Fully Diluted Shares Outstanding ¹ 53.684 Plus: Debt (as of 10/05/15) Plus: Minority Interest (as of 06/30/15) Less: Cash (as of 10/05/15) $38.0 (0.5) (76.6) TEV / Adj. EBITDA Consensus Estimates Adj. EBITDA LTM 06/30/15A Adj. EBITDA CY15E Adj. EBITDA CY16E Adj. EBITDA $52.7 51.7 78.0 Premium / (Discount) Per Share Price Premium (Unaffected) ² Price 1-Day Prior (10/01/14) 10-Day Prior VWAP 30-Day Prior VWAP $9.27 9.63 9.83 Premium / (Discount) Per Share Price Premium (Current) Price 1-Day Prior (10/13/15) 10-Day Prior VWAP 30-Day Prior VWAP $10.34 9.96 9.96 Source: 1. 2. 3. Company Information Calculated based on securities outstanding as of July 27, 2015 Unaffected dates as of October 1, 2014; date of Starboard offer Nine months ending 12/31/16 estimated based on FY2017 projections and average quarterly EBITDA contributions over the past four years [ 8 ] 0.10% 3.92% 3.92% 11.65% 7.51% 5.31% 9.8x 10.0x 6.6x Total Enterprise Value$516.5 9.8x 9.2x 6.4x Implied Equity Value$555.6 Offer Price$10.35

GRAPHIC

 


STRICTLY CONFIDENTIAL Summary of Remaining Diligence Rizvi Traverse has indicated that they have the remaining diligence areas that they will commit the necessary resources to complete diligence by November 6th  Confirmatory Legal Due Diligence - - - - - - - Review draft Company Disclosure Schedules Review material customer Systems License Agreements Review Company equity plans and equity award agreements Conduct intellectual property review Understand pending litigation matters relating to infringement of Company intellectual property in US and foreign jurisdictions Review information technology organization and management structure Tax structuring in connection with anticipated debt and equity financing  Confirmatory Tax Due Diligence - - Discuss the Company’s historic tax filing profile and significant tax issues with management and the Company’s tax advisors Understand the Company’s legal entity structure, including current filing status, global presence, and domicile, as well as any changes in recent corporate history - - Review and analyze US federal and state income tax returns and tax provision work papers for the prior three tax years Consider the historic generation of tax attributes and the utilization thereof, including any limitations on the ability to utilize such attributes - Review and analyze internal and external memos with respect to advice regarding any material tax issue or tax planning issue, including ruling requests submitted to tax authorities and Section 382 studies or other similar analysis with respect to the tax historical period - Understand the Company’s historic and current tax examination profile and the nature of any material issues that have been raised in connection therewith. Review of tax examination documentation as applicable - Understand the Company’s non-income tax profile and the potential impact of foreign taxes on the Company’s operations [ 9 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL Summary of Recent Buyer Activity Other than Rizvi Traverse, there has been limited recent buyer activity Firm☨ Last Date Data Room Accessed Commentary  October 5th  Has not engaged in active diligence following recent discussions Party D  Reached out week of October 12th to inquire about opportunity to re-engage in potential merger discussions  NA Party F  Multiple calls held and in-person meetings conducted  Ultimately, could not get comfortable with growth prospects of core business Party H  September 25th  October 5th  Has not engaged in active diligence following recent discussions Party I ☨Names of parties (other than Rizvi Traverse and Starboard Value) have been replaced with generic references. [ 10 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL Discussion of Other Process Participants The Company has spent a substantial amount of time educating buyers about its business Firm☨ Commentary Status  Areas of focus included: core business growth projections, review of projected film slate, key exhibitor review and growth initiatives review (e.g., InteliLight)  Multiple calls held and in-person meetings conducted  Did not proceed, could not get comfortable with growth prospects of core business Party H  Met with management in Boulder and in Beverly Hills  Held numerous calls with Moelis and the Company  Engaged strategic advisors – Dale Fuller, tech executive, and Matthew Kearny, media executive  Chose to partner with strategic (Party G)  Proposed Merger of Equals (MOE)  Engaged Centerview Partners to help in their review of the business  Held meetings in Boulder and Beverly Hills to learn more about the business  Numerous calls to understand financials; in particular, revenue model Party F  Did not participate in final round  Did not proceed; was highly focused on financeable EBITDA, as well as renewals  Met with management in Boulder for management presentation  Had numerous follow-up calls to discuss the business Party E  Management presentation and technical meeting held on separate days in Boulder  Focused on IP protection of the business  Sought greater understanding of the core business and marketplace dynamics  Did not proceed; expressed greater interest in the consumer opportunities available to RealD Party G ☨Names of parties (other than Starboard Value) have been replaced with generic references. [ 11 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL II. Situation Overview

GRAPHIC

 


STRICTLY CONFIDENTIAL Stock Price Performance RHOMBUS TWO-YEAR STOCK PRICE PERFORMANCE $15.00 3.500 02/09/15 Announcement Pre-Starboard Offer $12.00 2.800 Rizvi Offer Current Price $10.35 $10.34 $9.00 2.100 $6.00 1.400 $3.00 0.700 $ ---- Oct-13 Feb-14 Jun-14 Oct-14 Feb-15 Jun-15 Oct-15 [ 13 ] Source: Capital IQ Note: Market data as of 10/13/15 Price per Share ($) Trading Volume 10/01/14Pre-Strategic Alternatives ($9.27 )($11.03) Share Price History Close Price (10/13/15)$10.34 52 Week High (02/19/15)13.42 52 Week Low (08/24/15)8.91 Historical Share PricesLowVWAPHigh 10 Days$9.69$9.96$10.54 30 Days9.179.9610.75 6 Months8.9111.2013.04 1 Year8.9111.4713.42 18 Months8.9111.2813.42 2 Years6.9210. 4113.42

GRAPHIC

 


STRICTLY CONFIDENTIAL Rhombus Management Financial Projections OVERVIEW Revenues License Product & Other  The Company has provided periodic updates to projected FY16 to potential buyers throughout the course of the process $137.8 77.8 $132.5 66.7 $109.3 54.1 $122.8 69.1 $130.7 70.2 $138.9 70.4 Total Revenues $215.6 $199.2 $163.5 $192.0 $200.8 $209.3  The current projections were provided to buyers at the end of September % Growth (12.6%) (7.6%) (18.0%) 17.4% 4.6% 4.2%  In addition to the updated FY16 financials, the Company provided revised estimates for FY17 and FY18 Total COGS $125.4 $104.0 $82.7 $88.3 $78.8 $77.0 Revenue model was updated and based on projected film slate for all years of the projection period (previously FY17 and FY18 were projected using growth rates) Gross Margin 41.8% 47.8% 49.4% 54.0% 60.8% 63.2%  Operating Expenses Sales & Marketing Research & Development General & Administrative $19.5 25.3 47.8 $19.7 27.1 50.6 $19.5 21.7 49.4 $20.0 14.4 52.2 $20.8 21.6 45.6 $21.1 22.1 46.0 Film slate includes unidentified titles (three in 2017 and four in 2018)  Total Operating Expenses $92.6 $97.4 $90.6 $86.6 $88.0 $89.2 Assumes Company would remain in Boulder and Beverly Hills facilities  Includes InteliLight revenues from Lenovo contract, as well as the associated R&D overhead to support InteliLight  EBITDA Margin 26.9% 32.7% 31.8% 38.1% 41.5% 43.4% Includes revenues from indigenous content for China  Source: Company Management estimates [ 14 ] 1. Calculated as operating income plus depreciation & amortization, stock-based compensation, restructuring & impairment and gains/losses on foreign exchange (in FY13A-FY15A only) Adjusted EBITDA ¹$57.9$65.1$52.0$73.1$83.3$90.9 Operating Income($2.4)($2.2)($9.8)$17.1$34.0$43.1 Gross Profit$90.2$95.3$80.8$103.7$122.1$132.3 ($ in millions)FY13AFY14AFY15AFY16EFY17EFY18E

GRAPHIC

 


STRICTLY CONFIDENTIAL Fiscal Year 2016 EBITDA Bridge The initial budget shared with buyers contemplated $86.6 million of FY16 Adjusted EBITDA; latest forecast shared with projects $73.1 million of FY16 Adjusted EBITDA ¹ FY16 EBITDA FORECAST ($ in millions) $86.6 $6.8 Budgeted Adj. EBITDA Reduction in License Gross Profit Increase in Glass Gross Increase in Consumer Increase in Operating Expenses ² Reduction in EBITDA Adjustments ³ Latest Estimate Adj. EBITDA Profit / Other Gross Profit EBITDA MARGIN 45% 38% Source: 1. 2. 3. Management Estimates Adjusted EBITDA projections before public company cost savings Increase in operating expenses comprised of increase of S&M and G&A expense of $4.4 and $4.3 million, respectively, and a reduction of R&D expense of $0.2 million Reduction in EBITDA adjustments comprised of increase in D&A expense of $0.9 million and reduction in restructuring and impairment expenses of $2.0 million [ 15 ] $1.8$8.5 $1.2Latest forecast shared with buyers $1.1$73.1 Projections provided in Overview Presentation for buyers

GRAPHIC

 


STRICTLY CONFIDENTIAL Debt Capital Market Conditions Leveraged loan and high yield new issue volume continues to be limited as issuers seek to wait out current market volatility INSTITUTIONAL LEVERAGED LOAN NEW ISSUE VOLUME ($BN) HIGH YIELD NEW ISSUE VOLUME ($BN) $60 $50 $40 $40 $30 $20 $20 $10 $0 $0 O N D J F M A M J J A S O N D J F M A M J J A S O N D J F M A M J J A S O N D J F M A M J J A S O 2013 2014 2015 2013 2014 2015 LEVERAGED LOAN AVERAGE SECONDARY SPREAD HIGH YIELD – YTW (1) * Current rate parallels November 2011 levels 10/2011 900 800 700 600 500 400 300 8.9% 9.0% 10/8/2015 7.9% 3-year B high 682 8.0% 7.0% 6.0% 455 5.0% 4.0% Oct-11 Jul-12 May-13 Mar-14 Dec-14 Oct-15 Oct-11 Jun-12 Jan-13 Oct-13 Jun-14 Jan-15 Oct-15 [ 16 ] Source: Prospect News and S&P LCD, as of October 8, 2015 1. Source: Advantage Data North American High Yield Corporate Bond Index 5/2013 4.5% BB LoansB Loans *

GRAPHIC

 


STRICTLY CONFIDENTIAL III. Preliminary Valuation Perspectives

GRAPHIC

 


STRICTLY CONFIDENTIAL Valuation Summary Per Share Price Premiums (Unaffected) ¹ Statistic $9.27 9.63 9.83 1-Day Prior to Starboard offer (10/01/14) 10-Day Prior to Starboard offer VWAP 30-Day Prior to Starboard offer VWAP 11.5% 7.4% 5.2% 11.7% 7.5% 5.3% Per Share Price Premiums (Current) Statistic $10.34 9.96 9.96 Current (10/13/15) 10-Day Prior VWAP 30-Day Prior VWAP --3.8% 3.8% 0.1% 3.9% 3.9% FD Shares Outstanding 53.683 53.684 Plus: Net Debt ² ($39.1) ($39.1) Statistic Valuation Multiples (Management) Valuation Multiples (Consensus) Statistic Source: 1. 2. Capital IQ, Wall Street Research, Company Filings Unaffected dates based from October 1, 2014, date of Starboard offer Includes debt and cash balances as of October 5, 2015 and minority interest as of June 30, 2015 [ 18 ] TEV / LTM (6/30/15) EBITDA$52.79.8x9.8x TEV / CY2015E EBITDA51.710.0x10.0x TEV / CY2016E EBITDA78.06.6x6.6x TEV / LTM (6/30/15) EBITDA$52.79.8x9.8x TEV / CY2015E EBITDA56.49.1x9.2x TEV / CY2016E EBITDA80.36.4x6.4x Implied Enterprise Value$516.0$516.5 Market Capitalization$555.1$555.6 CurrentRizvi 10/13/15Offer $10.34$10.35

GRAPHIC

 


STRICTLY CONFIDENTIAL Public Company Benchmarking VALUATION BENCHMARKING Media / Technology Licensing Dolby Laboratories ¹ $33.79 73% $3,469 $2,850 2.9x 2.8x 9.1x 8.6x IMAX 36.26 83% 2,545 2,506 7.0x 6.5x 16.6x 14.7x TiVo 9.23 69% 1,005 648 1.6x 1.5x 5.3x 4.4x Rovi 10.88 41% 946 1,799 3.5x 3.1x 9.1x 7.8x DTS ² 28.98 76% 500 572 3.2x 2.8x 10.0x 8.4x Theater Exhibitors Cinemark $34.93 76% $4,049 $5,525 1.9x 1.9x 8.2x 7.9x Regal Entertainment 19.57 80% 3,047 5,141 1.6x 1.6x 8.5x 8.1x AMC Entertainment 27.17 75% 2,642 4,327 1.5x 1.4x 8.0x 7.6x Other IP Licensing Iconix Brand Group $15.29 37% $738 $2,259 5.4x 5.2x 10.4x 10.2x Sequential Brands Group ³ 13.74 74% 560 904 11.0x 8.5x 17.8x 13.6x Source: Note: 1. 2. 3. Capital IQ, Wall Street Research, Company Filings Rhombus financials are based on consensus estimates Financials calendarized for year end 12/31 Pro forma for iBiquity acquisition Pro forma for Galaxy Brand Holdings acquisition [ 19 ] Rhombus - Consensus ¹$10.3476%$555$5163.1x2.8x10.0x6.6x Rhombus - Management Projections ¹$10.3476%5555163.0x2.5x9.1x6.4x Overall Average70%3.6x3.2x10.0x8.9x Overall Median75%2.4x2.3x8.8x8.0x Other IP Licensing Average56%8.2x6.9x14.1x11.9x Other IP Licensing Median56%8.2x6.9x14.1x11.9x Theater Exhibitors Average77%1.7x1.6x8.2x7.9x Theater Exhibitors Median76%1.6x1.6x8.2x7.9x Media / Technology Licensing Average68%3.6x3.3x10.0x8.8x Media / Technology Licensing Median73%3.2x2.8x9.1x8.4x As of 10/13/15Share% of 52MarketEnterprise EV / Revenue EV / EBITDA ($ in millions, except per share amounts)PriceWeek HighValueValueCY'15ECY'16ECY'15ECY'16E

GRAPHIC

 


STRICTLY CONFIDENTIAL Precedent Transactions Analysis ($ in millions) Media / Technology Licensing Sep-15 iBiquity Digital DTS $172 $45 ~$15 33% ~11x 220 290 27 9% 8.1x Feb-14 Grass Valley USA Belden 342 151 16 11% NM May-12 Bona Film Twenty-First Century Fox Dec-10 Sonic Solutions Rovi Corporation 661 106 7 6% NM Theater Exhibitors Hollywood Theaters 1 367 NA 61 NA 6.0x Feb-13 Regal Entertainment Jul-12 CinemaxX Vue Beteiligungs 269 258 42 16% 6.5x Nov-10 Vue Entertainment Doughty Hanson & Co. 1,183 NA 135 NA 8.8x Other IP Licensing $108 $11 $6 58% 16.9x Mar-13 Brand Matter Sequential Brands Oct-11 HIT Entertainment Mattel 680 179 72 40% 9.5x Jul-10 Playboy Rizvi Traverse; Hugh Hefner 324 215 11 5% 7.0x Source: Note: 1. Capital IQ, Wall Street Research, Company Filings, Press Releases Excludes transactions less than $100 million Based on research estimates [ 20 ] Oct-15RhombusRizvi Traverse$516$162$5332.6%9.8x Overall Average$515$295$5418.5%9.8x Overall Median2971512313.2%8.7x Other IP Licensing Average$345$165$3026.7%10.6x Other IP Licensing Median2501311722.0%10.0x Apr-10Peanuts WorldwideIconix175761722%10.4x Mar-11RC2 CorporationTomy Corporation6254275613%11.1x Jul-12Classic MediaDreamWorks Animation155821822%8.6x Theater Exhibitors Average$1,015$1,029$12915.7%7.2x Theater Exhibitors Median7752589816.1%7.2x May-12AMC EntertainmentDalian Wanda2,6312,60133213%7.9x Nov-12Rave CinemasCinemark2402294118%5.8x Jul-13Vue EntertainmentAIMCo; OMERS$1,396NA$164NA8.5x Media / Technology Licensing Average$268$117$1513.5%12.5x Media / Technology Licensing Median206901210.1%10.4x Jun-10DivXSonic Solutions19275912%20.9x Apr-12SRS LabsDTS1103437%NM Jun-12Miranda TechnologiesBelden3321773520%9.4x Nov-14ChyronHego CorporationVector Capital1155858%NM DateImplied AnnouncedTargetAcquirorTEV LTMEBITDATEV / RevenueEBITDAMarginLTM EBITDA

GRAPHIC

 


STRICTLY CONFIDENTIAL Discounted Cash Flow Analysis UNLEVERED FREE CASH FLOWS EBITDA Less: Depreciation & Amortization Less: Share-Based Compensation Less: Impairment $19.2 (9.7) (2.9) (0.7) $83.3 (33.4) (13.4) (2.4) $90.9 (32.0) (13.4) (2.4) $90.9 (15.0) (13.4) --EBIT $5.8 $34.0 $43.1 $62.5 Less: Taxes at 40.0% Plus: Depreciation & Amortization Plus: Share-Based Compensation Plus: Impairment Less: Increases in Working Capital Less: Capital Expenditures ($2.3) 9.7 2.9 0.7 (2.4) (3.5) ($13.6) 33.4 13.4 2.4 (0.2) (15.0) ($17.2) 32.0 13.4 2.4 (0.2) (15.0) ($25.0) 15.0 13.4 --(0.2) (15.0) Unlevered Free Cash Flow $10.9 $54.4 $58.5 $50.7 PRICE PER SHARE ² IMPLIED EXIT MULTIPLE Discount Rate 11.0% 12.0% 13.0% 14.0% Perpetuity Growth Rate Discount Rate 11.00% 12.00% 13.00% 14.00% Perpetuity Growth Rate 2.0% 2.5% 3.0% 3.5% 4.0% 2.0% 2.5% 3.0% 3.5% 4.0% Source: 1. 2. Company Management Assumes terminal year D&A equal to terminal year capital expenditures Includes present value of expected future tax savings from the $133.7mm federal net operating loss carryforward balance as of 03/31/15 [ 21 ] $11.72$12.26$12.87$13.56$14.35 10.6711.1011.5812.1212.72 9.8110.1610.5410.9711.44 9.089.379.6910.0410.42 6.3x6.7x7.2x7.7x8.3x 5.7x6.0x6.4x6.8x7.2x 5.2x5.4x5.7x6.1x6.4x 4.7x5.0x5.2x5.5x5.8x 3 Mo Ending,Fiscal Year Ending March 31,Terminal ($ in millions)03/31/16E2017E2018EFCF ¹

GRAPHIC

 


STRICTLY CONFIDENTIAL IV. Review of Strategic Alternatives

GRAPHIC

 


STRICTLY CONFIDENTIAL Review of Strategic Alternatives for Rhombus key initiatives immediate liquidity for  Transaction execution risk transaction  Ability to win in competitive repurchase could be utilized subject to earnings scrutiny (investments in support of  Investments outside of core [ 23 ] CONS PROS  No change / disruption to Opportunity to return capital Acquisitions could bolster current operationsto shareholdersgrowth prospects or  No transaction execution risk Signaling impact toaccelerate productization of  Preserves flexibility forshareholders that stock is future strategic decisionsundervalued Potential to enhance Rhombus’s size and scale as a public company  Allow Company to operate privately, outside of the scrutiny of public investors  All-cash acquisition provides Rhombus shareholders  Current stock price includes If utilizing debt, will increase List of logical acquisition anticipated M&A premium;financial leverage / limittargets limited may decrease uponflexibility Transaction execution risk announcement of no Cash used for share  Rhombus will continue to befor strategic purposesprocesses for attractive assets  Maintain public company corecore business / growth)licensing business may upset structure Sizeable share repurchaseactivist investors  Risk of proxy fight withwould reduce stock liquidity Starboard remains  Public investors may not be supportive of Company’s R&D initiatives (e.g., InteliLight, Ultimate Screen, LUXE)  No ability for shareholders to participate in potential upside (R&D initiatives, etc.) Sale of Company Acquisitions Share Repurchase Status Quo

GRAPHIC

 


STRICTLY CONFIDENTIAL Considerations Regarding Remaining a Public Company INDUSTRY LEVEL CONSIDERATIONS COMPANY LEVEL CONSIDERATIONS   Strength of film slate Dependency on film slate   Trends in 3D take rates Outlook for exhibitor renewals   Uncertainty in emerging markets Activist presence in stock   Competition from lower-cost and lower-quality providers InteliLight — upside / execution risk   Overall movie theater attendance trends Capital expenditure investment needs (e.g., renewals, R&D, growth initiatives)  Investment in corporate level staff (e.g., finance, marketing, etc.) [ 24 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL Next Steps Discussion Regarding Rizvi Counter Offer  Price  Remaining due diligence  Certainty of financing  Exclusivity  Contract terms  Management Discussion Regarding Starboard Value  Proxy nomination window [ 25 ]

GRAPHIC

 


STRICTLY CONFIDENTIAL Appendix

GRAPHIC

 


STRICTLY CONFIDENTIAL A. Additional Valuation Detail

GRAPHIC

 


STRICTLY CONFIDENTIAL Public Company Benchmarking OPERATING METRICS BENCHMARKING Media / Technology Licensing Dolby Laboratories ¹ $988 $1,029 4.1% $314 $332 31.8% 32.3% IMAX 361 387 7.3% 151 170 41.8% 43.9% TiVo 395 428 8.3% 122 146 30.8% 34.1% Rovi 517 574 11.0% 198 231 38.2% 40.2% DTS ² 177 204 15.4% 57 68 32.2% 33.2% Theater Exhibitors Cinemark $2,861 $2,972 3.9% $671 $701 23.5% 23.6% Regal Entertainment 3,123 3,200 2.5% 605 632 19.4% 19.8% AMC Entertainment 2,974 3,116 4.8% 543 573 18.3% 18.4% Other IP Licensing Iconix Brand Group 422 437 3.7% 218 222 51.6% 50.8% Sequential Brands Group ³ 82 106 28.4% 51 66 61.6% 62.7% Source: Note: 1. 2. 3. Capital IQ, Wall Street Research, Company Filings Rhombus financials are based on consensus estimates Financials calendarized for year end 12/31 Pro forma for iBiquity acquisition Pro forma for Galaxy Brand Holdings acquisition [ 28 ] Rhombus - Consensus ¹$168$182 8.6%$52$7830.8%42.8% Rhombus - Management Projections ¹ 174 20719.2%568032.4%38.8% Overall Average8.1%32.4%33.3% Overall Median4.5%31.3%32.7% Other IP Licensing Average16.0%56.6%56.7% Other IP Licensing Median16.0%56.6%56.7% Theater Exhibitors Average3.7%20.4%20.6% Theater Exhibitors Median3.9%19.4%19.8% Media / Technology Licensing Average9.2%35.0%36.7% Media / Technology Licensing Median8.3%32.2%34.1% As of 10/13/15 ($ in millions, except per share amounts) RevenueGrowthEBITDAEBITDA Margin CY'15ECY'16E'15E-'16ECY'15ECY'16ECY'15ECY'16E

GRAPHIC

 


STRICTLY CONFIDENTIAL Wall Street Commentary SELECT ANALYST COMMENTARY  “Fundamental improvement in profitability will result from the improved film slate over the next several quarters combined with cost cuts and somewhat better product gross margins”  “The strategic evaluation should provide an added support to the stock” $15.00 $74.9mm 08/14/15 Buy  “We believe the ongoing strategic review is likely to pressure expenses in Q2 and Q3”  “We expect the focus to remain on the potential outcome of the strategic review and whether a sale is possible or if a buyback/tender is necessary on remaining public”  “We remain optimistic that the ongoing process/delays is an indication of potential outside interest in the company and continued discussions” 09/23/15 Buy $16.00 $70.0mm  “We view the continued strategic review as a negative at this stage, the realistic pool of bidders is relatively limited and will not include exhibitors or studios and as a result we are perplexed as to the duration the review has taken other than to think a sale is unlikely” N/A $68.3mm 10/13/15 Hold  “Investors have been frustrated with the slow strategic evaluation process which has resulted in numerous extensions to the bidding deadline”  “We think additional bidders and updated financials are the reason for the most recent delay”  “The delay is not a bad thing for…shareholders in our view, as it brings in fresh bidders, enables [Rhombus] to update financials (better film performance and better clarity on consumer initiatives), provides more time to resolve patent lawsuits, but also keeps Starboard Value at bay” $15.00 $67.6mm 10/12/15 Buy  “Filed an 8K declaring that the deadline for proxy submissions has been extended yet again to the period between October 15th and 30th…we take the extension as a signal that the company's process is still ongoing”  “Our belief is that management is using the extra time to finalize some sort of licensing agreement around its consumer technology”  “Baring that the strategic process concludes with the sale of the company, we anticipate management unveils some cost cuts, but we believe that it will take the influence of a major shareholder, like Starboard, to pressure the company to cut deep enough to maximize the opportunity” 10/13/15 $14.00 $76.6mm Buy [ 29 ] Source: Wall Street Research MEAN$15.00$71.5mm MANAGEMENT$73.1mm TARGET PRICE FY16 EBITDA

GRAPHIC

 


STRICTLY CONFIDENTIAL Weighted Average Cost of Capital Analysis PEER GROUP BETA ANALYSIS Media / Technology Licensing IMAX 0.997 1.391 22 2,545 0.9% 26.0% 0.991 1.382 4.9% Rovi 1.569 1.332 1,070 946 113.1% 55.2% 1.041 0.884 6.4% Theater Exhibitors Regal Entertainment 0.795 1.049 2,362 3,047 77.5% 39.7% 0.542 0.715 5.3% Other IP Licensing Sequential Brands Group ⁴ 1.150 3.357 296 560 52.8% 48.8% 0.905 2.643 6.2% Source: Notes: 1. 2. 3. 4. Bloomberg, Company filings, U.S. Department of the Treasury, 2015 Duff & Phelps Market data as of 10/13/15 2-year weekly and 5-year monthly adjusted beta per Bloomberg Average of the past 8 quarters per Capital IQ Pro forma for iBiquity acquisition; debt/equity prior to acquisition was 5.0% Pro forma for Galaxy Brand Holdings acquisition [ 30 ] Rhombus0.8521.693$38$5556.8%27.8%0.8121.6134.0% Overall Mean1.0271.45463.3%35.8%0.7761.0985.4% Overall Median0.9871.32551.6%34.4%0.8210.9505.6% Other IP Licensing Average1.0872.452126.6%38.4%0.6621.6385.9% Other IP Licensing Median1.0872.452126.6%38.4%0.6621.6385.9% Iconix Brand Group1.0241.547$1,479$738200.4%28.1%0.4190.6345.7% Theater Exhibitors Average0.860 1.10466.2%37.2%0.6070.7755.7% Theater Exhibitors Median0.8131.04970.6%39.7%0.6250.7155.6% AMC Entertainment0.9711.3811,8642,64270.6%31.5%0.6550.9316.1% Cinemark0.8130.882$2,041$4,04950.4%40.4%0.6250.6785.6% Media / Technology Licensing Averag1.1031.26536.3%33.9%0.9221.0765.0% Media / Technology Licensing Median0.9971.31832.0%27.9%0.9371.0715.0% DTS ³1.0371.31816050032.0%27.9%0.8431.0713.8% TiVo0.9761.3153561,00535.4%37.2%0.7991.0765.0% Dolby Laboratories0.9370.968$--$3,469--23.4%0.9370.968NA As of 10/13/15Levered Beta 1TotalMVDebt/EffectiveAsset BetaInt. Expense / ($ in millions)2-Year5-YearDebtEquityEquityTax Rate ²2-Year5-YearTotal Debt

GRAPHIC

 


STRICTLY CONFIDENTIAL Weighted Average Cost of Capital Analysis (cont’d) ILLUSTRATIVE COST OF CAPITAL CALCULATION WACC SENSITIVITY Long-Term Risk Free Rate ¹ Market Risk Premium ² Size Premium ³ Tax Rate ⁴ Cost of Debt ⁵ Debt / Equity Unlevered Beta 2.49% 6.21% 1.000 1.100 1.200 1.300 1.400 2.42% 36.7% 5.0% --5.0% 10.0% 15.0% Source: Notes: 1. 2. 3. 4. 5. Bloomberg, Company filings, U.S. Department of the Treasury, 2015 Duff & Phelps Valuation Handbook Market data as of 10/13/15 U.S. Department of the Treasury, 20-Year Treasury Supply-side long-horizon expected equity risk premium per 2015 Duff & Phelps Valuation Handbook Average of CRSP deciles 8 and 9 per 2015 Duff & Phelps Valuation Handbook Rhombus federal statutory rate plus state tax rate, net of federal benefits per latest 10-K Average of Media / Technology Licensing peer group [ 31 ] 11.1%11.7%12.4%13.0%13.6% 10.9%11.5%12.1%12.8%13.4% 10.8%11.4%12.0%12.6%13.2% 10.6%11.2%11.8%12.4%13.0%

GRAPHIC

 


STRICTLY CONFIDENTIAL B. Shareholder Basis Analysis

GRAPHIC

 


STRICTLY CONFIDENTIAL Estimated Shareholder Cost Basis Analysis Source: FactSet [ 33 ] 1. Assumes shares purchased at average quarterly VWAP; assumes FIFO method on sales Shares% Shares Top 10 Insitutional ShareholdersOwnedOustanding Estimated Cost Basis ¹ Bares Capital Management, Inc. 7,102,434 13.9% Starboard Value LP 4,950,000 9.7% T. Rowe Price Associates, Inc. 3,785,614 7.4% The Vanguard Group, Inc. 2,912,090 5.7% BlackRock Fund Advisors 2,212,379 4.3% Nokomis Capital LLC 1,585,876 3.1% Rivulet Capital LLC 1,504,938 3.0% Fidelity Management & Research Co. 1,181,924 2.3% Gabelli Funds LLC 1,129,176 2.2% SSgA Funds Management, Inc. 665,029 1.3% $11.00 $11.22 $16.42 $14.26 $14.74 $10.82 $11.73 $11.28 $10.70 $18.27 Total27,029,46053.1% $12.64

GRAPHIC

 


STRICTLY CONFIDENTIAL C. Historical Box Office Trends

GRAPHIC

 


STRICTLY CONFIDENTIAL Rhombus Box Office Over Time RHOMBUS BOX OFFICE PERFORMANCE OVER TIME ($ in millions) $1,174 $787 $532 Q1 12 Q2 12 Q3 12 Q4 12 Q1 13 Q2 13 Q3 13Q4 13 Q1 14 Q2 14 Q3 14 Q4 14 Q1 15 Q2 15 Q3 15 Q4 15 Q1 16 Europe Russia Latin America Australasia Domestic % of 3D Box Office [ 35 ] Source: Rentrak Note: For Rentrak reporting countries only; does not include China NA NA 83% 61% 61% 60% 61% 58% 62% 59% 59% 56% 58% 56% 59% 54% 60% $724 $933 $589 $838$841 $708 $751 $617 $326 $582 $496 $642$614 $278

GRAPHIC

 


STRICTLY CONFIDENTIAL D. Rizvi Bid Package

GRAPHIC

 


 

 

9465 Wilshire Blvd.

 

Suite 840

 

Beverly Hills, CA 90212

 

 

 

Tel: 310.786.7443

 

Fax: 310.786.1792

 

www.rizvitraverse.com

 

 

October 13, 2015

 

Anish Aswani

Moelis & Company LLC

1999 Avenue of the Stars, 19th Floor

Los Angeles, CA 90067

 

Dear Mr. Aswani:

 

The purpose of this letter is to present the general terms and conditions upon which Rizvi Traverse Management LLC (“RT”) would be willing to acquire (the “Transaction”) RealD, Inc. (“RealD” or the “Company”).

 

RT is a private equity firm formed in 2005 that has managed over $5 billion of equity capital investments and has a successful track record in closing many complex transactions, including take-privates, in the media and entertainment industry. We believe that our experience and track record underscore our ability to provide certainty of closing and uniquely position us to be the preferred acquirer of RealD. Past examples of RT’s investments include ICM Partners, one of the talent agency industry “majors” and a leader in TV show packaging, Summit Entertainment, one of the largest independent film studios, SESAC, one of three US performing rights organizations representing songwriters and music publishers, and Playboy, one of the world’s most iconic brands. In addition to the foregoing companies, RT has made several investments in the technology and social media space including Twitter, Facebook, Flipboard, Square, Snapchat and Vessel.

 

RT’s proposed Transaction terms are set forth below.

 

Based on our review of the materials provided and discussions with management, we would be willing to consummate a Transaction on the following general terms and conditions:

 

1.            Structure: An acquisition vehicle formed by RT will acquire 100% of the outstanding stock of the Company by means of a merger of a wholly owned subsidiary of such vehicle into the Company, with the Company surviving such merger.

 

2.            Purchase Price: RT will acquire all of the outstanding shares of stock of the Company for $10.35 per fully diluted share in cash.

 

3.            Financing: The Transaction will be fully financed via a combination of debt provided by Jefferies Finance LLC (a draft of the commitment letter in connection with such financing is attached as Annex A-1 hereto) and equity from RT and its affiliates (a draft of the commitment letter in connection with such equity financing is attached as

 



 

Annex A-2 hereto). An outline of our anticipated sources and uses of funds in connection with the Transaction is set forth below:

 

 

($millions)

 

 

 

 

 

 

Sources of Funds

 

Uses of Funds

 

 

Senior Secured

 

 

 

 

 

 

Financing

280

 

Purchase Price

556

 

 

 

 

 

Debt

 

 

 

Net Cash

57

 

Repayment

41

 

 

 

 

 

 

 

 

 

Equity

283

 

Deal Costs

23

 

 

 

 

 

 

 

 

 

Total

620

 

Total

620

 

 

4.            Due Diligence; Michael Lewis: As previously discussed, our proposal is subject to the completion of our final confirmatory legal and tax due diligence review (including with respect to those outstanding diligence matters listed on Annex B attached hereto). We have committed (and will be in a position to further commit) significant resources to completing such review in a timely manner, and in no event later than November 6, 2015 (provided that the Company agrees to the exclusivity obligations described in paragraph 10 below and such outstanding diligence matters are addressed promptly following the date hereof), and without causing undue delay to the negotiation and execution of definitive Transaction documentation. Further, our proposal is subject to reaching agreement with Michael Lewis prior to the execution of the definitive Merger Agreement regarding the rollover and voting of his existing shares of stock of the Company and his continued employment by RealD following the consummation of the Transaction.

 

5.            Required Approvals: RT’s internal investment committee has approved the submission of this updated offer letter. RT’s investment committee is comprised of RT private equity professionals and does not require any external approvals. Based on the information reviewed to date, RT is unaware of any required regulatory or third party approvals other than filings under the Hart-Scott-Rodino Act.

 

6.            Documentation: The Transaction will be subject to the terms of a definitive Agreement and Plan of Merger (the “Merger Agreement”) containing provisions consistent with those set forth in the auction draft of the Merger Agreement prepared by the Company’s counsel, as modified by the summary of proposed revisions attached as Annex C hereto and certain other customary provisions for transactions of this type.

 

7.            Timing: We are prepared to move quickly to consummate the acquisition of the Company and have the necessary resources to complete our due diligence concurrently with the negotiation of the definitive Merger Agreement, which we expect the parties to be in a position to execute (together with the executed financing commitment letters and Mr. Lewis’ definitive documentation) no later than November 6, 2015. Further,

 

2



 

assuming delivery of the Company’s third fiscal quarter 2015 financial statements by January 15, 2016, we anticipate closing the Transaction no later than 30 days thereafter.

 

8.            Contacts: Contact information for RT’s counsel and financing sources is as follows:

 

Latham & Watkins LLP (counsel to RT)

Christopher Brearton; Jason Silvera

(424) 653-5522; (213) 891-8828

 

Jefferies Finance LLC

Craig Mineard

(212) 323-3917

 

9.            Fees and Expenses: Each of RT and the Company will bear its own fees and expenses incurred in connection with the proposed Transaction, subject to the provisions of paragraph 10 hereof.

 

10.    Exclusivity; Expense Reimbursement. As a condition to RT’s willingness to continue its diligence and discussions with the Company with respect to a possible Transaction, we expect that the Company will by separate agreement (the form of which has been separately provided to you) agree to (i) negotiate exclusively with RT for the period and subject to the terms set forth therein and (ii) reimburse RT for any out-of-pocket fees and expenses incurred by RT and its affiliates in relation to their due diligence of the Company and its business and the negotiation and preparation of the Merger Agreement and the other Transaction documents as promptly as practicable following RT’s written demand therefor.

 

11.    Confidentiality: Each of RT and the Company acknowledges the confidential nature of this letter, the terms of RT’s offer set forth herein and Transaction process as a whole.

 

12.    Miscellaneous: Except as provided in this paragraph and paragraphs 9 and 11 above, this letter does not create a binding commitment or agreement in any respect. Such a binding commitment or agreement shall only occur upon the execution by the parties of a definitive agreement regarding the Transaction.

 

*          *           *

 

3



 

We remain enthusiastic about this opportunity and look forward to proceeding to the final stages of completing definitive documentation with respect to the Transaction. Please feel free to call Ben Kohn or me at (310) 786-7443 if you have any questions about the terms of this letter.

 

 

 

Sincerely,

 

 

 

 

 

 

 

RIZVI TRAVERSE MANAGEMENT LLC

 

 

 

 

 

/s/ Hayden Bower

 

 

 

 

Hayden Bower

 

Managing Director

 

 

 

 

CONFIRMED AND AGREED

on behalf of the Company as of the date written above:

 

 

 

Moelis & Company LLC

 

 

 

 

 



 

 

9465 Wilshire Blvd.

 

Suite 840

 

Beverly Hills, CA 90212

 

 

 

Tel: 310.786.7443

 

Fax: 310.786.1792

 

www.rizvitraverse.com

 

 

HIGHLY CONFIDENTIAL

 

 

October 13, 2015

 

 

RealD Inc.

c/o Moelis & Company LLC

1999 Avenue of the Stars, 19th Floor

Los Angeles, CA 90067

 

Re:       Exclusivity and Expense Reimbursement Agreement

 

This letter confirms our agreement with respect to the matters set forth below in connection with a potential acquisition, business combination, or other transaction between RealD Inc. (the “Company”) and Rizvi Traverse Management LLC (“Buyer”), directly or indirectly through one or more of Buyer’s affiliates (the “Transaction”).

 

In order to induce Buyer to engage in the substantial efforts, including with respect to due diligence and negotiations, necessary in connection with its review of the proposed Transaction, we request that the Company, by its signature below, confirm its agreement (which the Company intends to be legally binding) with the terms of this letter agreement as set forth below.

 

1.            Defined Terms. For the purposes of this letter agreement, the following terms have the following meanings:

 

a)            Alternative Transaction” means (i) the acquisition, in a single transaction or a series of related transactions, of 10% or more of the outstanding shares of any class of equity securities of the Company or its subsidiaries; (ii) the acquisition, in a single transaction or a series of related transactions, of 10% or more of the assets and properties of the Company or its subsidiaries (on a consolidated basis); (iii) the merger, consolidation or combination of the Company or any of its subsidiaries; or (iv) the recapitalization, restructuring, reorganization, liquidation, dissolution or other extraordinary transaction with respect to the Company or any of its subsidiaries.

 

b)           Definitive Agreement” means a definitive agreement containing mutually acceptable terms and conditions with respect to a Transaction.

 

c)            Exclusivity Period” means the period beginning on the date first written above and ending at 11:59 p.m. New York City time on November 6, 2015.

 

d)          Offer” means any offer, plan, or proposal from any person or group other than Buyer to effect an Alternative Transaction, or any offer, plan, proposal or inquiry

 



 

October 13, 2015

Page 2

 

from any person or group other than Buyer that could reasonably be expected to lead to an Alternative Transaction.

 

e)            Representatives” means, with respect to any party hereto, such party’s affiliates (as such term is defined under the Securities Exchange Act of 1934, as amended) and its and their respective financial advisors, financing sources, consultants, attorneys, accountants and other advisors, agents and representatives and its and their respective directors, officers, employees, consultants and agents.

 

2.            Exclusivity.

 

a)            During the Exclusivity Period, the Company shall negotiate in good faith exclusively with Buyer with respect to a Transaction and the Company shall not, and shall cause its Representatives not to, directly or indirectly, initiate, solicit, or respond to any Offer, engage in any discussions, negotiations or other communications with any person or group other than Buyer (and its Representatives acting on its behalf) concerning or relating to any Alternative Transaction, provide any person or group other than Buyer (and its Representatives acting on its behalf) with any information relating to the Company or any of its subsidiaries or their respective assets in furtherance of any Offer or Alternative Transaction, enter into any agreement, arrangement or understanding with any person or group other than Buyer relating to, or consummate, any Alternative Transaction, or otherwise cooperate in any way, assist or participate in, or take any action to facilitate or encourage any effort or attempt by any person or group (other than Buyer) to make an Offer or otherwise seek to effect an Alternative Transaction.

 

b)           The Company shall, and it shall cause each of its Representatives to, immediately terminate any and all discussions or negotiations with any person or group (other than Buyer and its Representatives acting on its behalf) with respect to, or that could reasonably be expected to lead to, an Alternative Transaction.

 

c)            In the event that the Company or any of its Representatives receives an Offer or any inquiry concerning any Alternative Transaction, the Company shall (i) within 24 hours of such receipt, inform the third party in writing (with a concurrent copy to Buyer) that it is bound by an exclusivity agreement and shall cease any further contact, and (ii) within 24 hours of receipt of any such Offer or inquiry, or other communication or written document (including emails) with respect thereto, provide Buyer with a complete and correct copy of each such written document (and a summary of the material terms of any oral Offer).

 

3.            Expense Reimbursement. Each party will bear its own fees and expenses incurred in connection with the Transaction, except as provided below or in a Definitive Agreement executed by the parties. The Company acknowledges that Buyer’s continued work to pursue a Transaction will confer a substantial benefit on the Company and that Buyer will, in connection with its continued due diligence and other work to pursue the

 

2



 

October 13, 2015

Page 3

 

Transaction, incur significant expense and be required to devote substantial time and other resources. Accordingly, in order to induce Buyer to continue its due diligence effort and otherwise work in an effort to reach a Definitive Agreement and related documentation, the Company agrees to reimburse Buyer promptly upon Buyer’s written request therefor (which request shall not be made prior to the expiration of the Exclusivity Period) for all out-of-pocket expenses (including, without limitation, fees and disbursements of counsel and Buyer’s other advisors and, to the extent Buyer is responsible therefor, its financing sources and their advisors) incurred by Buyer in connection with the Transaction and Buyer’s due diligence review and other efforts to enter into a Definitive Agreement and related documentation.

 

4.            Miscellaneous. Buyer and the Company each agree that, without the prior written consent of the other party, it shall not, and shall cause its Representatives not to, except as expressly set forth herein, disclose the existence of this letter agreement, the terms hereof, the existence or status of negotiations or any information concerning the Transaction, except to its respective Representatives who have a need to know in order to evaluate, negotiate or consummate the Transaction. Notwithstanding the foregoing, after consultation with the other party, a party may at any time make disclosure if such disclosure is required under applicable law or by a regulatory authority or a stock exchange. This provision is in addition to any obligations of the parties set forth in the Confidentiality Agreement dated as of April 14, 2015 by and between the Buyer and the Company (the “Confidentiality Agreement”). It is expressly understood that neither Buyer nor the Company is obligated to proceed with the Transaction and that no binding agreement with respect to the Transaction (except as expressly set forth herein, with respect to which this letter agreement will be a valid and binding agreement, and except for the Confidentiality Agreement) will exist unless and until such time as a Definitive Agreement has been executed by the parties. This letter agreement may be signed in counterparts, all of which taken together shall constitute one instrument, and the parties hereto may execute this letter agreement by signing any such counterpart. This letter agreement shall become effective upon execution by all parties hereto. A facsimile or electronic copy of an executed signature page hereof will be deemed an original. This letter agreement will be governed by the laws of the State of Delaware without giving effect to the principles of conflicts of laws thereof. The parties hereto acknowledge and agree that irreparable damage would occur in the event that any provision of this letter agreement was not performed in accordance with the terms hereof and that the parties shall be entitled to specific performance of the terms hereof (without the need to post any bond), in addition to any other remedy at law or in equity. This letter agreement (i) may not be assigned by either party hereto without the express written consent of the other party, and (ii) may not be amended or modified except by an instrument in writing signed by each of the parties hereto.

 

Please confirm your agreement with the foregoing by signing and returning to the undersigned a counterpart of this letter agreement.

 

3



 

October 13, 2015

Page 4

 

 

Sincerely,

 

 

 

RIZVI TRAVERSE MANAGEMENT LLC

 

 

 

 

 

By:

 

 

 

Name:

 

Title:

 

 

Acknowledged and Agreed to as of
the date first above written:

 

 

 

REALD INC.

 

 

 

 

 

By:

 

 

Name:

 

Title:

 

 

4



 

ANNEX B

 

Outstanding Diligence Review

 

1.            Legal

 

a.             Review draft Company Disclosure Schedules.

 

b.            Review material customer Systems License Agreements.

 

c.             Review Company equity plans and equity award agreements.

 

d.           Conduct intellectual property review (including customary patent, trademark and copyright searches).

 

e.             Understand pending litigation matters relating to infringement of Company intellectual property in US and foreign jurisdictions.

 

f.              Review information technology organization and management structure.

 

g.            Tax structuring in connection with anticipated debt and equity financing.

 

2.            Tax

 

a.             Discuss the Company’s historic tax filing profile and significant tax issues with management and the Company’s tax advisors.

 

b.            Understand the Company’s legal entity structure, including current filing status, global presence, and domicile, as well as any changes in recent corporate history (e.g., acquisitions, dispositions, restructurings, or other material transactions).

 

c.             Review and analyze US federal and state income tax returns and tax provision work papers for the prior three tax years.

 

d.           Consider the historic generation of tax attributes (e.g., net operating losses) and the utilization thereof, including any limitations on the ability to utilize such attributes (e.g., Section 382 limitations based on ownership changes).

 

e.             Review and analyze internal and external memos with respect to advice regarding any material tax issue or tax planning issue, including ruling requests submitted to tax authorities and Section 382 studies or other similar analysis with respect to the Tax Historical Period, if any.

 

f.              Understand the Company’s historic and current tax examination profile and the nature of any material issues that have been raised in connection therewith. Review of tax examination documentation as applicable.

 

g.            Understand the Company’s non-income tax profile (e.g., sales, withholding, and employment taxes) and the potential impact of foreign taxes on the Company’s operations (e.g., activities that could be treated as a permanent establishment in foreign jurisdictions).

 

7



 

Confidential

 

Project Rhombus Agreement and Plan of Merger

Summary of Proposed Revisions – October 12, 2015

 

The following summarizes certain changes that would be requested by an acquisition vehicle to be formed by Rizvi Traverse Management LLC or an affiliate thereof (such vehicle, “Purchaser”) to the Agreement and Plan of Merger (the “Agreement”) pursuant to which Purchaser would acquire all of the outstanding equity securities of the Company by means of a merger of a wholly owned subsidiary of Purchaser into the Company, with the Company surviving the merger. Capitalized terms used but not defined herein have the meaning given to them in the Agreement. The summary below is a high-level summary of certain of Purchaser’s proposed revisions and does not include all revisions that would be made to the Agreement. In addition, Purchaser must complete confirmatory due diligence and may consider additional revisions to the Agreement after completion of such due diligence and review of the Company Disclosure Letter.

 

Article I: Timing of Closing

 

·                 Closing: The Closing should not occur prior to the second Business Day following the final day of the Marketing Period.

 

·                 Marketing Period: The Marketing Period should not commence until the conditions to Closing set forth in Sections 6.01 and 6.02 have been satisfied (other than those which by their terms are to be satisfied at Closing) and should extend for any period during which the Required Information is not “Compliant” (to be defined in a manner customary for sponsor transactions of this type). The Marketing Period will only end prematurely in the event that the Debt Financing proceeds are funded to Purchaser.

 

Article II: Rollover; Treatment of Company Equity Awards

 

·                 Rollover: The Agreement will need to be revised to reflect the proposed contribution of shares of Common Stock held by Michael Lewis to Purchaser pursuant to the terms of a Contribution and Support Agreement in exchange for the issuance of shares of Purchaser at the Closing on a tax-deferred basis.

 

·                 Company Equity Awards: Treatment of Company Equity Awards is subject to completion of Purchaser’s review of Company equity plans and award agreements.

 

Article III: Company Representations and Warranties

 

·                Generally: Several reps and warranties should be expanded to include additional customary provisions, including Section 3.02 (Capital Stock), Section 3.06 (Absence of Certain Changes), Section 3.09 (Tax Matters), Section 3.10 (Employee Benefits), Section 3.13 (Intellectual Property), and Section 3.16 (Material Contracts), and a three-year look-back should be added to reps and warranties where customary (e.g., Section 3.08 (Compliance with Laws)). Other customary representations and warranties to be added, including with respect to insurance, real and personal property, customer/exhibitor relationships and related party transactions.

 



 

Article V: Certain Covenants

 

·                 No Solicitation; Change in Recommendation (Section 5.02):

 

o                No Solicitation: Fiduciary determination to be made before exercising window-shop exemption, and the Company should cause its Representatives to comply with the terms of the no-shop covenant (i.e., no efforts standard).

 

o                “Acceptable Confidentiality Agreement”: Purchaser expects that an Acceptable Confidentiality Agreement will contain a standstill provision consistent with Purchaser’s Confidentiality Agreement.

 

o                “Adverse Recommendation Change”: Definition should be expanded to include any change, amendment, modification or qualification to (or public proposal to change, amend, modify or qualify) the Company Board Recommendation, failure to include the Company Board Recommendation in the Proxy Statement, failure of the Company Board of Directors to reaffirm the Company Board Recommendation upon Purchaser’s request, or in the event of any tender offer or exchange offer for outstanding shares of Company common stock, failure of the Company Board of Directors to recommend against the acceptance of such offer.

 

o                Fiduciary Standard: The Company Board of Directors’ should only be permitted to effect an Adverse Recommendation Change or enter into a Company Acquisition Agreement in the event that the Board is required to do so to comply with the directors’ fiduciary duties to the Company’s stockholders under applicable Law.

 

o                Standard for “Superior Proposal”: A Superior Proposal should be limited to a transaction that is reasonably likely to be consummated in accordance with its terms and, if so consummated, would result in a transaction more favorable to its stockholders from a financial point of view than the proposed transaction with Purchaser.

 

o                Intervening Events: The Company Board of Directors should not be permitted to make any Adverse Recommendation Change other than in connection with a Superior Proposal, except for circumstances not involving a Takeover Proposal that are due to material events occurring after the execution of the Agreement that are not known or reasonably foreseeable as of the signing date.

 

o                Matching Right; Last Look: Purchaser should be provided with four Business Days’ notice prior to any Adverse Recommendation Change (including in connection with the proposed acceptance of a Superior Proposal or due to an intervening event), during which time Purchaser would be afforded the opportunity to negotiate with the Company and revise its offer. In the event of any revisions made to a proposed Superior Proposal thereafter, Purchaser should be afforded an additional two Business Days to further negotiate with the Company and revise its offer.

 

·                 Indemnification and Insurance (Section 5.07): Indemnification of Company directors and officers should be limited to the six year period following the Closing and should be the obligation of the Surviving Corporation, not the Purchaser.

 

·                 Employee Matters (Section 5.09): Purchaser’s obligation to continue Company Employee compensation and benefits levels should be limited to base salary and health/welfare and

 



 

retirement benefits (and excluding any existing equity arrangements), measured on an aggregate basis (not on a case-by-case basis).

 

·                Third Party Consent Fees (Section 5.04(e)): Purchaser’s agreement to bear responsibility for all fees and payments to third parties in order to obtain approvals (other than HSR) is subject to completion of Purchaser’s confirmatory diligence of required approvals.

 

Article VI: Conditions Precedent

 

·                Representations and Warranties: The Company’s representations and warranties as set forth in Section 3.01 (Organization and Standing; Subsidiaries), Section 3.02 (Capital Stock), clauses (a) and (b) of Section 3.03 (Authority), Section 3.04 (Voting Requirements), Section 3.14 (Rights Agreement; Anti-Takeover Provisions) and Section 3.18 (Brokers and Other Advisors) should be required to be true and correct in all respects, subject only to de minimis inaccuracies (with equivalent requirements for Purchaser’s representations and warranties, where applicable). The parties’ representations and warranties should be required to be true and correct as of the signing date as well as the Closing Date.

 

Article VII: Termination

 

·                 Termination Events: Purchaser should be entitled to terminate the Agreement as a result of the Company’s material breach of its covenants under Sections 5.02 (No Solicitation; Change in Recommendation) or 5.03 (Preparation of the Proxy Statement; Stockholders’ Meeting). The Company should not be permitted to terminate the Agreement in order to enter into a Superior Proposal if the Company has breached its covenants under Section 5.02.

 

·                 Company Termination Fee: A termination fee equal to 4% of equity value (which will not be liquidated damages) will be payable to the Purchaser by the Company upon the occurrence of the following events:

 

o                Termination by Parent due to an Adverse Recommendation Change or the Company’s material breach of its covenants under Sections 5.02 or 5.03;

 

o                Termination by the Company in order to enter into a Superior Proposal;

 

o                Termination by the Company or Purchaser following the failure to obtain the Company Stockholder Approval if an Adverse Recommendation Change has occurred prior to such termination; and

 

o                Termination by Purchaser due to a breach of the Company’s representations, warranties or covenants resulting in a closing condition failure, or termination by Purchaser or the Company due to the failure to obtain the Company Stockholder Approval or the failure to close on or prior to the End Date, in each case, where a Takeover Proposal was made prior to such termination and a definitive agreement is entered into in connection with a Takeover Proposal (or a Takeover Proposal is consummated) with 12 months following such termination (payable on the earlier of signing and closing such transaction).

 

·                Purchaser Expense Reimbursement: In the event that the Agreement is terminated due to a failure to obtain the Company Stockholder Approval, Purchaser should be entitled to reimbursement of all out-of-pocket fees and expenses incurred in connection with the proposed transaction up to 1%

 



 

of equity value, which would be netted out of any termination fee subsequently paid in the tail period.

 

·    Effect of Termination: Termination does not provide relief from liability for willful and material breach prior to termination.

 

·    Purchaser Termination Fee: Purchaser Termination Fee to equal 5% of equity value. The Company’s right to terminate due to Purchaser’s failure to close should require that the Marketing Period has ended and the Company has provided Purchaser with two Business Days’ notice of its readiness, willingness and ability to close and the Company must stand ready, willing and able to close through the end of such two Business Day period (with Purchaser failing to close during such two Business Day period). Purchaser expects to include customary liability-limiting language in favor of Purchaser, its affiliates and the Lenders and other Equity Investors such that the Purchaser Termination Fee is the only monetary recourse payable by Purchaser, its affiliates and the Lenders and other Equity Investors in connection with the Agreement or the transactions contemplated thereby, other than in connection with expense reimbursement relating to Purchaser’s proposed financing and breaches of the Confidentiality Agreement.

 

·    Payment of Interest: In the event that either the Company or Purchaser fails to pay any applicable termination fee, any interest payment should be limited to the Wall Street Journal prime rate.

 

Article VIII: Definitions

 

·    “Knowledge”: Standard for knowledge should be set at actual knowledge of the applicable knowledge persons (subject to Purchaser’s review of the Company Disclosure Letter) following reasonable inquiry.

 

·    “Company Material Adverse Effect”: Definition should be revised to take into account the impact of any effects, changes, events, circumstances or occurrences measured both individually and in the aggregate with all other effects, changes, events, circumstances and occurrences. The disproportionate adverse effect qualification should not include a materiality requirement and should also include clause (C) of the definition (changes in applicable Law, GAAP or accounting standards).

 



 

STRICTLY CONFIDENTIAL Contact Information Moelis & Company LLC is a U.S.-registered broker dealer and a member of FINRA & SIPC. Moelis & Company LLC 1999 Avenue of the Stars, Suite 1900 Los Angeles, CA 90067 Tel: 310-443-2300 399 Park Avenue, 5th Floor New York, NY 10022 Tel: 212-883-3800

GRAPHIC

 



Exhibit (d)(2)

 

EXECUTION VERSION

 

 

 

LIMITED GUARANTY

 

LIMITED GUARANTY, dated as of November 8, 2015 (this “Guaranty”), by Rizvi Opportunistic Equity Fund III, L.P., a Delaware limited partnership (the “Guarantor”), in favor of RealD Inc., a Delaware corporation (the “Guaranteed Party”).

 

1.         GUARANTY. To induce the Guaranteed Party to enter into that certain Agreement and Plan of Merger, of even date herewith (as amended, restated, supplemented or otherwise modified from time to time, the “Agreement”; capitalized terms used but not defined herein shall have the meanings given to such terms in the Agreement), by and among the Guaranteed Party, Rhombus Cinema Holdings, LLC, a Delaware limited liability company (“Purchaser”), and Rhombus Merger Sub, Inc., a Delaware corporation (“Merger Sub”), pursuant to which Merger Sub will be merged with and into the Guaranteed Party with the Guaranteed Party surviving as a wholly owned subsidiary of Purchaser, the Guarantor, intending to be legally bound, hereby absolutely, irrevocably and unconditionally guarantees to the Guaranteed Party, on the terms and subject to the conditions set forth herein, the due, complete, and punctual performance and discharge of (A) the payment obligations of Purchaser to the Guaranteed Party pursuant to Section 7.04(a) of the Agreement if, as and when due (the “Purchaser Fee Obligations”) and (B) the expense reimbursement and indemnification obligations of Purchaser to the Guaranteed Party pursuant to Section 7.04(d) and the final two sentences of Section 5.13(e) of the Agreement if, as and when due (the “Expense Obligations” and together with the Purchaser Fee Obligations, the “Guaranteed Obligations”). In no event shall the Guarantor’s aggregate liability under this Guaranty exceed an aggregate amount equal to (x) Twenty-Nine Million Dollars ($29,000,000) plus (y) any Expense Obligations of Purchaser minus (z) any Guaranteed Obligations actually paid by Purchaser, Merger Sub or the Guarantor to the Guaranteed Party (such limitation on the aggregate liability of the Guarantor for its Guaranteed Obligations being herein referred to as the Guarantor’s “Cap”). The guarantee by the Guarantor of the Guaranteed Obligations under this Guaranty may be enforced for the payment of money only. All payments hereunder shall be made in lawful money of the United States, in immediately available funds.

 

If Purchaser fails to discharge any Guaranteed Obligations when due, then all such Guaranteed Obligations shall, at the Guaranteed Party’s option, become immediately due and payable and the Guaranteed Party may, at any time and from time to time, at the Guaranteed Party’s option, take any and all actions available hereunder or under applicable law to collect the Guarantor’s liabilities hereunder in respect of such Guaranteed Obligations, subject to the terms and conditions of this Guaranty, including, without limitation, the Guarantor’s Cap.

 

2.         NATURE OF GUARANTEE. The Guarantor’s liability hereunder is absolute, unconditional, irrevocable and continuing irrespective of any modification, amendment or waiver of or any consent to departure from the Agreement or the Commitment Letters or any other agreement that may be agreed to by Purchaser or Merger Sub or any other Person and irrespective of whether any action is brought against Purchaser, Merger Sub or any other Person or whether Purchaser, Merger Sub or any other Person is joined in any such action or actions. This Guaranty is a guarantee of payment and not of collection. To the extent that any payment to the Guaranteed Party in respect of the Guaranteed Obligations is rescinded or must otherwise be, and is, repaid or returned to the Guarantor under any state or federal law, common law or

 



 

equitable cause or to any trustee, receiver or other person under any bankruptcy act in connection with any bankruptcy or insolvency proceeding with respect to the Guarantor or any of its Affiliates for any reason whatsoever (other than in connection with or following the valid termination of the Guarantor’s obligations in accordance with Section 7 hereof, except with regard to Guaranteed Obligations that were paid to the Guaranteed Party prior to such termination and so rescinded, repaid or returned, or in other circumstances where the Guarantor is not liable to make such payment), the Guarantor shall remain liable hereunder on the terms and subject to the conditions hereof as if such payment had not been made.

 

3.                                    CHANGES IN OBLIGATIONS, CERTAIN WAIVERS.

 

(a)        The Guarantor agrees that the Guaranteed Party may, in its sole discretion, at any time and from time to time, without notice to or further consent of the Guarantor, extend the time of payment of any of the Guaranteed Obligations, and may also make any agreement with Purchaser or Merger Sub for the extension, renewal, payment, compromise, discharge or release thereof, or agree to modify the terms of the Agreement or of any agreement between the Guaranteed Party and any other Person, in whole or in part, without in any way impairing or affecting the Guarantor’s obligations under this Guaranty or affecting the validity or enforceability of this Guaranty. The Guarantor agrees that, subject to the terms and provisions hereof, the obligations of the Guarantor hereunder shall not be released or discharged, in whole or in part, or otherwise affected by: (i) the failure or delay on the part of the Guaranteed Party to assert any claim or demand or to enforce any right or remedy against Purchaser or Merger Sub or any other Person; (ii) any change in the time, place or manner of payment of any of the Guaranteed Obligations or any rescission, waiver, compromise, consolidation or other amendment or modification of any of the terms of provisions of the Agreement or any other agreement, evidencing, securing or otherwise executed in connection with any Guaranteed Obligation; (iii) the addition, substitution or release of any Person now or hereafter liable with respect to the Guaranteed Obligations or otherwise interested in the transactions contemplated by the Agreement; (iv) any change in the corporate existence, structure or ownership of Purchaser, Merger Sub or any other Person; (v) any insolvency, bankruptcy, reorganization or other similar proceeding affecting Purchaser, Merger Sub or any other Person; (vi) the existence of any claim, set-off or other right which the Guarantor may have at any time against Purchaser or Merger Sub or the Guaranteed Party, whether in connection with the Guaranteed Obligations or otherwise; (vii) the adequacy of any other means the Guaranteed Party may have of obtaining payment related to the Guaranteed Obligations; or (viii) any discharge of the Guarantor as a matter of applicable Law (other than as a result of, and to the extent of, payment of the Guaranteed Obligations in accordance with the terms of the Agreement or otherwise in accordance with the terms hereof). To the fullest extent permitted by Law, the Guarantor hereby expressly waives any and all rights or defenses arising by reason of any Law which would otherwise require any election of remedies by the Guaranteed Party. The Guarantor waives promptness, diligence, notice of the acceptance of this Guaranty and of the Guaranteed Obligations, presentment, demand for payment, notice of non-performance, default, dishonor and protest, notice of any Guaranteed Obligations incurred and all other notices of any kind (other than notices required to be made to Purchaser or Merger Sub pursuant to the Agreement and notices pursuant to this Guaranty), all defenses which may be

 

2



 

available by virtue of any valuation, stay, moratorium Law or other similar Law now or hereafter in effect or any right to require the marshalling of assets of Purchaser, Merger Sub or any other Person now or hereafter liable with respect to the Guaranteed Obligations or otherwise interested in the transactions contemplated by the Agreement. The Guarantor acknowledges that it will receive substantial direct and indirect benefits from the transactions contemplated by the Agreement and that the waivers set forth in this Guaranty are knowingly made in contemplation of such benefits.

 

(b)        (i) The Guarantor hereby unconditionally waives any rights that it may now have or hereafter acquire against Purchaser or Merger Sub that arise from the existence, payment, performance, or enforcement of the Guarantor’s obligations under or in respect of this Guaranty, including, without limitation, any right of subrogation, reimbursement, exoneration, contribution or indemnification and any right to participate in any claim or remedy of the Guaranteed Party against Purchaser or Merger  Sub, whether or not such claim, remedy or right arises in equity or under contract, statute or common Law, including, without limitation, the right to take or receive from Purchaser or Merger Sub, directly or indirectly, in cash or other property or by set-off or in any other manner, payment or security on account of such claim, remedy or right, and (ii) the Guarantor shall not exercise any such rights, in the case of each of (i) and (ii), unless and until all amounts payable by the Guarantor under this Guaranty shall have been paid in full in immediately available funds. If any amount shall be paid to the Guarantor in violation of the immediately preceding sentence at any time prior to the payment in full in immediately available funds of all amounts payable by the Guarantor under this Guaranty, such amount shall be received and held in trust for the benefit of the Guaranteed Party, shall be segregated from other property and funds of the Guarantor and shall forthwith be promptly paid or delivered to the Guaranteed Party in the same form as so received (with any necessary endorsement or assignment) to be credited and applied to all amounts payable by the Guarantor under this Guaranty.

 

(c)        Notwithstanding anything to the contrary contained in this Guaranty or otherwise, the Guaranteed Party hereby agrees that: (i) to the extent Purchaser is relieved of all or any portion of the Guaranteed Obligations by satisfaction thereof on the terms and subject to the conditions set forth in the Agreement, the Guarantor shall be similarly relieved of its corresponding payment obligations under this Guaranty; and (ii) the Guarantor shall have all defenses to the payment of its obligations under this Guaranty that would be available to Purchaser and/or Merger Sub under the Agreement with respect to the Guaranteed Obligations (except for defenses arising from the bankruptcy or insolvency of Purchaser, Merger Sub, Guarantor or any of their Affiliates), as well as any defenses in respect of any breach by the Guaranteed Party of this Guaranty.

 

4.                                    REPRESENTATIONS AND WARRANTIES.

 

(a)                               The Guarantor hereby represents and warrants that:

 

(i)         it has all requisite limited partnership or other power and authority to execute, deliver and perform this Guaranty and the execution, delivery and performance of this Guaranty have been duly authorized by all necessary action

 

3



 

and do not contravene any provision of the Guarantor’s partnership agreement, operating agreement or similar organizational documents or any Law, regulation, rule, decree, order, judgment or contractual restriction binding on the Guarantor or its assets;

 

(ii)        except as would not reasonably be expected to impair or delay the Guarantor’s performance of its obligations hereunder and except as set forth in or contemplated by the terms and provisions of the Agreement, (A) all consents, approvals, authorizations, permits of, filings with (other than filings to be made with the U.S. Securities and Exchange Commission) and notifications to, any governmental authority necessary for the due execution, delivery and performance of this Guaranty by the Guarantor have been obtained or made and all conditions thereof have been duly complied with, and (B) no other action by, and no notice to or filing with (other than filings to be made with the U.S. Securities and Exchange Commission), any governmental authority or regulatory body is required in connection with the execution, delivery or performance of this Guaranty by the Guarantor;

 

(iii)       assuming due execution and delivery by the Guaranteed Party, this Guaranty constitutes a legal, valid and binding obligation of the Guarantor enforceable against the Guarantor in accordance with its terms, subject to the effect of any applicable bankruptcy, reorganization, insolvency, moratorium or similar Laws affecting creditors’ rights generally and subject, as to enforceability, to the effect of general principles of equity; and

 

(iv)       the Guarantor has the financial capacity to pay and perform its obligations under this Guaranty, and all funds necessary for the Guarantor to fulfill its obligations under this Guaranty shall be available to the Guarantor for so long as this Guaranty shall remain in effect in accordance with Section 7 hereof.

 

5.         NO ASSIGNMENT. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned, in whole or in part, by operation of Law or otherwise, by any of the parties hereto without the prior written consent of the other party hereto; provided, however, that the Guarantor may assign or delegate all or part of its rights, interests and obligations hereunder, without the prior written consent of the Guaranteed Party, to any other Person to which it has allocated all or a portion of its investment commitment to Purchaser pursuant to the Sponsor Commitment Letter; provided, further, that no such assignment or delegation shall relieve the Guarantor of its obligations hereunder. Any purported assignment not permitted under this Section 5 shall be null and void.

 

6.         NOTICES. All notices, requests, claims, demands and other communications hereunder shall be given in the manner set forth in the Agreement; provided, that notices, requests, claims, demands and other communications to the Guarantor shall be sent to:

 

Rizvi Opportunistic Equity Fund III, L.P.

 

4



 

c/o Rizvi Traverse Management, LLC

9465 Wilshire Blvd. Suite 840

Beverly Hills, California 90212

Attention: Ben Kohn

Facsimile: (323) 544-6444

Email:       Ben.Kohn@RizviTraverse.com

 

with a copy (which shall not constitute notice) to:

 

Rizvi Traverse Management, LLC

260 East Brown Street, Suite 380

Birmingham, Michigan 48009

Attention: Audrey DiMarzo, General Counsel

Facsimile: (917) 591-7400

Email:          Audrey.DiMarzo@RizviTraverse.com

 

with a copy (which shall not constitute notice) to:

 

Latham & Watkins LLP

355 S. Grand Avenue

Los Angeles, California 90071

Attention: Chris Brearton

Jason Silvera

Facsimile: (213) 891-8763

Email:       chris.brearton@lw.com

jason.silvera@lw.com

 

7.         CONTINUING GUARANTEE. Subject to Section 3(c) hereof, this Guaranty may not be revoked or terminated and shall remain in full force and effect until all of the Guaranteed Obligations have been indefeasibly paid, observed, performed and satisfied in full. Notwithstanding the foregoing, or anything express or implied in this Guaranty or otherwise, except with respect to accrued Expense Obligations, this Guaranty shall terminate and the Guarantor shall have no further obligations under or in connection with this Guaranty as of the earliest of: (a) the Effective Time; (b) the termination of the Agreement in accordance with its terms by mutual consent of the parties thereto or in circumstances in which the Purchaser Termination Fee is not payable and there are no unpaid Expense Obligations of Purchaser at such time; (c) the termination of the Agreement pursuant to Section 7.01(b)(i) thereof (unless, in the case of this clause (c), the Guaranteed Party has previously commenced a claim for payment of the Guarantor’s liabilities hereunder in respect of the Guaranteed Obligations, in which case this Guaranty shall terminate upon the final, non-appealable resolution of such action and satisfaction by the Guarantor of any obligations finally determined or agreed to be owed by the Guarantor, consistent with the terms hereof); and (d) the receipt by the Guaranteed Party of the payment in full of the Guaranteed Obligations payable under this Guaranty. Notwithstanding the foregoing, or anything express or implied in this Guaranty or otherwise, in the event that the Guaranteed Party or any of its Affiliates asserts in any litigation or other proceeding (A) that the provisions of Section 1 hereof limiting the Guarantor’s liability to the Guarantor’s Cap and limiting the Guaranteed Party’s enforcement hereof to the payment of money only or the provisions of this

 

5



 

Section 7 or Section 3(c), Section 8, Section 9, Section 10, Section 12 or Section 14 hereof are illegal, invalid or unenforceable in whole or in part, (B) that the Guarantor is liable in respect of Guaranteed Obligations in excess of or to a greater extent than the Guarantor’s Cap, or (C) any theory of liability against any Recourse Party or any Non-Recourse Party (each as defined in Section 8 hereof) with respect to this Guaranty, the Sponsor Commitment Letter, the Rollover Commitment Letter, the Agreement, any other agreement or instrument delivered in connection with this Guaranty or the Agreement, or the transactions contemplated hereby or thereby, other than Retained Claims (as defined in Section 8 hereof) asserted by the Guaranteed Party against the Recourse Party(ies) against which such Retained Claims may be asserted in accordance with Section 8 hereof, then: (i) the obligations of the Guarantor under or in connection with this Guaranty shall terminate ab initio and be null and void; (ii) if the Guarantor has previously made any payments under or in connection with this Guaranty, it shall be entitled to recover and retain such payments; and (iii) neither the Guarantor nor any other Recourse Parties or any Non- Recourse Parties shall have any liability whatsoever (whether at law or in equity, whether sounding in contract, tort, statute or otherwise) to the Guaranteed Party or any other Person in any way under or in connection with this Guaranty, the Agreement, any other agreement or instrument delivered in connection with this Guaranty or the Agreement (including, without limitation, the Sponsor Commitment Letter and the Rollover Commitment Letter), or the transactions contemplated hereby or thereby.

 

8.         NO RECOURSE. The Guaranteed Party acknowledges and agrees that the sole asset of Purchaser and Merger Sub (other than contract rights) is cash in a de minimis amount (less than $1,000) and that no additional funds are expected to be contributed to Purchaser or Merger Sub unless and until the Closing occurs under the Agreement. Notwithstanding anything that may be expressed or implied in this Guaranty or any document or instrument delivered in connection herewith or otherwise, and notwithstanding the fact that the Guarantor may be a partnership, by its acceptance of the benefits of this Guaranty, the Guaranteed Party, on behalf of itself and its stockholders, Affiliates, directors, officers, employees, representatives and agents (collectively with the Guaranteed Party, the “Guaranteed Party Related Parties”) acknowledges and agrees that: (a) no Person other than the Guarantor and the Guaranteed Party shall have any obligations under or in connection with this Guaranty, (b) the Guarantor shall have no obligations under or in connection with this Guaranty except as expressly provided by this Guaranty, and (c) no liability shall attach to, and no recourse shall be had by any Guaranteed Party Related Party, or any Person purporting to claim by or through any of them or for the benefit of any of them under any theory of liability (including, without limitation, by attempting to pierce a corporate, limited liability company or partnership veil, by attempting to compel Purchaser or Merger Sub to enforce any rights that they may have against any Person, by attempting to enforce any assessment, or by attempting to enforce any purported right at law or in equity, whether sounding in contract, tort, statute or otherwise) against, any Recourse Party or any Non-Recourse Party in any way under or in connection with this Guaranty, the Agreement, any other agreement or instrument delivered in connection with this Guaranty or the Agreement (including, without limitation, the Sponsor Commitment Letter and the Rollover Commitment Letter), or the transactions contemplated hereby or thereby (whether at law or in equity, whether sounding in contract, tort, statute or otherwise), except that, notwithstanding the foregoing, the Guaranteed Party may assert claims against: (i) Rizvi Traverse Management, LLC under, and pursuant to the terms and conditions of, the Confidentiality Agreement; (ii) the Guarantor under, and pursuant to the terms and conditions of, this Guaranty (subject to the Guarantor’s Cap); (iii)

 

6



 

Purchaser, to cause Purchaser to seek specific performance of the Guarantor’s obligation under, and pursuant to the terms and conditions of, the Sponsor Commitment Letter and Section 8.08 of the Agreement to fund the Financing Commitment (as defined therein) thereunder; (iv) Purchaser, to cause Purchaser to seek specific performance of any Rollover Investors’ obligation under, and pursuant to the terms and conditions of, the Rollover Commitment Letter and Section 8.08 of the Agreement to fund the Commitment (as defined therein) thereunder; and (v) Purchaser or Merger Sub to enforce the terms and conditions of the Agreement in accordance with the terms and conditions of the Agreement (the claims described in clauses (i) through (v) collectively, the “Retained Claims”). As used herein, the term “Recourse Parties” shall mean Purchaser, Merger Sub, the Rollover Investors and the Guarantor, collectively, and the term “Non-Recourse Parties” shall mean, collectively, the Recourse Parties’ respective former, current and future holders of any equity, partnership or limited liability company interest, controlling persons, directors, officers, employees, agents, attorneys, Affiliates, members, managers, general or limited partners, stockholders, assignees or successors, and any future holders of any equity, partnership or limited liability company interest, controlling persons, directors, officers, employees, agents, attorneys, Affiliates, members, managers, general or limited partners, stockholders, assignees or successors of any of the foregoing; provided that none of the Recourse Parties shall be Non-Recourse Parties. The Guaranteed Party, on behalf of itself and the other Guaranteed Party Related Parties, hereby covenants and agrees that it shall not, and it shall cause its Affiliates not to, institute any proceeding or bring any claim in any way under or in connection with this Guaranty, the Agreement, any other agreement or instrument delivered in connection with this Guaranty, the Agreement, the Sponsor Commitment Letter and the Rollover Commitment Letter, or the transactions contemplated hereby or thereby (whether at law or in equity, whether sounding in contract, tort, statute or otherwise) against (i) the Non-Recourse Parties or (ii) the Recourse Parties, except in the case of clause (ii) for Retained Claims asserted by the Guaranteed Party against the Recourse Party(ies) against which such Retained Claims may be asserted in accordance with the second sentence of this Section 8.

 

9.         GOVERNING LAW; JURISDICTION. THIS LIMITED  GUARANTY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE REGARDLESS OF THE LAWS THAT MIGHT OTHERWISE GOVERN UNDER ANY APPLICABLE CONFLICT OF LAWS PRINCIPLES. Any such actions or proceedings shall be heard and determined in the Court of Chancery of the State of Delaware and any state appellate court therefrom within the State of Delaware (or, if the Court of Chancery of the State of Delaware declines to accept jurisdiction over a particular matter, any federal court within the State of Delaware or, in the event each federal court within the State of Delaware declines to accept jurisdiction over a particular matter, any state court within the State of Delaware). In addition, each of the parties hereto (i) consents to submit itself, and hereby submits itself, to the exclusive jurisdiction and venue of such courts in the event any dispute arises out of this Guaranty or any of the transactions contemplated by this Guaranty, (ii) agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court, and agrees not to plead or claim any objection to the laying of venue in any such court or that any judicial proceeding in any such court has been brought in an inconvenient forum, (iii) agrees that it will not bring any action relating to this Guaranty or any of the transactions contemplated by this Guaranty in any court other than the Court of Chancery of the State of Delaware (or, if the Court of Chancery of the State of Delaware declines to accept jurisdiction over a particular matter, any federal court within the

 

7



 

State of Delaware or, in the event each federal court within the State of Delaware declines to accept jurisdiction over a particular matter, any state court within the State of Delaware) and (iv) consents to service of process being made through the notice procedures set forth in Section 6.

 

10.       WAIVER OF JURY TRIAL. EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE UNDER THIS GUARANTY IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES,  TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS GUARANTY AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH PARTY HERETO CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVER, (C) IT MAKES SUCH WAIVER VOLUNTARILY AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS GUARANTY BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 10.

 

11.       COUNTERPARTS. This Guaranty may be executed in one or more counterparts (including by email), each of which shall be deemed to be an original but all of which taken together shall constitute one and the same agreement, and shall become effective when one or more counterparts have been signed by each of the parties hereto and delivered to the other party hereto.

 

12.       THIRD PARTY BENEFICIARIES. This Guaranty shall be binding upon and inure solely to the benefit of the parties hereto and their respective successors and permitted assigns, and nothing express or implied in this Guaranty is intended to, or shall, confer upon any other Person any benefits, rights or remedies under or by reason of, or any rights to enforce or cause the Guaranteed Party to enforce, the obligations set forth herein; except that as a material aspect of this Guaranty, the parties hereto intend that all Recourse Parties other than the Guarantor and all Non-Recourse Parties shall be, and such Recourse Parties and Non-Recourse Parties are, intended third party beneficiaries of this Guaranty who may rely on and enforce the provisions of this Guaranty that bar the liability, or otherwise protect the interests, of such Recourse Parties and Non-Recourse Parties.

 

13.       CONFIDENTIALITY. This Guaranty shall be treated as confidential and is being provided to the Guaranteed Party solely in connection with the transactions contemplated by the Agreement. This Guaranty may not be used, circulated, quoted or otherwise referred to in any document or otherwise disclosed, except with the prior written consent of the Guarantor in each instance; provided, that no such written consent is required for any disclosure of the existence of this Guaranty by the Guaranteed Party (i) to the extent required by applicable Law or the applicable rules of any national securities exchange (provided that the Guaranteed Party will provide the Guarantor an opportunity to review such required disclosure in advance of such

 

8



 

public disclosure being made, which review shall not unreasonably delay such public disclosure), (ii) to the extent that the information is already publicly available other than as a result of a breach of this Agreement by the Guaranteed Party or any other Person, (iii) pursuant to any litigation relating to the Agreement or the transactions contemplated thereby or (iv) to the Guaranteed Party’s representatives and Affiliates who need to know of the existence of this Agreement and are subject to confidentiality obligations.

 

14.                            MISCELLANEOUS.

 

(a)        Together with the Agreement, the Sponsor Commitment Letter, the Rollover Commitment Letter and the Confidentiality Agreement, this Guaranty constitutes the entire agreement with respect to the subject matter hereof and supersedes any and all prior discussions, negotiations, proposals, undertakings, understandings and agreements, whether written or oral, among the Guarantor or any of its Affiliates, on the one hand, and the Guaranteed Party or any of its Affiliates, on the other hand. No amendment, supplementation, modification or waiver of this Guaranty or any provision hereof shall be enforceable unless approved by the Guaranteed Party and the Guarantor in writing. The Guaranteed Party and its Affiliates are not relying upon any prior or contemporaneous statement, undertaking, understanding, agreement, representation or warranty, whether written or oral, made by or on behalf of the Guarantor, any other Recourse Party or any Non-Recourse Party in connection with this Guaranty except as expressly set forth herein or in the Agreement, the Sponsor Commitment Letter, the Rollover Commitment Letter or the Confidentiality Agreement. The Guarantor and its Affiliates are not relying upon any prior or contemporaneous statement, undertaking, understanding, agreement, representation or warranty, whether written or oral, made by or on behalf of the Guaranteed Party in connection with this Guaranty except as expressly set forth herein or in the Agreement, the Sponsor Commitment Letter, the Rollover Commitment Letter or the Confidentiality Agreement.

 

(b)        Any term or provision of this Guaranty that is invalid, illegal or unenforceable in any jurisdiction (as determined by a court of competent jurisdiction) shall be, as to such jurisdiction, ineffective solely to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction; provided, however, that, notwithstanding anything to the contrary contained in the Sponsor Commitment Letter or this Guaranty, neither the Sponsor Commitment Letter nor this Guaranty may be enforced without giving effect to Section 1 hereof limiting the Guarantor’s liability to the Guarantor’s Cap and limiting the Guaranteed Party’s enforcement hereof to the payment of money only, Section 7, Section 8, Section 9, Section 10, Section 12, this Section 14 and Section 3(c) hereof. Each party hereto covenants and agrees that it shall not assert, and shall cause its respective Affiliates and representatives not to assert, that this Guaranty or any part hereof is invalid, illegal or unenforceable in accordance with its terms.

 

9



 

(c)        The descriptive headings contained in this Guaranty are for reference purposes only and shall not affect in any way the meaning or interpretation of this Guaranty.

 

(d)       All parties acknowledge that each party and its counsel have reviewed this Guaranty and, in the event an ambiguity or question of intent or interpretation arises, no presumption or burden of proof shall arise favoring or disfavoring any party hereto by virtue of the authorship of any provision of this Guaranty.

 

(e)        The parties hereto agree that irreparable damage, for which monetary damages (even if available) would not be an adequate remedy, would occur in the event that the parties hereto do not perform any provision of this Guaranty in accordance with its specified terms or otherwise breach such provisions. Accordingly, the parties hereto acknowledge and agree that the parties hereto shall be entitled to an injunction, specific performance and other equitable relief to prevent breaches of this Guaranty and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled in Law or in equity. Each of the parties hereto agrees that it will not oppose the granting of an injunction, specific performance and other equitable relief on the basis that the other party has an adequate remedy at Law or that any award of specific performance is not an appropriate remedy for any reason at Law or in equity. Any party hereto seeking an injunction or injunctions to prevent breaches of this Guaranty and to enforce specifically the terms and provisions of this Guaranty shall not be required to provide any bond or other security in connection with such order or injunction.

 

[Remainder of page intentionally left blank]

 

10



 

IN WITNESS WHEREOF, the Guarantor has caused this Limited Guaranty to be executed and delivered as of the date first written above by its officer or representative thereunto duly authorized.

 

 

 

RIZVI OPPORTUNISTIC EQUITY FUND III, L.P.

 

 

 

By: Rizvi Traverse GP III, LLC, its general partner

 

 

 

By:

/s/ Ben Kohn

 

Name:  Ben Kohn

 

Title:  Managing Director

 

[Limited Guaranty Signature Page (1 of 2)]

 



 

IN WITNESS WHEREOF, the Guaranteed Party has caused this Limited Guaranty to be executed and delivered as of the date first written above by its officer thereunto duly authorized.

 

 

 

REALD INC.

 

 

 

 

By:

/s/ Vivian W. Yang

 

Name:

Vivian W. Yang

 

Title:

EVP & General Counsel

 

[Limited Guaranty Signature Page (2 of 2)]

 




Exhibit (d)(3)

 

Execution Version

 

AMENDED AND RESTATED VOTING AGREEMENT

 

This AMENDED AND RESTATED VOTING AGREEMENT (this “Agreement”), dated as of November 25, 2015, is entered into by and among Michael V. Lewis, an individual, and the MVL Trust dated August 3, 2010 (collectively, the “Stockholders”), and Rhombus Cinema Holdings, LLC, a Delaware limited liability company (“Purchaser”).

 

WHEREAS, Purchaser, Rhombus Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and RealD Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger, dated as of November 8, 2015 (as may be modified or amended from time to time, the “Merger Agreement”), providing, among other things, for the merger of Merger Sub with and into the Company (the “Merger”);

 

WHEREAS, this Agreement amends and restates in its entirety that certain Voting Agreement, dated as of November 8, 2015, by and among the Stockholders and Purchaser, for purposes of revising Schedule I hereto to correct the number of shares of Company Common Stock owned beneficially and of record by the Stockholders as of the date hereof; and

 

WHEREAS, as a condition of and inducement to Purchaser’s and Merger Sub’s willingness to enter into the Merger Agreement, Purchaser and Merger Sub have required that the Stockholders enter into this Agreement.

 

NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth in this Agreement and in the Merger Agreement, and intending to be legally bound hereby, the parties hereto agree as follows:

 

1.   Certain Definitions.  For the purposes of this Agreement, capitalized terms used and not otherwise defined herein shall have the respective meanings ascribed to them in this Section 1.

 

Additional Owned Shares” means all shares of Company Common Stock and any other equity securities of the Company which are beneficially owned by any Stockholder or any of its Affiliates and are acquired after the date hereof and prior to the termination of this Agreement.

 

Affiliate” has the meaning set forth in the Merger Agreement; provided, however, that for the purposes of this Agreement (i) the Company shall be deemed not to be an Affiliate of any Stockholder and (ii) for the avoidance of doubt, no Stockholder shall be deemed an Affiliate of any other holder of Company Common Stock or equity interests of the Company solely by virtue of deemed common control of the Company.

 

beneficial ownership” (and related terms such as “beneficially owned” or “beneficial owner”) has the meaning set forth in Rule 13d-3 under the Exchange Act.

 

Business Day” has the meaning set forth in the Merger Agreement.

 

Company Common Stock” has the meaning set forth in the Merger Agreement.

 



 

Covered Shares” means the Owned Shares and Additional Owned Shares.

 

Effective Time” has the meaning set forth in the Merger Agreement.

 

Exchange Act” has the meaning set forth in the Merger Agreement.

 

DGCL” means the Delaware General Corporation Law, as amended.

 

Disclosed Owned Shares” has the meaning assigned thereto in Section 5(a) hereof.

 

Governmental Authority” has the meaning set forth in the Merger Agreement.

 

HSR Act” has the meaning set forth in the Merger Agreement.

 

Improved Proposal” has the meaning assigned thereto in Section 2(a) hereof.

 

Liens” has the meaning assigned thereto in Section 5(a) hereof.

 

Owned Shares” means all shares of Company Common Stock and any other equity securities of the Company which are beneficially owned by any Stockholder or any of its Affiliates as of the date hereof.

 

person” means an individual, corporation, limited liability company, partnership, association, trust, unincorporated organization or other entity or group (as defined in Section 13(d) of the Exchange Act).

 

Representatives” has the meaning assigned thereto in Section 3(b) hereof.

 

Rollover Commitment Letter” has the meaning set forth in the Merger Agreement.

 

Stockholders Meeting” has the meaning assigned thereto in Section 2 hereof.

 

Subsidiary” has the meaning set forth in the Merger Agreement.

 

Survival Period” has the meaning assigned thereto in Section 5.A hereof.

 

Takeover Proposal” has the meaning set forth in the Merger Agreement.

 

Term” has the meaning assigned thereto in Section 6 hereof.

 

Transfer” means, with respect to a security, the transfer, pledge, hypothecation, encumbrance, assignment or other disposition (whether by sale, merger, consolidation, liquidation, dissolution, dividend, distribution or otherwise) of such security or the beneficial ownership thereof, the offer to make such a transfer or other disposition, and each option, agreement, arrangement or understanding, whether or not in writing, to effect any of the foregoing.  As a verb, “Transfer” shall have a correlative meaning.

 



 

2.   Stockholder Vote.  At any meeting of the stockholders of the Company, however called, or at any adjournment or postponement thereof, or in any other circumstance in which the vote, consent or other approval of the stockholders of the Company is sought, in any case, during the Term (each, a “Stockholders Meeting”), each Stockholder shall, and shall cause any other holder of record of Covered Shares to, (i) appear at each such meeting or otherwise cause all Covered Shares to be counted as present thereat for purposes of calculating a quorum and (ii) vote (or cause to be voted), or execute and deliver a written consent (or cause a written consent to be executed and delivered) covering, all Covered Shares:

 

(a)  in favor of the adoption of the Merger Agreement and the approval of the terms thereof, the Merger and each of the other actions contemplated by the Merger Agreement;

 

(b)  in favor of any other transaction (including its adoption and approval, where applicable) pursuant to which Purchaser or any of its Affiliates proposes to acquire the Company, whether by tender offer, merger or otherwise, (i) in which stockholders of the Company would receive consideration per share of Company Common Stock having a value equal to or greater than the consideration to be received by such stockholders in the Merger and (ii) is of the kind contemplated by clause (2) of the proviso to Section 5.02(d) or clause (ii) of the proviso to Section 5.02(e) of the Merger Agreement (an “Improved Proposal”);

 

(c)  in favor of any adjournment or postponement recommended by the Company with respect to any stockholder meeting with respect to the Merger Agreement and the Merger or any Improved Proposal;

 

(d) against any Takeover Proposal or any proposal relating to a Takeover Proposal (other than any Improved Proposal); and

 

(e)  against any proposal, action or agreement that would (1) impede, delay, interfere with, prevent or nullify any provision of this Agreement, the Merger Agreement or the Merger or would otherwise adversely affect the timely consummation of the Merger, (2) result in a breach in any respect of any covenant, representation, warranty or any other obligation or agreement of the Company under the Merger Agreement or (3) except as expressly contemplated by the Merger Agreement, change in any manner the dividend policy or capitalization of, including the voting rights of any class of capital stock of, the Company, in each cash other than any Improved Proposal.

 

The Stockholders shall not commit or agree to take any action inconsistent with the foregoing, and shall cause any other record holder of Covered Shares not to commit or agree to take any action inconsistent with the foregoing.

 

3.   No Disposition or Solicitation.

 

(a)  No Disposition or Adverse Act.  Each Stockholder hereby covenants and agrees that, except as contemplated by this Agreement, the Rollover Commitment Letter and the Merger Agreement, such Stockholder shall not, throughout the Term: (i) offer to Transfer, Transfer or consent to any Transfer of any or all of the Covered Shares or any interest therein without the prior written consent of Purchaser, (ii) tender any or all of the Covered Shares into any exchange or tender offer commenced by a person other than Purchaser, Merger Sub or any

 



 

Affiliate of Purchaser or Merger Sub, (iii) enter into any contract, option or other agreement, arrangement or understanding (including any profit sharing arrangement) with respect to any Transfer of any or all Covered Shares or any interest therein, (iv) grant or permit to be granted any proxy, power-of-attorney or other authorization or consent in or with respect to any or all of the Covered Shares, (v) deposit or permit to be deposited any or all of the Covered Shares into a voting trust, (vi) enter into a voting agreement or arrangement with respect to any or all of the Covered Shares or permit any record holder of Covered Shares to enter into any voting agreement or arrangement with respect to any or all of the Covered Shares, or (vii) take or permit to be taken any other action that would make any representation or warranty of such Stockholder contained herein untrue or incorrect in any material respect or in any way restrict, limit or interfere with the performance of such Stockholder’s obligations hereunder or the transactions contemplated hereby or by the Merger Agreement.  Any attempted Transfer of Covered Shares or any interest therein in violation of this Section 3(a) shall be null and void.

 

(b)  Non-Solicitation.  Subject to Section 7 hereof, during the Term, each Stockholder hereby agrees that such Stockholder shall not, and shall cause its Affiliates, representatives and agents (including its investment bankers, attorneys and accountants) (collectively, its “Representatives”) not to, directly or indirectly, (i) initiate, solicit, cause, or knowingly facilitate or encourage any inquiries or the making of any proposal or offer that constitutes, or could reasonably be expected to lead to, any Takeover Proposal, or (ii) engage in, continue or otherwise participate in any discussions or negotiations regarding, or furnish to any other person any non-public information, or afford any other person with access to the business, employees, officers, contracts, properties, assets, or books and records of the Company or its Subsidiaries, in each case in connection with, or that could reasonably be expected to lead to, a Takeover Proposal.  Each Stockholder shall immediately cease any inquiries, solicitation, encouragement, discussions or negotiations with any persons with respect to a Takeover Proposal (or that could reasonably be expected to lead to a Takeover Proposal) that existed on or prior to the date of this Agreement.  Each Stockholder shall promptly (and in any event within twenty-four (24) hours) notify Purchaser in the event that such Stockholder or any of its Affiliates or Representatives receives a Takeover Proposal and shall provide Purchaser with a copy of such Takeover Proposal (if in writing) and disclose to Purchaser the material terms and conditions of any such Takeover Proposal, the identity of the person or group of persons making such Takeover Proposal and any arrangements with such Stockholder or its Affiliates contemplated thereby, and such Stockholder shall keep Purchaser reasonably informed on a prompt basis (and in any event within twenty-four (24) hours) of the status and terms of any such discussions or negotiations and any material developments with respect to any such Takeover Proposal (including any amendments, modifications or other changes thereto); provided that compliance by the Company with its obligations set out in Section 5.02(c) of the Merger Agreement in respect of such Takeover Proposal shall satisfy each Stockholder’s obligations in respect of this final sentence of this Section 3(b) of this Agreement.

 

4.   Additional Agreements.

 

(a)  Certain Events.  In the event of any stock split, stock dividend, merger, reorganization, recapitalization or other change in the capital structure of the Company affecting the Covered Shares or the acquisition of Additional Owned Shares or other securities or rights of the Company by a Stockholder or any of its Affiliates, (i) the type and number of Covered Shares

 



 

shall be adjusted appropriately and (ii) this Agreement and the obligations hereunder shall automatically attach to any additional Covered Shares or other securities or rights of the Company issued to or acquired by such Stockholder or any of its Affiliates.

 

(b)  [Reserved].

 

(c)  Waiver of Appraisal and Dissenters’ Rights and Actions.  Each Stockholder hereby (i) waives and agrees not to demand, assert or exercise any rights of appraisal or rights to dissent from the Merger that such Stockholder may have under Section 262 of the DGCL or otherwise and (ii) agrees not to commence or participate in, and to take all actions necessary to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Purchaser, Merger Sub, the Company or any of their respective successors or directors, officers or agents relating to the negotiation, execution or delivery of this Agreement or the Merger Agreement or the consummation of the Merger, including any claim (x) challenging the validity of, or seeking to enjoin the operation of, any provision of this Agreement or (y) alleging a breach of any fiduciary duty of the Board of Directors of the Company or any officer of the Company, or any claim alleging aiding and abetting breach of fiduciary duty on the part of any other person in connection with the evaluation, negotiation, entry into or performance of the Merger Agreement or the transactions contemplated thereby; provided that nothing in this clause (ii) shall limit or prohibit (I) any Stockholder in any way in connection with (A) any Action or dispute (other than class actions) arising out of or relating to this Agreement, the Merger Agreement, the Rollover Commitment Letter or any other instrument entered into by a Stockholder in connection herewith or therewith, or any action filed or initiated against a Stockholder which includes claims or allegations of fraud or intentional misconduct by a Stockholder, or (B) the defense of any Action contemplated by this clause (ii) or (II) any rights of any Stockholder for indemnification, contribution or other reimbursement.

 

(d) Communications.  Except as may be required by applicable Law (including any filing by a Stockholder with the Securities Exchange Commission (the “SEC”) as required by applicable securities laws (including the Exchange Act)), court process or the rules and regulations of any national securities exchange or national securities quotation system (and then only after as much advance notice and consultation as is feasible), and except as may be permitted by Section 5.05 of the Merger Agreement, each Stockholder shall not, and shall instruct its Representatives not to, make any press release, public announcement or other communication with respect to the business or affairs of the Company, Purchaser or Merger Sub, including this Agreement and the Merger Agreement and the transactions contemplated hereby and thereby, without the prior written consent of Purchaser.  Each Stockholder hereby (i) consents to and authorizes the publication and disclosure by Purchaser of such Stockholder’s identity and holding of Covered Shares, and (following prior review by the Stockholders, and with the Stockholders’ reasonable comments taken into consideration by the Purchaser) the nature of such Stockholder’s commitments, arrangements and understandings under this Agreement and any other information that Purchaser reasonably determines to be necessary or desirable in any press release or any other disclosure document in connection with the Merger or any other transactions contemplated by the Merger Agreement and (ii) agrees as promptly as practicable to notify Purchaser of any required corrections with respect to any written information supplied by such Stockholder specifically for use in any such disclosure document.

 



 

(e)  Additional Owned Shares.  Each Stockholder hereby agrees to notify Purchaser promptly in writing of the number and description of any Additional Owned Shares.

 

5.   Representations and Warranties of the Stockholders.  Each Stockholder hereby represents and warrants to Purchaser as of the date hereof as follows:

 

(a)  Title.  Such Stockholder is the sole record and beneficial owner of the shares of Company Common Stock set forth on Schedule I (the “Disclosed Owned Shares”).  The Disclosed Owned Shares constitute all of the capital stock and any other equity securities of the Company owned of record or beneficially by such Stockholder and its Affiliates on the date hereof and neither such Stockholder nor any of its Affiliates is the beneficial owner of, or has any right to acquire (whether currently, upon lapse of time, following the satisfaction of any conditions, upon the occurrence of any event or any combination of the foregoing) any shares of Company Common Stock or any other equity securities of the Company or any securities convertible into or exchangeable or exercisable for shares of Company Common Stock or such other equity securities, in each case other than the Disclosed Owned Shares.  Such Stockholder has sole voting power, sole power of disposition and sole power to issue instructions with respect to the matters set forth in Sections 3 and 4 hereof and all other matters set forth in this Agreement, in each case with respect to all of the Owned Shares with no limitations, qualifications or restrictions on such rights applicable to the covenants and other obligations of each Stockholder under the terms of this Agreement, subject to applicable securities laws and the terms of this Agreement and the Rollover Commitment Letter.  Except as permitted by this Agreement and pursuant to the Rollover Commitment Letter, the Owned Shares and the certificates representing such shares, if any, are now, and at all times during the term hereof will be, held by such Stockholder, or by a nominee or custodian for the benefit of such Stockholder, free and clear of any and all liens, pledges, claims, options, proxies, voting trusts or agreements, security interests, understandings or arrangements or any other encumbrances whatsoever on title, transfer or exercise of any rights of a stockholder in respect of the Owned Shares (other than under applicable securities laws and as created by this Agreement and the Rollover Commitment Letter) (collectively, “Liens”).

 

(b)  Organization and Qualification.  If not a natural person, such Stockholder is duly organized and validly existing in good standing under the laws of its jurisdiction of organization.

 

(c)  Authority.  Such Stockholder has all necessary power and authority and legal capacity to execute, deliver and perform all of such Stockholder’s obligations under this Agreement, and consummate the transactions contemplated hereby, and no other proceedings or actions on the part of such Stockholder or its board of directors or governing body or trustees, or its stockholders, members, partners (limited or otherwise) or other equity holders or beneficiaries, as applicable, are necessary to authorize the execution, delivery or performance of this Agreement or the consummation of the transactions contemplated hereby.

 

(d) Due Execution and Delivery.  This Agreement has been duly and validly executed and delivered by such Stockholder and, assuming due authorization, execution and delivery hereof by Purchaser, constitutes a legal, valid and binding agreement of such Stockholder, enforceable against such Stockholder in accordance with its terms, subject to the

 



 

effect of any applicable bankruptcy, reorganization, insolvency, moratorium or similar laws affecting creditors’ rights generally and subject, as to enforceability, to the effect of general principles of equity.  If such Stockholder is married, and any of the Covered Shares constitute community property or spousal approval is otherwise necessary for this Agreement to be legal, binding and enforceable, this Agreement has been duly authorized, executed and delivered by, and constitutes the legal, valid and binding obligation of, such Stockholder’s spouse, enforceable against such Stockholder’s spouse in accordance with its terms.

 

(e)  No Filings; No Conflict or Default.  Except for the matters described in Section 3.03(d)(i) of the Merger Agreement, and compliance with the applicable requirements of the Exchange Act, no filing with, and no permit, authorization, consent or approval of, any Governmental Authority or any other person is necessary for the execution and delivery of this Agreement by such Stockholder, the consummation by such Stockholder of the transactions contemplated hereby and the compliance by such Stockholder with the provisions hereof.  None of the execution and delivery of this Agreement by such Stockholder, the consummation by such Stockholder of the transactions contemplated hereby or compliance by such Stockholder with any of the provisions hereof will (i) result in a violation or breach of, or constitute (with or without notice or lapse of time or both) a default (or give rise to any third party right of termination, cancellation, modification or acceleration) under, any of the terms, conditions or provisions of any note, bond, mortgage, indenture, lease, license, permit, contract, commitment, arrangement, understanding, agreement or other instrument or obligation of any kind, including any voting agreement, proxy arrangement, pledge agreement, shareholders agreement or voting trust, to which such Stockholder is a party or by which such Stockholder or any of such Stockholder’s properties or assets may be bound, (ii) violate any judgment, order, writ, injunction, decree or award of any court, administrative agency or other Governmental Authority that is applicable to such Stockholder or any of such Stockholder’s properties or assets, (iii) constitute a violation by such Stockholder of any law or regulation of any jurisdiction, (iv) assuming the Company has taken all necessary action to exempt the Merger, the Merger Agreement, this Agreement and the transactions contemplated hereby and thereby from the restrictions set forth in Section 203 of the DGCL (and in connection therewith, assuming the accuracy of the Purchaser’s representations and warranties set forth in Section 4.06 of the Merger Agreement), render Section 203 of the DGCL, or any other state takeover statute or similar statute or regulation, applicable to the Merger or (v) contravene or conflict with such Stockholder’s certificate of incorporation and bylaws or other organizational documents, in each case, except for any conflict, breach, default or violation described above which would not adversely affect in any material respect the ability of such Stockholder to perform its obligations hereunder or consummate the transactions contemplated hereby.

 

(f)  No Litigation.  There is no suit, claim, action, investigation or proceeding pending or, to the knowledge of such Stockholder, threatened against such Stockholder at law or in equity before or by any Governmental Authority that could reasonably be expected to impair the ability of such Stockholder to perform its obligations hereunder or consummate the transactions contemplated hereby.

 

(g)  No Fees.  No broker, investment banker, financial advisor or other person is entitled to any broker’s, finder’s, financial advisor’s or other similar fee or commission in

 



 

connection with the transactions contemplated hereby based upon arrangements made by or on behalf of such Stockholder in its capacity as a stockholder of the Company.

 

(h)  Reliance.  Each Stockholder understands and acknowledges that Purchaser and Merger Sub are entering into the Merger Agreement in reliance upon such Stockholder’s concurrent execution and delivery of this Agreement.

 

5.A.  Survival.  None of the representations and warranties of the Stockholders in this Agreement shall survive the Effective Time; provided that (a) the representations and warranties set forth in Sections 5(a), 5(e), 5(f) and 5(g) shall survive the Effective Time for a period of twelve (12) months following the Effective Time (the “Survival Period”) and (b) the expiration of such representations and warranties shall not affect the rights of Purchaser or its Affiliates in respect of any claim for breaches of such representations and warranties made in writing prior to the expiration of the Survival Period.

 

6.   Termination.  The term (the “Term”) of this Agreement shall commence on the date hereof and shall terminate upon the earliest of (i) the mutual agreement of Purchaser and the Stockholders, (ii) the Effective Time and (iii) the termination of the Merger Agreement in accordance with its terms; provided that (A) nothing herein shall relieve any party hereto from liability for any breach of this Agreement prior to termination and (B) Section 5.A, this Section 6 and Section 8 shall survive any termination of this Agreement.

 

7.   No Limitation.  Each Stockholder is entering into this Agreement solely in its capacity as a beneficial owner of Covered Shares, and not in its capacity (if applicable) as an officer or member of the Board of Directors of the Company. Nothing in this Agreement shall be construed to prohibit or limit any Stockholder from taking any action (including any action prohibited by Section 4 hereof) in his capacity as an officer or member of the Board of Directors of the Company, including from taking any action with respect to any Takeover Proposal as an officer or member of such Board of Directors.

 

8.   Miscellaneous.

 

(a)  Entire Agreement.  This Agreement (together with Schedule I) constitutes the entire agreement among the parties hereto with respect to matters described herein and supersedes all other prior agreements and understandings, both written and oral, among the parties hereto with respect to such matters.

 

(b)  Further Assurances.  Subject to the terms and conditions of this Agreement, at the other party’s reasonable request and without further consideration, each party hereto shall execute and deliver such additional documents and take all such further lawful action as may be necessary or desirable to consummate and make effective, in the most expeditious manner practicable, the transactions contemplated hereby.

 

(c)  No Assignment.  This Agreement shall not be assigned by operation of law or otherwise without the prior written consent of the Stockholders (in the case of any assignment by Purchaser) or Purchaser (in the case of an assignment by any Stockholder); provided that Purchaser may assign its rights and obligations hereunder to Merger Sub or any other person to

 



 

whom the Merger Agreement is validly assigned in accordance with Section 8.04 thereof, but no such assignment shall relieve Purchaser of its obligations hereunder.

 

(d) Binding Successors.  Without limiting any other rights Purchaser may have hereunder in respect of any Transfer of the Covered Shares, each Stockholder agrees that this Agreement and the obligations hereunder shall attach to the Covered Shares beneficially owned by such Stockholder and its Affiliates and shall be binding upon any person to which legal or beneficial ownership of such Covered Shares shall pass, whether by operation of law or otherwise, including, without limitation, such Stockholder’s heirs, guardians, administrators, representatives or successors.

 

(e)  Amendments.  This Agreement may not be amended, changed, supplemented or otherwise modified except by an instrument in writing signed on behalf of Purchaser and the Stockholders.

 

(f)  Notice.  All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given (and shall be deemed to have been duly received) (i) upon receipt, if delivered personally or by first class mail, postage pre-paid, (ii) on the date of transmission, if sent by facsimile transmission (with confirmation of receipt) or email, or (iii) on the Business Day after dispatch, if sent by nationally recognized, documented overnight delivery service, as follows:

 

If to the Stockholders:

 

At the address and facsimile number set forth on Schedule I hereto.

 

with a copy (which shall not constitute notice) to:

 

Freshfields Bruckhaus Deringer US LLP

601 Lexington Avenue, 31st Floor

New York, NY 10022

Attention:

Matthew F. Herman

 

Howard Klein

Email:

matthew.herman@freshfields.com

 

howard.klein@freshfields.com

 

 

If to Purchaser:

 

c/o Rizvi Traverse Management, LLC

9465 Wilshire Blvd. Suite 840

Beverly Hills, California  90212

Attention:

Audrey DiMarzo, General Counsel

Email:

Audrey.DiMarzo@RizviTraverse.com

 

 

with a copy (which shall not constitute notice) to:

 

Latham & Watkins LLP

 



 

355 S. Grand Avenue

Los Angeles, California 90071

Attention:

Chris Brearton

 

Jason Silvera

Email:

chris.brearton@lw.com

 

jason.silvera@lw.com

 

or to such other address or facsimile number as the person to whom notice is given may have previously furnished to the other parties hereto in writing in the manner set forth above.

 

(g)  Severability.  If any term, condition or other provision of this Agreement is determined by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced by any rule of Law or public policy, all other terms, provisions and conditions of this Agreement shall nevertheless remain in full force and effect.  Upon such determination that any term, condition or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible to the fullest extent permitted by applicable Law in an acceptable manner to the end that the transactions contemplated by this Agreement are fulfilled to the extent possible.

 

(h)  Remedies.  All rights, powers and remedies provided under this Agreement or otherwise available in respect hereof at law or in equity shall be cumulative and not alternative, and the exercise of any such right, power or remedy by any party hereto shall not preclude the simultaneous or later exercise of any other such right, power or remedy by such party.

 

(i)   No Waiver.  The failure of any party hereto to exercise any right, power or remedy provided under this Agreement or otherwise available in respect hereof at law or in equity, or to insist upon compliance by any other party hereto with such party’s obligations hereunder, and any custom or practice of the parties at variance with the terms hereof, shall not constitute a waiver by such party of such party’s right to exercise any such or other right, power or remedy or to demand such compliance.

 

(j)   No Third Party Beneficiaries.  This Agreement shall be binding upon and inure solely to the benefit of each party hereto, and nothing in this Agreement, express or implied, is intended to confer upon any other person any rights or remedies of any nature whatsoever under or by reason of this Agreement.

 

(k)  Governing Law.  This Agreement (and any claim or controversy arising out of or relating to this letter agreement) shall be governed by, and construed in accordance with, the laws of the State of Delaware, applicable to contracts executed in and to be performed entirely within that State, regardless of the laws that might otherwise govern under any applicable conflict of laws principles.

 

(l)   Submission to Jurisdiction.  All actions and proceedings arising out of or relating to this Agreement shall be heard and determined in the Chancery Court of the State of Delaware and any state appellate court therefrom within the State of Delaware (or, if the Chancery Court of the State of Delaware declines to accept jurisdiction over a particular matter,

 



 

any state or federal court within the State of Delaware) and the parties hereto hereby irrevocably submit to the exclusive jurisdiction of such courts in any such action or proceeding and irrevocably waive, and agree not to assert, by way of motion, as a defense, counterclaim or otherwise, in any action or proceeding with respect to this Agreement, (i) any claim that such party is not personally subject to the jurisdiction of the aforementioned courts, (ii) any claim that it or its property is exempt or immune from jurisdiction of the aforementioned courts or from any legal process commenced in such courts, and (iii) any claim that the action, suit or proceeding in such court is brought in an inconvenient forum, the venue of such action, suit or proceeding is improper, or this Agreement, or the subject matter hereof, may not be enforced in or by such court.  The consents to jurisdiction and venue set forth in this Section 8(l) shall not constitute general consents to service of process in the State of Delaware and shall have no effect for any purpose except as provided in this paragraph and shall not be deemed to confer rights on any person other than the parties hereto.  Each party hereto agrees that service of process upon such party in any action or proceeding arising out of or relating to this Agreement shall be effective if notice is given by overnight courier at the address set forth in Section 8(f) hereof.

 

(m)  Waiver of Jury Trial.  EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY.  EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE EITHER OF SUCH WAIVERS, (B) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVERS, (C) IT MAKES SUCH WAIVERS VOLUNTARILY AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 8(m).

 

(n)      Specific Performance.  The parties hereto agree that Purchaser would be irreparably harmed in the event that any of the provisions of this Agreement were not performed by each Stockholder in accordance with their specific terms or were otherwise breached by such Stockholder, and that Purchaser would not have an adequate remedy at law for money damages in such event.  It is accordingly agreed that Purchaser shall be entitled, without posting any bond or other undertaking, to specific performance and injunctive and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement, this being in addition to any other remedy to which Purchaser is entitled at law or in equity.

 

(o)      Interpretation.  The descriptive headings used herein are inserted for convenience of reference only and are not intended to be part of or to affect the meaning or interpretation of this Agreement.  The words “include,” “includes” and “including” shall be deemed to be followed by “without limitation” whether or not they are in fact followed by such words or words of like import.  The parties hereto have participated jointly in the negotiation and

 



 

drafting of this Agreement.  No provision of this Agreement shall be interpreted for or against any party hereto because that party or its legal representatives drafted the provision.  The words “hereof,” “hereto,” “hereby,” “herein,” “hereunder” and words of similar import, when used in this Agreement, shall refer to this Agreement as a whole and not any particular section in which such words appear.

 

(p)      Counterparts.  This Agreement may be executed in counterparts (including by facsimile or by .pdf delivered via email), each of which shall be deemed to be an original, but all of which, taken together, shall constitute one and the same agreement.

 

(q)      Expenses.  Except as otherwise provided herein, each party hereto shall pay such party’s own expenses incurred in connection with this Agreement. Notwithstanding the foregoing, the parties agree and acknowledge that (i) following the Closing, the fees and expenses of the Stockholders incurred in connection with this Agreement, the Rollover Commitment Letter and the transactions contemplated hereby and thereby shall be borne as set forth in the employment agreement to be entered into between Michael V. Lewis and the Company at the Closing in substantially the form set forth on Schedule C to the Rollover Commitment Letter; and (ii) without limitation of any liability in connection with a breach of this Agreement, the Rollover Commitment Letter or any other document or instrument to which any of the Stockholders is party in connection with the transactions contemplated hereby and thereby, under no circumstances shall any Stockholder be liable for any portion of the Purchaser Termination Fee or any other amount that may be payable by the Purchaser, the Guarantor or any of their respective Affiliates to the Company or any other Person (including any Financing Source) in connection with the Merger and the transactions contemplated by the Merger Agreement (whether or not consummated).

 

(r)         No Ownership Interest.  Nothing contained in this Agreement shall be deemed, upon execution, to vest in Purchaser any direct or indirect ownership or incidence of ownership of or with respect to any Covered Shares.  All rights, ownership and economic benefits of and relating to the Covered Shares shall remain vested in and belong to the Stockholders, and Purchaser shall have no authority to manage, direct, superintend, restrict, regulate, govern or administer any of the policies or operations of the Company or exercise any power or authority to direct the Stockholders in the voting of any of the Covered Shares, except as otherwise provided herein or in accordance with the terms of the Merger Agreement.

 

(s)        ConsentEach Stockholder’s spouse, if any, shall be required to execute the form of spousal consent set forth on Exhibit A to evidence such spouse’s agreement and consent to be bound by the terms and conditions of this Agreement as to such spouse’s interest, whether as community property or otherwise, if any, in such Stockholder’s Covered Shares.

 

[Signature page follows.]

 



 

IN WITNESS WHEREOF, Purchaser and the Stockholders have caused this Agreement to be duly executed as of the day and year first above written.

 

 

 

RHOMBUS CINEMA HOLDINGS, LLC

 

 

 

 

 

 

 

By:

/s/ Ben Kohn

 

Name:

Ben Kohn

 

Title:

Authorized Signatory

 

 

 

 

 

 

 

/s/ Michael V. Lewis

 

Name: Michael V. Lewis

 

 

 

 

 

 

The MVL Trust dated August 3, 2010

 

 

 

 

 

 

By:

/s/ Michael V. Lewis

 

Name:

Michael V. Lewis

 

Title:

Trustee

 

[Signature page to Voting Agreement]

 



 

SCHEDULE I

 

Name and Contact Information for the Stockholders

 

Number of Shares of
Company Common Stock
Beneficially Owned

 

 

 

 

 

Michael V. Lewis
603 Ocean Ave 2C, Santa Monica 90402
Fax: 310-861-8156

Email: michaellewisv@gmail.com

 

49,983

 

 

 

 

 

The MVL Trust dated August 3, 2010
603 Ocean Ave 2C, Santa Monica 90402
Fax: 310-861-8156

Attention: Michael V. Lewis, Trustee
Email: michaellewisv@gmail.com

 

5,288,336

 

 



 

Exhibit A

 

SPOUSAL CONSENT

 

Stockholder’s spouse, if any, is fully aware of, understands and fully consents and agrees to the provisions of this Agreement and its binding effect upon any marital or community property interests he or she may now or hereafter own with respect to such Stockholder’s Covered Shares, and agrees that the termination of his or her and such Stockholder’s marital relationship for any reason shall not have the effect of removing any of such Covered Shares otherwise subject to this Agreement from coverage hereunder and that his or her awareness, understanding, consent and agreement are evidenced by his or her signature below.  Further, the undersigned acknowledges that he or she has been advised to and given the opportunity to consult his or her own independent attorneys and advisors prior to signing this Spousal Consent, and has done so to the extent the undersigned deemed appropriate.

 

 

 

 

Spouse’s Name:

 




Exhibit (d)(4)

 

Execution Version

 

November 25, 2015

 

Rhombus Cinema Holdings, LLC

c/o Rizvi Traverse Management LLC
9465 Wilshire Blvd. Suite 840

Beverly Hills, CA 90212

 

Re:  Amended and Restated Rollover Investment Commitment

 

Ladies and Gentlemen:

 

This amended and restated letter agreement (this “Agreement”) sets forth the commitment of each of Michael V. Lewis and the MVL Trust dated August 3, 2010 (collectively, the “Rollover Investors”), subject to the terms and conditions contained herein, to transfer, contribute and deliver the number of shares of Company Common Stock described in Section 1 below to Rhombus Cinema Holdings, LLC, a Delaware limited liability company (“Purchaser”) in exchange for equity securities of Purchaser described in Section 1 below.  This Agreement amends and restates in its entirety that certain letter agreement, dated as of November 8, 2015, by and among the Rollover Investors and Purchaser, for purposes of revising Schedule A hereto to correct the number of shares of Company Common Stock owned by the Rollover Investors as of the date hereof and attaching an amended and restated Schedule B hereto (the “LLC Term Sheet”).  It is contemplated that, pursuant to an Agreement and Plan of Merger (as amended, restated, supplemented or otherwise modified from time to time, the “Merger Agreement”), dated as of November 8, 2015, by and among RealD Inc., a Delaware corporation (the “Company”), Purchaser and Rhombus Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Purchaser (“Merger Sub”), Merger Sub will be merged with and into the Company (the “Merger”), with the Company being the surviving entity of such Merger and a wholly-owned subsidiary of Purchaser.  Each capitalized term used and not defined herein shall have the meaning ascribed thereto in the Merger Agreement.

 

1.                                    Commitment.  Each Rollover Investor hereby commits (its “Commitment”), subject to the terms and conditions set forth herein, to transfer, contribute and deliver to Purchaser immediately prior to the Effective Time the number of shares of Company Common Stock set forth opposite such Rollover Investor’s name on Schedule A hereto (its “Rollover Investment”) in exchange for a membership interest in Purchaser represented by a number of common units equal to (A) the number of common units of Purchaser to be issued to the Guarantor in exchange for the equity contribution to Purchaser to be made by the Guarantor in connection with the Merger multiplied by (B) a fraction, the numerator of which is the value of such Rollover Investor’s Rollover Investment (assuming that the value of each share of Company Common Stock is equal to the Merger Consideration) and the denominator of which is the equity contribution to Purchaser to be made by the Guarantor in connection with the Merger

 

1



 

(such membership interest (represented in the form of common units) in Purchaser to be issued to such Rollover Investor in exchange for the Rollover Investment, its “Purchaser Equity Securities”); provided that each Rollover Investor shall not, under any circumstances, be obligated to transfer, contribute or deliver to Purchaser any amounts or consideration other than its respective Rollover Investment, or to otherwise provide funds to Purchaser or any of its Affiliates in connection with the transactions contemplated by the Merger Agreement.  In connection with its Rollover Investment, each Rollover Investor hereby commits to execute and deliver at the Closing an Amended and Restated Limited Liability Company Agreement (or limited partnership equivalent(s)) for Purchaser containing the terms and conditions set forth on the LLC Term Sheet and such other customary terms and conditions reasonably agreed between the Guarantor and such Rollover Investor, and such other ancillary agreements in forms and substance reasonably satisfactory to such Rollover Investor, as Purchaser or the Guarantor may reasonably request.  Notwithstanding the foregoing, prior to the Effective Time, the Rollover Investors may elect to reduce their aggregate Rollover Investment by an amount equal to $6 million (calculated net of applicable withholding taxes and other applicable deductions), subject to the terms set forth in the first paragraph under “Approximate Equity Capitalization at the Closing” and clause (vi) of the first paragraph under “Transfer Restrictions” on the LLC Term Sheet.  The parties hereto intend for the Rollover Investment to be made on a tax-free basis under the Internal Revenue Code of 1986, as amended, and will treat the Rollover Investment as such for all tax purposes unless otherwise required by applicable law.  At the Closing, Purchaser shall cause the Company to, and Michael V. Lewis shall, execute and deliver an employment agreement in substantially the form set forth on Schedule C hereto. For the avoidance of doubt, the parties agree and acknowledge that in connection with the Rollover Investment, each share of Company Common Stock forming the Rollover Investment shall be valued at the Merger Consideration.

 

2.                                    Conditions.  The obligation of each Rollover Investor to fund its respective Commitment shall be subject to (i) the execution and delivery of the Merger Agreement by the parties thereto, (ii) the satisfaction or waiver of each of the conditions to Purchaser’s obligations to effect the Closing set forth in Article VI of the Merger Agreement (other than any conditions that by their nature are to be satisfied at the Closing, but subject to the prior or substantially concurrent satisfaction or waiver of such conditions), and (iii) the substantially simultaneous (A) funding of the Sponsor Equity Financing contemplated by, and in accordance with the terms of, the Sponsor Commitment Letter and (B) consummation of the Merger in accordance with the terms of the Merger Agreement, in each case, without waiver by Purchaser of any condition thereto, or amendment of any term thereof, not consented to in writing by the Rollover Investors (such consent not to be unreasonably withheld, delayed or conditioned) other than any such waiver or amendment that would not reasonably be expected to be adverse (in any respect) to the interests of the Rollover Investors.

 

3.                                    Parties in Interest; Third Party Beneficiaries.  The parties hereto hereby agree that their respective agreements and obligations set forth herein are solely for the benefit of the other party hereto and its respective successors and permitted assigns, in accordance with and subject to the terms of this Agreement, and this Agreement is not intended to, and does not, confer upon any Person other than the Guarantor (on behalf of the Purchaser) and the parties hereto and their

 

2



 

respective successors and permitted assigns any benefits, rights or remedies under or by reason of, or any rights to enforce or cause Purchaser to enforce, the obligations set forth herein; provided, however, that the Company has relied on this Agreement and, accordingly, the Company is an express third-party beneficiary hereof and shall have the enforcement rights described in Section 4 hereof.

 

4.                                    Enforceability.  This Agreement may be enforced only by (i) Purchaser, (ii) the Guarantor (on behalf of the Purchaser), (iii) each Rollover Investor or (iv) the Company, pursuant to its right to seek specific performance of Purchaser’s obligation to enforce each Rollover Investor’s obligation to fund its respective Commitment in accordance with the terms hereof, pursuant to, and subject to, solely in accordance with, and to the extent permitted by, the terms and conditions of Section 8.08 of the Merger Agreement and the terms and conditions set forth herein (provided that the Company is also pursuing such right to enforce the Sponsor Commitment Letter if the Guarantor is in breach of its obligation to fund the Sponsor Equity Financing thereunder).  Purchaser’s creditors shall have no right to enforce this Agreement or to cause Purchaser to enforce this Agreement.

 

5.                                    No Modification; Entire Agreement.  This Agreement may not be amended or otherwise modified without the prior written consent of Purchaser, each Rollover Investor and the CompanyThis Agreement constitutes the sole agreement, and supersedes all prior agreements, understandings and statements, written or oral, between the Rollover Investors or any of their Affiliates (provided, that the Company shall not be deemed to be an Affiliate of any Rollover Investor), on the one hand, and Purchaser or any of its Affiliates, on the other, with respect to the Commitment of each Rollover Investor to contribute its respective Rollover Investment in exchange for membership interests in the Purchaser and the other transactions contemplated hereby.

 

6.                                    Governing Law; Jurisdiction; Venue; Waiver of Jury Trial.

 

(a)                               This Agreement (and any claim or controversy arising out of or relating to this letter agreement) shall be governed by, and construed in accordance with, the laws of the State of Delaware, applicable to contracts executed in and to be performed entirely within that State, regardless of the laws that might otherwise govern under any applicable conflict of laws principles.

 

(b)                              All actions and proceedings arising out of or relating to this Agreement shall be heard and determined in the Chancery Court of the State of Delaware and any state appellate court therefrom within the State of Delaware (or, if the Chancery Court of the State of Delaware declines to accept jurisdiction over a particular matter, any state or federal court within the State of Delaware) and the parties hereto hereby irrevocably submit to the exclusive jurisdiction of such courts in any such action or proceeding and irrevocably waive, and agree not to assert, by way of motion, as a defense, counterclaim or otherwise, in any action or proceeding with respect to this Agreement, (i) any claim that such party is not personally subject to the jurisdiction of the aforementioned courts, (ii) any claim that it or its property is exempt or immune from jurisdiction of the aforementioned courts or from any legal process

 

3



 

commenced in such courts, and (iii) any claim that the action, suit or proceeding in such court is brought in an inconvenient forum, the venue of such action, suit or proceeding is improper, or this Agreement, or the subject matter hereof, may not be enforced in or by such court.  The consents to jurisdiction and venue set forth in this Section 6(b) shall not constitute general consents to service of process in the State of Delaware and shall have no effect for any purpose except as provided in this paragraph and shall not be deemed to confer rights on any person other than the parties hereto.  Each party hereto agrees that service of process upon such party in any action or proceeding arising out of or relating to this Agreement shall be effective if notice is given by overnight courier at the address set forth in Section 8.10 of the Merger Agreement, in the case of Purchaser, and at the address set forth on Schedule A, in the case of the Rollover Investor.

 

(c)                               EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY.  EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE EITHER OF SUCH WAIVERS, (B) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVERS, (C) IT MAKES SUCH WAIVERS VOLUNTARILY AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 6(c).

 

7.                                    Counterparts.   This Agreement may be executed in counterparts (including by facsimile or by .pdf delivered via email), each of which shall be deemed to be an original, but all of which, taken together, shall constitute one and the same agreement.

 

8.                                    Confidentiality; Cooperation.  Except as may be required by applicable Law (including any filing by a Rollover Investor with the Securities Exchange Commission (the “SEC”) as required by applicable securities laws (including the Exchange Act)), court process or the rules and regulations of any national securities exchange or national securities quotation system (and then only after as much advance notice and consultation as is feasible), and except as may be permitted by Section 5.05 of the Merger Agreement, each Rollover Investor shall not, and shall instruct its Representatives not to, make any press release, public announcement or other communication with respect to the business or affairs of the Company, Purchaser or Merger Sub, including this Agreement and the Merger Agreement and the transactions contemplated hereby and thereby, without the prior written consent of Purchaser.   Each Rollover Investor hereby (i) consents to and authorizes the publication and disclosure by Purchaser of such Rollover Investor’s identity and holding of shares of Company Common Stock and any

 

4



 

other equity securities of the Company which are beneficially owned by any Rollover Investor or any of its Affiliates as of the date hereof or acquired after the date hereof and prior to the termination of this Agreement, and (following prior review by the Rollover Investor, and with the Rollover Investor’s reasonable comments taken into consideration by the Purchaser) the nature of such Rollover Investor’s commitments, arrangements and understandings under this Agreement and any other information that Purchaser reasonably determines to be necessary or desirable in any press release or any other disclosure document in connection with the Merger or any other transactions contemplated by the Merger Agreement and (ii) agrees as promptly as practicable to notify Purchaser of any required corrections with respect to any written information supplied by such Rollover Investor specifically for use in any such disclosure document.  Without limitation of the foregoing, each Rollover Investor shall provide to Purchaser all information concerning such Rollover Investor and cooperation as may be reasonably requested by Purchaser in connection with the Company’s preparation and filing of the Proxy Statement and any other filings required under applicable securities Laws and the resolution of any comments thereto received from the SEC.  Each Rollover Investor shall promptly correct any information provided by it or him for use in the Proxy Statement and any other filings required under applicable securities Laws if and to the extent such information shall have become false or misleading in any material respect.

 

9.                                    Termination.  The obligation of each Rollover Investor under or in connection with this Agreement will terminate automatically and immediately upon the earliest to occur of (a) the Closing (at which time all such obligations shall be discharged), (b) the valid termination of the Merger Agreement pursuant to Article VII thereof (unless the Company has previously commenced an action described in Section 4 hereof, in which case this Agreement shall terminate upon the final, non-appealable resolution of such action and satisfaction by each Rollover Investor of any obligations finally determined or agreed to be owed by such Rollover Investor, consistent with the terms hereof), (c) the termination (for any reason) of the Guarantor’s obligation to fund the Sponsor Equity Financing pursuant to the Sponsor Commitment Letter and (d) the Company or any of its Affiliates, or any Person claiming by, through or for the benefit of the Company, accepting payment of the Purchaser Termination Fee pursuant to the Merger Agreement or accepting payment thereof from the Guarantor under the Guaranty in respect of such obligation; provided that no such termination shall relieve any Rollover Investor from any liability to Purchaser or its Affiliates for any material breach of this Agreement by such Rollover Investor prior to such termination, and Purchaser or its Affiliates shall be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising from such material breach (it being acknowledged and agreed that, for the avoidance of doubt, the failure of the Rollover Investors to fund their respective Commitments if and when due and payable pursuant to this Agreement shall constitute a material breach of this Agreement).

 

10.                            No Assignment.  The Commitment evidenced by this Agreement shall not be assignable, in whole or in part, by Purchaser without the Rollover Investors’ prior written consent, and the granting of such consent in a given instance shall be solely in the discretion of the Rollover Investors and, if granted, shall not constitute a waiver of this requirement as to any subsequent assignment; provided, that the rights, interests and obligations of Purchaser

 

5



 

hereunder (including the Commitment) may be assigned by Purchaser to any Person (i) to whom the Merger Agreement is validly assigned in accordance with the terms thereof, (ii) to whom the right to receive the Sponsor Equity Financing is validly assigned in accordance with the terms of the Sponsor Commitment Letter and (iii) that is an entity formed for purposes of the transactions contemplated by the Merger Agreement and that does not have any assets, liabilities or operations (other than in connection with the transactions contemplated by the Merger Agreement or those incidental to its formation).  No transfer of any rights or obligations hereunder by any Rollover Investor shall be permitted without the prior written consent of Purchaser and the Company.  Any purported assignment of this Agreement or the Commitment in contravention of this Section 10 shall be void.

 

11.                            Representations and Warranties.  Each Rollover Investor hereby represents and warrants to Purchaser that (a) if the Rollover Investor is not a natural person, it has all limited partnership, trust or other organizational power and authority to execute, deliver and perform this Agreement; (b) if the Rollover Investor is not a natural person, the execution, delivery and performance of this Agreement by it has been duly and validly authorized and approved by all necessary limited partnership, trust or other organizational action by it; (c) this Agreement has been duly and validly executed and delivered by it or him and constitutes a valid and legally binding obligation of it or him, enforceable against it or him in accordance with the terms of this Agreement, subject to the effect of any applicable bankruptcy, reorganization, insolvency, moratorium or similar laws affecting creditors’ rights generally and subject, as to enforceability, to the effect of general principles of equity; (d) it or he is the record and beneficial owner of the shares of Company Common Stock identified with respect to it or him (as set forth on Schedule A), free and clear of any Lien (other than those arising under applicable securities laws and those arising under this Agreement and under the Voting Agreement), and has full and unrestricted power to dispose of all of such shares of Company Common Stock as contemplated by this Agreement without the consent or approval of, or any other action on the part of, any other Person; (e) other than any filing by it or him with the SEC as required by Sections 13(d) or 16(a) of the Exchange Act (and other than the providing of any information required by it or him in connection with the matters described in Section 3.03(d) of the Merger Agreement), none of the execution and delivery of this Agreement by it or him, the consummation by it or him of the transactions contemplated hereby or compliance by it or him with any of the provisions hereof: (i) requires any consent or other permit of, or filing by it or him with or notification to, any Governmental Authority or any other Person by it or him, (ii) results in a violation or breach of, or constitutes (with or without notice or lapse of time or both) a default (or gives rise to any third party right of termination, cancellation, material modification or acceleration) under any of the terms, conditions or provisions of any organizational document or contract to which it or he is a party or by which it or he or any of the shares of Company Common Stock identified with respect to it or him (as set forth on Schedule A) may be bound or affected, (iii) violates any Law or Order applicable to it or him or the shares of Company Common Stock identified with respect to it or him (as set forth on Schedule A), or (iv) results in a Lien upon any of the shares of Company Common Stock identified with respect to it or him (as set forth on Schedule A) (other than any Lien arising under this Agreement), other than, in each case in this clause (e), any matter which would not adversely affect in any material respect the ability of such Rollover Investor to perform his or its obligations hereunder or consummate the transactions contemplated

 

6



 

hereby; (f) it or he has not entered into any stock transfer, disposition, commitment or other agreement or arrangement that is inconsistent with this Agreement (including, without limitation, its Commitment described herein); (g) it or he had access to all of the information required in order to evaluate an investment in Purchaser; (h) it or he is an “accredited investor” within the meaning of Rule 501 under Regulation D promulgated by the SEC under the Securities Act of 1933, as amended (the “1933 Act”); (i) it or he is acquiring the Purchaser Equity Securities for its or his own account (or for the account of the trust or plan or other entity referred to in the signature block at the end of this Agreement), for investment and not with a view to any resale or distribution thereof in violation of applicable securities laws; (j) it or he understands that the Purchaser Equity Securities have not been registered under the 1933 Act or any United States state securities laws and may not be assigned, sold or otherwise transferred without registration under the 1933 Act or any relevant state securities laws or exemption therefrom, and that as of the date hereof Purchaser has no obligation or intention to register the Purchaser Equity Securities under the 1933 Act or United States state securities laws; and (k) that it or he may therefore be required to bear the economic risk of holding the Purchaser Equity Securities for an indefinite period of time.

 

12.                            Severability.  If any term, condition or other provision of this Agreement is determined by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced by any rule of Law or public policy, all other terms, provisions and conditions of this Agreement shall nevertheless remain in full force and effect.  Upon such determination that any term, condition or other provision hereof is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible to the fullest extent permitted by applicable Law in an acceptable manner to the end that the transactions contemplated by this Agreement are fulfilled to the extent possible.

 

13.                            Power of Attorney.  In order to effect the obligation of each Rollover Investor to make its Rollover Investment on the terms and subject to the conditions set forth in this Agreement, each Rollover Investor hereby grants a power of attorney to the Secretary of Purchaser, with full power of substitution, with respect to the matters set forth herein, and hereby authorizes the Secretary of Purchaser to execute all appropriate documents and instruments to effect such Rollover Investment by such Rollover Investor as shall be required under the terms of this Agreement, if such Rollover Investor fails to execute such documents and instruments substantially simultaneously upon the satisfaction of the conditions set forth in Section 2 above.  The power of attorney granted pursuant to the immediately preceding sentence is given in consideration of the agreements and covenants of the parties hereto in connection with this Agreement and the transactions contemplated by the Merger Agreement and, as such, is coupled with an interest and shall be irrevocable until the valid termination of this Agreement.

 

14.                            Specific Performance.  The parties hereto agree that irreparable damage, for which monetary damages (even if available) would not be an adequate remedy, would occur in the event that the parties hereto do not perform any provision of this Agreement in accordance with its specified terms or otherwise breach such provisions.  Accordingly, the parties hereto acknowledge and agree that the parties hereto and the Guarantor (on behalf of the Purchaser)

 

7



 

shall be entitled to an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled in Law or in equity.  Each of the parties hereto agrees that it will not oppose the granting of an injunction, specific performance and other equitable relief on the basis that any other party has an adequate remedy at law or that any award of specific performance is not an appropriate remedy for any reason at law or in equity.  Any party hereto or the Guarantor (on behalf of the Purchaser) seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement shall not be required to provide any bond or other security in connection with such order or injunction.

 

15.                            Spousal Consent.  Each Rollover Investor’s spouse, if any, shall be required to execute the form of spousal consent set forth on Exhibit A to evidence such spouse’s agreement and consent to be bound by the terms and conditions of this Agreement as to such spouse’s interest, whether as community property or otherwise, if any, in such Rollover Investor’s Rollover Investment and the Purchaser Equity Securities issued to such Rollover Investor.

 

 

[remainder of the page intentionally left blank – signature page follows]

 

8



 

 

Sincerely,

 

 

 

 

 

By: /s/ Michael V. Lewis               

 

Michael V. Lewis

 

 

 

 

 

The MVL Trust dated August 3, 2010

 

 

 

 

 

By: /s/ Michael V. Lewis               

 

      Name: Michael V. Lewis

 

      Title: Trustee

 

 

[Signature Page to Rollover Commitment Letter]

 



 

Agreed to and accepted:

 

 

 

RHOMBUS CINEMA HOLDINGS, LLC

 

 

 

 

 

By: /s/ Ben Kohn                 

 

       Name: Ben Kohn

 

       Title: Authorized Signatory

 

 

[Signature Page to Rollover Commitment Letter]

 



 

Exhibit A

 

SPOUSAL CONSENT

 

Such Rollover Investor’s spouse, if any, is fully aware of, understands and fully consents and agrees to the provisions of this Agreement and its binding effect upon any marital or community property interests he or she may now or hereafter own with respect to such Rollover Investor’s Rollover Investment and the Purchaser Equity Securities issued to such Rollover Investor in exchange therefor, and agrees that the termination of his or her and such Rollover Investor’s marital relationship for any reason shall not have the effect of removing any of such Rollover Investment or the Purchaser Equity Securities otherwise subject to this Agreement from coverage hereunder and that his or her awareness, understanding, consent and agreement are evidenced by his or her signature below.  Further, the undersigned acknowledges that he or she has been advised to and given the opportunity to consult its own independent attorneys and advisors prior to signing this Spousal Consent, and has done so to the extent the undersigned deemed appropriate.

 

 

 

 

Spouse’s Name:

 



 

Schedule A

 

Rollover Investor;
Address

Number of
Shares of
Company
Common Stock

Rollover
Investment

Michael V. Lewis

Address: 603 Ocean
Avenue, 2C, Santa
Monica 90402

49,983

$549,813

The MVL Trust dated
August 3, 2010

Address: 603 Ocean
Avenue, 2C, Santa
Monica 90402

5,288,336

$58,171,696

Total

5,338,319

$58,721,509

 



 

Schedule B

 

A&R Limited Liability Company Agreement Term Sheet

 



 

Project Rhombus

Limited Liability Company Agreement Term Sheet

 

 

Company:

 

Rhombus Cinema Holdings, LLC (the “Company”), a holding company that will indirectly wholly-own RealD Inc. (“Rhombus”) upon the closing (the “Closing”) of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 8, 2015, by and among the Company, Rhombus and Rhombus Merger Sub, Inc. (the “Merger Agreement”).

 

 

 

Form of the Company:

 

The Company shall initially be a Delaware limited liability company; provided that the Investors will cause the Company to be converted into, or merged with and into a newly-formed Delaware limited partnership not later than 30 days after the Closing, which will at all times be the sole stockholder of RT Rhombus Holdings, Inc., which in turn will be the sole stockholder of Rhombus.

 

 

 

RT Investor:

 

One or more funds or vehicles managed or otherwise controlled by Rizvi Traverse Management, LLC (collectively and including its permitted transferees, “RT”).

 

 

 

Rollover Investor:

 

Michael V. Lewis (“Lewis”) and the MVL Trust dated August 3, 2010 (collectively and including their permitted transferees, the “Rollover Investor”).

 

 

 

Other Investors:

 

One or more funds or affiliates managed by Fortress Investment Group (“Fortress”) and any other investors that participate in the Fortress Investment (collectively and including their permitted transferees, the “Other Investors” and, together with RT and the Rollover Investor, the “Investors”).

 

 

 

Approximate Equity Capitalization at the Closing:

 

Depending upon the amount of cash, debt and transaction expenses (including change-of-control payments) of or incurred by the Company and/or Rhombus at the Closing, the Fortress Investment described below, approximately $100,433,767 from RT to be invested in Class A Common Units of the Company (the “Class A Common Units”) and approximately $58,733,873 from the Rollover Investor to be invested in Class A Common Units (subject to reduction as described below). The equity investment of RT in Class A Common Units will be made in cash and the Rollover Investor’s equity investment in Class A Common Units will be made solely via the rollover of existing common stock of Rhombus. Notwithstanding the foregoing, if the definitive documents in connection with the debt financing to be funded at Closing prohibit the Company or its subsidiaries from making available an $6,000,000 revolving loan to the Rollover Investor at

 



 

 

 

Closing (the “Lewis Revolving Loan”), at the Rollover Investor’s election, either (i) RT and the Rollover Investor will cooperate in good faith to seek to reduce the Rollover Investor’s investment in Class A Common Units at Closing by an amount that results in after-tax proceeds to the Rollover Investor of $6,000,000 (the “Rollover Investment Adjustment”) (and RT’s equity investment in the Company at Closing will increase accordingly) or (ii) the Rollover Investor will be permitted to transfer a portion of his Class A Common Units in accordance with clause (vi) under the “Transfer Restrictions” section below.

 

 

 

 

 

Fortress has committed to make a (i) $125,000,000 investment in Preferred Units of the Company (the “Preferred Units”) at Closing, which amount will be reduced if and to the extent that, following the date of the Merger Agreement (but prior to Closing), additional investors commit to make an equity investment in the Company, and (ii) $5,000,000 investment in Class A Common Units (the “Co-Invest Units”) (the commitments of Fortress and such additional investors collectively, the “Fortress Investment”). In connection with the Fortress Investment, for each $5,000,000 investment in Preferred Units, the Other Investor(s) shall receive an aggregate number of Class A Common Units equal to 1% of the outstanding Class A Common Units as of the Closing (such dilution to be borne by all holders of Class A Common Units on a pro rata basis). After consultation with the Rollover Investor, RT may also offer other senior members of Rhombus management the opportunity to invest in Class A Common Units via the rollover of additional Rhombus common stock or transferable equity awards at Closing (with such other rollover management member responsible for all taxes due as a result of the basis in the assigned shares being less than current market value), which will correspondingly reduce RT’s investment in Class A Common Units at Closing (and such senior members of Rhombus management will be Investors and Common Members hereunder).

 

 

 

Units:

 

Preferred Units, Class A Common Units and Class B Common Units of the Company representing profits interests to be issued pursuant to the management equity incentive plan and award agreements thereunder, as more fully described on Annex B hereto (such Class B Common Units being referred to herein as the “MIP Units” and, together with the Class A Common Units, the “Common Units”; the Preferred Units and the Common Units, collectively, the “Units”). The holders of Common Units from time to time are referred to herein as the “Common Members”.

Assuming (i) funding in respect of the Units by the persons described above in the amounts described above, (ii) Fortress funds

 

2



 

 

 

the full Fortress Investment amount and (iii) there is no Rollover Investment Adjustment or additional management rollover, a pro forma table of the equity capitalization of the Company (excluding the MIP Units) is set forth on Annex A hereto.

 

 

 

Terms of the Preferred Units:

 

As set forth in or contemplated by that certain Amended and Restated Equity Commitment Letter, dated as of November 25, 2015, by and among Fortress Credit Advisors LLC, the Company and Rizvi Traverse Management, LLC (the “Fortress Commitment Letter”).

 

 

 

 

 

 

Management Equity Incentive Plan:

 

See Annex B hereto.

 

 

 

Board of Managers:

 

The Company will be managed by a Board of Managers (the “Board”). The Board will have full power to manage and control the business and affairs of the Company and its subsidiaries, subject to the supermajority voting rights described below and the terms of the Preferred Units. All actions of the Board shall be approved by a majority of the entire Board, and the Board may act by written consent.


Subject to the terms of the Preferred Units, the Board shall consist of five (5) managers, two (2) of which (including with respect to each committee of the Board) shall be appointed by RT, one (1) of which (including with respect to each committee of the Board) shall be appointed by the Other Investors holding a majority in interest of Preferred Units held, in the aggregate, by the Other Investors, and two (2) of which (including with respect to each committee of the Board) shall be appointed by the Rollover Investor (the “Rollover Designees”); provided that if at any time after the Closing (i) (A) the Rollover Investor fails to own at least 15% of the total issued and outstanding Class A Common Units and (B) Lewis is no longer the Chief Executive Officer of the Company, or (ii) Lewis dies or becomes disabled (as the term “disability” is defined in his employment agreement), the Rollover Investor shall no longer be entitled to appoint the Rollover Designees to the Board, and RT shall have the right to appoint such members of the Board thereafter. So long as the Rollover Investor is entitled to appoint the Rollover Designees, Lewis shall at all times be a Rollover Designee and Chairman of the Board. Following such time as, pursuant to the terms of the Preferred Units, the Other Investors are no longer entitled to appoint a member of the Board, the size of the Board shall be reduced to four (4) managers, to be appointed by RT and the Rollover Investor as provided above.

 

3



 

Voting:

 

Holders of Class A Common Units shall be entitled to one vote per Class A Common Unit.  The Preferred Units (subject to the terms of the Preferred Units) and the MIP Units shall be non-voting except to the extent required by applicable law.

 

Notwithstanding the full power of the Board to manage and control the business and affairs of the Company and its subsidiaries, the Company and its subsidiaries shall not take the following actions without the affirmative vote of at least 80% in interest of the issued and outstanding Class A Common Units:

 

(i)        liquidation, dissolution or winding up or effecting of any plan of liquidation, dissolution or the commencement of proceedings relating to bankruptcy, insolvency, reorganization or relief of debtors of the Company or any of its subsidiaries, except in each case in connection with a Drag-Along Sale;

 

(ii)        amendment or modification of the articles of incorporation, bylaws or equivalent organizational documents of the Company or any of its subsidiaries;

 

(iii)                          sale or other disposition of all or substantially all of the assets or business of the Company and its subsidiaries, except in connection with a Drag-Along Sale;

 

(iv)                          transaction in which the Company or its subsidiaries merge or consolidate with or into any person, except (x) in the case of such transaction among the Company and its subsidiaries or among such subsidiaries, (y) where the holders of the capital stock or equity interests of the surviving or the resulting entity immediately following such transaction are the same (in kind and amount) as those of the Company immediately prior to the transactions, or (z) in connection with a Drag-Along Sale;

 

(v)        any acquisition by the Company or its subsidiaries of stock or other equity securities (whether by merger, consolidation, purchase of stock or other equity securities or otherwise) or of the assets (outside the ordinary course of business) of any other entity, except any such acquisition where the aggregate consideration for such acquisition is less than certain threshold amounts (individually and in the aggregate) as agreed upon in the definitive agreement;

 

(vi)       other than as described in clause (iii) above, any sale, transfer or other disposition of assets of the Company and

 

4



 

 

 

its subsidiaries outside the ordinary course of business, except any such sale, transfer or other disposition of assets where the aggregate consideration for such assets is less than certain threshold amounts (individually and in the aggregate) as agreed upon in the definitive agreement;

 

(vii)                      dividends or other distributions to members, including, but not limited to, any dividend or other distribution by means of a redemption or repurchase of Units, except (x) vested Units repurchased from former employees or consultants in connection with the cessation of their employment/services with the Company or any of its subsidiaries, (y) the redemption or repurchase of Preferred Units or (z) the exercise of the Call Right;

 

(viii)                  issuance by the Company or any of its subsidiaries of equity securities, except for (x) options or other securities issued pursuant to any incentive equity plan or agreement or other benefit plan in place at the time of Closing or approved by the Board from time to time, (y) in connection with the consummation of an Initial Public Offering (as defined below) or (z) in connection with a Drag-Along Sale;

 

(ix)                          incurrence after the Closing of any indebtedness for borrowed money (including guarantees of indebtedness for borrowed money) in excess of a cap (as agreed upon in the definitive agreement) by the Company or its subsidiaries, other than (x) pursuant to a credit facility in place at Closing or (y) any refinancing of then-existing indebtedness for borrowed money on terms and conditions that are not materially less favorable to the Company and its subsidiaries, in the aggregate, than such then-existing indebtedness for borrowed money;

 

(x)                              permit the creation of material liens on the assets of the Company and its subsidiaries;

 

(xi)                          make any loans or advances to any person or entity outside the ordinary course of business and in excess of a cap (as agreed upon in the definitive agreement), other than in connection with any draws by Lewis on the Lewis Revolving Loan (if any);

 

(xii)      other than the Lewis Revolving Loan, transactions, material contracts, agreements or arrangements, or amendments to an agreement, between the Company or any of its

 

5



 

 

 

subsidiaries, on the one hand, and any Investor or affiliate of any Investor, on the other hand, in each case, either (A) that is not entered into on arms-length terms or (B) that includes fees or other amounts payable to RT or any Other Investor (whether pursuant to an amendment to the Management Services Agreement or otherwise (but excluding the amount of fees and expenses contemplated by the Management Services Agreement in effect at Closing));

 

(xiii)                  increase or decrease the size of the Board;

 

(xiv)     approval of the annual operating budget of the Company and its subsidiaries; provided that in the event that the requisite holders of Class A Common Units are unable to approve an annual operating budget for the upcoming fiscal year, the annual operating budget from the prior fiscal year shall be deemed to be approved for such upcoming fiscal year until such time as a new annual operating budget is approved;

 

(xv)      material change in the line of business of the Company and its subsidiaries from that conducted or reasonably contemplated to be conducted as of the Closing;

 

(xvi)                  change in the outside auditor of the Company and its subsidiaries; or

 

(xvii)              enter into any agreement or arrangement to do any of the foregoing;

 

provided that, following the death or disability (as defined in his employment agreement) of Lewis, the affirmative vote of a majority in interest of the issued and outstanding Class A Common Units will be sufficient to approve the actions set forth in clauses (v), (vi), (vii), (viii), (ix), (x), (xi), (xiii), (xiv), (xv), (xvi) and the entry into any agreement or arrangement to do any of the foregoing;

 

provided, further, that if the holders of the Preferred Units have the right to elect a majority of the Board pursuant to the terms of the Preferred Units, then the approval by a majority of the Board will be sufficient to approve the actions set forth in clauses (vi), (viii), (ix), (x) and (xiv).

 

Notwithstanding the foregoing, no holder of Class A Common Units shall be permitted to grant or withhold consent to any of the foregoing actions if such action or the failure to take such action, as the case may be, would result in a breach of the definitive

 

6



 

 

 

documents in connection with the debt and preferred equity financing to be funded at Closing (or any refinancing thereof).

 

 

 

Additional Capital Contributions:

 

Following the Closing, no member of the Company shall be required to make any additional capital contributions to the Company or any of its subsidiaries.

 

 

 

Distributions:

 

Subject to the terms of the Preferred Units, distributions of available cash in respect of Common Units shall be made as follows:

 

First, to the holders of Class A Common Units on a pro rata basis until RT and the Rollover Investor have received aggregate distributions in an amount that represents an 8% annualized internal rate of return on invested capital; and

 

Second, any remaining amounts to the Common Members on a pro rata basis, subject, in the case of the MIP Units, to applicable distribution restrictions to preserve profits interest treatment; provided that any distributions in respect of unvested MIP Units shall be retained by the Company until such time as such MIP Units vest.

 

Notwithstanding the foregoing, proper provision shall be made so that at all times the MIP Units qualify as profits interests for tax purposes.

 

 

 

Drag-Along Rights:

 

If on or after the three (3)-year anniversary of the Closing and subject to the terms of the Preferred Units, RT determines to effect a transaction that results in a Change in Control (as defined in Annex B) of the Company and that otherwise meets the requirements of clauses (1) through (3) below (a “Drag-Along Sale”), RT may require the other Common Members to consent to or otherwise participate in such Drag-Along Sale, and each such Common Member will (if such Drag-Along Sale involves a sale of Common Units, merger, business combination or similar transaction) be obligated to sell in such Drag-Along Sale a percentage of the number of Common Units owned by such Common Member (allocated proportionately among the Class A Common Units and tranches of MIP Units owned by such Common Member, as applicable), equal to the quotient of (a) the aggregate number of Common Units that are proposed to be sold by RT in such Drag-Along Sale divided by (b) the aggregate number of Common Units owned by RT, so long as (1) such Drag-Along Sale is to a non-affiliated third party of RT, (2) the purchase price is paid in cash or marketable securities in the same proportion for all Common Members in respect of their Common Units and

 

7



 

 

 

(3) the other terms of such Drag-Along Sale are the same for all Common Members (other than any Common Member, other than RT, if such Common Member elects to contribute Common Units to the acquiring or surviving company in such transaction and, in the case of the MIP Units, other than as provided in the immediately following paragraph).  Furthermore, but subject to the foregoing conditions, each of the other Common Members will be obligated, as the case may be, to (x) vote all its Common Units in favor of, and waive all dissenters and appraisal rights in connection with, such Drag-Along Sale, (y) consent to the appointment of RT or its affiliate as representative of the Common Members with respect to matters affecting the Common Members in connection with such Drag-Along Sale and (z) appoint RT as attorney-in-fact and proxy with respect to the Common Units to be sold by such Common Member in such Drag-Along Sale.  No Common Member, without such Common Member’s consent, shall be required to (A) make representations and warranties in an individual capacity, except as to authorization, non-contravention, ownership and related matters or (B) provide any indemnity in excess of the net proceeds received by such Common Member from such Drag-Along Sale, or that applies on a non-pro rata basis.

 

The purchase price to be paid in a Drag-Along Sale for any transferred MIP Unit shall be equal to the amount that would be received by the holder of such MIP Unit following a hypothetical sale of all of the Company’s assets at the valuation implied by such Drag-Along Sale (net of selling expenses of RT in connection with such Drag-Along Sale) and a distribution of the distributable proceeds from such hypothetical sale to the Common Members in accordance with the “Distributions” section above.

 

This drag-along right shall terminate immediately upon the consummation of an Initial Public Offering.

 

 

 

Tag-Along Rights:

 

If any Investor desires to, directly or indirectly, in any Permitted Third Party Transfer, sell any outstanding Class A Common Units then it must offer each other Investor holding Class A Common Units the right to participate in such sale (on the same terms and subject to the same conditions as those afforded to the selling Investor) on a pro rata basis.  In the event that less than all of the non-selling Investors elect to participate in such sale or any of the non-selling Investors elects to sell less than the number of Class A Common Units it is entitled to include in such sale, the selling Investor and the other participating Investors shall have the right to include in such sale a corresponding number of additional Class A Common Units on a pro rata basis (based on their respective number of Class A Common Units initially included in such sale). 

 

8



 

 

 

No Investor, without such Investor’s consent, shall be required to (x) make representations and warranties in an individual capacity, except as to authorization, non-contravention, ownership and related matters or (y) provide any indemnity in excess of the net proceeds received by such Investor from such sale, or that applies on a non-pro rata basis.

 

 

 

 

 

This tag-along right shall terminate immediately upon consummation of an Initial Public Offering.

 

 

 

Transfer Restrictions:

 

Prior to an Initial Public Offering, no Common Member may transfer its Common Units to any third party, other than (i) (A) with the consent of RT and the Rollover Investor or (B) by RT after (but not before) the three (3)-year anniversary of the Closing; provided that, so long as the Preferred Units remain outstanding, such transfer is not to a direct competitor of Rhombus (a “Permitted Third Party Transfer”; any transfer pursuant to this clause (i) being subject to the tag-along rights described above), (ii) transfers pursuant to the drag-along and tag-along rights described above, (iii) in the case of RT and the Other Investors, transfers to controlling, controlled or commonly controlled affiliates, (iv) in the case of the Rollover Investor, transfers to trusts and other estate planning vehicles for the sole benefit of the Rollover Investor or family members of the Rollover Investor so long as the Common Units remain under the sole control of the Rollover Investor, (v) in the case of a Common Member that is an investment fund, other investment funds or vehicles under common management or control or to the limited partners of an investment fund in connection with a pro rata distribution so long as the general partner (or equivalent) of the distributing fund retains a proxy over the voting and disposition of such Common Units, (vi) if the Rollover Investment Adjustment does not occur, one or more transfers by the Rollover Investor of an aggregate number of Class A Common Units not to exceed 20% of the Class A Common Units owned by the Rollover Investor as of immediately after the Closing; provided that if the Rollover Investor transfers any of its Class A Common Units pursuant to this clause (vi), the Lewis Revolving Loan will immediately terminate and all outstanding amounts thereunder must be immediately repaid by the Rollover Investor; provided, further, that RT shall have a right of first refusal on any proposed transfer of Class A Common Units by the Rollover Investor pursuant to clause (vi) above, and the Other Investor shall have a secondary right of first refusal if and to the extent that RT does not purchase all of such Class A Common Units, (vii) one or more transfers by RT of an aggregate number of Class A Common Units not to exceed 25% of the Class A Common Units owned by RT as of immediately after the Closing,

 

9



 

 

 

and (viii) so long as the Preferred Units remain outstanding, transfers of Class A Common Units by the Other Investors to purchaser(s) of, and together with, Preferred Units; provided that the percentage of Class A Common Units to be transferred by an Other Investor (based on the number of Class A Common Units owned by such Other Investor) shall be equal to the percentage of Preferred Units so sold by such Other Investor (based on the number of Preferred Units owned by such Other Investor), excluding for purposes of such determination the Co-Invest Units.

 

Any acquirer of Common Units (a) must agree to execute the LLC Agreement and be bound by the provisions of the LLC Agreement, including the transfer restrictions and drag-along provisions of the LLC Agreement, and to make customary representations including as to its status as an “accredited investor”, and (b) will be entitled to exercise the tag-along rights, registration rights and other rights of the transferor under the LLC Agreement.

 

 

 

Preemptive Rights:

 

The Investors shall have customary preemptive rights on all issuances of Common Units or securities convertible into Common Units prior to an Initial Public Offering in order to maintain their respective pro rata ownership of Common Units (excluding MIP Units), subject to customary exceptions and exclusions.  The Investors shall be entitled to participate in such issuance on the same terms and conditions as are applicable to other participants in the issuance, and shall not, as a condition to participation, be obligated to agree to any terms, conditions or restrictions not applicable to all other purchasers of such securities.

 

If the Board determines in good faith that emergency funding is required, and therefore accommodating preemptive rights would have an adverse effect on the Company and its financial condition, then the Board shall be permitted to authorize and issue the additional Common Units without regard to the preemptive rights; provided that the Company shall be required to, not later than thirty (30) days after such issuance, offer each Investor the opportunity to purchase a portion of such additional Common Units, in a manner and on terms that substantially give effect to the ability of such Investor to acquire a portion of such additional Common Units pursuant to the exercise of preemptive rights.

 

 

 

Call Right:

 

In the event of the death or disability (as defined in his employment agreement) of Lewis, the Company shall have the right, but not the obligation, to repurchase the Rollover Investor’s Common Units (the “Call Right”) for a purchase price equal to the fair market value of such Common Units (as reasonably determined by the Board in good faith, without taking into account

 

10



 

 

 

any discount to fair market value for (x) the illiquid nature of the Common Units or (y) the fact that the Rollover Investor’s Common Units may represent a minority interest in the Company (or the fact that the Rollover Investor’s Common Units may represent a controlling interest in the Company), but taking into account the fact that Lewis is no longer serving as Chief Executive Officer), which right shall be additional to any other Company call rights otherwise applicable to MIP Units.

 

 

 

Initial Public Offering:

 

At any time following the three (3)-year anniversary of the Closing, the Company (upon approval by the Board) may consummate an initial public offering of the Company (an “Initial Public Offering”).  In connection with the Initial Public Offering, the Common Members shall convert or exchange their Common Units into shares of capital stock of a corporation and take all other reasonable actions in order to facilitate the Initial Public Offering.

 

Common Units (or any shares of capital stock of a corporation into which the Common Units are required to be converted in connection with an Initial Public Offering) may be subject to the vesting terms applicable to any unvested underlying MIP Units and to an underwriters lock-up for up to 180 days following an Initial Public Offering.

 

The board designation and supermajority voting rights shall terminate immediately upon consummation of an Initial Public Offering.

 

 

 

Registration Rights:

 

After an Initial Public Offering, RT and the Rollover Investor shall be permitted to exercise unlimited demand registration rights and each Investor shall have customary pro rata piggyback registration rights in respect of any demand registration effected by RT or the Rollover Investor or on any other registration effected by the Company, subject to customary underwriter cutbacks on a pro rata basis.  The Company shall bear the registration expenses of all piggyback and demand registrations, and shall reimburse the holders of registrable securities included in each registration (including registrations pursuant to an Initial Public Offering) for the reasonable fees and disbursements of counsel.

 

 

 

Information Rights:

 

Investors holding Class A Common Units shall have customary information rights, including the right to receive regularly prepared consolidated annual and quarterly financial statements of the Company and its subsidiaries (subject to appropriate confidentiality restrictions).  Holders of MIP Units will not be entitled to such information rights in respect of their MIP Units,

 

11



 

 

 

except as may be required by applicable law.

 

 

 

Waiver of Corporate Opportunity Doctrine; Fiduciary Duties:

 

None of RT, the Rollover Investor (but only if Lewis is no longer serving as Chief Executive Officer of the Company) or the Other Investors, or any of their respective affiliates, shall (i) be in any way prohibited or restricted from engaging or investing in any business opportunity or (ii) be required to present any business opportunity to the Company and its subsidiaries.

 

To the greatest extent permitted by applicable law: (a) neither the Investors nor the members of the Board shall, in their capacities as such, owe any fiduciary or similar duty or obligation whatsoever to the Company, its subsidiaries or any other Investor, and (b) the LLC Agreement shall eliminate any such duties or obligations that would otherwise apply thereto.

 

 

 

Indemnification:

 

Each officer (subject to compliance with such officer’s duties and obligations to the Company) and each member of the Board shall be entitled to indemnification from the Company to the maximum extent permitted by law, including advancement of expenses, and director and officer liability coverage.  Each member of the Board shall be entitled to receive an Indemnification Agreement from the Company on equivalent terms.

 

 

 

Management Services: Agreement:

 

 

As set forth in or contemplated by the Fortress Commitment Letter.

 

 

 

Amendments:

 

Subject to the terms of the Preferred Units, the LLC Agreement may be amended or waived by the vote of at least 80% in interest of the issued and outstanding Class A Common Units; provided that no amendment to, or waiver of, the LLC Agreement that materially adversely affects any Investor in a disproportionate manner shall be made without the consent of such Investor.

 

12



 

Annex A

 

Pro Forma Capitalization*

 

Holder

Preferred Units

% of Outstanding 
Preferred Units

Class A Common Units

% of Outstanding 
Class A Common 
Units

Fortress

125,000,000

100.0 %

59,714,333

27.3 %

RT

-

-

100,433,767

45.9 %

Rollover Investor

-

-

58,733,873

26.8 %

Total

125,000,000

100.0 %

218,881,973

100.0 %

 

*Subject to adjustment based on cash, indebtedness and transaction expenses of or incurred by the Company and/or Rhombus at Closing.

 



 

Annex B

 

[Management Equity Incentive Plan Term Sheet]

 



 

Project Rhombus

Profits Interest Unit Plan Term Sheet

 

Overview:

 

The Profits Interest Plan (the “Plan”) will provide for the grant of awards of Class B Units (“Profits Interest Units”) in a Delaware limited liability company (the “Company”).

 

 

 

Reserve:

 

Initially, the Plan will reserve for issuance a number of Class B Units of the Company representing the right to participate in up to 10% of the aggregate profits and capital appreciation of the Company allocable to the Common Units (from and above the applicable 8% IRR hurdle) following the closing of the proposed merger. Allocation of the incentive equity pool among eligible participants will be made by the Board of Managers in its discretion after good faith consultation with Mr. Lewis.

 

 

 

Eligibility:

 

Employees, consultants and managers of the Company and its subsidiaries will be eligible to receive awards of Profits Interest Units.

 

 

 

Vesting:

 

Initial awards of Profits Interest Units will vest as follows, subject to the participant’s continued employment with the Company or its subsidiaries through the applicable vesting date:

 

·       One-half of the Profits Interest Units will vest in substantially equal annual installments over the four (4)-year period following the applicable vesting start date (“Tranche I Units”); and

 

·       One-half of the Profits Interest Units will vest in substantially equal annual installments over the five (5)-year period following the applicable vesting start date (“Tranche II Units”).

 

Notwithstanding the foregoing, in the event that a Change in Control occurs and the participant remains in continued employment with the Company or its subsidiaries through the date of such Change in Control, the Profits Interest Units will vest in full (to the extent not then-vested) immediately prior to such Change in Control. The Company’s Board of Managers may also accelerate the vesting of any unvested Profits Interest Units at any time in its sole discretion.

 

·       Change in Control” shall mean (i) a merger or consolidation of the Company with or into any corporation or other entity or person, (ii) a sale, lease, exchange or other transfer in one transaction or a series of related transactions of all or substantially all of the Company’s business or assets (including through the sale, merger or consolidation of the equity of one or more Affiliates of the Company), or (iii) any other transaction, including the sale by the Company of new equity interests or a transfer of existing equity interests of the Company, the result of which is that a third party that is not an affiliate of the Company or its unitholders (or a group of third parties not affiliated with the Company or its unitholders) immediately prior to such transaction acquires or holds equity interests of the Company representing a majority of the Company’s outstanding voting power immediately following such transaction; provided that the following

 



 

 

 

events shall not constitute a “Change in Control”: (A) a transaction (other than a sale of all or substantially all of the Company’s assets) in which the holders of the voting securities of the Company immediately prior to the merger or consolidation hold, directly or indirectly, at least a majority of the voting securities in the successor corporation or its parent immediately after the merger or consolidation in the same proportions as in effect immediately before such transaction; (B) a sale, lease, exchange or other transaction in one transaction or a series of related transactions of all or substantially all of the Company’s assets to an affiliate of the Company; (C) an initial public offering of any of the Company’s securities; (D) a reincorporation of the Company solely to change its jurisdiction; or (E) a transaction undertaken for the primary purpose of creating a holding company that will be owned in substantially the same proportion by the persons who held the Company’s securities immediately before such transaction.

 

·       Affiliate” shall mean, with respect to any entity, any other entity that directly or indirectly through one or more intermediaries controls, is controlled by or is under common control with, the entity in question. As used herein, the term “control” means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of an entity, whether through ownership of voting securities, by contract or otherwise.

 

In addition, with respect to any initial award of Profits Interest Units to Mr. Lewis, in the event that Mr. Lewis’ employment with the Company is terminated by the Company without “Cause,” due to the Company’s delivery of a “Renewal Termination Notice” (provided that Mr. Lewis is willing and able at the time of receipt of such Renewal Termination Notice to continue providing services to the Company under his employment agreement with RealD Inc. (the “Employment Agreement”)) or by Mr. Lewis for “Good Reason,” in each case, subject to his timely execution and non-revocation of the “Release” (each such term as defined in the Employment Agreement) in accordance with the terms of the Employment Agreement, any Tranche I Units and Tranche II Units subject thereto that would have otherwise vested (absent his termination) during the twelve (12)-month period immediately following his termination of employment will vest upon such termination.

 

 

 

Distribution Threshold:1

 

Profits Interest Units will be issued subject to a “Distribution Threshold” below which the profits interests may not participate in liquidation distributions. The Distribution Threshold will be equal to the grant date liquidation value of the Class B Units in order to preserve profits interest tax treatment, and is expected to equal $0 with respect to initial awards of Profits Interest Units.

 

 

 

Payments:

 

To the extent that any distributions would be payable with respect to Profits Interest Units prior to the vesting of such Profits Interest Units, any such distributions will be retained by the Company and will be paid to the relevant participant only if and when the Profits Interest Units to which such distributions

 


1 Note that Profits Interest Units will sit behind an 8% IRR to RT, as set forth in the LLC Term Sheet.

 



 

 

 

relate become vested.

 

 

 

IPO:

 

If the Company converts to a c-corporation in connection with an initial public offering, any Profits Interest Units outstanding at such time will be converted into an economically equivalent number of shares of common stock (or, in the case of unvested Profits Interest Units, restricted common stock subject to the same vesting terms as applied to the underlying Profits Interest Units) that are being offered to the public in the offering and such securities will be registered on Form S-8, if available. Transfer restrictions will cease to apply to the Profits Interest Units (or the equivalent shares of common stock into which they are converted) following an initial public offering, except to the extent such interests remain subject to vesting conditions as described above or are made subject to an underwriters lock-up (such lock-up not to exceed 180 days) following an initial public offering.

 

 

 

 

Termination for Cause; Call Right:

 

If a participant’s employment is terminated for “cause,” the participant will forfeit all vested and unvested Profits Interest Units upon such termination. If a participant’s employment terminates for any reason other than due to a termination by the Company for “cause,” the Company will have the right, but not the obligation, to repurchase any Profits Interest Units that have vested as of the date of such termination for a purchase price equal to the fair market value of such Profits Interest Units (as determined in good faith by the Company’s Board of Managers, without taking into account any discount to fair market value for (x) the illiquid nature of the Profits Interest Units or (y) the fact that the Profits Interest Units may represent a minority interest in the Company (or the fact that the Rollover Investor’s (as defined in the Company’s operating agreement) Common Units may represent a controlling interest in the Company), but taking into account the fact that Mr. Lewis is no longer serving as Chief Executive Officer of RealD, Inc.). The foregoing call rights will expire upon completion of an initial public offering.

 

 

 

Award Agreements:

 

Each Profits Interest Unit will be subject to a written award agreement between the recipient and the Company.

 

 

 

Administrator:

 

The Plan will be administered by the Company’s Board of Managers (or a committee thereof), which shall have authority to delegate its duties and responsibilities under the Plan to the extent permitted by applicable law.

 

 

 

Governing Law:

 

The Plan and the Profits Interest Units will be construed and interpreted in accordance with Delaware law, without reference to conflicts of laws principles.

 

 

 

83(b) Election:

 

Recipients will make an 83(b) election within 30 days of the grant of any Profits Interest Units.

 



 

Schedule C

 

Michael V. Lewis Employment Agreement

 




Exhibit (d)(5)

 

[              ], 2015

 

Michael V. Lewis

[c/o RealD Inc.

100 N. Crescent Dr., Suite 120

Beverly Hills, CA 90210]

 

Dear Michael:

 

In connection with the consummation of the merger of [     ] (“Merger Sub”) with and into RealD Inc., a Delaware corporation (the “Company”), with the Company surviving the merger and becoming a wholly owned subsidiary of [                     ] (“Purchaser”), pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of [     ], 2015, by and among the Company, Purchaser and Merger Sub, and effective as of the date hereof (the “Effective Date”), I am pleased to provide you with this letter setting forth the terms and conditions of your continued employment with the Company (this “Agreement”). Effective as of the Effective Date, this Agreement amends, restates and supersedes in its entirety your Employment Agreement with the Company dated March 25, 2015 (the “Prior Agreement”).

 

1.                                    Title; Duties; Reporting; Outside Activities.

 

(a)        Title; Duties; Reporting.  You will serve as the Company’s Chief Executive Officer and shall report directly to the Board of Managers of Purchaser (the “Board”).  There shall be no other officers of the Company who are equal or senior to you. You shall have the authority to run the day-to-day operations of the Company and such other duties and responsibilities as shall be consistent with your position.  All employees of the Company shall report (directly or indirectly) to you, except that the Chief Financial Officer of the Company shall also have a “dotted line” report to the Board.  You shall work out of the Company’s headquarters in Beverly Hills, California. You will also devote your full time, efforts, abilities, and energies to promote the general welfare and interests of the Company and any related enterprises of the Company. You will loyally, conscientiously, and professionally do and perform all duties and responsibilities of your position, as well as any other duties and responsibilities as will be reasonably assigned to you by the Company, consistent with your position. You will strictly adhere to and obey all Company rules, policies, procedures, regulations and guidelines including, but not limited to, those contained in the Company’s employee handbook, as well as any others that the Company may establish. You will strictly adhere to all applicable state and/or federal laws and/or regulations relating to your employment with the Company.

 

(b)        Board Seat Appointment.  You will serve as a member of the Board as a “Rollover Designee” (as defined in the Amended and Restated Limited Liability Company Agreement of Purchaser (the “LLC Agreement”)), and will be appointed as the Chairman of the Board throughout your tenure as Chief Executive Officer of the

 



 

Company, pursuant to and in accordance with the terms of the terms of the LLC Agreement.

 

(c)        Outside Activities.  Notwithstanding anything to the contrary contained herein, you may (i) serve as a director or member of a committee or organization involving no actual or potential conflict of interest with the Company and its subsidiaries and affiliates; (ii) deliver lectures and fulfill speaking engagements; (iii) engage in charitable and community activities; and (iv) invest your personal assets in such form or manner that will not violate this Agreement; provided, however, that the activities described in clauses (i), (ii), (iii) or (iv) do not materially affect or interfere with the performance of your duties and obligations to the Company and further provided that the Board must provide its advance written consent with respect to the items referenced in clause (i).

 

2.                                    Term.

 

(a)        Initial Term.  The initial term of this Agreement shall commence on the Effective Date and end on the fourth (4th) anniversary of the Effective Date unless terminated earlier or extended further in accordance with the terms herein.

 

(b)        Renewal Term.  On the day immediately following the fourth (4th) anniversary of the Effective Date and on each successive anniversary thereafter (each, a “Renewal Date”), the period of your employment hereunder shall automatically be extended by one (1) additional year, unless either party has previously provided written notice to the other party at least thirty (30) days prior to the applicable Renewal Date to not so extend your period of employment hereunder (a “Renewal Termination Notice”). The period of time between the Effective Date and the termination of your employment hereunder shall be referred to herein as the “Term”. Once a Renewal Termination Notice has been so provided, the Term shall no longer be extended on the Renewal Date following the date of the Renewal Termination Notice and your employment hereunder shall continue through the expiration of the then-current Term (unless terminated earlier in accordance with the terms herein). The terms of Sections 6 through 15 shall survive any termination or expiration of this Agreement or of your employment.

 

(c)        Resignation. Upon termination of your employment for any reason, unless otherwise agreed in writing between you and the Company, you shall be deemed to have immediately resigned from all positions as an employee, officer and director of the Company and any of its affiliates as of your last day of employment and you shall execute any documentation reasonably necessary to effectuate any such resignations. Notwithstanding the foregoing, following any termination of your employment with the Company, you shall retain your right to serve as a member of the Board, if and to the extent provided under, and in accordance with the terms and conditions of, the LLC Agreement.

 

2



 

3.                                    Compensation.

 

(a)        Base Salary.

 

(i)         During the Term, you shall have a minimum base salary of $1,000,000 per year, payable in accordance with the Company’s standard payroll procedures (but no less often than monthly).

 

(ii)        For purposes of this Agreement, the term “Base Salary” shall refer to the base salary in effect from time to time and without giving effect to any salary payment conditions that may be agreed to between you and the Company’s Compensation Committee, including but not limited to for purposes of calculating any severance benefits.  During the Term, your Base Salary will be reviewed annually and is subject to increase (but not decrease) at the discretion of the Board.

 

(b)                              Bonus.

 

During each fiscal year of the Term, you will annually be eligible to earn a cash performance bonus (“Performance Bonus”) with a target amount of one hundred twenty percent (120%) of your Base Salary.  Your actual bonus, if any, for each fiscal year will be based on your successful completion of the performance objectives (“MBO Goals”) prescribed and established by the Board in its sole discretion after good faith consultation with you (provided that MBO Goals may be replaced with a successor incentive plan for you (and/or other employees) at the direction of the Board acting in good faith). The Performance Bonus shall be paid to you no later than the fifteenth (15th) day of the third (3rd) month immediately following the fiscal year with respect to which the Performance Bonus relates. To earn any Performance Bonus, you must remain employed by the Company through the applicable payment date (except as otherwise provided in Sections 3(d) and 4 below).

 

(c)                               Company-Sponsored Benefits.

 

As a member of the senior management team of the Company, you will also be eligible to receive all employee benefits pursuant to the Company’s standard benefit plans that the Company generally provides to the other members of the senior management team that may be in effect from time to time. These currently include, without limitation, paid vacation, 401(k) retirement benefits, business expense reimbursements, paid-time-off, sick time and Company-paid holidays.  The Company may, in its sole discretion and from time to time, amend or eliminate any of these benefits.

 

(d)                             Severance and Other Termination Benefits.

 

(i)         Qualifying Termination.  If, during the Term, (1) the Company terminates your employment without “Cause” (as defined below), (2) you resign for “Good Reason” (as defined below) or (3) your employment terminates due to

 

3



 

the Company’s delivery to you of a Renewal Termination Notice and you are willing and able at the time of receipt of such Renewal Termination Notice to continue providing services to the Company pursuant to this Agreement (each, a “Qualifying Termination”), then, in any case, subject to Section 3(d)(ii) below, the Company shall pay you (or cause to occur, as applicable) each of the following:

 

(A)       cash severance installment payments in an aggregate amount equal to two hundred percent (200%) of your annual Base Salary as in effect on your “Termination Date” (as defined below) (the “Cash Severance”), with the first installment of Cash Severance being paid on the ninetieth (90th) day after the Termination Date and with the remaining amount of Cash Severance being paid in equal monthly pro-rata installments commencing four (4) months after the Termination Date such that the last installment is paid on the second (2nd) anniversary of the Termination Date, it being understood that such final payment date may be later than the second (2nd) anniversary of the Termination Date to the extent required to comply with Section 4(a)(v) below;

 

(B)       any earned but unpaid Performance Bonus for the fiscal year immediately preceding the fiscal year in which the Termination Date occurs (if any), payable on the ninetieth (90th) day after the Termination Date without regard to any otherwise applicable continued employment requirement (a “Prior-Year Bonus”);

 

(C)       the Company will continue to pay the cost (to the same extent that the Company was doing so immediately before the Termination Date) for all group employee benefit coverage continuation under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) to the same extent provided by the Company’s group plans immediately before the Termination Date for eighteen (18) months after the Termination Date or, if earlier, until you become eligible for group insurance benefits from another employer, whichever occurs first, provided that you timely elect COBRA coverage (“COBRA Benefits”); provided, however, if the Company determines, in its sole discretion, that it cannot pay for the COBRA Benefits without potentially incurring financial cost or penalties under applicable law (including without limitation, Section 2716 of the Public Health Service Act), then the Company shall, in lieu thereof, pay you a taxable cash amount that it would otherwise have paid for the COBRA Benefits, in monthly installments over the same time period, which payment shall be made regardless of whether you elect health care continuation coverage. You agree (i) at any time either before or during the period of time you are receiving benefits under this subsection (C), to inform the Company promptly in writing if you become eligible to receive group health coverage from another employer; and (ii) that you may not increase the number of your designated dependents, if any, during this time unless you

 

4



 

do so at your own expense. The period of such COBRA Benefits shall be considered part of your COBRA coverage entitlement period; and

 

(D)       the “Accrued Obligations” (defined below) as of the Termination Date.

 

For avoidance of doubt, any Cash Severance benefits provided under Section 3(d)(i) above shall be calculated prior to giving effect to any reduction in Base Salary that would give rise to your right to terminate for Good Reason.

 

(ii)        Release of Claims.  Notwithstanding anything to the contrary, in order to receive any payments or benefits under Section 3(d)(i)(A), (B) and (C), or under Section 4(d), (e) or (g), as applicable, you must timely execute and deliver (and not revoke) a separation agreement and general release of claims in favor of the Company, any affiliates or related entities, and their employees and affiliates, in the form and content attached as Exhibit A hereto (the “Release”),1 that becomes effective no later than the sixtieth (60th) day following the Termination Date (the “Release Deadline”). However, you shall receive the Accrued Obligations regardless of whether a Release is executed and timely provided to the Company.

 

(iii)       Golden Parachute Excise Tax.  If any payment or benefit received or to be received by you (including any payment or benefit received pursuant to this Agreement or otherwise) would be (in whole or part) subject to the excise tax imposed by Internal Revenue Code (“Code”) Section 4999, or any successor provision thereto, or any similar tax imposed by state or local law, or any interest or penalties with respect to such excise tax (such tax or taxes, together with any such interest and penalties, are hereafter collectively referred to as the “Excise Tax”), then the payments or benefits provided under this Agreement or any other agreement pursuant to which you receive payments that give rise to the Excise Tax will either be (a) paid in full or (b) reduced to the extent necessary to make such payments and benefits not subject to such Excise Tax (whichever would result in a greater after-tax payment to you).  The Company shall reduce or eliminate the payments first by reducing those payments that are not payable in cash and then by reducing or eliminating cash payments, in each case, in reverse order beginning with payments that are to be paid the farthest in time from the determination. You shall receive the greater, on an after-tax basis, of (a) or (b). However, if the imposition of such Excise Tax could be avoided by approval of stockholders as described in Code Section 280G(b)(5)(B), and the Company agrees to solicit a vote of such stockholders (described in Code Section 280G(b)(5)(B), then you will cooperate and execute any such waivers of compensation as may be necessary to enable the stockholder vote to comply with the requirements specified under Code Section 280G and the regulations


 

1 Form of Separation Agreement and Release of Claims to be substantially similar to the form attached to executive’s existing employment agreement, with updates to conform to the changes made in this employment agreement.

 

5



 

promulgated thereunder.  In no event will the Company be required to gross up any payment or benefit to you to avoid the effects of the Excise Tax or to pay any regular or excise taxes arising from the application of the Excise Tax.  Unless the Company and you otherwise agree in writing, any parachute payment calculation will be made in writing by independent public accountants selected by the Company, at the Company’s sole cost and expense.  The Company and you will furnish to the accountants such information and documents as the accountants may reasonably request in order to make a parachute payment determination. The accountants will provide its calculations with respect to your payments, together with detailed supporting documentation, both to the Company and to you, before making any payments to you that may be subject to the Excise Tax. As expressly permitted by Q/A #32 of the Code Section 280G regulations, with respect to performing any present value calculations that are required in connection with this Section, the parties affirmatively elect to utilize the Applicable Federal Rates that are in effect on the Effective Date (the “Agreement AFRs”) and the accountants shall therefore use such Agreement AFRs in their determinations and calculations.

 

(iv)       No Duty to Mitigate; No Right of Offset.  In the event of a Qualifying Termination, you shall not be obligated to seek other employment or take any actions to mitigate the payments or continuation of benefits required under Section 3(d).  In addition, the Company will not retain or have a right of offset against the amounts payable to you under this Agreement and the Company will not be entitled to reduce the amount of any compensation or benefits payable to you under this Agreement by the amount of salary, bonus or other compensation of any kind, and/or corresponding benefits, earned or received by you from any employment, self-employment or other activities at any time after the Termination Date.

 

(e)        Expense Reimbursement. You shall be reimbursed for all documented reasonable business expenses that are incurred in the ordinary course of business in accordance with the Company’s expense reimbursement policy as in effect from time to time. Any reimbursements or in-kind benefits provided under this Agreement that are subject to Code Section 409A (together with the Department of Treasury regulations and other interpretive guidance issued thereunder, “Section 409A”) shall be made or provided in compliance with the requirements of Section 409A, including, where applicable, the requirement that (i) any reimbursement is for expenses incurred during the period of time specified in this Agreement, (ii) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during a fiscal year may not affect the expenses eligible for reimbursement or in-kind benefits to be provided, in any other fiscal year, (iii) the reimbursement of an eligible expense will be made no later than the last day of the fiscal year following the year in which the expense is incurred, and (iv) the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.

 

4.           Other Termination Rules. Notwithstanding anything to the contrary in this Agreement whether express or implied, the Company may terminate your employment with the Company and the Term at any time and for any reason or no reason, with or without Cause, and you may

 

6



 

resign from your employment with or without Good Reason and terminate the Term, all as set forth in greater detail in this Section 4.

 

(a)        The following definitions shall apply for purposes of this Agreement:

 

(i)         “Accrued Obligations” shall mean the sum of (i) any portion of your accrued but unpaid Base Salary through the Termination; (ii) subject to Section 14, any compensation previously earned but deferred by you (together with any interest or earnings thereon) that has not yet been paid and that is not otherwise to be paid at a later date pursuant to any deferred compensation arrangement of the Company to which you are a party, if any; (iii) your accrued but unpaid vacation pay through the Termination Date; (iv) any reimbursements that you are entitled to receive under Section 3(e) of the Agreement or otherwise; and (v) any vested benefits or amounts that you are otherwise entitled to receive under any plan, policy, practice or program of or any other contract or agreement with the Company in accordance with the terms thereof (other than any such plan, policy, practice or program of the Company that provides benefits in the nature of severance or continuation pay).

 

(ii)        “Cause” shall mean, and shall consist only of:  (i) your commission of fraud or embezzlement relating to the Company’s assets or business; (ii) your willful misconduct relating to the Company’s assets or business, which has or is reasonably likely to have a material and adverse impact on the Company; (iii) your willful and material violation of any Company policy, including any such policy pertaining to ethics or conflicts of interest; (iv) your material breach of the Employee Invention Assignment and Confidentiality Agreement; (v) your plea of guilty or nolo contendere to, or indictment for, a felony offense or other crime involving moral turpitude; (vi) your material breach of this Agreement; or (vii) your willful failure to substantially perform your duties to the Company (including, but not limited to, the willful and repeated failure to follow any lawful directive from the Board within the reasonable scope of your duties).  For purposes of this definition of Cause, no act, or failure to act, on your part shall be considered “willful” if it is done, or omitted to be done, by you good faith with the reasonable belief that your action or omission was in the best interests of the Company.  Any act, or failure to act, based upon (A) authority given pursuant to a resolution duly adopted by the Board or the board of directors of the Company, or (B) the advice of counsel for the Company shall be conclusively presumed to be done, or omitted to be done, by you in good faith and with the belief that your action or omission was in the best interests of the Company.

 

(iii)       “Disability” shall mean your medically-determined incapacity due to physical or mental illness which results in you not substantially performing the duties pertaining to your employment, with or without reasonable accommodation, for a period of six (6) consecutive months.

 

(iv)       “Good Reason” shall mean any one or more of the following: (1) a material diminution in your Base Salary, (2) a diminution in your title or a

 

7



 

material diminution in your authority, duties, reporting or responsibilities; provided, however, that a change in your authority, duties or responsibilities resulting from any spin-off or other separation of one or more of the Company’s divisions or businesses (other than the Company’s core theatrical business) shall not constitute Good Reason, (3) a material change in the geographic location at which you must perform your services to the Company, which shall be defined to be a relocation of your principal workplace to a new location that is more than thirty (30) miles away from the workplace location specified in Section 1 above, (4) you are not appointed as a member of the Board or the Chairman of the Board, in either case, unless such appointment is prohibited by applicable law or regulation, or (5) a material breach by the Company of this Agreement.

 

(v)         “Termination Date” means the date on which your employment with the Company is terminated in accordance with the terms of this Agreement; provided, that a termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amount or benefit that constitutes “nonqualified deferred compensation” for purposes of Section 409A upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Section 409A and, for purposes of any such provision of this Agreement, references to a “termination,” “termination of employment” or like terms shall mean your “separation from service” within the meaning of Section 409A.

 

(b)        Termination for Cause.  The Company may terminate your employment and the Term at any time for Cause, provided that the Company provides you with written notice of the Cause event and the Company’s intention to terminate your employment as a result thereof within ninety (90) days of the date on which the general counsel of the Company or a member of the Board (other than you) first gains actual knowledge of the initial existence of the condition(s).  If the Company does not timely provide such notice during the applicable ninety (90) days, then the Company will be deemed to have waived any Cause with respect to such condition(s) provided that at least one of such persons with knowledge of the initial existence of the condition(s) remains in service with the Company through the conclusion of the ninety (90)-day notice period. Notwithstanding the foregoing, in the event of any breach of the provisions of clause (iii), (iv), (vi) or (vii) in the Cause definition (see Section 4(a)(ii) above), the Company shall provide you with written notice of the Cause event and the Company’s intention to terminate you for Cause as a result thereof at least twenty (20) days prior to the effective Termination Date, and in the event that you cure the circumstances giving rise to the Cause event within such twenty (20) day period as determined by the Board (but without prejudicing your ability to later challenge such Board decision), the Company shall not have the right to terminate you for Cause.  Upon a termination of your employment by the Company for Cause, you will be entitled to receive (or be allowed to retain, as applicable) only the Accrued Obligations as of the Termination Date, subject to Section 14 below.

 

(c)        Termination without Cause. The Company shall have the unilateral right to terminate your employment and the Term at any time without Cause, and without

 

8



 

notice, in the Company’s sole and absolute discretion. Any such termination without Cause shall not constitute a breach of any term of this Agreement, express or implied, or a wrongful deprivation of your office or position.  If the Company terminates your employment and the Term without Cause, it shall be treated as a Qualifying Termination and the Company shall have no obligation to you, except to continue to pay you (or cause to occur, if applicable) the amounts (and actions) set forth in Section 3(d)(i) above in accordance with the terms thereof and any related provisions of this Agreement.

 

(d)       Termination due to Death.  Your employment and the Term will be automatically terminated on the date of your death.  In the event of your death, the Company shall pay your estate or assignees (or allow your estate or assignees to retain, as applicable) within thirty (30) days of the Termination Date the Accrued Obligations, subject to Section 14 below.  In addition, you shall be eligible to receive, subject to your estate’s timely execution and non-revocation of a Release in accordance with Section 3(d)(ii) above (provided that the time period for executing the Release shall be extended by such reasonable period of time as may be required for the representatives of your estate to make an informed decision as to whether to execute the Release (such extended period not to exceed six (6) months following your date of death)): (i) a pro-rated Performance Bonus for the year in which your employment terminates, calculated as the product of (x) the Performance Bonus that would have been earned during the fiscal year in which the Termination Date occurred, assuming that the Termination Date had not occurred and that you remained employed through the end of such fiscal year, which Performance Bonus, if any, shall be based on the extent to which the Company achieved the MBO Goals (or the performance standards set forth in any successor incentive plan) during such fiscal year, multiplied by (y) a fraction, the numerator of which is the number of days of the Company’s fiscal year prior to the Termination Date and the denominator of which is 365 days, and (ii) any unpaid Prior-Year Bonus (if any), paid as provided in Section 3(d)(i)(B) above.  You shall also be eligible for a discretionary bonus (as determined by the Board) for the portion of the year served through the Termination Date. The pro-rated Performance Bonus and any such discretionary bonus described in this Section 4(d) (collectively, a “Pro-Rated Bonus”) shall be paid to you no later than the fifteenth (15th) day of the third (3rd) month immediately following the fiscal year in which the Termination Date has occurred without regard to any otherwise applicable continued employment requirement.

 

(e)        Termination due to Disability.  If you are subject to a Disability, and if within thirty (30) days after written notice is provided to you by the Company you shall not have returned to perform substantially your duties, your employment and the Term may be terminated by the Company due to your Disability.  During any period prior to such termination during which you are unable to perform substantially such duties due to Disability, the Company shall continue to pay all amounts required to be paid under this Agreement (including without limitation your Base Salary), offset by any amounts payable to your under any disability insurance plan or policy provided by the Company, and the Company shall continue to provide all benefits to you hereunder.  Upon termination of your employment due to Disability, the Company shall pay you (or allow you to retain, as applicable) within thirty (30) days of such termination the Accrued Obligations, subject to Section 14 below.  In addition, subject to your (or your legal

 

9



 

representative’s) timely execution and non-revocation of a Release in accordance with Section 3(d)(ii) above, you shall be eligible to receive (i) a Pro-Rated Bonus for the year in which your employment is terminated, calculated with reference to the Termination Date, and calculated and paid as provided in Section 4(d) above, and (ii) any unpaid Prior-Year Bonus (if any), paid as provided in Section 3(d)(i)(B) above.

 

(f)        Resignation for Good Reason. You may terminate your employment and the Term at any time for Good Reason, provided that you provide written notice to the Company describing the existence of any Good Reason condition(s) within ninety (90) days of the date of the initial existence of the condition(s) or else you will be deemed to have waived any Good Reason with respect to such condition(s). Upon the Company’s receipt of such written notice, the Company shall then have thirty (30) days during which it may cure or remedy the condition(s).  If the Company does cure or remedy the condition(s) during such thirty (30)-day period then Good Reason will be deemed to have not occurred with respect to such condition(s).  If the Company does not cure or remedy the condition(s) during such thirty (30)-day period then your employment with the Company and the Term shall be terminated for Good Reason as of the day following the expiration of the thirty (30)-day cure/remedy period.  If you terminate your employment for Good Reason in accordance with the provisions of this Section 4(f), it shall be treated as a Qualifying Termination and the Company shall pay you (or cause to occur, if applicable) the amounts (and actions) set forth in Section 3(d)(i) above in accordance with the terms thereof and any related provisions of this Agreement.

 

(g)        Resignation without Good Reason. You may terminate your employment and the Term at any time for no reason, or for any reason that does not otherwise constitute Good Reason, in your sole and absolute discretion, but only if you provide written notice to the Company at least thirty (30) days prior to the effective date of your resignation (and such notice must specify the effective date of your resignation of employment).  In the event you so terminate your employment without Good Reason, you shall only be entitled to receive (subject to Section 14 below) the Accrued Obligations through the effective date of your resignation, as well as all other compensation and benefits required under this Agreement through the effective date of your resignation, and neither you nor the Company shall have any further obligations to the other except as set forth in Section 6 (Confidential Information), Section 7 (Covenants) and Sections 8 through and including 15. The Company is not obligated to actually utilize your services at any time during the thirty (30)-day period preceding the effective date of your resignation, and may prevent you from accessing any of the Company premises or resources during such thirty (30)-day period. Additionally, the Company may terminate your employment prior to the expiration of such thirty (30)-day period without triggering a Qualifying Termination or any rights to or eligibility for severance, including without limitation those payments and benefits described under Sections 3(d)(i) above.  However, in the event you terminate your employment without Good Reason and the effective date of your resignation occurs prior to the end of the required minimum thirty (30)-day notice period provided in this Section 4(g), then, the Company shall preserve all of its rights or remedies in law and/or equity in respect of such violation. Notwithstanding the foregoing or anything herein to the contrary, if you terminate your employment and the Term without Good Reason and, at the time of such

 

10



 

termination, no circumstances constituting Cause exist, then, subject to your timely execution and non-revocation of a Release in accordance with Section 3(d)(ii), you shall be eligible to receive any unpaid Prior-Year Bonus (if any), paid as provided in Section 3(d)(i)(B) above.

 

5.         Equity Compensation.  You shall be eligible to receive equity awards from the Purchaser pursuant to the [Profits Interest Plan] in accordance with the terms and conditions set forth on the equity term sheet attached hereto as Exhibit B hereto.

 

6.         Confidential Information. As an employee of the Company, you will have access to certain confidential information of the Company and you may, during the course of your employment or thereafter, develop certain information or inventions which will be the property of the Company.  In consideration of, and as a condition to, your continued employment with the Company, and as an essential inducement to the Company to enter into this Agreement, this Agreement is expressly subject to your continuing to abide by the terms of the Employee Invention Assignment and Confidentiality Agreement previously executed by you and the Company, dated as of April 1, 2010 (the “Confidentiality Agreement”) in the form enclosed hereto as Exhibit C.

 

7.         Covenants.  You agree to timely and fully comply with all of the covenants set forth in this Section 7 and further understand and agree that such covenants shall survive any termination of your employment and termination or expiration of this Agreement.

 

(a)        Return of Company Property.  On your Termination Date, or at any other time as required by the Company, you will immediately surrender to the Company all Company property, including but not limited to Confidential Information (as such term is defined in the Confidentiality Agreement), keys, key cards, computers, telephones, pagers, credit cards, automobiles, equipment, and/or other similar property of the Company; provided, however, the Company agrees that you shall be permitted to retain a copy of your outlook rolodex and any personal files.

 

(b)        Cooperation. You agree that, upon the Company’s request and without any payment therefor (other than reimbursement of your out of pocket costs), you shall reasonably cooperate with the Company (and be available as necessary subject to reasonably accommodating your professional availability) after the Termination Date in connection with any matters involving events that occurred during your period of employment with the Company.

 

(c)        Amounts Due. You will fully pay off any outstanding amounts owed to the Company no later than their applicable due date or within thirty (30) days following the Termination Date (if no other due date has previously been established). Within thirty (30) days following the Termination Date, you will submit any outstanding business expense reports to the Company for business expenses incurred prior to the Termination Date.

 

(d)       Company Resources. As of the Termination Date, you will no longer represent that you are an officer, director or employee of the Company or any of its

 

11



 

affiliates or a member of the Board, and you will immediately discontinue using the Company mailing address, telephone, facsimile machines, voice mail and e-mail, unless otherwise expressly agreed between you and the Company. Notwithstanding the foregoing, following any termination of your employment with the Company, you shall retain your right to serve as a member of the Board, if and to the extent provided under, and subject to and in accordance with the terms and conditions of, the LLC Agreement.

 

(e)        Representations. You represent that you have not entered into any agreements, understandings, or arrangements with any person or entity that you would breach as a result of, or that would in any way preclude or prohibit you from entering into, this Agreement with the Company or performing any of the duties and responsibilities provided for in this Agreement. You represent that you will not use any confidential, proprietary business information belonging to any other entity in connection with your employment with the Company. You represent that you are not resigning employment or relocating any residence in reliance on any promise or representation by the Company regarding the kind, character, or existence of such work, or the length of time such work will last, or the compensation therefor.

 

(f)        Clawback. You understand and agree that all payments and benefits provided to you will be subject to the terms and conditions of any clawback policy which shall survive any termination or expiration of this Agreement or termination of your employment.

 

(g)        Violations. You acknowledge that (i) upon a violation of any of the covenants contained in this Section 7; or (ii) if the Company is terminating your employment for Cause as provided under this Agreement, the Company would sustain irreparable harm as a result and that the Company would not have entered into this Agreement without such restrictions, and, therefore, you agree that in addition to any other remedies which the Company may have, the Company shall be entitled, without bond of any kind, to seek equitable relief including specific performance and injunctions restraining you from committing or continuing any such violation.

 

8.         Entire Agreement.  This Agreement and its attachments, the Employee Invention Assignment and Confidentiality Agreement, the Indemnification Agreement, and any other agreements referenced herein (including those agreements and arrangements referenced in Section 15 hereof), as amended or superseded from time to time, contain the entire agreement between you and the Company regarding their terms and supersede any and all prior written or oral understandings (including, without limitation, the Prior Agreement). Except as otherwise provided herein, this Agreement may not be amended or modified except in a writing, executed by you and a duly authorized officer of the Company other than yourself.  This Agreement may be executed by facsimile signatures and in counterparts, each of which shall constitute an original, and all of which shall constitute one and the same instrument.

 

9.         Choice of Law; Severability; Waiver.  This Agreement will be governed by the laws of the State of California, United States, without reference to the conflict of law provisions thereof. If any provision of this Agreement, or portion thereof, shall be held invalid or unenforceable by a court of competent jurisdiction, such invalidity or unenforceability shall attach only to such

 

12



 

provision or portion thereof, and shall not in any manner affect or render invalid or unenforceable any other provision, or portion thereof, of this Agreement.  No breach of any provision hereof can be waived unless in writing.  Waiver of any one breach of any provision hereof will not be deemed to be a waiver of any other breach of the same or any other provision of this Agreement.

 

10.         Successors and Assigns.  The Company may assign this Agreement to any successor (whether by amalgamation, merger, consolidation, sale of assets, purchase or otherwise) to all or substantially all of the equity, assets or business of the Company, and this Agreement will be binding upon and inure to the benefit of such successors and assigns, including any successor entity.  You may not assign this Agreement or your obligations hereunder.

 

11.         Notice.  Any and all notices required or permitted to be given to you or the Company pursuant to the provisions of this Agreement will be in writing, and will be effective and deemed to provide such party sufficient notice hereunder on the earliest of the following: (i) at the time of personal delivery, if delivery is in person; (ii) one (1) business day after deposit with an express overnight courier for United States deliveries, or two (2) business days after such deposit for deliveries outside of the United States; (iii) three (3) business days after deposit in the United States mail by certified mail (return receipt requested) for United States deliveries. All notices that the Company is required to or may desire to give you that are not delivered personally will be sent with postage and/or other charges prepaid and properly addressed to you at your home address of record with the Company, or at such other address as you may from time to time designate by one of the indicated means of notice herein. All notices that you are required to or may desire to give to the Company that are not delivered personally will be sent with postage and/or other charges prepaid and properly addressed to the Company’s General Counsel at its principal office, or at such other office as the Company may from time to time designate by one of the indicated means of notice herein.  In addition, the Company shall send a courtesy copy of any notice sent to you (in the same manner described above) to the following person:

 

Freshfields Bruckhaus Deringer US LLP

601 Lexington Avenue, 56th Floor

New York, NY, 10022

Attn:  Howard M. Klein

Matthew F. Herman

 

12.         Withholding and Taxes. The Company shall have the right to withhold and deduct from any payment hereunder any federal, state or local taxes of any kind required by law to be withheld with respect to any such payment. The Company (including without limitation members of the Board) shall not be liable to you or other persons as to any unexpected or adverse tax consequence realized by you and you shall be solely responsible, subject to any withholding obligation of the Company mandated by applicable law, for the timely payment of all taxes arising from this Agreement that are imposed on you.

 

13.         Indemnification; D&O Coverage.  You acknowledge and agree that, concurrently with the execution of this Agreement, you and Purchaser are entering into an indemnification agreement, substantially in a form attached hereto as Exhibit D (the “Indemnification

 

13



 

Agreement”).2  Without limiting any of your rights to indemnification under the Indemnification Agreement, the LLC Agreement, the Company’s certificate of incorporation or bylaws, California Labor Code Section 2802 and other applicable law or otherwise, the Company shall indemnify, defend and hold you harmless for any claims, costs, liabilities, expenses and judgments (including without limitation reasonable attorney’s fees and costs) arising from, in connection with or as a result of any acts and omissions in your capacity as an officer, director, manager and/or employee of the Company and/or any of its subsidiaries to the maximum extent permitted under applicable law, including the advancement of fees and expenses.  In addition, the Company shall cover you under directors’ and officers’ liability insurance both during and, while potential liability exists, after the term of this Agreement in the same amount and to the same extent as the Company covers its other officers and directors. This Section 13 shall survive the termination or expiration of your employment and this Agreement.

 

14.         Section 409A.  It is the intention of the parties that the compensation arrangements under this Agreement be in full compliance with, or exempt from, Section 409A. Without limiting the foregoing, all payments under this Agreement (as amended) are intended to be excluded from the requirements of Section 409A or payable on a fixed date or schedule under Section 409A, and this Agreement shall be construed in a manner to give effect to such intention. Your right to any payment that constitutes “nonqualified deferred compensation” (within the meaning of Section 409A) shall not be subject to borrowing, assignment, sale, transfer, pledge, encumbrance, attachment or any similar claim by creditors, to the extent necessary to avoid any additional taxes under Section 409A. For purposes of Section 409A, your right to receive any installment payments pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments. Notwithstanding anything to the contrary set forth herein, in the event that you are a “specified employee” (within the meaning of Section 409A) on the Termination Date, then with regard to any payment or the provision of any benefit that is considered “nonqualified deferred compensation” under Section 409A payable on account of a “separation from service,” (i) the payment of such amount or benefit scheduled to be paid within the first six months following the Termination Date (the “Initial Payment Period”) shall be paid, without interest, on the first business day of the seventh calendar month after the Termination Date; and (ii) any portion of such amount or benefit that is payable after the Initial Payment Period shall be paid at the times set forth in Section 3(d)(i) above.  Similarly, if you have any other nonqualified deferred compensation amounts that are subject to the delay in payment required for specified employees, then such delayed “nonqualified deferred compensation” amounts will also be paid, without interest, on the first business day of the seventh calendar month after your “separation from service”.

 

Notwithstanding anything to the contrary set forth herein, if the severance benefits are not covered by one or more exemptions from the application of Section 409A and the Release could become effective in the calendar year following the calendar year in which you have a Separation from Service, the Release will not be deemed effective any earlier than the Release Deadline.  None of the severance benefits will be paid or otherwise delivered prior to the effective date or deemed effective date of the Release.

 


 

2 Form of indemnification agreement to be mutually agreed upon, taking into account, where applicable, the executive’s current indemnification agreement with the Company and position as Chief Executive Officer.

 

14



 

It is intended that payments under this Agreement will be exempt from or comply with Section 409A but the Company makes no representation or covenant to ensure that the payments under this Agreement are exempt from, or compliant with, Section 409A, and will have no liability to you or any other party if a payment under this Agreement that is intended to be exempt from, or compliant with, Section 409A is not so exempt or compliant, provided that the Company is otherwise in strict compliance with its obligations as to the timing of payments under this Agreement.

 

15.         Reimbursement of Legal Fees. The Company shall pay directly to your legal counsel your reasonable legal fees and costs incurred in connection with the negotiation of this Agreement, including the related agreements referenced herein, the Voting Agreement, dated as of [     ], by and among you, the MVL Trust dated August 3, 2010, the Purchaser and the Company, the Rollover Commitment Letter, dated as of [     ], from you and the MVL Trust dated August 3, 2010 to the Purchaser (including the exhibits thereto), and all documentation required to implement the equity award term sheet attached as Exhibit B hereto. Payment will be made within forty-five (45) days after the Company’s receipt of applicable invoices, which invoices shall be submitted to the Company no later than sixty (60) days following the consummation of the transactions contemplated by the Merger Agreement.

 

16.         Exhibits. All Exhibits attached to this Agreement shall be incorporated herein by this reference as though fully set forth herein.

 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

15



 

A duplicate original of this Agreement is enclosed for your records.  If you decide to accept the terms of this Agreement, please sign the enclosed copy of this Agreement and the Employee Invention Assignment and Confidentiality Agreement in the spaces indicated and return it to me. Your signature will acknowledge that you have read and understood and agreed to the terms and conditions of this Agreement and Employee Invention Assignment and Confidentiality Agreement. Should you have anything else that you wish to discuss, please do not hesitate to contact me.

 

 

Sincerely,

 

 

 

RealD Inc.

 

 

 

 

 

By:

 

 

 

[Name]

 

 

[Title]

 

 

 

 

 

Purchaser, solely for purposes of Sections 1(b) and 5 hereof.

 

 

 

 

 

By:

 

 

 

[Name]

 

 

[Title]

 

 

I have read, understand, and accept this offer. Furthermore, in choosing to accept this offer, I agree that I am not relying on any representations, whether verbal or written, except as specifically set out within this Agreement.

 

 

 

 

Michael V. Lewis

 

 

 

Date:

 

, 2015

 

 

 

 

 

Enclosures:

Duplicate Original Letter

 

 

EXHIBIT A:

FORM OF SEPARATION AGREEMENT AND RELEASE OF CLAIMS

 

EXHIBIT B:

EQUITY TERM SHEET

 

EXHIBIT C:

EMPLOYEE INVENTION ASSIGNMENT AND CONFIDENTIALITY AGREEMENT

 

EXHIBIT D:

INDEMNIFICATION AGREEMENT

 



 

EXHIBIT A

FORM OF SEPARATION AGREEMENT AND RELEASE OF CLAIMS

 

A-1



 

EXHIBIT B

EQUITY TERM SHEET

 

B-1



 

EXHIBIT C

EMPLOYEE INVENTION ASSIGNMENT AND CONFIDENTIALITY AGREEMENT

 

C-1



 

EXHIBIT D

INDEMNIFICATION AGREEMENT

 

D-1




Exhibit (d)(6)

 

Execution Version

 

 

November 8, 2015

 

 

Rhombus Cinema Holdings, LLC

c/o Rizvi Traverse Management LLC

9465 Wilshire Blvd. Suite 840

Beverly Hills, CA 90212

 

 

Re: Equity Financing Commitment

 

 

Ladies and Gentlemen:

 

This letter agreement sets forth the commitment of Rizvi Opportunistic Equity Fund III, L.P. (the “Fund”), subject to the terms and conditions contained herein, to purchase certain securities of Rhombus Cinema Holdings, LLC, a Delaware limited liability company (“Purchaser”).  It is contemplated that, pursuant to an Agreement and Plan of Merger (as amended, restated, supplemented or otherwise modified from time to time, the “Agreement”), dated as of the date hereof, by and among RealD Inc., a Delaware corporation (the “Company”), Purchaser and Rhombus Merger Sub, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Purchaser (“Merger Sub”), Merger Sub will be merged with and into the Company, with the Company being the surviving entity of such merger and a wholly owned subsidiary of Purchaser. Each capitalized term used and not defined herein shall have the meaning ascribed thereto in the Agreement.

 

1.           Commitment.  The Fund hereby commits, subject to the terms and conditions set forth herein, at or prior to the Closing, to purchase, or cause the purchase of, directly or indirectly through one or more intermediate entities, securities of Purchaser with an aggregate purchase price in cash equal to One Hundred Twelve Million Dollars ($112,000,000) (collectively, as such amount may be reduced pursuant to this letter, the “Financing Commitment”), solely to the extent necessary to fund a portion of the Closing Date Payments pursuant to and in accordance with the Agreement and to pay fees and expenses contemplated thereby; provided, that the amount of the Financing Commitment to be funded under this letter agreement will be reduced, on a dollar for dollar basis, to the extent that Purchaser does not require the full amount of the Financing Commitment to fund the Closing Date Payments pursuant to and in accordance with the Agreement and to pay fees and expenses contemplated thereby (including to satisfy any minimum equity condition in the Debt Commitment Letter). Notwithstanding any other provision of this letter agreement, the Fund shall not, under any circumstances, be obligated to contribute to, purchase equity or debt of or otherwise provide funds to Purchaser in any amount in excess of the Financing Commitment.

 

2.           Conditions.  The obligation of the Fund to fund the Financing Commitment shall be subject to (i) the execution and delivery of the Agreement by the Company, (ii) the satisfaction or written waiver of each of the conditions to Purchaser’s obligations to effect the Closing set forth in Article VI of the Agreement (other than any conditions that by their nature are to be satisfied at the Closing, but subject to the prior or substantially concurrent satisfaction

 



 

or written waiver by Purchaser of such conditions), (iii) the substantially simultaneous funding of (x) the Debt Financing contemplated by the Debt Commitment Letter in accordance with the terms and conditions of such Debt Commitment Letter (subject only to the receipt of the equity financing contemplated by this letter agreement) or (y) any alternative financing (in accordance with the terms and conditions of any debt commitment letter related thereto) that Purchaser accepts from alternative sources pursuant to Section 5.13 of the Agreement, and (iv) the substantially simultaneous consummation of the Merger in accordance with the terms and conditions of the Agreement.  The Fund may allocate all or a portion of its investment to other Persons, and the Fund’s Financing Commitment hereunder will be reduced by any amounts actually contributed to Purchaser by such Persons on or prior to the Closing Date and available on the Closing Date to make the Closing Date Payments.

 

3.           Parties in Interest; Third Party Beneficiaries. The parties hereto hereby agree that their respective agreements and obligations set forth herein are solely for the benefit of the other parties hereto and their respective successors and permitted assigns, in accordance with and subject to the terms of this letter agreement, and this letter agreement is not intended to, and does not, confer upon any Person other than the parties hereto and their respective successors and permitted assigns any benefits, rights or remedies under or by reason of, or any rights to enforce or cause Purchaser to enforce, the obligations set forth herein; provided, however, that the Company relied on this letter agreement and, accordingly, the Company is an express third-party beneficiary hereof and shall have the enforcement rights described in Section 4 hereof.

 

4.           Enforceability.  This letter agreement may be enforced only by (i) Purchaser at the direction of the Fund or (ii) the Company, pursuant to its right to seek specific performance of Purchaser’s obligation to enforce the Fund’s obligation to fund the Financing Commitment in accordance with the terms hereof, pursuant to, and subject to, and solely in accordance with, the terms and conditions of Section 8.08 of the Agreement and the terms and conditions set forth herein.  Purchaser’s creditors shall have no right to enforce this letter agreement or to cause Purchaser to enforce this letter agreement.

 

5.           No Modification; Entire Agreement.  This letter agreement may not be amended or otherwise modified without the prior written consent of Purchaser, the Fund and the Company. This letter agreement constitutes the sole agreement, and supersedes all prior agreements, understandings and statements, written or oral, between the Fund or any of its Affiliates (other than Purchaser), on the one hand, and Purchaser or any of its Affiliates (other than the Fund), on the other, with respect to the subject matter hereof.

 

6.           Governing Law; Jurisdiction; Venue; Waiver of Jury Trial.

 

(a)        This letter agreement (and any claim or controversy arising out of or relating to this letter agreement) shall be governed by, and construed in accordance with, the laws of the State of Delaware, applicable to contracts executed in and to be performed entirely within that State, regardless of the laws that might otherwise govern under any applicable conflict of laws principles.

 

(b)        All actions and proceedings arising out of or relating to this letter agreement shall be heard and determined in the Chancery Court of the State of Delaware and any state appellate court therefrom within the State of Delaware (or, if the Chancery Court of the State of Delaware declines to accept jurisdiction over a particular matter, any state or federal court of the State of Delaware), and the parties hereto hereby irrevocably submit to the exclusive jurisdiction and venue of such courts in any such action or proceeding and

 

-2-



 

irrevocably waive the defense of an inconvenient forum or lack of jurisdiction to the maintenance of any such action or proceeding. The consents to jurisdiction and venue set forth in this Section 6(b) shall not constitute general consents to service of process in the State of Delaware and shall have no effect for any purpose except as provided in this paragraph and shall not be deemed to confer rights on any Person other than the parties hereto. Each party hereto agrees that service of process upon such party in any action or proceeding arising out of or relating to this letter agreement shall be effective if notice is given by overnight courier at the address set forth in Section 8.10 of the Agreement, in the case of Purchaser, and in Section 6 of the limited guaranty of even date herewith delivered by the Fund in favor of the Company (the “Guaranty”), in the case of the Fund.

 

(c)        EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING BETWEEN THE PARTIES HERETO ARISING OUT OF OR RELATING TO THIS LETTER AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

7.           Counterparts.  This letter agreement may be executed in any number of counterparts (including by facsimile or by PDF delivered via email), each such counterpart when executed being deemed to be an original instrument, and all such counterparts shall together constitute one and the same agreement.

 

8.           Termination.  The obligation of each Fund under or in connection with this letter agreement will terminate automatically and immediately upon the earliest to occur of (a) the Closing (at which time all such obligations shall be discharged, following the funding of the Financing Commitment in accordance with the terms hereof), (b) the termination of the Agreement pursuant to Article VII thereof (unless the Company has previously commenced an action described in Section 4 hereof, in which case this letter agreement shall terminate upon the final, non-appealable resolution of such action and satisfaction by the Fund of any obligations finally determined or agreed to be owed by the Fund, consistent with the terms hereof), (c) the Company or any of its Affiliates, or any Person claiming by, through or for the benefit of the Company, accepting payment of the Purchaser Termination Fee pursuant to the Agreement or accepting payment thereof from the Guarantor (as defined in the Guaranty) under the Guaranty in respect of such obligation, and (d) the Company or any of its Affiliates, or any Person claiming by, through or for the benefit of the Company, asserting a claim in any litigation or other proceeding against (i) the Fund or any other Recourse Party (as defined in the Guaranty) under or in connection with the Agreement or any of the transactions contemplated thereby other than the Company asserting any Retained Claim (as defined in the Guaranty) against the Recourse Parties against which such Retained Claim may be asserted in accordance with Section 8 of the Guaranty, or (ii) any Non-Recourse Party (as defined in the Guaranty).

 

9.           No Assignment.  The Financing Commitment evidenced by this letter agreement shall not be assignable, in whole or in part, by Purchaser without the Fund’s prior written consent, and the granting of such consent in a given instance shall be solely in the discretion of the Fund and, if granted, shall not constitute a waiver of this requirement as to any subsequent assignment.  Except as expressly permitted in Section 2 hereof, no transfer of any rights or obligations hereunder by the Fund shall be permitted without the prior written consent of Purchaser and the Company.  Any purported assignment of this letter agreement or the Financing Commitment in contravention of this Section 9 shall be void.

 

10.         Representations and Warranties.  The Fund hereby represents and warrants to Purchaser that, except as would not reasonably be expected to impair or delay the Fund’s

 

-3-



 

performance of the Financing Commitment obligations hereunder in any material respect, (a) it has all limited partnership power and authority to execute, deliver and perform this letter agreement, (b) the execution, delivery and performance of this letter agreement by it has been duly and validly authorized and approved by all necessary limited partnership action by it, (c) this letter agreement has been duly and validly executed and delivered by it and constitutes a valid and legally binding obligation of it, enforceable against it in accordance with the terms of this letter agreement, subject to the effect of any applicable bankruptcy, reorganization, insolvency, moratorium or similar laws affecting creditors’ rights generally and subject, as to enforceability, to the effect of general principles of equity, (d) the Financing Commitment is less than the maximum amount that it is permitted to invest in any one portfolio investment pursuant to the terms of its organizational or governing documents or otherwise, (e) it has uncalled capital commitments or otherwise has available funds in excess of the sum of the Financing Commitment hereunder plus the aggregate amount of all other commitments and obligations it currently has outstanding and (f) the execution, delivery and performance by it of this letter agreement do not (i) violate its organizational documents, (ii) violate any applicable law or judgment or (iii) result in any violation of, or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation or acceleration of any obligation or to the loss of any benefit under, any contract to which it is a party.

 

11.         Severability.  If any term, condition or other provision of this letter agreement is determined by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced by any rule of law or public policy, all other terms, provisions and conditions of this letter agreement shall nevertheless remain in full force and effect.  Upon such determination that any term or other provision hereof is invalid, illegal or incapable of being enforced, (a) a suitable and equitable term or provision determined by a court of competent jurisdiction shall be substituted therefor in order to carry out, so far as may be valid, legal and enforceable under applicable law, the intent and purpose of such invalid, illegal or unenforceable term or provision and (b) the remainder of this letter agreement and the application of such terms and other provision to other Persons or circumstances shall not be affected by such invalidity, illegality or unenforceability, nor shall such invalidity, illegality or unenforceability affect the validity, legality or enforceability of such term or provision, or the application of such term or provision, in any other jurisdiction.

 

[remainder of the page intentionally left blank – signature page follows]

 

-4-



 

 

Sincerely,

 

 

 

 

 

RIZVI OPPORTUNISTIC EQUITY FUND III, L.P.

 

 

 

By: Rizvi Traverse GP III, LLC, its general partner

 

 

 

By:

/s/ Ben Kohn

 

Name:  Ben Kohn

 

Title:  Managing Director

 

 

 

Agreed to and accepted:

 

 

 

RHOMBUS CINEMA HOLDINGS, LLC

 

 

 

 

 

By:

/s/ Ben Kohn

 

Name:  Ben Kohn

 

Title:  Authorized Signatory

 

 

 

Signature Page to Equity Commitment Letter

 




Exhibit (d)(7)

 

Execution Version

 

 

 

 

 

November  25, 2015

 

Rhombus Cinema Holdings, LLC

 

c/o Rizvi Traverse Management, LLC
9645 Wilshire Boulevard, Suite 840
Beverly Hills CA 90212

 

Re:  Equity Commitment Letter

 

Ladies and Gentlemen:

 

This amended and restated commitment letter (as amended, supplemented or otherwise modified, the “Commitment Letter”) amends, restates and supersedes that certain commitment letter, dated as of November 8, 2015 (the “Original Commitment Letter”) from Fortress Credit Advisors LLC, a Delaware limited liability company, on behalf of itself and/or as arranger on behalf of one or more investment funds managed directly or indirectly by one or more affiliates (“Investor”), to Rhombus Cinema Holdings, LLC, a Delaware limited liability company (“Purchaser”), and Rizvi Traverse Management, LLC (together with its affiliated funds and co-investment vehicles, “Sponsor”).

 

This Commitment Letter sets forth the commitment of Investor to purchase, subject to the terms and conditions hereof, certain equity securities to be issued by Purchaser in connection with the transactions contemplated by the Agreement and Plan of Merger, dated as of November 8, 2015, by and among Purchaser, Rhombus Merger Sub, Inc., a newly formed, wholly owned, indirect Delaware corporate subsidiary of Purchaser (“Merger Sub”), and RealD Inc., a Delaware corporation (“Company”), a copy of which is attached hereto as Exhibit A (as amended, restated, supplemented or otherwise modified from time to time, the “Merger Agreement”), pursuant to which, once all conditions precedent to the Closing under the Merger Agreement have been satisfied or validly waived, Purchaser has agreed to cause the merger of Merger Sub with and into Company, with Company as the survivor, and pursuant to which all shareholders of Company would receive cash for their shares in Company and all options, warrants and other rights to acquire securities of Company would be cashed out and/or cancelled (but subject to the Equity Rollover (as defined below)).  Guarantor (as defined below) has, in connection with execution of the Merger Agreement, executed a Limited Guaranty in favor of Company guaranteeing certain payment obligations of Purchaser under the Merger Agreement if and when payable thereunder. Capitalized terms used but not otherwise defined herein have the meanings ascribed to such terms in the Merger Agreement.

 

1.                                    Commitment.  In connection with the execution of the Merger Agreement, Purchaser has received an equity commitment letter (the “Rizvi Equity Commitment Letter”), dated as of November 8, 2015, from Rizvi Opportunistic Equity Fund III, L.P. (the “Guarantor”).  Pursuant to the Rizvi Equity Commitment Letter, the Guarantor has committed, subject to the terms and conditions set forth in the Rizvi Equity Commitment Letter, to contribute or cause to

 



 

be contributed at the Closing directly or indirectly to Purchaser up to the amount of equity set forth on the attached Exhibit B (collectively, the “Rizvi Equity Commitment”).  Sponsor has procured one or more commitments from financing sources (“Financing Letters”) to provide not less than $315,000,000 in debt financing (such financing, including as modified in accordance with any “flex” provisions, and any high yield notes issued in lieu thereof, the “Debt Financing”) to Rhombus Holdings, Inc (“Holdco”), the borrower and a wholly owned subsidiary of Purchaser. Michael V. Lewis and MVL Trust dated August 3, 2010 (the “Rollover Investors”) have committed to transfer, contribute and deliver the equity securities of the Company to the Purchaser as set forth in Exhibit C (the “Rollover Commitment Letter” and such transactions collectively, the “Equity Rollover”).  It is contemplated that at the Closing Michael V. Lewis will enter into an employment agreement to be the Chief Executive Officer of the Company substantially in the form included in Exhibit D.  Investor hereby irrevocably agrees to contribute, or cause to be contributed, as an equity contribution to Purchaser, an aggregate amount equal to $125,000,000 (“Contribution”), in accordance with the terms and conditions set forth on Exhibit E, but subject only to satisfaction of the terms and conditions set forth in this Commitment Letter.  The proceeds from the Rizvi Equity Commitment, the Equity Rollover, the Contribution and the Debt Financing shall be used by Purchaser to the extent necessary, solely to fund a portion of (a) the Merger Consideration and (b) costs, fees and expenses relating to the transactions which are the subject of the Merger Agreement in each case at the Closing (collectively, the “Purchaser Payments”), (c) for working capital of the Company and its subsidiaries after the Merger, and for no other purpose; provided that Investor shall not, under any circumstances, be obligated to contribute to Purchaser an amount greater than the amount of the Contribution.

 

2.                                    Closing Conditions.   Investor’s obligation to make the Contribution pursuant to this Commitment Letter is subject to the following conditions: (a) the execution and delivery of the Merger Agreement in the form attached hereto (which occurred on November 8, 2015), without any amendment or modification thereto not consented to by Investor in writing other than amendments or modifications that would not reasonably be expected to be adverse to the interests of Investor, (b) the satisfaction or waiver by Purchaser of all conditions precedent to the obligations of Purchaser to consummate the transactions contemplated by the Merger Agreement (other than any conditions that by their nature are to be satisfied at the Closing, but subject to the prior or substantially concurrent satisfaction of such conditions at the Closing); provided that any such waiver that would (i) reasonably be expected to be adverse to the interests of Investor or (ii) give Purchaser the right to terminate the Merger Agreement, must also be approved in writing by Investor, (c) substantially concurrently (i) the Debt Financing (or any alternative financing in accordance with Section 5.13 of the Merger Agreement) has been funded (or the sources of the Debt Financing (or any such alternative financing) have irrevocably confirmed in writing that the Debt Financing (or such alternative financing) will be concurrently funded if the Contribution is funded by the Investor), (ii) the Rizvi Equity Commitment is funded by the Guarantor or by Sponsor and (iii) the Equity Rollover is consummated; (d) the execution and delivery of investment documents (including an Investment Agreement and a limited partnership agreement) containing the terms set forth on Exhibit E, in customary form, and accompanied by customary closing certificates, in each case, except as specified within Exhibit E herein, in forms consistent with prior similar agreements between the Sponsor and the Investor in connection with the “SESAC” transaction, as the same may be modified by mutual agreement to take into account

 

2



 

the industry of the Company, and as modified by the terms set forth in Exhibits E and F and giving due regard to operational and strategic requirements of Purchaser and its subsidiaries in light of their size and capitalization, geographic location, line of business, the proposed business plan, the disclosure schedules in the Merger Agreement and the definition of “Material Adverse Effect” in the Merger Agreement and (e) the substantially contemporaneous consummation of the Closing.

 

3.                                    Enforcement/Recourse.   This Commitment Letter is solely for the benefit of Sponsor and Purchaser and is not intended to, nor does it, confer any benefits on, or create any rights or remedies in favor of, any Person other than Sponsor and Purchaser, this Commitment Letter may only be enforced by Purchaser or Sponsor and in no event shall any of Purchaser’s creditors have any right to enforce this Commitment Letter or to cause Purchaser to enforce this Commitment Letter.  Purchaser and Sponsor shall be entitled to specific performance in connection with any breach by the Investor of this Commitment Letter.  Neither Purchaser nor Sponsor may seek or accept any form of monetary relief that may be available for breach of this Commitment Letter (including monetary, punitive, indirect, special, consequential and/or any other damages) other than an order compelling Investor to fund, and/or to pay damages (other than punitive, indirect, special or consequential damages) arising from breach of this Commitment Letter in an amount not to exceed the Contribution.  In connection with the foregoing, the parties hereto hereby waive (x) any defenses in any action for specific performance, including the defense that a remedy at law would be adequate and (y) any requirement under any law to post a bond or other security as a prerequisite to obtaining specific performance.

 

4.                                    Expiration.   All obligations under this Commitment Letter shall expire and terminate automatically and immediately and without any further action upon the earliest to occur of (a) the termination of the Merger Agreement in accordance with its terms, (b) the Closing (at which time the Contribution shall be funded in accordance with the terms hereof), (c) the Company or any of its Affiliates asserting any claim against Investor or any of its Affiliates in connection with the Merger Agreement, (d) payment in full by the Guarantor of its Obligations under the Guarantee, and (e) 11:59 p.m., New York City time, on April 6, 2016, if the Closing has not occurred by that date, unless such failure is due to the breach by Investor of this Commitment Letter; provided that no such termination shall relieve Investor from any liability to Purchaser, Sponsor or their Affiliates for any breach of this Agreement by Investor prior to such termination.

 

5.                                    No Assignment.   The Investor’s commitment evidenced by this Commitment Letter (the “Commitment”) shall not be assignable by Purchaser without the prior written consent of Investor and the granting of such consent in a given instance shall be solely in the discretion of the Investor and if granted, shall not constitute a waiver of this requirement as to any subsequent assignment; provided, that the rights of Purchaser hereunder (including the Commitment) may only be assigned by Purchaser to a Person who is an Affiliate of Sponsor and (i) to whom the Merger Agreement is validly assigned in accordance with the terms thereof, (ii) to whom the Rizvi Equity Commitment is validly assigned in accordance with the terms of the Rizvi Equity Commitment Letter and (iii) that is an entity formed for purposes of the transactions contemplated by the Merger Agreement and that does not have any assets, liabilities

 

3



 

or operations (other than in connection with the transactions contemplated by the Merger Agreement or those incidental to its formation).  The Commitment shall not be assignable by Investor without the prior written consent of Purchaser and the granting of such consent in a given instance shall be solely in the discretion of the Purchaser and if granted, shall not constitute a waiver of this requirement as to any subsequent assignment; provided, that without any such consent, Investor may (i) assign its rights hereunder to a Person who is an Affiliate of Investor, and (ii) assign up to $50 million of the Contribution to another Person so long as Investor and its Affiliates retain $75 million or more of the Commitment (as reduced pro rata in connection with a reduction of the Preferred Units by Purchaser), provided in either case, that no such assignment shall relieve Investor of its obligations hereunder.  Any purported assignment of this Commitment by Purchaser or Investor in contravention of this Section 5 shall be null and void ab initio.

 

6.                                    No Other Beneficiaries.  This Commitment Letter shall be binding on the Investor solely for the benefit of Purchaser and Sponsor, and nothing set forth in this Commitment Letter is intended to or shall confer upon or give to any Person other than Purchaser and Sponsor any benefits, rights or remedies under or by reason of, or any rights to enforce or cause Purchaser to enforce, the Contribution or any provisions of this Commitment Letter.

 

7.                                    Representations and Warranties.  Investor  hereby represents and warrants that (a) it has all power and authority to execute, deliver and perform this Commitment Letter; (b) the execution, delivery and performance of this Commitment Letter by Investor  has been duly and validly authorized and approved by all necessary action, and no other proceedings or actions on the part of Investor  are necessary therefor; (c) this Commitment Letter has been duly and validly executed and delivered by it and constitutes a valid and legally binding obligation of it, enforceable against Investor  in accordance with its terms (subject to (i) the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other similar laws affecting creditors’ rights generally and (ii) general equitable principles (whether considered in a proceeding in equity or at law)); (d) the execution, delivery and performance by Investor  of this Commitment Letter do not and will not violate the organizational documents of Investor  or any applicable law, or require any consent or other action by any Person under, constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in any breach of or give rise to any right of termination, cancellation, amendment or acceleration of, any right or obligation of Investor , (e) Investor  has  available funds sufficient to satisfy the aggregate Contribution plus the aggregate amount of all other commitments and obligations Investor  currently has outstanding; and (f) all consents, approvals, authorizations, permits of, filings with and notifications to, any Governmental Authority necessary for the due execution, delivery and performance of this Agreement by Investor have been obtained or made and all conditions thereof have been duly complied with, and no other action by, and no notice to or filing with, any Governmental Authority is required in connection with the execution, delivery or performance of this Commitment Letter.

 

8.                                    Severability.  If any term, provision, agreement, covenant or restriction of this Commitment Letter is held by a court of competent jurisdiction to be invalid, void or unenforceable, the remainder of the terms, provisions, agreements, covenants and restrictions of this Commitment Letter shall remain in full force and effect and shall in no way be affected,

 

4



 

impaired or invalidated so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party hereto.  Upon such a determination, the parties hereto shall negotiate in good faith to modify this Commitment Letter so as to effect the original intent of the parties as closely as possible in a reasonably acceptable manner so that the transactions contemplated hereby may be consummated as originally contemplated to the fullest extent possible.  No party hereto shall assert, and each party hereto shall cause its respective Affiliates not to assert, that this Commitment Letter or any part hereof is invalid, illegal or unenforceable.

 

9.                                    Expenses; Indemnification.

 

Sponsor  agrees that, from and after November 8, 2015, it will, or will cause one or more of its Subsidiaries or Affiliates to, pay and hold Investor, its Affiliates,  and their respective officers, members, managers, legal successors and assigns,  heirs and representatives (collectively, the “Indemnified Persons”),  and each of them,  harmless against any and all liability for any and all actions, suits, proceedings (including any investigations or inquiries), actual losses (excluding lost profits), claims, damages, liabilities or expenses of any kind or nature whatsoever (excluding any  punitive, special or consequential damages based on the bad faith or willful misconduct of the Indemnified Person) which may be suffered, incurred by or asserted against or involve the Indemnified Persons as a result of or arising out of or in any way related to the transactions described in this Commitment Letter, or out-of-pocket expenses (including attorneys’ fees) of Investor in connection with the transactions contemplated hereby and its  investment in Purchaser, all to the extent set forth in the Financing Letter, provided, however, that the foregoing will not apply to (a) any losses of an Indemnified Person to the extent found by a final and non-appealable order of a court of competent jurisdiction  to have resulted solely from the bad faith, gross negligence or willful misconduct of such Indemnified Person or from a material breach by the Investor of the terms hereof or (b) any disputes solely among Indemnified Persons.  The provisions of this Section 10 are independent of all other obligations of Purchaser and/or Sponsor under any other document and shall survive termination or expiration of the Commitment embodied in this letter.  Sponsor  agrees that no Indemnified Person shall be required to (but at its sole election, may) seek indemnification from any other Person or Persons with respect to any matter for which such Indemnified Person is entitled to indemnification hereunder and agrees, for the benefit of the Investor  and each other Indemnified Person to waive any right to contribution from any such Indemnified  Person; provided, that the foregoing shall not be deemed to limit or waive any contractual rights that Purchaser or Sponsor  may have against  Investor under any other document.  EACH OF   PURCHASER  AND SPONSOR  HEREBY ACKNOWLEDGES THAT THE FOREGOING INDEMNITY SHALL BE APPLICABLE TO ALL CLAIMS, LIABILITIES, LOSSES, DAMAGES OR EXPENSES THAT HAVE RESULTED FROM OR ARE ALLEGED TO HAVE RESULTED FROM THE SOLE, JOINT OR CONCURRENT ORDINARY NEGLIGENCE OF THE INVESTOR AND/OR ANY OTHER INDEMNIFIED PERSON (WHETHER ACTIVE OR PASSIVE).

 

10.  GOVERNING LAW.  THIS COMMITMENT LETTER AND ANY CLAIM OR CONTROVERSY HEREUNDER SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT GIVING EFFECT TO ANY CHOICE OR CONFLICT OF LAW PROVISION OR RULE (WHETHER

 

5



 

OF THE STATE OF NEW YORK OR ANY OTHER JURISDICTION) THAT WOULD CAUSE THE APPLICATION OF THE LAWS OF ANY JURISDICTION OTHER THAN THE STATE OF NEW YORK.

 

11.                            Jurisdiction.  Any legal action, suit or proceeding arising out of or relating to this Commitment Letter or the transactions contemplated hereby may only be instituted in the United States District Court for the Southern District of New York,  or if such court does not have jurisdiction, in the Supreme Court of the State of New York,  and each party hereto waives any objection which such party may now or hereafter have to the laying of the venue of any such action, suit or proceeding, and irrevocably submits to the jurisdiction of any such court in any such action, suit or proceeding.

 

12.                            WAIVER OF JURY TRIAL.  EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS COMMITMENT LETTER OR THE TRANSACTIONS CONTEMPLATED (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY).  EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS COMMITMENT LETTER BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 13.  NO PARTY HERETO, NOR ANY OF ITS AFFILIATES, WILL BRING, OR SUPPORT THE BRINGING OF, ANY PROCEEDING, WHETHER AT LAW OR IN EQUITY, WHETHER IN CONTRACT OR IN TORT OR OTHERWISE, IN ANY WAY RELATING TO THIS COMMITMENT LETTER ANYWHERE OTHER THAN IN ANY THE CHOSEN COURTS.

 

13.                            Confidentiality; Cooperation.  This Commitment Letter shall be treated as confidential and is being provided to Purchaser solely in connection with the Merger Agreement.  This Commitment Letter may not be used, circulated, quoted or otherwise referred to in any document (other than the Merger Agreement, or as required by law and any other filings required under applicable securities laws), except with the written consent of the Investor, provided, that no such written consent shall be required for disclosures to the Company, or except as otherwise required by law, including any disclosure required in the Proxy Statement and any other filings required under applicable securities laws.  Investor shall provide to Purchaser all information concerning Investor and cooperation as may be reasonably requested by Purchaser in connection with the Company’s preparation and filing of the Proxy Statement and any other filings required under applicable securities laws and the resolution of any comments thereto received from the SEC.  Investor shall promptly correct any information provided by it for use in the Proxy Statement and any other filings required under applicable securities laws if and to the extent such information shall have become false or misleading in any material respect.

 

14.                            Interpretation.  Unless the context of this Agreement otherwise requires, (i) words of any gender include each other gender; (ii) words using the singular or plural number also

 

6



 

include the plural or singular number, respectively; (iii) the terms “hereof,” “herein,” “hereby” and derivative or similar words refer to this entire Agreement; (iv) the terms “Article” or “Section” refer to the specified Article or Section of this Agreement; (v) the terms “ $” or “dollars” refer to U.S. dollars; (vi) the word “including” means “including without limitation”; and (vii) the use of “or” or “any” is not intended to be exclusive unless expressly indicated otherwise.

 

15.                            Miscellaneous.  The headings contained in this Commitment Letter are for convenience purposes only and will not in any way affect the meaning or interpretation hereof.  This Commitment Letter, the Rizvi Equity Commitment Letter, the Equity Rollover Commitment Letter,  the Debt Financing Commitments, the Guaranty, the Merger Agreement and any other written agreement among the parties hereto entered into contemporaneously herewith constitute the entire agreement with respect to the subject matter hereof, and supersede all prior agreements, understandings and statements, both written and oral, between or among Investor and/or any of its Affiliates and the Purchaser, the Guarantor  or any of their Affiliates.  This Commitment Letter may not be amended, and no provision hereof waived or modified, except by an instrument in writing signed by each of the Investor, the  Guarantor and Purchaser.  This Commitment Letter may be executed in one or more counterparts, all of which shall be considered one and the same agreement and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other parties (including by facsimile or other electronic image scan transmission).

 

 

 

 

 

[Remainder of page intentionally left blank]

 

7



 

 

Very truly yours,

 

 

 

FORTRESS CREDIT ADVISORS LLC

 

 

 

By:

/s/ Constantine Dakolias

 

 

 

 

Name: Constantine Dakolias

 

Title: President

 

8



 

Agreed to and accepted as of the date first written above:

 

 

RHOMBUS CINEMA HOLDINGS, LLC

 

 

 

By:

/s/ Ben Kohn

 

 

Name: Ben Kohn

 

 

 

Title: Authorized Signatory

 

 

 

 

 

RIZVI TRAVERSE MANAGEMENT, LLC

 

 

 

By:

/s/ Ben Kohn

 

 

Name: Ben Kohn

 

 

 

Title: Managing Partner

 

 

9



 

EXHIBIT A

 

AGREEMENT AND PLAN OF MERGER

 

10



 

EXHIBIT B

 

RIZVI EQUITY COMMITMENT LETTER

 

11



 

EXHIBIT C

 

ROLLOVER COMMITMENT LETTER

 

12



 

EXHIBIT D

 

FORM OF EMPLOYMENT AGREEMENT

 

13



 

EXHIBIT E

 

TERM SHEET

 

 

Issuer (“Purchaser”):

 

Rhombus Cinema Holdings, LLC, a Delaware limited liability company which shall be converted into, or merged with and into a newly formed Delaware limited partnership not later than 30 days after the Closing, which shall at all times be the sole stockholder of RT Rhombus Holdings, Inc., a Delaware corporation (“Intermediate Holdco”), which in turn will be the sole stockholder of Company. The Purchaser’s limited liability company agreement shall have terms consistent with Exhibit F attached hereto.

 

 

 

Company(s):

 

RealD Inc. (“Company”).

 

 

 

Commitment Amount:

 

$125 Million of Preferred equity (the “Preferred Units”), which amount can be reduced by Purchaser (but not below $75 million) prior to closing the Merger in its sole discretion.

 

 

 

Acquisition:

 

To fund, in part, the acquisition of the Company (the “Acquisition”).

 

 

 

Investor:

 

Fortress Credit Advisors LLC (the “Investor”).

 

 

 

Ranking:

 

Senior in right of liquidation, winding up, dissolution and payment to all other equity issued or to be issued by Purchaser.

 

 

 

Preferred Return:

 

10.0% preferred return, per-annum, compounding quarterly payable when and if determined by the Board (the “Preferred Return”). The Preferred Return will accrue if not paid, on a cumulative basis, compounding quarterly in arrears. No distribution will be paid on the Common Units unless and until all accrued and unpaid Preferred Return has been paid on the Preferred Units.

 

 

 

Issue Price:

 

$1,000 per Preferred Unit.

 

 

 

Liquidation Preference:

 

$1,000 per Preferred Unit, plus accumulated Preferred Return.

 

 

 

Voting:

 

Non-voting, subject to agreed upon consent rights and other limited exceptions.

 

 

 

Transfer Restrictions:

 

The Preferred Units shall be subject to first refusal purchase rights as provided in the SESAC transaction, except that Investor may, during the 12 months following Closing, sell or transfer up

 



 

 

 

to 40% of the total Preferred Units without complying with the aforesaid first refusal provisions.

 

 

 

Equity Participation:

 

Investor will receive Common equity (the “Common Equity Participation”) equal to 1.0% of all Common equity outstanding upon the consummation (including the Rollover Equity), if any, of the Transaction (before giving effect to issuances pursuant to management equity plan of up to 10% of the outstanding common units of Purchaser (the “Common)) for each $5.0 Million of Preferred Units invested at the Closing of the Transaction for no additional consideration, with standard minority equity rights (including, but not limited to, tag-along, structural anti-dilution (including stock splits and reclassifications) and preemptive rights) and standard restrictions on non-affiliate transfers and drag-along rights.

 

 

 

Voting Agreement:

 

So long as Sponsor owns no less than 80% of its initially purchased Common, and Sponsor is not in default in performance of its obligations under any of the agreements with Investor and no preferred right event default is continuing, all Common units acquired pursuant to the “Equity Participation” above and “Co-Investment Right” below will be voted by Sponsor.

 

 

 

Amendments to Charter Documents or Voting Agreement:

 

66 2/3% vote of Preferred Units must consent.

 

 

 

Co-Investment Right:

 

Investor shall make an investment in Common at the consummation, if any, of the Transaction in an amount equal to $5.0 million at the same price per share of Common as the Sponsor.

 



 

EXHIBIT F

 

LIMITED LIABILITY COMPANY AGREEMENT TERM SHEET

 


Reald (NYSE:RLD)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Reald.
Reald (NYSE:RLD)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Reald.